data_2fmc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fmc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.689 0.281 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.597 HG21 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -79.13 100.82 7.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.204 0.526 . . . . 0.0 110.816 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.12 112.41 18.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.359 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 58' ' ' VAL . 12.9 mt -77.71 120.94 29.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.7 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.66 167.84 12.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.797 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.85 -16.62 41.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.919 2.413 . . . . 0.0 112.501 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 43.6 1.92 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.275 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -65.41 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.166 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 70.4 1.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.978 175.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.53 67.24 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.739 -172.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -87.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.46 -167.19 1.66 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -73.79 76.47 1.59 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -95.82 137.16 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.648 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 22.8 mtmt -91.65 120.16 68.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 14.9 Cg_exo -69.01 141.71 49.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.712 2.275 . . . . 0.0 111.539 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -137.42 135.2 36.7 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.81 124.5 52.73 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.275 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 p -156.06 162.51 40.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.29 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.06 107.77 13.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.006 0.432 . . . . 0.0 110.281 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.828 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.342 0 CA-C-O 120.697 0.284 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -113.07 119.32 37.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.918 0.39 . . . . 0.0 110.155 176.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.1 87.45 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.221 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.73 171.3 14.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.569 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.44 154.07 22.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.931 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.842 HG23 HD13 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -64.33 134.1 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.221 0.534 . . . . 0.0 110.87 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.25 105.42 2.36 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.05 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.437 ' HB ' ' OG ' ' A' ' 52' ' ' SER . 4.7 t -68.29 130.77 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.544 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.4 pt -68.42 125.33 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.444 0.64 . . . . 0.0 110.456 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.74 -11.08 66.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.599 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.437 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 63.9 m -88.09 155.3 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.529 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.46 121.51 45.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.645 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 116.68 29.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.88 56.22 3.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.19 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.88 -179.03 7.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.7 128.19 33.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.597 HG23 HG21 ' A' ' 2' ' ' THR . 16.3 t -98.87 127.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.84 169.71 11.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.783 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.7 m -118.37 124.68 48.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.9 m -129.34 135.32 48.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 0.0 111.568 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 12.7 tttt -112.71 117.79 33.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.092 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -172.55 163.77 5.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.416 -176.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -109.36 111.62 23.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.159 0.505 . . . . 0.0 110.504 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 74' ' ' ILE . 2.1 t -97.41 146.99 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.637 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.4 138.27 31.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.405 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -78.39 -30.1 47.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.382 0.611 . . . . 0.0 110.62 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 3.79 48.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.973 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.0 -76.16 0.63 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.083 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -119.04 -179.98 3.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.77 7.34 15.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.373 0.606 . . . . 0.0 110.746 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -156.56 169.85 23.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.622 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.842 HD13 HG23 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -79.15 92.88 5.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.102 179.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 1.1 tt -75.62 136.29 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 43' ' ' LEU . 2.8 mt -92.18 128.78 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.961 0.41 . . . . 0.0 110.747 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 10.3 m-80 -64.18 -20.58 66.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.493 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 61.72 26.2 15.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.078 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -56.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.712 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 4.7 m-80 -124.33 84.19 2.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.924 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 33.2 m -115.55 135.78 53.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.949 0.404 . . . . 0.0 110.986 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.24 130.6 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.851 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.279 -178.678 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.678 0.275 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 103.41 12.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.79 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.24 137.37 37.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.801 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.561 HG22 ' HA3' ' A' ' 48' ' ' GLY . 7.8 mt -109.55 137.0 43.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.83 -169.76 17.73 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.163 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.11 -17.01 15.43 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.406 2.071 . . . . 0.0 112.649 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.37 13.54 33.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.806 0.336 . . . . 0.0 111.477 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -75.45 -29.73 59.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.33 89.97 1.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.967 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.41 27.98 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.036 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.479 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -84.03 -109.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.482 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.479 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 1.9 t70 -92.91 -164.31 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -74.55 66.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.617 0.722 . . . . 0.0 109.495 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 5.3 m-85 -93.85 128.02 39.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.42 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -87.74 119.67 70.67 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.29 144.43 41.4 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.013 2.476 . . . . 0.0 110.815 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.71 143.75 45.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.998 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.4 t -97.36 113.13 24.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 58.2 m -118.94 130.27 55.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 111.586 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.45 105.51 17.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.151 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.671 -178.731 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.825 0.345 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -140.75 104.31 4.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.46 89.74 0.44 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.18 175.26 9.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 111.891 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 46' ' ' VAL . 2.4 m -119.17 156.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -61.98 139.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.387 . . . . 0.0 110.478 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 4' ' ' ILE . . . -60.93 115.38 7.76 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.184 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -63.67 95.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -60.41 103.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.469 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.98 22.44 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.19 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.457 ' HB2' HG21 ' A' ' 49' ' ' VAL . 3.7 m -112.0 158.73 19.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.873 0.368 . . . . 0.0 110.526 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -98.65 153.16 18.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.229 0.537 . . . . 0.0 110.527 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 153.92 45.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.139 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.32 47.99 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.678 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 19' ' ' CYS . . . -158.62 -171.82 3.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.44 137.26 37.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.87 121.71 58.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.978 0.418 . . . . 0.0 110.544 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 mtpp -122.96 170.01 10.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.67 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 70.9 m -129.5 123.48 31.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.9 45.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 0.0 112.242 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -105.35 113.11 26.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' CG ' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -165.42 163.55 19.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.949 -172.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.04 93.14 5.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -85.59 132.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.366 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.09 143.3 31.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.921 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.05 5.53 38.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.29 0.566 . . . . 0.0 110.076 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.36 101.77 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.684 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.14 37.24 81.63 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -133.45 120.13 20.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.644 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -36.71 71.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.476 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -136.49 -168.26 2.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 47' ' ' VAL . 2.7 mp -90.67 95.8 10.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 112.069 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.76 118.38 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.767 HG21 ' H ' ' A' ' 77' ' ' ALA . 2.7 mp -93.02 132.14 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -15.37 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.519 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.847 ' HB2' HD21 ' A' ' 43' ' ' LEU . . . 61.92 25.23 15.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.897 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.35 -56.31 11.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.015 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.635 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 12.0 m-80 -121.03 82.79 1.97 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.182 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -115.24 130.29 56.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.103 0.478 . . . . 0.0 111.06 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.422 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -114.45 159.47 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 173.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 O-C-N 123.686 0.616 . . . . 0.0 109.989 -175.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.763 0.316 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.29 99.52 9.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 2.0 m -81.15 113.84 19.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.556 HD11 ' HA3' ' A' ' 48' ' ' GLY . 23.4 mt -71.56 131.01 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.09 -164.57 13.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.793 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.04 -25.31 73.58 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.784 2.323 . . . . 0.0 111.934 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -90.07 77.06 6.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.944 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -100.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.377 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 91.97 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.67 67.33 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.577 0.703 . . . . 0.0 111.204 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -135.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.621 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.79 -165.32 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.01 107.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.595 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 15.5 m-85 -136.63 145.84 45.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.771 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' NZ ' HG21 ' A' ' 65' ' ' VAL . 13.3 mtmt -102.33 124.85 38.15 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.804 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.9 Cg_exo -75.58 120.23 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.935 2.423 . . . . 0.0 111.981 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.694 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 81.6 m-85 -118.08 131.87 56.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.236 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.8 t -107.43 113.65 27.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.365 . . . . 0.0 110.959 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -148.09 151.09 35.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 104.97 11.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.706 0.765 . . . . 0.0 109.653 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.755 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.639 ' HB3' HD11 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -94.74 108.52 20.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.076 0.465 . . . . 0.0 111.204 -175.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.33 77.35 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.694 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 2.6 m -128.66 163.18 25.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.791 0.329 . . . . 0.0 111.134 -174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -118.28 155.12 20.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.027 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.81 128.19 31.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.423 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 4' ' ' ILE . . . -85.86 102.96 2.71 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.7 139.14 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.94 122.57 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.869 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.72 -12.51 20.64 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.19 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -102.03 141.5 34.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.941 0.4 . . . . 0.0 110.727 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.649 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.6 mp0 -86.17 144.91 27.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.449 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 143.8 51.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.782 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.5 43.74 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.738 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.45 -168.78 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.65 147.73 25.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.01 122.58 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 8.6 ptmt -128.55 156.56 43.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 1.3 m -106.14 129.61 54.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.831 0.348 . . . . 0.0 110.643 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m -127.62 140.77 51.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.5 . . . . 0.0 110.996 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.8 ttmm -123.13 127.53 48.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.692 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 175.39 169.08 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.612 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.06 99.69 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.516 HG21 ' NZ ' ' A' ' 15' ' ' LYS . 95.5 t -82.49 118.68 30.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 125.92 54.86 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.353 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -77.67 106.91 9.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 111.052 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -87.32 59.31 5.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.578 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.58 52.53 45.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.973 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.15 157.4 46.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -39.67 72.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.56 ' HB2' HG21 ' A' ' 46' ' ' VAL . 7.5 p90 -111.55 175.38 5.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.499 HD11 ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -93.38 120.86 34.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -176.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 tt -87.8 123.97 40.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.187 0.517 . . . . 0.0 110.408 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.711 HG21 ' H ' ' A' ' 77' ' ' ALA . 2.2 mp -93.8 135.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.805 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -69.46 -18.55 63.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.711 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.711 ' H ' HG21 ' A' ' 75' ' ' ILE . . . 63.65 31.51 14.46 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.507 -177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.28 -56.73 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 6.5 m-80 -119.89 85.57 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.906 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 58.5 m -116.38 133.89 55.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.784 0.326 . . . . 0.0 110.431 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -132.77 141.48 44.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.425 0.631 . . . . 0.0 111.171 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.78 141.5 28.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -101.21 121.19 41.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.005 0.431 . . . . 0.0 110.787 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 50' ' ' ILE . 82.7 mt -84.55 124.72 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.182 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 168.4 12.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.936 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HA ' HG12 ' A' ' 50' ' ' ILE . 21.9 Cg_exo -64.85 -25.64 60.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.747 2.298 . . . . 0.0 111.635 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.574 ' HA ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -138.44 55.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.828 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -44.94 77.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.301 0.572 . . . . 0.0 110.368 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.82 27.42 0.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.371 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.854 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -82.86 82.95 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.533 -174.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 11' ' ' ILE . 2.9 mm -70.91 -55.02 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.503 0.668 . . . . 0.0 109.485 173.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -149.94 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.838 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.4 55.17 2.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.226 1.013 . . . . 0.0 109.229 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.854 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 7.0 m-30 -78.96 107.99 12.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.048 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HB3' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -83.3 135.58 44.08 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.839 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.4 Cg_exo -70.12 133.94 26.06 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.461 2.107 . . . . 0.0 111.404 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -114.71 142.72 46.12 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 t -119.25 112.56 19.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.936 0.398 . . . . 0.0 110.578 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -152.57 146.8 25.5 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -93.32 136.07 33.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 0.0 111.02 -176.503 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.71 142.56 35.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.603 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.707 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -101.78 -53.34 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 169.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 m 65.38 -176.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.891 -0.654 . . . . 0.0 112.31 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.17 154.19 38.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 15' ' ' LYS . 64.0 t -74.69 132.0 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.068 0.461 . . . . 0.0 110.45 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.1 134.75 13.14 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.185 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.23 129.58 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.566 ' HA ' HG23 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -71.2 135.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.075 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.17 76.58 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -108.33 170.66 7.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.015 0.436 . . . . 0.0 111.514 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -96.29 146.14 24.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.66 154.0 49.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.137 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.4 48.42 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.649 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.55 -171.46 3.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.502 0.192 . . . . 0.0 110.573 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -79.49 127.79 32.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.801 0.334 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.02 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.795 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -122.56 152.63 40.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 178.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 15.2 m -114.18 107.84 16.16 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -127.87 156.21 42.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.97 0.891 . . . . 0.0 113.345 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -145.86 150.8 36.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.631 -1.622 . . . . 0.0 107.047 168.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.517 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 1.5 m-20 -158.52 -165.53 1.69 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -88.57 4.47 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 75' ' ' ILE . 1.5 t -76.58 105.9 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.548 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.465 ' HB ' ' H ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -101.0 -120.7 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.268 176.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.465 ' H ' ' HB ' ' A' ' 66' ' ' THR . 13.7 t-20 -99.29 81.4 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.219 0.533 . . . . 0.0 110.074 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.18 151.11 23.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.72 69.73 3.27 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.637 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -137.97 165.6 26.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -30.67 71.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.184 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.707 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 8.7 p90 -145.94 -173.01 4.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.907 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -102.12 100.32 10.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -80.98 115.85 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.646 ' HA ' HG23 ' A' ' 65' ' ' VAL . 5.1 pt -92.44 154.73 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.05 -14.94 57.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.199 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.14 34.49 5.0 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.201 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.475 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . . . -88.47 -62.79 1.41 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.979 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.694 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 9.9 m-80 -95.35 50.91 1.27 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.168 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 51.1 t -123.81 129.94 51.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -129.73 123.78 57.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.687 -177.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.57 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.318 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.565 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -78.99 103.52 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.24 0.543 . . . . 0.0 111.258 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 135.61 33.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.415 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.04 124.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.661 0.267 . . . . 0.0 110.662 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -110.73 -168.43 19.23 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -0.82 9.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.783 2.322 . . . . 0.0 112.44 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 151.84 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.934 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.54 -70.66 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.553 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.69 42.68 0.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.151 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 14.5 m -79.86 76.05 6.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.822 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.474 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -80.47 -92.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.058 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 32.1 t70 -91.79 88.78 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.561 0.22 . . . . 0.0 111.042 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.736 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.8 t70 50.47 38.47 18.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.431 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.692 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 13.4 m-85 -88.35 112.29 22.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.849 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.44 146.31 31.09 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.28 120.55 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.58 2.187 . . . . 0.0 111.458 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HE2' HG21 ' A' ' 75' ' ' ILE . 3.3 m-85 -113.96 130.88 56.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.82 118.55 36.97 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -144.46 173.02 12.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.957 0.408 . . . . 0.0 110.922 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 158.76 26.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.405 ' CB ' ' HG ' ' A' ' 57' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.644 HD13 ' SG ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -138.71 104.68 5.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 0.0 110.883 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.75 75.23 0.21 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.644 ' SG ' HD13 ' A' ' 43' ' ' LEU . 96.0 m -104.16 156.74 17.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -132.07 160.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.563 175.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.42 120.29 15.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.877 0.37 . . . . 0.0 110.804 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.88 112.12 3.98 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.0 151.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.309 0.576 . . . . 0.0 111.577 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.609 ' H ' HD11 ' A' ' 50' ' ' ILE . 4.9 mp -58.67 124.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.814 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.83 -23.8 11.46 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.21 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -83.08 149.64 26.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.841 0.353 . . . . 0.0 110.786 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -114.35 120.23 39.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.963 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -110.01 110.8 21.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.536 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.69 4.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.868 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HB1' ' H ' ' A' ' 57' ' ' SER . . . -149.17 -113.24 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.483 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 58.3 m -131.08 119.64 22.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.023 0.439 . . . . 0.0 111.147 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.08 114.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.402 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.408 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 ptmt -124.76 169.97 11.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.793 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.692 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 87.6 m -110.34 121.05 44.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -129.02 147.5 50.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.106 0.479 . . . . 0.0 110.799 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.736 ' HE3' ' HB3' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -134.09 131.03 38.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.618 175.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.69 178.25 6.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.474 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.81 102.06 8.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.176 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.78 154.16 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.76 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.62 120.34 42.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.049 0.452 . . . . 0.0 111.106 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -92.86 55.62 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.465 0.65 . . . . 0.0 109.897 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -21.85 45.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.881 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.17 52.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -115.5 164.63 14.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.311 . . . . 0.0 110.672 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -42.84 13.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 109.909 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.402 ' HB2' HG22 ' A' ' 46' ' ' VAL . 2.9 p90 -145.26 165.37 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.799 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -87.1 93.46 9.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 110.97 -178.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.05 111.85 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -92.99 153.25 3.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -174.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.83 -11.09 59.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.721 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.85 33.06 12.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.506 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -58.67 3.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.287 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.2 m-80 -107.06 84.65 2.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.231 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.97 129.46 50.97 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.843 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.08 121.51 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.238 0.542 . . . . 0.0 111.038 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.724 176.478 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.43 109.01 13.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.029 0.442 . . . . 0.0 110.56 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.31 134.71 42.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.628 HD13 ' HA3' ' A' ' 48' ' ' GLY . 4.7 mt -98.18 102.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.33 -167.86 16.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.946 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.85 -27.22 59.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 0.0 111.922 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -108.72 54.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.079 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -74.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.159 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -104.55 126.25 51.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.908 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.49 70.52 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 111.307 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.5 -161.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.823 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -67.54 178.97 1.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.91 99.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.574 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 15.1 m-85 -115.33 157.29 24.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.936 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -90.78 117.55 68.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.0 Cg_exo -79.41 131.47 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.263 2.642 . . . . 0.0 111.777 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -125.88 141.61 51.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 4' ' ' ILE . 21.1 m -95.49 112.49 24.19 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.437 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -131.91 141.39 49.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.675 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.71 105.45 17.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.843 0.354 . . . . 0.0 110.055 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.571 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 3.0 mm? -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.453 0.644 . . . . 0.0 111.16 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.421 ' C ' ' HE2' ' A' ' 72' ' ' PHE . . . -165.57 93.04 0.11 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.3 m -139.47 -178.04 5.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.181 0.515 . . . . 0.0 111.733 -169.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.26 153.25 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.39 137.51 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.962 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -69.2 129.67 23.52 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.997 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.453 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -76.67 105.02 5.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 11.3 mt -64.66 108.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.747 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.39 -8.72 20.25 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.58 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -110.95 160.92 16.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.593 ' HG2' ' HB2' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -93.47 153.18 18.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.633 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 116.64 12.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.125 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.19 60.17 4.26 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' A' ' 57' ' ' SER . . . -158.32 -152.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 -174.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.468 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 2.0 m -114.81 136.63 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 110.174 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.73 117.53 37.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.424 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 4.7 mmpt? -109.96 138.96 45.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.077 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -111.98 100.97 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -120.83 135.21 55.23 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.347 0.594 . . . . 0.0 111.156 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -94.46 103.86 15.83 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.915 175.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -160.45 127.1 4.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.527 -1.669 . . . . 0.0 106.878 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.63 66.59 5.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 0.0 112.309 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.63 100.7 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 169.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -128.07 -32.76 2.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.795 0.807 . . . . 0.0 110.389 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -96.08 125.16 40.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.44 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 102.0 8.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.417 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 -32.98 49.91 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.424 ' HB2' ' H ' ' A' ' 71' ' ' SER . 10.8 p30 -124.57 -161.03 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -77.8 6.16 8.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' C ' ' A' ' 44' ' ' GLY . 2.9 p90 -157.28 -158.88 0.79 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.112 -0.367 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mp -104.13 99.24 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.144 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tp -81.55 116.51 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 109.908 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -101.48 137.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.22 -175.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -76.51 154.53 34.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.25 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.03 99.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.427 ' HB2' ' H ' ' A' ' 79' ' ' ASN . . . 21.25 -102.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 125.198 1.561 . . . . 0.0 114.08 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 11.7 m-80 -121.08 70.87 0.92 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 38.6 t -114.3 129.9 56.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.376 -0.828 . . . . 0.0 111.199 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 135.81 42.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.152 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 112.4 20.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.719 0.295 . . . . 0.0 110.525 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.36 124.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.916 0.388 . . . . 0.0 111.081 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 54' ' ' CYS . 19.8 mt -88.48 94.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.284 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 175.58 30.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.369 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.96 -13.82 34.65 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.503 2.135 . . . . 0.0 111.983 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.31 41.59 1.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.484 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.6 -53.96 4.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.304 0.573 . . . . 0.0 110.749 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.18 64.85 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.459 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.75 65.32 4.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 110.659 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -113.43 -133.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.055 178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.469 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 14.9 t0 -78.87 66.9 4.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.174 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 21.5 t0 46.79 80.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.927 0.767 . . . . 0.0 111.58 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -110.67 157.99 19.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.929 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 15.6 mtmt -106.31 124.52 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.799 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -80.33 128.68 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.142 2.561 . . . . 0.0 111.321 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.85 132.67 53.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.752 0.31 . . . . 0.0 110.723 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB2' HD13 ' A' ' 4' ' ' ILE . 12.7 t -103.52 113.2 26.53 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 126.42 33.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.269 0.556 . . . . 0.0 111.553 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.604 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 2.4 mp0 -80.3 129.64 34.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.202 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.897 0.38 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -145.95 102.94 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.11 94.14 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.449 ' HB2' HD13 ' A' ' 75' ' ' ILE . 35.3 m -131.17 -176.09 3.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 111.284 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.26 159.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.295 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.14 133.75 30.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.38 104.66 0.95 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.867 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.511 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -62.76 110.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.851 0.358 . . . . 0.0 110.787 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.4 pt -59.02 120.1 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.2 -26.61 9.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.565 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m -94.33 164.53 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.759 0.314 . . . . 0.0 110.491 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.62 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 68.1 mt-30 -106.09 149.37 26.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.168 0.509 . . . . 0.0 111.695 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.572 ' HB2' HD13 ' A' ' 4' ' ' ILE . 10.5 t -108.73 134.87 50.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.289 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.73 -19.47 51.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.104 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -125.39 -123.8 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.909 0.355 . . . . 0.0 111.941 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.458 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -90.19 96.84 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.258 0.551 . . . . 0.0 112.279 -172.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.14 125.65 45.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -141.77 170.39 15.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.641 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -112.07 124.16 51.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 69.5 m -134.21 132.5 39.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.937 0.399 . . . . 0.0 110.473 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 14.9 tptm -104.38 121.89 44.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.597 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.689 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -164.96 165.51 20.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.768 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -115.01 102.61 10.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.961 0.41 . . . . 0.0 110.736 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.79 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.5 129.15 34.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -9.12 59.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.6 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.4 117.96 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.425 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.39 -50.49 0.78 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.787 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -123.15 149.99 43.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.45 -46.16 14.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.992 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.64 157.41 18.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 97.14 10.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mp -69.41 133.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 7.8 mt -91.44 129.81 41.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.323 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 21.5 m-80 -65.63 -16.03 63.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.103 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.84 36.02 25.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.341 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.7 -57.17 3.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.428 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.1 m-80 -117.5 97.96 6.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.595 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.5 m -124.04 130.55 52.76 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.922 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.69 152.95 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.254 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.582 -179.591 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.589 HG22 HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -103.26 101.37 11.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.909 0.385 . . . . 0.0 110.265 176.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.661 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.31 125.13 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.939 -178.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt -86.04 86.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.172 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 169.49 51.27 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.762 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.79 -42.59 30.74 Favored 'Trans proline' 0 CA--C 1.527 0.168 0 C-N-CA 122.615 2.21 . . . . 0.0 113.045 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.88 33.09 3.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -59.29 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 110.233 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.82 71.44 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.123 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.8 8.85 11.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.47 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.466 HG22 ' H ' ' A' ' 12' ' ' ASP . 2.6 mt -65.18 161.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.379 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -18.68 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.806 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -149.6 86.63 1.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 27.8 m-85 -140.95 166.21 25.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.978 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -117.25 142.36 30.03 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.507 175.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 9.3 Cg_exo -71.36 124.87 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.565 2.177 . . . . 0.0 111.281 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.2 m-85 -121.81 130.82 53.68 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -93.93 112.84 24.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.27 163.92 29.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.93 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -100.65 105.73 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.963 0.411 . . . . 0.0 110.301 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.324 -0.51 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.756 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.314 0.102 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.546 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -159.14 107.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.107 0.48 . . . . 0.0 110.458 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.06 87.13 0.38 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.429 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -128.53 168.59 15.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -176.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.6 158.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.588 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.73 142.03 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.31 147.13 34.02 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.396 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.3 t -86.0 120.78 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 0.0 110.561 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.38 123.12 21.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.67 3.32 68.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.068 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 19.6 m -108.09 160.34 15.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.017 0.436 . . . . 0.0 110.877 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.661 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -96.95 127.85 43.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.3 t -108.46 138.33 44.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.08 12.9 58.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.978 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.18 177.4 4.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 116.85 20.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.255 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -85.46 113.02 23.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.289 0.566 . . . . 0.0 111.244 -178.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 12.6 ptpt -115.3 171.45 7.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.18 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 33.4 m -117.75 119.64 35.52 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.972 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.71 146.02 50.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.483 0.659 . . . . 0.0 111.427 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -137.77 133.36 33.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.014 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.84 -174.32 4.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.98 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -79.33 -72.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.51 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 47.79 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.337 1.023 . . . . 0.0 112.89 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 t -84.15 139.11 32.64 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.383 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 59.84 0.87 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.237 0.541 . . . . 0.0 110.312 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -42.07 24.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.588 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.1 57.28 0.22 Allowed Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.51 139.82 52.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -42.68 95.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.691 -175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 162.41 33.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.285 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -90.87 130.53 36.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.96 0.409 . . . . 0.0 111.833 -172.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.43 128.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.546 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -97.47 150.36 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.843 0.354 . . . . 0.0 110.364 -178.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -95.98 -2.55 46.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.16 31.13 19.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.539 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.74 -46.94 67.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -127.4 97.93 5.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.13 139.07 33.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.24 0.543 . . . . 0.0 111.606 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.82 127.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.97 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 O-C-N 124.252 0.97 . . . . 0.0 111.346 -179.699 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.78 111.36 19.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 131.66 35.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.497 HG12 HG13 ' A' ' 58' ' ' VAL . 11.9 mt -83.1 103.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.647 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.73 -173.5 26.8 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.847 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -13.56 24.64 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.718 2.279 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.12 45.3 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.25 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -84.66 -61.96 1.66 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.077 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.3 p -160.63 164.41 31.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.662 0.267 . . . . 0.0 110.663 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.75 -113.25 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 175.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.493 ' H ' ' HB2' ' A' ' 10' ' ' SER . 0.9 OUTLIER 53.17 -110.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 122.953 0.501 . . . . 0.0 111.541 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.16 177.59 5.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' N ' ' CG ' ' A' ' 12' ' ' ASP . 12.2 t70 -67.29 77.18 0.15 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.768 0.794 . . . . 0.0 109.797 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 9.9 m-85 -97.5 140.89 31.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.805 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.654 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -105.39 135.09 19.39 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HB3' HG21 ' A' ' 8' ' ' THR . 41.0 Cg_endo -70.47 132.34 21.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.175 1.917 . . . . 0.0 111.137 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.892 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 6.7 m-85 -119.13 130.72 55.71 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.159 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.05 112.93 25.05 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 157.95 36.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.434 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -80.53 111.27 16.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.272 0.558 . . . . 0.0 110.533 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.106 177.487 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD11 ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -122.43 176.99 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.348 . . . . 0.0 110.758 -175.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.9 -60.22 0.12 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.892 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 4.1 m 63.29 179.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.742 0.782 . . . . 0.0 112.701 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.19 146.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.889 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.87 122.1 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.067 0.461 . . . . 0.0 109.856 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 99.98 1.37 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.208 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.14 126.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.89 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.741 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.62 -17.18 12.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.061 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -89.44 162.9 15.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -110.68 156.58 20.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.008 0.432 . . . . 0.0 111.113 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.37 137.85 47.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.01 -5.57 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.947 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 20' ' ' GLN . . . -102.88 -105.77 0.27 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.89 147.08 49.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.551 0.215 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.497 HG13 HG12 ' A' ' 4' ' ' ILE . 4.1 t -111.57 106.19 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -120.33 157.52 29.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 60.0 m -104.0 120.13 40.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.084 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.53 151.7 44.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.356 0.598 . . . . 0.0 110.868 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -137.93 135.35 35.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.087 174.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -153.46 -170.64 3.66 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -106.37 38.36 2.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 110.259 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 63' ' ' ASP . 3.1 p -103.32 129.24 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.404 0.621 . . . . 0.0 110.859 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -128.91 -174.06 3.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.23 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -117.58 130.66 56.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.209 0.528 . . . . 0.0 111.737 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -112.51 -6.32 13.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.059 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.61 43.89 0.25 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.1 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.16 170.48 9.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.734 0.302 . . . . 0.0 110.876 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -39.39 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 0.0 110.43 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.29 -174.18 1.65 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.519 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -85.91 155.56 20.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.74 114.43 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.971 176.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 pt -105.24 153.3 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.318 0.58 . . . . 0.0 111.189 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -94.52 -4.0 48.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.486 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.66 30.92 14.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.887 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.31 82.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.762 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.4 m-80 -129.05 80.44 1.97 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.61 54.69 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.481 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 148.24 30.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.043 0.449 . . . . 0.0 111.149 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.169 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.65 0.262 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.45 99.99 11.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.876 0.369 . . . . 0.0 110.293 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 110.07 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.62 HD13 ' SG ' ' A' ' 18' ' ' CYS . 3.6 mt -70.6 122.44 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.13 -161.38 9.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.769 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.36 -22.19 52.98 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.128 2.552 . . . . 0.0 113.075 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -102.14 5.87 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -92.34 -47.79 7.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 10.2 t -135.39 87.54 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.966 0.412 . . . . 0.0 110.9 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -108.0 -89.41 0.46 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.954 175.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.3 mt 54.5 -103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 122.934 0.494 . . . . 0.0 110.657 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 8.2 t70 -100.72 -113.59 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 24.3 t70 -121.06 66.43 0.86 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 167.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 2.5 m-85 -90.14 151.87 21.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.895 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtmt -102.14 127.46 30.76 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HG3' ' HB3' ' A' ' 9' ' ' CYS . 6.6 Cg_exo -72.8 136.19 24.91 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.543 2.162 . . . . 0.0 110.922 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -129.38 130.41 45.99 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.868 0.366 . . . . 0.0 110.255 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.1 m -99.48 112.59 24.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.854 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.8 m -115.13 115.73 27.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.787 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.644 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 9.9 pt20 -80.46 117.22 21.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -109.13 103.81 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.29 82.11 1.49 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' HB2' HD13 ' A' ' 75' ' ' ILE . 1.8 m -134.9 168.27 19.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.516 0.198 . . . . 0.0 110.506 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.55 157.25 21.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.971 0.415 . . . . 0.0 110.819 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -70.64 143.46 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.079 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.14 106.92 3.02 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.899 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.55 133.86 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.733 0.301 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -71.22 140.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.8 -14.01 66.14 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.597 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -97.81 158.08 15.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -116.16 137.7 51.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 0.0 111.378 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.0 m -115.13 152.05 33.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.188 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -119.99 49.5 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.644 ' CB ' ' HA ' ' A' ' 20' ' ' GLN . . . -153.25 -135.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.584 0.23 . . . . 0.0 110.809 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 1.9 m -107.41 122.49 46.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.077 0.465 . . . . 0.0 110.783 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.53 118.62 56.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.764 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -123.47 163.71 20.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.248 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 91.7 m -111.47 123.62 50.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 97.7 m -133.26 148.05 51.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.088 0.471 . . . . 0.0 111.192 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 2.4 tptm -130.35 140.49 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.698 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 p30 178.37 -177.29 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.877 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.06 116.13 28.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.179 0.514 . . . . 0.0 110.91 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 73' ' ' LEU . 2.4 t -124.37 94.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.631 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.27 141.27 30.57 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.152 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.34 89.89 4.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.476 0.655 . . . . 0.0 110.64 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.53 75.16 1.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.87 -74.61 0.29 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.235 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.68 119.0 22.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.61 -3.54 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 110.663 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -99.07 148.32 24.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HA ' HG13 ' A' ' 65' ' ' VAL . 2.0 mp -76.86 91.58 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.672 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.61 133.15 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.713 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.557 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -94.19 138.27 20.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.245 0.545 . . . . 0.0 111.069 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.13 -18.57 33.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 66.44 24.23 10.43 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.655 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.83 -55.27 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.321 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 5.7 m-80 -114.71 90.56 3.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.691 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 52.7 m -122.2 129.59 52.41 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.653 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.41 131.32 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.377 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.191 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.94 108.71 13.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.857 0.36 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -79.6 119.04 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 54' ' ' CYS . 53.4 mt -68.82 119.22 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.879 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.68 -179.19 30.81 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.116 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HA ' HG12 ' A' ' 50' ' ' ILE . 57.2 Cg_endo -69.51 -38.93 7.63 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.43 54.46 2.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -55.29 6.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.483 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -83.0 123.88 29.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -22.87 43.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.612 0.72 . . . . 0.0 109.338 172.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -81.61 134.77 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.737 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.16 140.77 33.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.22 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 69.79 48.68 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.026 0.829 . . . . 0.0 111.19 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 4.7 m-85 -135.47 150.96 49.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 26.5 mtmt -99.09 135.32 20.86 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 4.5 Cg_exo -77.44 140.23 19.06 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.784 2.323 . . . . 0.0 111.511 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.44 140.07 42.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.8 114.12 27.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.493 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 8.9 m -111.78 132.75 54.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.768 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -80.67 121.59 26.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.995 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 0.0 110.071 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.518 ' HB3' HD12 ' A' ' 75' ' ' ILE . 1.4 mm? -84.17 134.13 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 110.686 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.1 91.07 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.4 m -138.43 179.4 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.07 153.95 21.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 73' ' ' LEU . 96.4 t -61.64 127.84 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.628 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.5 76.51 2.08 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.773 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 HG22 ' OG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -71.45 146.63 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.76 0.314 . . . . 0.0 110.2 178.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 6' ' ' PRO . 2.2 mt -61.75 124.11 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.669 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.03 -11.56 20.26 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -89.38 137.51 32.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -96.74 115.46 27.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HB2' HD12 ' A' ' 4' ' ' ILE . 21.7 t -107.25 108.04 19.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.88 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.87 36.01 3.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.974 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 19' ' ' CYS . . . -140.03 -110.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.329 0.109 . . . . 0.0 110.839 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.458 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -125.92 125.88 43.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.538 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 t -107.33 127.35 63.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.03 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -145.87 170.28 16.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.306 -179.02 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 57.7 m -116.2 136.9 52.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 110.632 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.9 m -141.83 151.3 42.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.081 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -116.04 118.62 33.39 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.103 175.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -162.58 166.85 24.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.875 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.59 70.02 0.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 73' ' ' LEU . 0.7 OUTLIER -76.58 1.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.424 0.63 . . . . 0.0 111.051 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.55 70.77 6.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.559 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.54 -171.32 2.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.137 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.23 108.18 12.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.001 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.66 150.96 18.61 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.751 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.97 119.17 22.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.412 0.148 . . . . 0.0 111.123 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 m 71.51 -59.24 0.55 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.084 0.865 . . . . 0.0 111.929 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -139.49 -163.06 1.42 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.62 0.248 . . . . 0.0 110.564 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 47' ' ' VAL . 7.1 mt -82.48 108.4 15.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.628 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.481 HG21 HD12 ' A' ' 74' ' ' ILE . 7.0 mm -84.84 116.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 43' ' ' LEU . 42.4 mt -91.89 130.69 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 0.0 111.541 -170.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 6.7 t-20 -72.23 106.87 4.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.06 56.74 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 111.673 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.64 -60.73 1.8 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.093 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 6.8 m-80 -111.39 103.8 12.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.008 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.94 132.49 36.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.28 159.33 42.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 116.06 31.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.678 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 1.9 m -80.01 121.19 25.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.35 126.18 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 111.53 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.92 169.69 14.68 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' HG3' HG22 ' A' ' 50' ' ' ILE . 30.4 Cg_exo -61.66 -40.36 46.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.305 2.67 . . . . 0.0 112.395 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 67.21 0.79 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.487 178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.695 HG22 HG11 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -62.1 -45.06 95.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.43 132.07 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.782 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 71.42 6.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.215 0.531 . . . . 0.0 111.421 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -172.2 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.8 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.35 -135.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.16 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.35 101.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.587 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.461 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 23.1 m-85 -146.53 150.62 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.568 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -116.26 135.48 22.84 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 177.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 7.3 Cg_exo -73.44 128.89 13.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.677 2.251 . . . . 0.0 111.646 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CE1' HD12 ' A' ' 75' ' ' ILE . 47.2 m-85 -123.74 146.49 48.26 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.66 112.74 24.37 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 4.9 m -124.61 151.49 44.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.994 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -80.84 141.51 34.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.739 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.582 HD13 ' SG ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -128.44 124.37 36.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.423 0.63 . . . . 0.0 111.092 -178.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.17 83.88 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' HD13 ' A' ' 43' ' ' LEU . 24.4 m -127.35 173.09 10.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.251 0.548 . . . . 0.0 111.87 -172.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.97 158.82 19.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.641 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.98 129.05 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 132.91 17.09 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.088 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.5 t -87.92 114.45 26.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 6' ' ' PRO . 2.4 mp -64.43 118.13 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.18 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.44 -14.89 35.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.73 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 49.6 m -102.87 164.44 11.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.772 0.32 . . . . 0.0 110.143 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.2 pt20 -108.92 149.07 29.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.089 0.471 . . . . 0.0 110.759 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.4 m -122.15 120.81 35.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.448 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.59 48.41 3.67 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 19' ' ' CYS . . . -158.18 -133.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.501 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -113.95 145.18 41.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.975 177.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.695 HG11 HG22 ' A' ' 8' ' ' THR . 21.9 t -102.93 109.52 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.77 156.48 17.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.118 -174.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 105.26 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -124.36 137.85 54.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.195 0.521 . . . . 0.0 110.998 -176.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -119.2 123.65 44.84 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.632 175.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -178.68 155.75 0.84 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.764 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 94.36 6.34 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -52.08 126.48 7.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.456 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.49 45.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.008 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -27.06 17.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.482 0.658 . . . . 0.0 110.126 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 86.48 5.01 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.681 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.48 -45.33 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -134.89 169.54 17.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.656 0.265 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -19.22 63.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.412 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.25 169.07 12.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.442 ' HB2' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -65.62 105.5 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 178.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.55 140.55 15.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.0 110.517 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -107.29 130.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.357 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -71.7 -13.2 61.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.727 0.298 . . . . 0.0 110.323 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.427 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . 59.49 28.8 18.27 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.653 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.82 82.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.817 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 2.9 m-80 -123.73 83.28 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.119 176.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 131.42 52.44 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.556 -176.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.01 148.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.504 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.704 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.669 0.271 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 136.65 35.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.667 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.16 137.03 40.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.803 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.53 123.75 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.774 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.502 ' H ' HG23 ' A' ' 8' ' ' THR . . . -146.83 -178.93 22.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.68 -30.43 90.4 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.776 2.317 . . . . 0.0 112.093 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -114.3 62.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.511 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -72.27 -65.94 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 -178.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.75 157.51 15.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.932 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -82.84 85.36 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.163 0.506 . . . . 0.0 111.314 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -144.03 -170.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.295 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.32 108.95 3.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.799 ' HB2' HD11 ' A' ' 11' ' ' ILE . 21.5 m-85 -132.58 156.41 46.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.359 -172.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.65 125.42 82.58 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.3 Cg_exo -76.59 125.46 8.28 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.789 2.326 . . . . 0.0 111.848 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 61' ' ' CYS . 93.7 m-85 -123.31 149.18 45.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.35 116.01 8.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.02 175.09 10.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.374 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 137.66 37.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.267 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 120.938 0.399 . . . . 0.0 109.933 178.329 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.57 ' O ' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -138.34 110.45 7.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.059 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.0 112.87 2.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 t -153.97 178.33 10.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 m -122.05 158.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.72 125.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.56 135.61 41.78 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.118 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.43 98.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.449 HG21 ' HA2' ' A' ' 5' ' ' GLY . 2.7 pt -60.49 120.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.415 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 -8.02 26.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.957 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -116.93 154.22 31.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.802 0.334 . . . . 0.0 110.854 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 15.2 mt-30 -84.35 151.28 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.299 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.27 106.63 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.093 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.41 58.97 3.04 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.93 -166.59 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.08 95.75 6.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.619 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.67 135.52 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.175 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.17 155.15 45.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.9 m -128.32 108.44 10.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 70.7 m -124.01 142.02 51.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.362 0.601 . . . . 0.0 112.037 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.82 120.26 41.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.473 172.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.35 -170.5 3.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.167 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.24 50.02 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.444 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 75' ' ' ILE . 51.5 t -61.84 124.84 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.068 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.72 119.57 35.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -79.9 100.25 7.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.252 0.549 . . . . 0.0 111.854 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -19.93 48.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.912 0.863 . . . . 0.0 109.81 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.52 53.22 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -111.49 139.65 46.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.87 -51.29 68.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.428 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.12 148.06 41.88 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 98.75 8.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.488 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 74' ' ' ILE . 1.6 mt -69.18 126.16 28.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.558 HG23 ' H ' ' A' ' 77' ' ' ALA . 3.9 mt -92.33 146.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.227 0.537 . . . . 0.0 110.249 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -76.48 -0.48 23.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.281 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.558 ' H ' HG23 ' A' ' 75' ' ' ILE . . . 64.42 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 79' ' ' ASN . . . 52.04 -95.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.862 0.726 . . . . 0.0 111.496 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 19.4 m-80 -91.71 78.66 5.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.251 -176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.7 m -114.43 130.2 56.7 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.782 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 159.48 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.79 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.243 178.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 107.19 19.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.339 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -79.05 125.46 29.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.0 0.429 . . . . 0.0 110.826 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -80.53 95.06 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.41 171.08 17.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.78 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' HD3' HG23 ' A' ' 50' ' ' ILE . 57.1 Cg_endo -70.77 -15.49 33.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 111.709 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.409 HD21 ' HA ' ' A' ' 7' ' ' ASN . 4.2 m120 -107.49 46.81 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.918 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -64.8 0.88 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 128.88 52.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.843 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.43 79.25 9.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.915 0.388 . . . . 0.0 110.853 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -162.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.65 163.74 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.978 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.14 103.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 111.158 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CE1' ' HG2' ' A' ' 62' ' ' LYS . 6.3 m-85 -121.8 165.99 15.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.075 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -112.84 137.61 21.86 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -75.06 130.24 13.02 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.801 2.334 . . . . 0.0 111.31 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 40.1 m-85 -124.2 135.58 53.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.767 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -105.22 115.27 29.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.449 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.68 152.63 28.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.804 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -80.38 105.49 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.144 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.985 179.545 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -114.23 117.1 30.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.313 0.578 . . . . 0.0 111.341 -174.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.96 49.14 4.08 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.685 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 53.6 m -95.29 154.36 17.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.332 . . . . 0.0 110.797 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 72' ' ' PHE . 1.1 p -117.84 152.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.77 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.42 117.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.97 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.53 125.33 6.9 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.057 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' H ' HG11 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -77.07 125.16 36.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.446 HG23 ' HD3' ' A' ' 6' ' ' PRO . 1.8 mp -62.01 127.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.548 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.01 -16.77 11.96 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.211 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.69 165.06 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.783 0.325 . . . . 0.0 111.169 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -110.58 132.08 54.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.15 145.71 38.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.471 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.38 -11.1 46.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.495 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.23 -177.11 4.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.125 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 125.17 29.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.905 0.383 . . . . 0.0 110.519 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 3.9 t -97.11 120.15 46.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.815 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 mtpt -112.68 169.76 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.81 102.95 10.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 2.9 m -132.22 161.09 34.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.504 0.669 . . . . 0.0 112.099 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 2.2 pttt -156.45 157.73 36.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.456 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.6 -173.2 2.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.422 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.06 69.26 10.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -122.6 107.56 19.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.215 175.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -75.58 0.27 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.414 0.626 . . . . 0.0 110.946 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -149.19 147.43 28.42 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.075 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 120.14 7.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.78 46.9 3.19 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.121 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.85 175.12 6.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.27 -24.75 65.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.94 0.4 . . . . 0.0 111.531 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.596 ' HB2' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -160.22 152.72 20.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.004 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.523 ' HB2' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -112.23 125.13 53.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.043 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.46 136.47 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.373 0.606 . . . . 0.0 111.545 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.501 HD13 ' CE1' ' A' ' 17' ' ' TYR . 35.8 mm -98.1 119.06 45.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -63.81 -24.96 67.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 81.3 31.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.734 0.814 . . . . 0.0 111.166 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -56.9 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.446 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -120.94 75.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.036 -179.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.622 ' SG ' ' HE2' ' A' ' 59' ' ' LYS . 18.3 t -134.79 130.32 35.94 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.02 152.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.379 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.815 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.312 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -84.18 121.69 27.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.923 0.392 . . . . 0.0 111.337 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 106.97 18.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 12.2 mt -82.75 130.25 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 111.384 -173.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 50' ' ' ILE . . . -133.06 -171.86 12.84 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.864 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' A' ' 50' ' ' ILE . 36.4 Cg_endo -66.19 -27.64 48.73 Favored 'Trans proline' 0 CA--C 1.525 0.066 0 C-N-CA 122.539 2.159 . . . . 0.0 112.687 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -96.63 14.24 25.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.475 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -86.68 -22.58 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.254 0.55 . . . . 0.0 110.322 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -135.09 105.11 6.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.614 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.19 33.11 4.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.468 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -108.6 163.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.291 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.55 109.61 4.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.307 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.7 27.44 15.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.32 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.66 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 11.2 m-85 -95.87 123.21 39.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.031 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 16.8 mttt -91.4 134.38 29.68 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.45 137.81 34.26 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.636 2.224 . . . . 0.0 111.175 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 21.5 m-85 -131.62 138.6 48.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -95.5 112.94 24.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 m -113.5 120.16 40.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 105.88 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.448 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.538 0.209 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.564 ' HB3' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -150.52 141.97 23.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.929 171.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.12 88.56 0.53 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.643 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.813 ' HB2' HD12 ' A' ' 75' ' ' ILE . 36.3 m -141.52 165.78 26.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.08 152.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.12 133.57 30.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.345 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.4 89.78 0.36 Allowed Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.903 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -61.36 117.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.537 0.208 . . . . 0.0 110.486 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.478 HG22 ' HD3' ' A' ' 6' ' ' PRO . 3.3 mp -56.79 116.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.75 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.19 -9.5 17.88 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.833 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.01 165.85 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 0.0 110.345 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -121.11 125.49 47.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.141 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 82.6 m -108.44 122.5 47.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.974 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.15 56.64 4.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.269 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.13 -165.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.6 136.21 35.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.747 0.308 . . . . 0.0 110.32 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.4 t -108.29 123.93 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.208 0.527 . . . . 0.0 110.796 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -130.22 171.15 13.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.12 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 95.6 m -114.78 120.53 40.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.97 0.414 . . . . 0.0 109.972 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.2 m -125.19 123.22 39.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.341 0.591 . . . . 0.0 111.586 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.85 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 23.1 tptt -88.2 90.69 8.49 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.44 130.42 44.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.518 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 52.65 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.129 0.49 . . . . 0.0 111.038 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.18 128.29 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.949 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -84.96 146.49 27.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -91.45 97.73 11.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.558 0.694 . . . . 0.0 111.102 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -24.9 12.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.534 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 57.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.665 -1.607 . . . . 0.0 109.67 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.19 97.31 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.212 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.54 -35.58 45.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.672 0.749 . . . . 0.0 109.282 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.32 146.85 50.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.61 92.42 5.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.996 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.98 126.69 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.902 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -92.9 136.51 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 -174.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -79.62 -9.74 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.59 36.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.523 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.08 -66.43 0.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.31 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.85 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.5 m-80 -122.5 85.05 2.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.881 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.3 m -114.99 130.26 56.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.042 0.449 . . . . 0.0 111.209 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.85 160.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.949 -179.532 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -86.46 126.76 34.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -90.33 135.69 33.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.041 175.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 30.0 mt -91.21 130.86 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.745 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.65 -170.07 40.85 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.16 -13.27 39.11 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.365 2.043 . . . . 0.0 111.701 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -78.92 -35.99 42.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.286 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.701 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 t -140.08 123.3 16.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.828 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.31 93.96 3.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -133.69 152.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -18.48 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.204 1.402 . . . . 0.0 114.09 -174.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -119.87 47.88 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.575 0.702 . . . . 0.0 109.658 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.4 m-85 -108.84 119.47 39.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.84 -176.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -92.91 134.29 27.67 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.658 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.6 Cg_exo -68.76 125.61 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.612 2.208 . . . . 0.0 111.363 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 16.0 m-85 -114.35 144.97 42.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.097 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.77 113.62 27.22 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.35 120.27 37.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.865 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 17.8 mt-30 -82.03 103.96 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.906 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 2.1 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.469 HD12 ' SG ' ' A' ' 45' ' ' CYS . 1.6 mm? -112.03 113.62 26.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.938 0.399 . . . . 0.0 110.951 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.79 66.64 3.87 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.08 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 43' ' ' LEU . 1.8 m -121.14 162.08 20.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.84 153.34 21.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -65.27 137.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.796 -178.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.87 119.72 5.78 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.667 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.86 108.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.92 0.39 . . . . 0.0 110.602 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 2.4 mp -54.43 118.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.181 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.26 -0.16 29.7 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.415 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.77 151.51 43.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 7.6 mt-30 -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 157.41 44.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.102 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.24 43.97 1.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 20' ' ' GLN . . . -142.25 -172.03 3.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.854 -0.173 . . . . 0.0 110.56 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 104.8 12.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 30.6 m -88.97 144.03 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 6.5 ptpt -157.33 171.55 20.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.483 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -110.5 122.06 46.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.973 0.416 . . . . 0.0 110.271 -177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.72 136.62 51.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.423 0.63 . . . . 0.0 111.755 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.53 136.03 53.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -157.18 177.1 11.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.07 27.77 6.35 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.446 0.641 . . . . 0.0 109.952 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.63 128.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.903 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 68' ' ' THR . 12.8 t -118.02 -175.12 2.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.112 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.1 -14.31 59.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 111.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 66' ' ' THR . 0.3 OUTLIER -80.85 70.11 7.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.77 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.908 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.28 170.71 15.32 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -24.64 61.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.258 0.551 . . . . 0.0 110.154 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -107.2 142.97 36.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 47' ' ' VAL . 66.6 mt -78.92 92.91 4.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.034 0.445 . . . . 0.0 110.578 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -74.29 125.91 34.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.901 177.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 137.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.559 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 64.7 t30 -80.72 -4.95 56.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.547 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 64.56 26.92 13.36 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.625 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.72 87.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -130.27 75.25 1.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.665 177.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 9.5 m -113.85 130.2 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.651 0.263 . . . . 0.0 110.359 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.11 159.72 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.894 0.378 . . . . 0.0 110.958 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.371 178.168 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 99.86 10.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.45 126.92 31.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.419 HG21 ' HA3' ' A' ' 48' ' ' GLY . 25.7 mt -96.35 115.81 36.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.055 0.455 . . . . 0.0 111.646 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.93 17.49 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.496 ' HD3' HG12 ' A' ' 50' ' ' ILE . 47.1 Cg_endo -68.26 -23.24 39.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -84.23 -13.09 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.396 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -82.05 -53.69 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.872 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -152.65 105.01 2.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 111.175 -177.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.4 m -152.81 74.05 1.03 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.346 0.593 . . . . 0.0 109.586 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.61 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -94.59 -151.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.909 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.3 94.42 0.26 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.872 0.367 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 t0 54.5 37.3 27.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.039 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.61 ' HD2' ' HB ' ' A' ' 11' ' ' ILE . 6.2 m-85 -111.04 123.72 50.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.742 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -104.97 149.6 37.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.944 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.2 Cg_exo -77.33 138.73 18.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.88 2.387 . . . . 0.0 112.252 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' OH ' ' HB3' ' A' ' 64' ' ' ASP . 16.6 m-85 -126.31 145.06 50.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.225 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -96.74 112.94 24.48 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.21 141.99 18.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.068 0.461 . . . . 0.0 110.758 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -112.79 114.07 26.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 176.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.376 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.42 ' O ' HD21 ' A' ' 43' ' ' LEU . 5.5 m . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.656 0.265 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -132.44 103.34 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 0.0 110.281 175.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.21 98.99 0.65 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -153.55 -174.73 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.52 154.01 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 111.851 -170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.97 144.49 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -87.61 95.28 2.06 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.517 HG22 ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -63.87 127.12 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.718 0.294 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.496 HG12 ' HD3' ' A' ' 6' ' ' PRO . 1.7 mp -56.82 121.97 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.568 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.18 27.12 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.517 ' OG ' HG22 ' A' ' 49' ' ' VAL . 1.6 m -98.88 156.28 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.523 0.202 . . . . 0.0 110.577 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.57 154.56 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 m -134.19 145.51 49.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.054 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.08 -10.45 80.57 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 20' ' ' GLN . . . -89.52 -174.68 4.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.725 -0.737 . . . . 0.0 110.123 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -92.83 160.34 14.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.757 0.313 . . . . 0.0 110.415 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.55 128.62 53.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.03 153.85 26.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 106.36 14.82 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -121.49 148.17 44.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.452 0.644 . . . . 0.0 111.486 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.9 tttp -137.82 141.01 40.82 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.759 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.81 78.77 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.799 1.312 . . . . 0.0 109.271 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HA ' HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -98.31 -109.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.194 -174.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' H ' ' HB2' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -107.82 134.66 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 111.121 -176.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -59.78 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.866 0.841 . . . . 0.0 110.255 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -115.59 139.45 50.08 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.639 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 51.8 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.15 0.5 . . . . 0.0 111.279 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.08 42.16 3.04 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.704 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.14 165.08 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -58.49 3.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.59 170.81 7.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.216 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -70.83 131.47 43.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.946 0.403 . . . . 0.0 111.177 -178.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.516 HD11 HG22 ' A' ' 74' ' ' ILE . 19.3 mt -118.3 133.43 65.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.012 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.617 HG22 ' HA ' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -102.93 142.16 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.284 -179.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -87.98 8.43 26.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.87 -124.6 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.976 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.38 -67.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.057 0.543 . . . . 0.0 111.377 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.2 m-80 -116.28 102.3 9.45 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 130.86 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.602 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.01 159.75 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.036 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.066 178.083 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.972 0.415 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 110.36 21.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -79.2 120.17 23.32 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 58' ' ' VAL . 6.0 mt -83.66 128.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 176.15 33.69 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.639 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.719 ' HA ' HG22 ' A' ' 50' ' ' ILE . 46.2 Cg_exo -57.15 -32.7 94.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.901 2.401 . . . . 0.0 112.093 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.07 87.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.779 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -36.68 82.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -103.39 156.16 17.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.95 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.41 51.59 1.47 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.529 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.507 HG23 HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -123.26 151.79 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.441 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.6 115.6 14.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.07 72.17 0.54 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.269 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.65 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 4.3 m-85 -125.9 141.58 51.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.242 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 11.4 mtmt -90.84 124.28 62.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.617 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.8 Cg_exo -76.03 139.27 21.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.089 2.526 . . . . 0.0 111.771 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.11 143.62 51.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -92.06 112.26 24.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 59' ' ' LYS . 98.4 m -119.34 125.07 48.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.476 ' HG2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.555 -174.509 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.788 0.328 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -117.68 103.91 10.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.364 0.602 . . . . 0.0 111.049 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.71 94.56 0.57 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.171 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.58 ' HB2' HD13 ' A' ' 75' ' ' ILE . 80.1 m -136.53 177.79 7.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.13 148.77 23.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.906 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.496 ' H ' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -65.32 141.64 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.967 0.413 . . . . 0.0 110.589 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.72 136.42 14.04 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.195 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 22.0 t -80.32 113.95 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.719 HG22 ' HA ' ' A' ' 6' ' ' PRO . 29.7 pt -62.9 115.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 0.0 110.635 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.01 -12.11 34.39 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.963 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 71.0 m -102.78 170.19 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.671 0.272 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -106.15 140.97 38.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 -177.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.18 124.04 38.09 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.385 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.12 52.96 3.76 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.07 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 20' ' ' GLN . . . -153.19 178.27 9.93 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -87.68 124.63 33.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.011 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 4' ' ' ILE . 5.9 t -83.01 130.57 35.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.218 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HG3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -120.3 163.64 17.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.489 176.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.5 117.1 27.53 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -126.47 133.04 51.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.51 0.671 . . . . 0.0 111.646 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.65 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 7.6 ttpt -106.99 118.39 36.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.431 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.66 175.13 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.66 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -124.0 105.06 9.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.064 0.459 . . . . 0.0 110.733 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.82 115.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.485 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.99 94.29 6.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.332 0.587 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -79.76 86.88 5.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.6 0.714 . . . . 0.0 110.659 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -125.17 52.58 1.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.618 0.723 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.28 31.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -140.2 148.74 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.36 -17.11 20.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.37 155.95 26.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -82.98 94.06 7.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.086 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 45' ' ' CYS . 2.4 mt -92.48 135.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -18.45 65.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.16 37.81 29.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.877 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.57 -52.57 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 10.2 m-80 -123.87 81.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.312 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.7 m -116.4 129.92 56.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.271 0.558 . . . . 0.0 110.891 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.2 159.89 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.324 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.32 179.743 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 m -79.41 117.77 20.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.413 . . . . 0.0 110.621 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 115.14 25.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.642 HG12 HG13 ' A' ' 58' ' ' VAL . 4.7 mt -68.79 110.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 152.94 44.36 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.921 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.45 -37.86 96.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 112.256 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.04 75.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.69 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -42.64 59.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.4 m -126.87 145.16 50.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -97.88 69.62 2.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.191 0.52 . . . . 0.0 110.459 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 -145.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.012 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.09 -164.68 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.177 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.48 97.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.677 . . . . 0.0 109.785 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 9.1 m-85 -125.98 145.3 50.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.995 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.674 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -100.83 131.2 23.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 38.3 Cg_endo -71.15 130.49 17.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.331 2.021 . . . . 0.0 110.696 171.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.674 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 7.4 m-85 -114.7 139.78 49.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.8 0.334 . . . . 0.0 110.954 -175.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.3 t -94.04 113.03 24.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 t -146.88 158.86 44.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.622 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 7.8 pt20 -141.26 106.1 4.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.315 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.836 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.64 0.257 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 2.7 mm? -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.44 66.98 0.56 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.993 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -134.25 171.75 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.466 0.174 . . . . 0.0 111.053 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.684 ' HA ' HD12 ' A' ' 73' ' ' LEU . 1.7 p -118.71 165.76 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -171.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 15' ' ' LYS . 32.0 t -69.15 136.31 26.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.725 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.47 132.84 11.26 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.478 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -73.34 136.79 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.091 0.472 . . . . 0.0 111.092 -177.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.76 147.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.36 12.55 79.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.02 152.4 47.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.707 0.289 . . . . 0.0 110.309 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -88.6 145.86 25.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.255 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.27 124.58 20.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.902 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.88 54.0 4.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.728 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.4 -163.73 1.24 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.76 147.73 22.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.642 HG13 HG12 ' A' ' 4' ' ' ILE . 7.7 t -111.37 120.67 62.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -108.66 169.23 8.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.827 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.8 m -119.47 105.86 11.67 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.5 m -129.08 139.28 52.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.482 0.658 . . . . 0.0 112.009 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.6 tptt -121.19 121.14 37.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.157 169.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.53 171.42 14.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.77 63.88 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.595 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.13 107.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.218 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.78 171.15 8.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.025 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -87.89 49.38 1.79 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.143 0.497 . . . . 0.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -12.57 60.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.308 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 93.8 1.14 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.883 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -152.82 153.11 32.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.72 0.295 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -46.45 21.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.479 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -135.96 164.15 28.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.191 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -80.95 122.16 26.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.911 0.386 . . . . 0.0 110.964 -177.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.48 145.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.057 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.46 HD12 ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -109.49 124.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.282 0.563 . . . . 0.0 110.81 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -84.37 -3.72 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.109 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.91 32.9 15.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.664 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -54.72 29.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 3.0 m-80 -127.23 78.08 1.79 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 m -117.05 130.34 56.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 111.143 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -134.07 160.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.321 178.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.257 0.973 . . . . 0.0 111.052 178.804 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -89.03 108.64 19.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.311 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 113.36 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.031 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 HD12 ' SG ' ' A' ' 18' ' ' CYS . 29.8 mt -70.7 109.56 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.602 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.93 -173.17 30.36 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.981 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HA ' HG12 ' A' ' 50' ' ' ILE . 93.6 Cg_endo -83.72 8.03 4.85 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.979 2.453 . . . . 0.0 113.452 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.33 36.12 3.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -48.17 58.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.368 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -92.91 124.35 36.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.15 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.94 17.82 2.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -122.92 159.95 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.937 177.163 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 4.8 t0 -69.52 -89.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 5.5 t70 -84.46 79.21 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.351 0.596 . . . . 0.0 111.213 -173.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.68 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 20.9 m-85 -144.71 138.98 27.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -106.83 138.9 19.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.908 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.5 Cg_exo -70.85 133.62 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.743 2.295 . . . . 0.0 111.53 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.567 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 33.0 m-85 -126.17 135.49 51.71 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.049 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.414 ' SG ' HD12 ' A' ' 4' ' ' ILE . 1.3 m -91.37 112.01 23.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 95.7 m -115.13 127.73 55.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.894 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.14 113.34 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.436 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.7 0.762 . . . . 0.0 109.666 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.854 ' HB3' HD13 ' A' ' 75' ' ' ILE . 3.6 mm? -104.74 130.88 52.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.049 0.452 . . . . 0.0 111.015 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.75 65.3 0.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB2' HD12 ' A' ' 75' ' ' ILE . 20.8 m -119.37 172.19 7.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -118.73 158.16 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.027 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.57 127.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.368 0.604 . . . . 0.0 111.4 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.08 77.77 0.77 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.25 151.29 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 6' ' ' PRO . 3.9 mp -56.65 126.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.68 10.69 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.033 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 143.74 34.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.626 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -99.37 143.07 30.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.66 136.09 50.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.46 17.13 43.82 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.9 -171.73 2.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.401 -0.399 . . . . 0.0 110.285 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 110.94 15.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.78 125.46 42.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -131.06 168.93 16.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.015 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 43.7 m -106.56 118.98 38.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 m -121.62 154.54 36.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.042 0.449 . . . . 0.0 110.866 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 2.2 tptm -151.0 135.25 16.85 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.04 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 78' ' ' ALA . 3.2 t70 178.74 -176.72 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.293 175.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -90.56 96.63 10.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.72 100.33 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -160.79 0.8 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.079 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.25 58.6 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 111.37 -173.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 25.85 3.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.549 0.69 . . . . 0.0 109.926 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.17 84.4 1.43 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.285 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -79.15 119.54 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.3 m 72.28 -50.66 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.811 0.694 . . . . 0.0 111.184 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.01 166.43 29.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.296 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.492 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -89.12 107.95 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 -177.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.1 139.81 19.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.854 HD13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -111.84 134.7 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.316 0.579 . . . . 0.0 111.281 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.03 139.48 36.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.643 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 51.78 2.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 0.0 111.4 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.449 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . . . -99.53 -71.83 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.406 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 10.2 m-80 -102.73 70.01 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.565 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 54.6 m -118.16 128.69 54.96 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.037 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.414 HG22 HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -142.83 159.78 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.567 -176.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.567 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.689 0.281 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.597 HG21 HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -79.13 100.82 7.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.204 0.526 . . . . 0.0 110.816 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.12 112.41 18.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.359 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 58' ' ' VAL . 12.9 mt -77.71 120.94 29.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.7 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.66 167.84 12.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.797 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.85 -16.62 41.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.919 2.413 . . . . 0.0 112.501 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 43.6 1.92 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.275 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -65.41 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.166 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 70.4 1.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.978 175.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.53 67.24 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.739 -172.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.83 -87.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -93.46 -167.19 1.66 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -73.79 76.47 1.59 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -95.82 137.16 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.648 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 22.8 mtmt -91.65 120.16 68.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 14.9 Cg_exo -69.01 141.71 49.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.712 2.275 . . . . 0.0 111.539 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -137.42 135.2 36.7 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.81 124.5 52.73 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.275 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 p -156.06 162.51 40.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.29 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.559 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 1.7 mt-30 -80.06 107.77 13.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.006 0.432 . . . . 0.0 110.281 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.29 27.78 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.828 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -89.39 -33.01 17.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.365 0.602 . . . . 0.0 109.546 173.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -160.46 -78.92 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.107 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . 159.27 131.71 1.28 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.603 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 6.5 Cg_exo -73.87 90.89 0.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.663 2.242 . . . . 0.0 111.47 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.7 -61.83 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.2 -143.77 16.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -75.18 116.68 56.65 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.506 0.193 . . . . 0.0 110.495 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.61 136.25 73.19 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.277 2.651 . . . . 0.0 112.716 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.84 -138.49 2.46 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.615 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.5 69.25 10.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.0 0.429 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.38 153.39 23.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.509 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -82.78 141.99 31.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.78 -18.16 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.119 0.485 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 36' ' ' PRO . 1.3 mp -114.18 132.24 22.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.574 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 35' ' ' ILE . 36.8 Cg_exo -57.96 124.22 15.47 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.502 2.135 . . . . 0.0 111.776 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.32 115.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.071 0.462 . . . . 0.0 111.453 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.08 166.69 27.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.2 -18.53 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.75 -80.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.288 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.12 132.93 4.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.924 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.55 103.24 9.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.515 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HB3' HD11 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -113.07 119.32 37.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.918 0.39 . . . . 0.0 110.155 176.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.1 87.45 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.221 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.9 m -137.73 171.3 14.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.569 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.44 154.07 22.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.931 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.842 HG23 HD13 ' A' ' 73' ' ' LEU . 0.7 OUTLIER -64.33 134.1 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.221 0.534 . . . . 0.0 110.87 -178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.25 105.42 2.36 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.05 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.437 ' HB ' ' OG ' ' A' ' 52' ' ' SER . 4.7 t -68.29 130.77 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.544 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.4 pt -68.42 125.33 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.444 0.64 . . . . 0.0 110.456 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.74 -11.08 66.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.599 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.437 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 63.9 m -88.09 155.3 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.529 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.46 121.51 45.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.645 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 116.68 29.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.88 56.22 3.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.19 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.88 -179.03 7.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.7 128.19 33.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.597 HG23 HG21 ' A' ' 2' ' ' THR . 16.3 t -98.87 127.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.84 169.71 11.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.783 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.7 m -118.37 124.68 48.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.9 m -129.34 135.32 48.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 0.0 111.568 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.712 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 12.7 tttt -112.71 117.79 33.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.092 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -172.55 163.77 5.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.416 -176.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -109.36 111.62 23.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.159 0.505 . . . . 0.0 110.504 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 74' ' ' ILE . 2.1 t -97.41 146.99 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.637 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.4 138.27 31.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.405 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -78.39 -30.1 47.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.382 0.611 . . . . 0.0 110.62 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 3.79 48.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.973 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.0 -76.16 0.63 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.083 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -119.04 -179.98 3.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.77 7.34 15.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.373 0.606 . . . . 0.0 110.746 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -156.56 169.85 23.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.622 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.842 HD13 HG23 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -79.15 92.88 5.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.102 179.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 65' ' ' VAL . 1.1 tt -75.62 136.29 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 43' ' ' LEU . 2.8 mt -92.18 128.78 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.961 0.41 . . . . 0.0 110.747 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 10.3 m-80 -64.18 -20.58 66.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.493 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 61.72 26.2 15.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.078 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -56.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.712 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 4.7 m-80 -124.33 84.19 2.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.924 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 33.2 m -115.55 135.78 53.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.949 0.404 . . . . 0.0 110.986 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.24 130.6 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.851 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.279 -178.678 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.678 0.275 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 103.41 12.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.79 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.24 137.37 37.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.801 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.561 HG22 ' HA3' ' A' ' 48' ' ' GLY . 7.8 mt -109.55 137.0 43.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.83 -169.76 17.73 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.163 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.11 -17.01 15.43 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.406 2.071 . . . . 0.0 112.649 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.37 13.54 33.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.806 0.336 . . . . 0.0 111.477 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -75.45 -29.73 59.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.33 89.97 1.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.967 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.41 27.98 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.036 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.479 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -84.03 -109.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.482 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.479 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 1.9 t70 -92.91 -164.31 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -74.55 66.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.617 0.722 . . . . 0.0 109.495 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 5.3 m-85 -93.85 128.02 39.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.42 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -87.74 119.67 70.67 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.29 144.43 41.4 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.013 2.476 . . . . 0.0 110.815 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.71 143.75 45.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.998 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.4 t -97.36 113.13 24.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 58.2 m -118.94 130.27 55.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 111.586 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.45 105.51 17.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.151 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -102.16 138.17 39.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.671 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -89.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.43 -43.95 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.517 0.675 . . . . 0.0 110.598 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.32 -166.55 24.97 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.505 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.42 137.78 40.61 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.767 2.311 . . . . 0.0 112.179 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.34 22.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.16 -61.38 0.74 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.891 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.55 122.24 85.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.789 0.328 . . . . 0.0 111.492 -175.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 35' ' ' ILE . 7.4 Cg_exo -73.65 99.11 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.077 2.518 . . . . 0.0 111.757 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.8 35.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.345 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.2 18.93 12.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.062 0.458 . . . . 0.0 110.579 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.68 -35.15 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.272 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -100.15 127.31 46.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.48 131.84 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 111.192 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.672 HG12 ' HA ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -106.55 123.33 39.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.773 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 16.5 Cg_exo -67.42 124.2 11.77 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.449 2.099 . . . . 0.0 111.921 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.43 53.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.53 0.681 . . . . 0.0 110.115 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.15 159.88 32.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.645 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -1.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.058 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.35 -34.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.08 -4.13 48.76 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 91.98 5.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.825 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -140.75 104.31 4.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.46 89.74 0.44 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.0 m -133.18 175.26 9.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 111.891 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 46' ' ' VAL . 2.4 m -119.17 156.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.567 HG13 HD22 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -61.98 139.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.387 . . . . 0.0 110.478 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 4' ' ' ILE . . . -60.93 115.38 7.76 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.184 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -63.67 95.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -60.41 103.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.469 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.98 22.44 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.19 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.457 ' HB2' HG21 ' A' ' 49' ' ' VAL . 3.7 m -112.0 158.73 19.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.873 0.368 . . . . 0.0 110.526 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -98.65 153.16 18.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.229 0.537 . . . . 0.0 110.527 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 153.92 45.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.139 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.32 47.99 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.678 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 19' ' ' CYS . . . -158.62 -171.82 3.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.44 137.26 37.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.87 121.71 58.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.978 0.418 . . . . 0.0 110.544 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 mtpp -122.96 170.01 10.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.67 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 70.9 m -129.5 123.48 31.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.9 45.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 0.0 112.242 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -105.35 113.11 26.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' CG ' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -165.42 163.55 19.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.949 -172.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.04 93.14 5.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -85.59 132.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.366 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.09 143.3 31.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.921 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.05 5.53 38.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.29 0.566 . . . . 0.0 110.076 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.36 101.77 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.684 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.14 37.24 81.63 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -133.45 120.13 20.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.644 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -36.71 71.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.476 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -136.49 -168.26 2.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.567 HD22 HG13 ' A' ' 47' ' ' VAL . 2.7 mp -90.67 95.8 10.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 112.069 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.76 118.38 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.767 HG21 ' H ' ' A' ' 77' ' ' ALA . 2.7 mp -93.02 132.14 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -15.37 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.519 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.847 ' HB2' HD21 ' A' ' 43' ' ' LEU . . . 61.92 25.23 15.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.897 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.35 -56.31 11.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.015 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.635 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 12.0 m-80 -121.03 82.79 1.97 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.182 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -115.24 130.29 56.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.103 0.478 . . . . 0.0 111.06 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.422 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -114.45 159.47 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 173.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 O-C-N 123.686 0.616 . . . . 0.0 109.989 -175.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.763 0.316 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.29 99.52 9.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 2.0 m -81.15 113.84 19.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.556 HD11 ' HA3' ' A' ' 48' ' ' GLY . 23.4 mt -71.56 131.01 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.09 -164.57 13.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.793 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.04 -25.31 73.58 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.784 2.323 . . . . 0.0 111.934 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -90.07 77.06 6.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.944 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -100.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.377 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 91.97 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.67 67.33 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.577 0.703 . . . . 0.0 111.204 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -135.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.621 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.79 -165.32 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.01 107.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.595 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 15.5 m-85 -136.63 145.84 45.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.771 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' NZ ' HG21 ' A' ' 65' ' ' VAL . 13.3 mtmt -102.33 124.85 38.15 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.804 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.9 Cg_exo -75.58 120.23 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.935 2.423 . . . . 0.0 111.981 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.694 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 81.6 m-85 -118.08 131.87 56.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.236 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.8 t -107.43 113.65 27.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.365 . . . . 0.0 110.959 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -148.09 151.09 35.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.09 104.97 11.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.706 0.765 . . . . 0.0 109.653 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 -18.07 5.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.755 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.426 ' C ' ' H ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -87.22 74.5 9.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.322 0.582 . . . . 0.0 110.511 178.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 30.19 0.28 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.978 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 22' ' ' MET . . . 144.08 96.52 0.22 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.47 -177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.48 122.16 10.43 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.662 2.242 . . . . 0.0 111.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.08 40.57 6.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.397 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 123.51 30.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.655 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -109.89 148.41 38.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.625 0.25 . . . . 0.0 111.267 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 24.2 Cg_exo -64.22 138.76 62.85 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.036 2.49 . . . . 0.0 112.07 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.62 -67.22 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.23 -38.05 21.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.12 110.08 21.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.098 172.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -99.14 20.62 13.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.713 0.768 . . . . 0.0 109.915 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.82 152.48 51.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.347 177.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.44 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -98.05 113.72 64.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.17 121.81 8.4 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.058 1.839 . . . . 0.0 111.988 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.17 127.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.319 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -92.25 117.59 30.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.15 0.5 . . . . 0.0 109.66 173.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.51 10.25 31.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.085 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.12 1.37 17.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.057 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.24 50.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 0.0 111.508 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m -92.42 -162.14 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.639 ' HB3' HD11 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -94.74 108.52 20.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.076 0.465 . . . . 0.0 111.204 -175.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.33 77.35 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.694 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 2.6 m -128.66 163.18 25.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.791 0.329 . . . . 0.0 111.134 -174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -118.28 155.12 20.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.027 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.81 128.19 31.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.423 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.556 ' HA3' HD11 ' A' ' 4' ' ' ILE . . . -85.86 102.96 2.71 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.7 139.14 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.94 122.57 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.869 -178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.72 -12.51 20.64 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.19 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -102.03 141.5 34.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.941 0.4 . . . . 0.0 110.727 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.649 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.6 mp0 -86.17 144.91 27.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.449 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 143.8 51.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.782 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.5 43.74 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.738 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.45 -168.78 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.65 147.73 25.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.01 122.58 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 8.6 ptmt -128.55 156.56 43.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 1.3 m -106.14 129.61 54.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.831 0.348 . . . . 0.0 110.643 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m -127.62 140.77 51.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.5 . . . . 0.0 110.996 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.8 ttmm -123.13 127.53 48.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.692 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 175.39 169.08 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.612 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.06 99.69 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.516 HG21 ' NZ ' ' A' ' 15' ' ' LYS . 95.5 t -82.49 118.68 30.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 125.92 54.86 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.353 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -77.67 106.91 9.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 111.052 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -87.32 59.31 5.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.578 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.58 52.53 45.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.973 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.15 157.4 46.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -39.67 72.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.56 ' HB2' HG21 ' A' ' 46' ' ' VAL . 7.5 p90 -111.55 175.38 5.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.499 HD11 ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -93.38 120.86 34.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -176.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.1 tt -87.8 123.97 40.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.187 0.517 . . . . 0.0 110.408 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.711 HG21 ' H ' ' A' ' 77' ' ' ALA . 2.2 mp -93.8 135.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.805 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -69.46 -18.55 63.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.711 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.711 ' H ' HG21 ' A' ' 75' ' ' ILE . . . 63.65 31.51 14.46 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.507 -177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.28 -56.73 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 6.5 m-80 -119.89 85.57 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.906 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 58.5 m -116.38 133.89 55.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.784 0.326 . . . . 0.0 110.431 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -132.77 141.48 44.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.425 0.631 . . . . 0.0 111.171 -178.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.78 141.5 28.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -101.21 121.19 41.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.005 0.431 . . . . 0.0 110.787 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 50' ' ' ILE . 82.7 mt -84.55 124.72 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.182 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 168.4 12.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.936 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HA ' HG12 ' A' ' 50' ' ' ILE . 21.9 Cg_exo -64.85 -25.64 60.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.747 2.298 . . . . 0.0 111.635 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' HA ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -138.44 55.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.828 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -44.94 77.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.301 0.572 . . . . 0.0 110.368 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.82 27.42 0.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.371 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.854 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -82.86 82.95 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.533 -174.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 11' ' ' ILE . 2.9 mm -70.91 -55.02 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.503 0.668 . . . . 0.0 109.485 173.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -149.94 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.838 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.4 55.17 2.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.226 1.013 . . . . 0.0 109.229 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.854 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 7.0 m-30 -78.96 107.99 12.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.048 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HB3' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -83.3 135.58 44.08 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.839 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.4 Cg_exo -70.12 133.94 26.06 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.461 2.107 . . . . 0.0 111.404 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -114.71 142.72 46.12 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 t -119.25 112.56 19.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.936 0.398 . . . . 0.0 110.578 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -152.57 146.8 25.5 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -93.32 136.07 33.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -89.84 50.87 1.95 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 0.0 111.02 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 116.85 5.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.591 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.88 -15.62 24.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.824 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.24 114.85 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.907 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.27 -167.51 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.94 2.426 . . . . 0.0 112.472 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.35 115.26 19.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.65 -94.92 1.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.247 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.34 112.58 51.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.732 0.301 . . . . 0.0 111.314 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.88 115.99 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.587 2.191 . . . . 0.0 111.133 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.16 -27.33 3.15 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.46 ' HB3' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -106.3 -137.65 0.36 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 177.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.46 ' H ' ' HB3' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -163.91 149.85 11.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.727 0.299 . . . . 0.0 110.667 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -87.23 101.31 13.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 125.96 29.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.236 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.35 130.78 14.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.414 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 131.76 32.45 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.629 2.219 . . . . 0.0 110.916 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.97 64.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.319 0.581 . . . . 0.0 110.995 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -93.86 112.51 24.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mp -86.54 151.26 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.247 -173.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m 61.36 52.21 3.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.204 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.06 96.47 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.173 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.98 168.72 19.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.815 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.71 142.56 35.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.603 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.707 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -101.78 -53.34 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 169.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 m 65.38 -176.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.891 -0.654 . . . . 0.0 112.31 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.17 154.19 38.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 15' ' ' LYS . 64.0 t -74.69 132.0 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.068 0.461 . . . . 0.0 110.45 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.1 134.75 13.14 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.185 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.23 129.58 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.793 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.566 ' HA ' HG23 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -71.2 135.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.075 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.17 76.58 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -108.33 170.66 7.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.015 0.436 . . . . 0.0 111.514 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -96.29 146.14 24.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.66 154.0 49.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.137 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.4 48.42 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.649 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.55 -171.46 3.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.502 0.192 . . . . 0.0 110.573 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -79.49 127.79 32.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.801 0.334 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.02 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.795 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -122.56 152.63 40.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 178.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 15.2 m -114.18 107.84 16.16 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -127.87 156.21 42.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.97 0.891 . . . . 0.0 113.345 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -145.86 150.8 36.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.631 -1.622 . . . . 0.0 107.047 168.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.517 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 1.5 m-20 -158.52 -165.53 1.69 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -88.57 4.47 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 75' ' ' ILE . 1.5 t -76.58 105.9 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.548 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.465 ' HB ' ' H ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -101.0 -120.7 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.268 176.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.465 ' H ' ' HB ' ' A' ' 66' ' ' THR . 13.7 t-20 -99.29 81.4 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.219 0.533 . . . . 0.0 110.074 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.18 151.11 23.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.72 69.73 3.27 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.637 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -137.97 165.6 26.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -30.67 71.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.184 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.707 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 8.7 p90 -145.94 -173.01 4.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.907 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -102.12 100.32 10.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -80.98 115.85 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.646 ' HA ' HG23 ' A' ' 65' ' ' VAL . 5.1 pt -92.44 154.73 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.05 -14.94 57.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.199 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.14 34.49 5.0 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.201 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.475 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . . . -88.47 -62.79 1.41 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.979 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.694 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 9.9 m-80 -95.35 50.91 1.27 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.168 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 51.1 t -123.81 129.94 51.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -129.73 123.78 57.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.687 -177.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.57 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.318 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.565 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -78.99 103.52 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.24 0.543 . . . . 0.0 111.258 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 135.61 33.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.415 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.04 124.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.661 0.267 . . . . 0.0 110.662 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -110.73 -168.43 19.23 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -0.82 9.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.783 2.322 . . . . 0.0 112.44 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 151.84 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.934 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.54 -70.66 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.553 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.69 42.68 0.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.151 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 14.5 m -79.86 76.05 6.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.822 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.474 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER -80.47 -92.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.058 174.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 32.1 t70 -91.79 88.78 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.561 0.22 . . . . 0.0 111.042 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.736 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.8 t70 50.47 38.47 18.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.431 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.692 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 13.4 m-85 -88.35 112.29 22.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.849 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.44 146.31 31.09 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.28 120.55 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.58 2.187 . . . . 0.0 111.458 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HE2' HG21 ' A' ' 75' ' ' ILE . 3.3 m-85 -113.96 130.88 56.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.82 118.55 36.97 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -144.46 173.02 12.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.957 0.408 . . . . 0.0 110.922 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 158.76 26.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.405 ' CB ' ' HG ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -119.64 103.5 9.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -174.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.452 ' HG2' HD23 ' A' ' 34' ' ' LEU . 4.8 ttp -80.35 109.02 14.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 0.0 109.743 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m -108.78 129.8 55.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.08 154.37 19.87 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.667 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.578 ' HG2' ' HG ' ' A' ' 32' ' ' LEU . 35.4 Cg_exo -60.41 120.27 7.93 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.035 2.49 . . . . 0.0 112.142 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.73 176.87 6.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.58 -96.49 2.09 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.511 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.1 85.96 57.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.827 0.346 . . . . 0.0 110.408 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 2.9 Cg_exo -75.69 57.87 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.124 2.549 . . . . 0.0 112.008 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.93 -23.96 70.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.355 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.575 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -90.33 -53.4 4.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.578 ' HG ' ' HG2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -148.7 135.29 19.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.403 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 25.3 t-20 -95.36 -29.11 14.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.959 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.452 HD23 ' HG2' ' A' ' 22' ' ' MET . 0.3 OUTLIER 63.57 66.52 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.946 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.52 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -90.27 135.83 29.3 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.8 122.17 11.28 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.048 1.832 . . . . 0.0 111.957 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.99 88.62 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.32 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.94 169.87 16.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.18 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -21.26 18.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -145.53 -68.65 0.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.7 108.1 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.009 0.433 . . . . 0.0 112.049 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.54 91.98 7.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.333 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.644 HD13 ' SG ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -138.71 104.68 5.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 0.0 110.883 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.75 75.23 0.21 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.644 ' SG ' HD13 ' A' ' 43' ' ' LEU . 96.0 m -104.16 156.74 17.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -132.07 160.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.563 175.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.42 120.29 15.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.877 0.37 . . . . 0.0 110.804 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.88 112.12 3.98 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.0 151.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.309 0.576 . . . . 0.0 111.577 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 50' ' ' ILE . 4.9 mp -58.67 124.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.814 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.83 -23.8 11.46 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.21 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -83.08 149.64 26.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.841 0.353 . . . . 0.0 110.786 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -114.35 120.23 39.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.963 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -110.01 110.8 21.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.536 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.69 4.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.868 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HB1' ' H ' ' A' ' 57' ' ' SER . . . -149.17 -113.24 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.483 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 58.3 m -131.08 119.64 22.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.023 0.439 . . . . 0.0 111.147 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.08 114.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.402 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.408 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 1.4 ptmt -124.76 169.97 11.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.793 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.692 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 87.6 m -110.34 121.05 44.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -129.02 147.5 50.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.106 0.479 . . . . 0.0 110.799 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.736 ' HE3' ' HB3' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -134.09 131.03 38.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.618 175.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.69 178.25 6.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.474 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.81 102.06 8.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.176 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.78 154.16 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.76 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.62 120.34 42.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.049 0.452 . . . . 0.0 111.106 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -92.86 55.62 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.465 0.65 . . . . 0.0 109.897 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -21.85 45.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.881 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.17 52.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -115.5 164.63 14.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.311 . . . . 0.0 110.672 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -42.84 13.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 109.909 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.402 ' HB2' HG22 ' A' ' 46' ' ' VAL . 2.9 p90 -145.26 165.37 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.799 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -87.1 93.46 9.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 110.97 -178.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.05 111.85 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -92.99 153.25 3.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -174.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.83 -11.09 59.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.721 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.85 33.06 12.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.506 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -58.67 3.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.287 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.2 m-80 -107.06 84.65 2.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.231 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.97 129.46 50.97 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.843 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.08 121.51 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.238 0.542 . . . . 0.0 111.038 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.724 176.478 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.593 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.43 109.01 13.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.029 0.442 . . . . 0.0 110.56 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.31 134.71 42.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.628 HD13 ' HA3' ' A' ' 48' ' ' GLY . 4.7 mt -98.18 102.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.33 -167.86 16.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.946 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.85 -27.22 59.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 0.0 111.922 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -108.72 54.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.079 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -74.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.159 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -104.55 126.25 51.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.908 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.49 70.52 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 111.307 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.5 -161.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.823 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -67.54 178.97 1.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.91 99.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.574 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 15.1 m-85 -115.33 157.29 24.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.936 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -90.78 117.55 68.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.0 Cg_exo -79.41 131.47 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.263 2.642 . . . . 0.0 111.777 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -125.88 141.61 51.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 4' ' ' ILE . 21.1 m -95.49 112.49 24.19 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.437 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -131.91 141.39 49.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.675 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.71 105.45 17.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.843 0.354 . . . . 0.0 110.055 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.53 139.79 31.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.571 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.5 ttm -81.49 113.26 19.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.193 0.521 . . . . 0.0 110.161 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.23 49.38 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.676 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.56 177.63 47.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.527 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.07 120.08 7.75 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.85 85.95 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.025 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.24 173.14 17.74 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.521 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.24 123.14 44.27 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.03 115.93 2.78 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.323 . . . . 0.0 112.306 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.65 150.56 9.39 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.828 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HB3' ' H ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -138.64 -121.46 0.13 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' H ' ' HB3' ' A' ' 31' ' ' LEU . 12.7 tp -86.52 -14.78 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.867 0.841 . . . . 0.0 109.024 175.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 157.88 43.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.992 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.4 101.7 2.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.08 0.466 . . . . 0.0 111.464 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.473 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -110.05 99.2 38.3 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.86 124.58 12.48 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.773 2.316 . . . . 0.0 113.118 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -119.7 120.62 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -103.24 144.42 31.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.412 0.625 . . . . 0.0 111.339 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.601 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -144.28 -4.25 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.424 174.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -34.82 10.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.208 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.23 19.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.105 0.479 . . . . 0.0 110.758 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 92.42 5.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.268 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 3.0 mm? -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.453 0.644 . . . . 0.0 111.16 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' C ' ' HE2' ' A' ' 72' ' ' PHE . . . -165.57 93.04 0.11 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.3 m -139.47 -178.04 5.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.181 0.515 . . . . 0.0 111.733 -169.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.26 153.25 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.39 137.51 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.962 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -69.2 129.67 23.52 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.997 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -76.67 105.02 5.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 11.3 mt -64.66 108.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.747 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.39 -8.72 20.25 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.58 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -110.95 160.92 16.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.593 ' HG2' ' HB2' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -93.47 153.18 18.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.633 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 116.64 12.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.125 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.19 60.17 4.26 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB1' ' H ' ' A' ' 57' ' ' SER . . . -158.32 -152.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 -174.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.468 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 2.0 m -114.81 136.63 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 110.174 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.73 117.53 37.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.424 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 4.7 mmpt? -109.96 138.96 45.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.077 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -111.98 100.97 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -120.83 135.21 55.23 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.347 0.594 . . . . 0.0 111.156 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -94.46 103.86 15.83 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.915 175.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -160.45 127.1 4.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.527 -1.669 . . . . 0.0 106.878 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.63 66.59 5.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 0.0 112.309 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.63 100.7 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 169.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -128.07 -32.76 2.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.795 0.807 . . . . 0.0 110.389 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -96.08 125.16 40.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.44 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 102.0 8.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.417 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 -32.98 49.91 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.424 ' HB2' ' H ' ' A' ' 71' ' ' SER . 10.8 p30 -124.57 -161.03 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 70' ' ' ASN . 0.7 OUTLIER -77.8 6.16 8.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HE2' ' C ' ' A' ' 44' ' ' GLY . 2.9 p90 -157.28 -158.88 0.79 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.112 -0.367 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mp -104.13 99.24 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.144 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tp -81.55 116.51 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 109.908 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -101.48 137.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.22 -175.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -76.51 154.53 34.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.25 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.03 99.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.427 ' HB2' ' H ' ' A' ' 79' ' ' ASN . . . 21.25 -102.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 125.198 1.561 . . . . 0.0 114.08 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 11.7 m-80 -121.08 70.87 0.92 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 38.6 t -114.3 129.9 56.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.376 -0.828 . . . . 0.0 111.199 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 135.81 42.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.152 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 112.4 20.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.719 0.295 . . . . 0.0 110.525 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.36 124.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.916 0.388 . . . . 0.0 111.081 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 54' ' ' CYS . 19.8 mt -88.48 94.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.284 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 175.58 30.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.369 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.96 -13.82 34.65 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.503 2.135 . . . . 0.0 111.983 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.31 41.59 1.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.484 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.6 -53.96 4.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.304 0.573 . . . . 0.0 110.749 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.18 64.85 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.459 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.75 65.32 4.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 110.659 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -113.43 -133.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.055 178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.469 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 14.9 t0 -78.87 66.9 4.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.174 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 21.5 t0 46.79 80.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.927 0.767 . . . . 0.0 111.58 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -110.67 157.99 19.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.929 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 15.6 mtmt -106.31 124.52 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.799 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -80.33 128.68 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.142 2.561 . . . . 0.0 111.321 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.85 132.67 53.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.752 0.31 . . . . 0.0 110.723 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB2' HD13 ' A' ' 4' ' ' ILE . 12.7 t -103.52 113.2 26.53 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 126.42 33.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.269 0.556 . . . . 0.0 111.553 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.604 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 2.4 mp0 -80.3 129.64 34.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.92 110.98 5.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.202 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 ttm -96.26 104.18 16.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.058 0.456 . . . . 0.0 109.989 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.78 -12.66 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.221 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.1 152.08 16.29 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.781 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.75 20.49 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.848 2.365 . . . . 0.0 112.648 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.54 -65.13 0.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.319 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.93 171.91 12.35 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.728 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 46.4 m -139.7 120.37 9.41 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.553 0.216 . . . . 0.0 110.446 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 7.0 Cg_exo -73.11 169.06 23.15 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 112.143 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.21 74.63 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.399 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -46.16 7.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.116 0.484 . . . . 0.0 109.804 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -135.17 134.22 39.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.277 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.1 137.3 37.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.412 0.625 . . . . 0.0 110.701 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.41 136.66 26.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -99.74 115.79 65.31 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 14.9 Cg_exo -67.69 121.93 9.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.985 1.79 . . . . 0.0 111.333 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.52 137.94 55.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -123.64 78.72 1.63 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.11 0.3 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.896 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.98 -7.47 57.03 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.167 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 59.14 45.34 14.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.096 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.8 91.26 4.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.631 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -145.95 102.94 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.11 94.14 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.449 ' HB2' HD13 ' A' ' 75' ' ' ILE . 35.3 m -131.17 -176.09 3.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 111.284 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.26 159.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.295 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.14 133.75 30.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.38 104.66 0.95 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.867 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG23 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -62.76 110.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.851 0.358 . . . . 0.0 110.787 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.4 pt -59.02 120.1 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.2 -26.61 9.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.565 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m -94.33 164.53 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.759 0.314 . . . . 0.0 110.491 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.62 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 68.1 mt-30 -106.09 149.37 26.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.168 0.509 . . . . 0.0 111.695 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.572 ' HB2' HD13 ' A' ' 4' ' ' ILE . 10.5 t -108.73 134.87 50.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.289 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.73 -19.47 51.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.104 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -125.39 -123.8 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.909 0.355 . . . . 0.0 111.941 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.458 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -90.19 96.84 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.258 0.551 . . . . 0.0 112.279 -172.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.14 125.65 45.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -141.77 170.39 15.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.641 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -112.07 124.16 51.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 69.5 m -134.21 132.5 39.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.937 0.399 . . . . 0.0 110.473 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 14.9 tptm -104.38 121.89 44.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.597 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.689 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -164.96 165.51 20.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.768 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -115.01 102.61 10.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.961 0.41 . . . . 0.0 110.736 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.79 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.5 129.15 34.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -9.12 59.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.6 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.4 117.96 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.425 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.39 -50.49 0.78 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.787 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -123.15 149.99 43.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.45 -46.16 14.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.992 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.64 157.41 18.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.14 97.14 10.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mp -69.41 133.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 7.8 mt -91.44 129.81 41.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.323 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 21.5 m-80 -65.63 -16.03 63.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.103 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.84 36.02 25.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.341 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.7 -57.17 3.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.428 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.1 m-80 -117.5 97.96 6.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.595 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.5 m -124.04 130.55 52.76 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.922 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.69 152.95 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.254 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.582 -179.591 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.589 HG22 HG23 ' A' ' 58' ' ' VAL . 0.7 OUTLIER -103.26 101.37 11.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.909 0.385 . . . . 0.0 110.265 176.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.661 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.31 125.13 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.939 -178.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.4 mt -86.04 86.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.172 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 169.49 51.27 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.762 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.79 -42.59 30.74 Favored 'Trans proline' 0 CA--C 1.527 0.168 0 C-N-CA 122.615 2.21 . . . . 0.0 113.045 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.88 33.09 3.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -59.29 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 110.233 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.82 71.44 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.123 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.8 8.85 11.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.47 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.466 HG22 ' H ' ' A' ' 12' ' ' ASP . 2.6 mt -65.18 161.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.379 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -18.68 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.806 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -149.6 86.63 1.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.553 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 27.8 m-85 -140.95 166.21 25.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.978 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -117.25 142.36 30.03 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.507 175.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 9.3 Cg_exo -71.36 124.87 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.565 2.177 . . . . 0.0 111.281 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.2 m-85 -121.81 130.82 53.68 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -93.93 112.84 24.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.27 163.92 29.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.93 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -100.65 105.73 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.963 0.411 . . . . 0.0 110.301 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -83.29 96.09 8.38 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.5 ttt -109.47 134.25 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.944 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.82 97.74 9.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . -92.68 117.17 5.28 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.948 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 4.1 Cg_exo -80.91 142.5 13.94 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.216 2.611 . . . . 0.0 111.901 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.15 50.21 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.426 0.632 . . . . 0.0 110.391 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.72 142.51 24.67 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.386 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.8 m -144.69 119.19 5.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.9 114.65 2.87 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.684 2.256 . . . . 0.0 111.6 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -143.1 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.91 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.7 126.82 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.833 0.349 . . . . 0.0 110.761 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.79 88.35 2.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.025 0.441 . . . . 0.0 109.863 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -79.7 133.64 36.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.32 84.92 7.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 110.189 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.523 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -89.95 142.78 29.18 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 122.73 11.8 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -152.11 158.35 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.374 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -124.05 130.49 52.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tp -123.33 25.82 8.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.523 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.24 -41.11 7.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.071 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.18 74.29 10.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.064 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 m -157.93 96.56 1.48 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.931 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.546 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -159.14 107.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.107 0.48 . . . . 0.0 110.458 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.06 87.13 0.38 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.429 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -128.53 168.59 15.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -176.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.6 158.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.588 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.73 142.03 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.31 147.13 34.02 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.396 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.3 t -86.0 120.78 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 0.0 110.561 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.38 123.12 21.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.67 3.32 68.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.068 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.41 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 19.6 m -108.09 160.34 15.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.017 0.436 . . . . 0.0 110.877 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.661 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -96.95 127.85 43.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.3 t -108.46 138.33 44.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.08 12.9 58.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.978 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.18 177.4 4.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 116.85 20.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.255 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.589 HG23 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -85.46 113.02 23.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.289 0.566 . . . . 0.0 111.244 -178.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 12.6 ptpt -115.3 171.45 7.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.18 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 33.4 m -117.75 119.64 35.52 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.972 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.71 146.02 50.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.483 0.659 . . . . 0.0 111.427 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HB2' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -137.77 133.36 33.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.014 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -160.84 -174.32 4.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.98 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -79.33 -72.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.51 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 47.79 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.337 1.023 . . . . 0.0 112.89 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 t -84.15 139.11 32.64 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.383 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 59.84 0.87 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.237 0.541 . . . . 0.0 110.312 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -42.07 24.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.588 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.1 57.28 0.22 Allowed Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.51 139.82 52.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -42.68 95.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.691 -175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 162.41 33.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.285 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -90.87 130.53 36.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.96 0.409 . . . . 0.0 111.833 -172.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.43 128.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.546 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -97.47 150.36 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.843 0.354 . . . . 0.0 110.364 -178.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -95.98 -2.55 46.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.16 31.13 19.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.539 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.74 -46.94 67.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -127.4 97.93 5.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.13 139.07 33.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.24 0.543 . . . . 0.0 111.606 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.82 127.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.97 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 O-C-N 124.252 0.97 . . . . 0.0 111.346 -179.699 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.78 111.36 19.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 131.66 35.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.497 HG12 HG13 ' A' ' 58' ' ' VAL . 11.9 mt -83.1 103.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.647 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.73 -173.5 26.8 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.847 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -13.56 24.64 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.718 2.279 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.12 45.3 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.25 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -84.66 -61.96 1.66 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.077 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.3 p -160.63 164.41 31.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.662 0.267 . . . . 0.0 110.663 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.75 -113.25 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 175.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.493 ' H ' ' HB2' ' A' ' 10' ' ' SER . 0.9 OUTLIER 53.17 -110.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 122.953 0.501 . . . . 0.0 111.541 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.16 177.59 5.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' N ' ' CG ' ' A' ' 12' ' ' ASP . 12.2 t70 -67.29 77.18 0.15 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.768 0.794 . . . . 0.0 109.797 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 9.9 m-85 -97.5 140.89 31.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.805 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -105.39 135.09 19.39 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HB3' HG21 ' A' ' 8' ' ' THR . 41.0 Cg_endo -70.47 132.34 21.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.175 1.917 . . . . 0.0 111.137 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.892 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 6.7 m-85 -119.13 130.72 55.71 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.159 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.05 112.93 25.05 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 157.95 36.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.434 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -80.53 111.27 16.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.272 0.558 . . . . 0.0 110.533 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -117.98 130.3 56.11 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.106 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.8 ptm -91.05 -176.2 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -172.93 3.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.487 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 112.51 0.31 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.04 118.35 4.71 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.121 2.547 . . . . 0.0 112.961 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.49 -14.09 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 57.41 3.15 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.635 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m -122.91 116.1 29.03 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 3.6 Cg_exo -75.24 78.15 3.03 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.215 2.61 . . . . 0.0 112.324 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.16 113.85 2.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.253 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.21 73.97 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 109.779 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.64 91.37 4.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.504 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -93.57 143.07 26.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.303 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.519 HD12 ' H ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -79.11 -77.09 0.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.949 0.404 . . . . 0.0 110.606 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 34' ' ' LEU . 4.6 mt -120.07 112.44 34.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.759 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.014 1.809 . . . . 0.0 111.925 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.93 7.5 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.869 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 41' ' ' ALA . 14.2 t0 -83.85 111.89 19.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.456 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mt -138.24 16.2 2.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.704 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.69 -2.17 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB3' ' OD1' ' A' ' 38' ' ' ASP . . . -84.63 18.07 2.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.39 . . . . 0.0 111.185 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 164.03 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.195 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD11 ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -122.43 176.99 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.348 . . . . 0.0 110.758 -175.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.9 -60.22 0.12 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.892 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 4.1 m 63.29 179.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.742 0.782 . . . . 0.0 112.701 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.19 146.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.889 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.87 122.1 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.067 0.461 . . . . 0.0 109.856 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 99.98 1.37 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.208 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.14 126.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.89 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.741 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.62 -17.18 12.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.061 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -89.44 162.9 15.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -110.68 156.58 20.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.008 0.432 . . . . 0.0 111.113 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.37 137.85 47.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.01 -5.57 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.947 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 20' ' ' GLN . . . -102.88 -105.77 0.27 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.89 147.08 49.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.551 0.215 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.497 HG13 HG12 ' A' ' 4' ' ' ILE . 4.1 t -111.57 106.19 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -120.33 157.52 29.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 60.0 m -104.0 120.13 40.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.084 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.53 151.7 44.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.356 0.598 . . . . 0.0 110.868 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -137.93 135.35 35.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.087 174.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -153.46 -170.64 3.66 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -106.37 38.36 2.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 110.259 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 63' ' ' ASP . 3.1 p -103.32 129.24 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.404 0.621 . . . . 0.0 110.859 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -128.91 -174.06 3.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.23 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -117.58 130.66 56.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.209 0.528 . . . . 0.0 111.737 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -112.51 -6.32 13.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.059 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.61 43.89 0.25 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.1 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.16 170.48 9.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.734 0.302 . . . . 0.0 110.876 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -39.39 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 0.0 110.43 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.29 -174.18 1.65 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.519 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -85.91 155.56 20.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.74 114.43 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.971 176.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.3 pt -105.24 153.3 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.318 0.58 . . . . 0.0 111.189 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -94.52 -4.0 48.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.486 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.66 30.92 14.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.887 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.31 82.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.762 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.52 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.4 m-80 -129.05 80.44 1.97 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.61 54.69 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.481 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 148.24 30.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.043 0.449 . . . . 0.0 111.149 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.169 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.65 0.262 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.45 99.99 11.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.876 0.369 . . . . 0.0 110.293 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 110.07 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.62 HD13 ' SG ' ' A' ' 18' ' ' CYS . 3.6 mt -70.6 122.44 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.13 -161.38 9.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.769 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.36 -22.19 52.98 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.128 2.552 . . . . 0.0 113.075 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -102.14 5.87 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -92.34 -47.79 7.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 10.2 t -135.39 87.54 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.966 0.412 . . . . 0.0 110.9 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.411 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -108.0 -89.41 0.46 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.954 175.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.3 mt 54.5 -103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 122.934 0.494 . . . . 0.0 110.657 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 8.2 t70 -100.72 -113.59 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 24.3 t70 -121.06 66.43 0.86 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 167.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 2.5 m-85 -90.14 151.87 21.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.895 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 3.8 mtmt -102.14 127.46 30.76 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HG3' ' HB3' ' A' ' 9' ' ' CYS . 6.6 Cg_exo -72.8 136.19 24.91 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.543 2.162 . . . . 0.0 110.922 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -129.38 130.41 45.99 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.868 0.366 . . . . 0.0 110.255 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' HD13 ' A' ' 4' ' ' ILE . 2.1 m -99.48 112.59 24.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.854 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.8 m -115.13 115.73 27.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.787 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.644 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 9.9 pt20 -80.46 117.22 21.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.91 143.45 50.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.43 84.91 2.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 110.203 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -79.24 122.29 26.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.824 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.39 160.06 35.88 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.408 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.88 -19.91 26.52 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 123.012 2.475 . . . . 0.0 112.698 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.76 112.04 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.251 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 91.58 0.86 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.041 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -54.07 131.71 59.35 Favored Pre-proline 0 C--N 1.324 -0.534 0 C-N-CA 122.586 0.354 . . . . 0.0 111.51 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 7.5 Cg_exo -72.97 59.89 3.65 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.509 2.806 . . . . 0.0 112.52 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.52 82.81 0.43 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 121.18 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.077 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.92 143.22 31.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.992 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.86 31.07 3.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.256 0.551 . . . . 0.0 110.077 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.66 141.56 47.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.387 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.437 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -117.51 143.44 32.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.078 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 123.31 10.34 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 111.969 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.39 -1.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.643 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -79.07 111.56 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.297 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -3.85 58.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.006 0.431 . . . . 0.0 110.773 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 37.49 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.475 0.655 . . . . 0.0 109.51 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.16 79.75 5.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.53 -162.01 0.89 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.095 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -109.13 103.81 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.29 82.11 1.49 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.439 ' HB2' HD13 ' A' ' 75' ' ' ILE . 1.8 m -134.9 168.27 19.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.516 0.198 . . . . 0.0 110.506 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.55 157.25 21.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.971 0.415 . . . . 0.0 110.819 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -70.64 143.46 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.079 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.14 106.92 3.02 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.899 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.55 133.86 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.733 0.301 . . . . 0.0 110.726 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -71.22 140.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.8 -14.01 66.14 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.597 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -97.81 158.08 15.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -116.16 137.7 51.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 0.0 111.378 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.0 m -115.13 152.05 33.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.188 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -119.99 49.5 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.644 ' CB ' ' HA ' ' A' ' 20' ' ' GLN . . . -153.25 -135.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.584 0.23 . . . . 0.0 110.809 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 1.9 m -107.41 122.49 46.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.077 0.465 . . . . 0.0 110.783 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.53 118.62 56.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.764 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -123.47 163.71 20.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.248 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 91.7 m -111.47 123.62 50.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 97.7 m -133.26 148.05 51.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.088 0.471 . . . . 0.0 111.192 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 2.4 tptm -130.35 140.49 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.698 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 p30 178.37 -177.29 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.877 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.06 116.13 28.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.179 0.514 . . . . 0.0 110.91 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 73' ' ' LEU . 2.4 t -124.37 94.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.631 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.27 141.27 30.57 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.152 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.34 89.89 4.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.476 0.655 . . . . 0.0 110.64 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.53 75.16 1.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.87 -74.61 0.29 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.235 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.68 119.0 22.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.61 -3.54 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 110.663 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -99.07 148.32 24.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HA ' HG13 ' A' ' 65' ' ' VAL . 2.0 mp -76.86 91.58 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.672 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.61 133.15 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.713 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.557 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -94.19 138.27 20.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.245 0.545 . . . . 0.0 111.069 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.13 -18.57 33.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 66.44 24.23 10.43 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.655 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.83 -55.27 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.321 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 5.7 m-80 -114.71 90.56 3.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.691 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 52.7 m -122.2 129.59 52.41 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.653 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.41 131.32 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.377 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.191 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.94 108.71 13.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.857 0.36 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -79.6 119.04 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 54' ' ' CYS . 53.4 mt -68.82 119.22 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.879 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.68 -179.19 30.81 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.116 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HA ' HG12 ' A' ' 50' ' ' ILE . 57.2 Cg_endo -69.51 -38.93 7.63 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.43 54.46 2.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -55.29 6.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.483 -176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -83.0 123.88 29.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -22.87 43.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.612 0.72 . . . . 0.0 109.338 172.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -81.61 134.77 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.737 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.16 140.77 33.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.22 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 69.79 48.68 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.026 0.829 . . . . 0.0 111.19 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 4.7 m-85 -135.47 150.96 49.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 26.5 mtmt -99.09 135.32 20.86 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 4.5 Cg_exo -77.44 140.23 19.06 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.784 2.323 . . . . 0.0 111.511 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.44 140.07 42.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.8 114.12 27.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.493 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 8.9 m -111.78 132.75 54.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.768 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -80.67 121.59 26.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.995 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.92 83.78 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 0.0 110.071 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.25 151.02 31.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 68.2 9.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.593 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.5 -158.44 10.07 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.187 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.72 113.33 2.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.072 2.515 . . . . 0.0 111.897 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.94 -24.05 19.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.667 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.62 119.66 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.01 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.88 89.85 35.02 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.73 141.85 42.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.333 2.022 . . . . 0.0 111.622 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.98 28.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tp -101.86 103.32 14.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 110.944 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mt -142.95 -157.9 0.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -106.64 98.04 7.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.04 114.07 15.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.157 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -108.03 147.78 36.17 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.934 177.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 34.7 Cg_exo -62.16 124.36 14.22 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.517 2.145 . . . . 0.0 112.236 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.37 -44.68 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.324 0.583 . . . . 0.0 110.055 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.4 125.46 34.59 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.7 mt -116.5 162.13 18.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.581 0.229 . . . . 0.0 111.517 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.83 55.88 4.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.443 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.98 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.03 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -110.42 -170.12 1.59 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.029 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.518 ' HB3' HD12 ' A' ' 75' ' ' ILE . 1.4 mm? -84.17 134.13 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 110.686 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.1 91.07 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.4 m -138.43 179.4 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.07 153.95 21.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 73' ' ' LEU . 96.4 t -61.64 127.84 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.628 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.5 76.51 2.08 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.773 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.504 HG22 ' OG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -71.45 146.63 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.76 0.314 . . . . 0.0 110.2 178.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 6' ' ' PRO . 2.2 mt -61.75 124.11 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.669 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.03 -11.56 20.26 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.504 ' OG ' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -89.38 137.51 32.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -96.74 115.46 27.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HB2' HD12 ' A' ' 4' ' ' ILE . 21.7 t -107.25 108.04 19.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.88 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.87 36.01 3.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.974 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 19' ' ' CYS . . . -140.03 -110.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.329 0.109 . . . . 0.0 110.839 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.458 ' H ' ' HB1' ' A' ' 56' ' ' ALA . 1.0 OUTLIER -125.92 125.88 43.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.538 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 t -107.33 127.35 63.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.03 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -145.87 170.28 16.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.306 -179.02 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 57.7 m -116.2 136.9 52.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 110.632 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.9 m -141.83 151.3 42.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.081 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -116.04 118.62 33.39 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.103 175.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -162.58 166.85 24.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.875 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.59 70.02 0.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 73' ' ' LEU . 0.7 OUTLIER -76.58 1.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.424 0.63 . . . . 0.0 111.051 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.55 70.77 6.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.559 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.54 -171.32 2.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.137 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.23 108.18 12.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.001 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.66 150.96 18.61 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.751 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.97 119.17 22.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.412 0.148 . . . . 0.0 111.123 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 m 71.51 -59.24 0.55 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.084 0.865 . . . . 0.0 111.929 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -139.49 -163.06 1.42 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.62 0.248 . . . . 0.0 110.564 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.568 HD12 HG22 ' A' ' 47' ' ' VAL . 7.1 mt -82.48 108.4 15.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.628 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.481 HG21 HD12 ' A' ' 74' ' ' ILE . 7.0 mm -84.84 116.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 43' ' ' LEU . 42.4 mt -91.89 130.69 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 0.0 111.541 -170.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 6.7 t-20 -72.23 106.87 4.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.06 56.74 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 111.673 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.64 -60.73 1.8 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.093 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 6.8 m-80 -111.39 103.8 12.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.008 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.94 132.49 36.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.28 159.33 42.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 116.06 31.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.678 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 1.9 m -80.01 121.19 25.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.35 126.18 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 111.53 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.92 169.69 14.68 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' HG3' HG22 ' A' ' 50' ' ' ILE . 30.4 Cg_exo -61.66 -40.36 46.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.305 2.67 . . . . 0.0 112.395 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 67.21 0.79 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.487 178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.695 HG22 HG11 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -62.1 -45.06 95.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.43 132.07 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.782 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 71.42 6.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.215 0.531 . . . . 0.0 111.421 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -172.2 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.8 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.35 -135.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.16 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.35 101.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.587 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.461 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 23.1 m-85 -146.53 150.62 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.568 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -116.26 135.48 22.84 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 177.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 7.3 Cg_exo -73.44 128.89 13.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.677 2.251 . . . . 0.0 111.646 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CE1' HD12 ' A' ' 75' ' ' ILE . 47.2 m-85 -123.74 146.49 48.26 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.66 112.74 24.37 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 4.9 m -124.61 151.49 44.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.994 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -80.84 141.51 34.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.739 -176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.09 154.22 18.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.0 46.91 0.9 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.566 0.698 . . . . 0.0 109.751 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.91 73.19 6.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.285 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . -90.56 -118.25 1.99 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.864 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 6.5 Cg_exo -74.31 82.93 1.76 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.106 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.41 149.67 40.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.9 20.12 44.55 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.926 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.62 113.89 30.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.05 9.08 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.83 2.353 . . . . 0.0 112.993 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.15 54.85 0.55 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.093 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.86 -43.86 6.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.98 0.419 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' HB3' ' H ' ' A' ' 33' ' ' ASN . 2.4 mp 59.01 -161.61 0.26 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.207 -176.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.424 ' H ' ' HB3' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -159.55 62.26 0.38 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.105 0.479 . . . . 0.0 109.887 175.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -60.78 2.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.036 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG21 ' HD2' ' A' ' 36' ' ' PRO . 3.5 mt -127.18 125.91 24.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 35' ' ' ILE . 15.7 Cg_endo -58.34 123.92 14.7 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.448 2.099 . . . . 0.0 112.259 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.52 99.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.846 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -102.37 142.84 32.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.75 34.67 2.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.318 0.58 . . . . 0.0 109.506 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.67 -9.39 20.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.59 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.83 11.06 39.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.875 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -142.12 107.41 5.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.991 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.582 HD13 ' SG ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -128.44 124.37 36.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.423 0.63 . . . . 0.0 111.092 -178.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.17 83.88 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' HD13 ' A' ' 43' ' ' LEU . 24.4 m -127.35 173.09 10.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.251 0.548 . . . . 0.0 111.87 -172.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.97 158.82 19.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.641 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.5 t -63.98 129.05 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 132.91 17.09 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.088 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.5 t -87.92 114.45 26.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.488 HG22 ' HG3' ' A' ' 6' ' ' PRO . 2.4 mp -64.43 118.13 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.18 178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.44 -14.89 35.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.73 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 49.6 m -102.87 164.44 11.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.772 0.32 . . . . 0.0 110.143 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.2 pt20 -108.92 149.07 29.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.089 0.471 . . . . 0.0 110.759 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.4 m -122.15 120.81 35.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.448 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.59 48.41 3.67 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 19' ' ' CYS . . . -158.18 -133.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.501 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -113.95 145.18 41.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.975 177.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.695 HG11 HG22 ' A' ' 8' ' ' THR . 21.9 t -102.93 109.52 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.704 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.77 156.48 17.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.118 -174.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 105.26 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -124.36 137.85 54.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.195 0.521 . . . . 0.0 110.998 -176.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -119.2 123.65 44.84 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.632 175.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -178.68 155.75 0.84 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.764 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 94.36 6.34 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -52.08 126.48 7.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.456 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.49 45.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.008 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -27.06 17.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.482 0.658 . . . . 0.0 110.126 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 86.48 5.01 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.681 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.48 -45.33 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -134.89 169.54 17.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.656 0.265 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -19.22 63.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.412 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.25 169.07 12.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' HB2' HG13 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -65.62 105.5 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 178.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.55 140.55 15.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.0 110.517 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -107.29 130.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.357 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -71.7 -13.2 61.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.727 0.298 . . . . 0.0 110.323 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.427 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . . . 59.49 28.8 18.27 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.653 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.82 82.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.817 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 2.9 m-80 -123.73 83.28 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.119 176.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 131.42 52.44 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.556 -176.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.01 148.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.504 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.704 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.669 0.271 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 136.65 35.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.667 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.16 137.03 40.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.803 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.53 123.75 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.774 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' H ' HG23 ' A' ' 8' ' ' THR . . . -146.83 -178.93 22.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.68 -30.43 90.4 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.776 2.317 . . . . 0.0 112.093 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -114.3 62.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.511 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -72.27 -65.94 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 -178.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.75 157.51 15.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.932 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -82.84 85.36 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.163 0.506 . . . . 0.0 111.314 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 14' ' ' TYR . 0.8 OUTLIER -144.03 -170.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.295 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.32 108.95 3.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.799 ' HB2' HD11 ' A' ' 11' ' ' ILE . 21.5 m-85 -132.58 156.41 46.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.359 -172.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.65 125.42 82.58 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.3 Cg_exo -76.59 125.46 8.28 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.789 2.326 . . . . 0.0 111.848 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 61' ' ' CYS . 93.7 m-85 -123.31 149.18 45.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.35 116.01 8.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.02 175.09 10.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.374 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 137.66 37.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.267 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -89.18 116.05 27.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.938 0.399 . . . . 0.0 109.933 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.16 106.17 9.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.432 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.39 143.42 26.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.203 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . 173.16 -131.83 2.19 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.421 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 2.9 Cg_exo -75.23 70.05 5.56 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.183 2.589 . . . . 0.0 112.291 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.93 -48.54 9.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.667 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.17 168.05 38.55 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.056 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -118.48 133.86 23.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.431 0.158 . . . . 0.0 110.598 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 28.2 Cg_exo -61.98 107.65 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.187 2.591 . . . . 0.0 111.993 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.41 -140.37 9.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.284 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.65 2.8 55.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.635 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -148.05 174.19 12.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.803 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -79.77 144.16 33.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.965 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 133.89 43.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -118.74 106.72 43.57 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.429 -179.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.96 124.31 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.505 2.137 . . . . 0.0 111.903 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.482 ' H ' HG21 ' A' ' 37' ' ' VAL . 1.8 m -79.24 -27.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.086 0.469 . . . . 0.0 110.033 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -113.26 108.13 16.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.118 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 -49.16 11.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.942 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -165.91 55.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.39 -5.61 26.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.255 0.55 . . . . 0.0 110.422 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.57 ' O ' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -114.41 109.47 18.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.159 176.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -138.34 110.45 7.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.059 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.0 112.87 2.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 t -153.97 178.33 10.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 m -122.05 158.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.72 125.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.56 135.61 41.78 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.118 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.43 98.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.449 HG21 ' HA2' ' A' ' 5' ' ' GLY . 2.7 pt -60.49 120.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.415 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 -8.02 26.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.957 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -116.93 154.22 31.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.802 0.334 . . . . 0.0 110.854 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 15.2 mt-30 -84.35 151.28 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.299 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.27 106.63 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.093 -177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.41 58.97 3.04 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.93 -166.59 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.08 95.75 6.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.619 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.67 135.52 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.175 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.17 155.15 45.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.9 m -128.32 108.44 10.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 70.7 m -124.01 142.02 51.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.362 0.601 . . . . 0.0 112.037 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.82 120.26 41.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.473 172.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.35 -170.5 3.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.167 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.24 50.02 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.444 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 75' ' ' ILE . 51.5 t -61.84 124.84 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.068 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.72 119.57 35.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -79.9 100.25 7.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.252 0.549 . . . . 0.0 111.854 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -19.93 48.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.912 0.863 . . . . 0.0 109.81 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.52 53.22 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -111.49 139.65 46.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.87 -51.29 68.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.428 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.12 148.06 41.88 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 98.75 8.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.488 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.428 ' H ' HG13 ' A' ' 74' ' ' ILE . 1.6 mt -69.18 126.16 28.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.558 HG23 ' H ' ' A' ' 77' ' ' ALA . 3.9 mt -92.33 146.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.227 0.537 . . . . 0.0 110.249 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -76.48 -0.48 23.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.281 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.558 ' H ' HG23 ' A' ' 75' ' ' ILE . . . 64.42 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 79' ' ' ASN . . . 52.04 -95.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.862 0.726 . . . . 0.0 111.496 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 19.4 m-80 -91.71 78.66 5.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.251 -176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.7 m -114.43 130.2 56.7 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.782 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 159.48 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.79 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.243 178.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 107.19 19.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.339 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -79.05 125.46 29.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.0 0.429 . . . . 0.0 110.826 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -80.53 95.06 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.368 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.41 171.08 17.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.78 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' HD3' HG23 ' A' ' 50' ' ' ILE . 57.1 Cg_endo -70.77 -15.49 33.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 111.709 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.409 HD21 ' HA ' ' A' ' 7' ' ' ASN . 4.2 m120 -107.49 46.81 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.918 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -64.8 0.88 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 128.88 52.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.843 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.43 79.25 9.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.915 0.388 . . . . 0.0 110.853 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -162.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -60.65 163.74 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.978 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.14 103.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 111.158 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CE1' ' HG2' ' A' ' 62' ' ' LYS . 6.3 m-85 -121.8 165.99 15.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.075 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -112.84 137.61 21.86 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -75.06 130.24 13.02 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.801 2.334 . . . . 0.0 111.31 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 40.1 m-85 -124.2 135.58 53.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.767 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -105.22 115.27 29.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.449 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.68 152.63 28.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.804 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -80.38 105.49 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.144 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -125.18 -25.49 3.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.985 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.417 ' HB3' ' H ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -96.61 -100.38 0.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.779 -178.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -123.03 157.81 31.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.429 . . . . 0.0 111.116 -177.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.83 -151.56 22.75 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.996 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.92 112.55 2.05 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.757 2.305 . . . . 0.0 112.375 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 140.21 37.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.29 -57.44 1.37 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.671 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.1 m -140.4 130.74 13.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.583 0.23 . . . . 0.0 111.194 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.61 141.91 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.791 2.327 . . . . 0.0 111.997 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 62.91 3.34 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.379 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.06 -20.81 37.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.068 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.1 -164.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -79.25 125.04 28.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.902 0.382 . . . . 0.0 110.28 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.91 132.11 43.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.493 175.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.656 HD13 HG11 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -93.08 139.29 23.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 36.0 Cg_exo -61.51 122.0 10.41 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.891 1.727 . . . . 0.0 110.848 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG11 HD13 ' A' ' 35' ' ' ILE . 9.8 p -179.34 147.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.541 -177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -119.55 131.08 55.46 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -1.09 9.77 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.09 72.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 111.174 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.07 -8.81 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.195 0.522 . . . . 0.0 110.305 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.46 176.48 9.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.036 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -114.23 117.1 30.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.313 0.578 . . . . 0.0 111.341 -174.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.96 49.14 4.08 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.685 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 53.6 m -95.29 154.36 17.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.332 . . . . 0.0 110.797 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 72' ' ' PHE . 1.1 p -117.84 152.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.77 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.42 117.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.97 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.53 125.33 6.9 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.057 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' H ' HG11 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -77.07 125.16 36.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.446 HG23 ' HD3' ' A' ' 6' ' ' PRO . 1.8 mp -62.01 127.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.548 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.01 -16.77 11.96 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.211 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.69 165.06 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.783 0.325 . . . . 0.0 111.169 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -110.58 132.08 54.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.15 145.71 38.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.471 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.38 -11.1 46.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.495 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.23 -177.11 4.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.125 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 125.17 29.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.905 0.383 . . . . 0.0 110.519 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 3.9 t -97.11 120.15 46.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.815 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 mtpt -112.68 169.76 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.81 102.95 10.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 2.9 m -132.22 161.09 34.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.504 0.669 . . . . 0.0 112.099 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 2.2 pttt -156.45 157.73 36.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.456 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.6 -173.2 2.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.422 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.06 69.26 10.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -122.6 107.56 19.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.215 175.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -75.58 0.27 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.414 0.626 . . . . 0.0 110.946 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -149.19 147.43 28.42 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.075 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 120.14 7.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.78 46.9 3.19 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.121 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.85 175.12 6.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.27 -24.75 65.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.94 0.4 . . . . 0.0 111.531 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.596 ' HB2' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -160.22 152.72 20.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.004 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' HB2' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -112.23 125.13 53.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.043 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.46 136.47 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.373 0.606 . . . . 0.0 111.545 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.501 HD13 ' CE1' ' A' ' 17' ' ' TYR . 35.8 mm -98.1 119.06 45.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -63.81 -24.96 67.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 81.3 31.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.734 0.814 . . . . 0.0 111.166 177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -56.9 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.446 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -120.94 75.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.036 -179.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.622 ' SG ' ' HE2' ' A' ' 59' ' ' LYS . 18.3 t -134.79 130.32 35.94 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.02 152.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.379 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.815 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.312 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -84.18 121.69 27.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.923 0.392 . . . . 0.0 111.337 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 106.97 18.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 12.2 mt -82.75 130.25 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 111.384 -173.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 50' ' ' ILE . . . -133.06 -171.86 12.84 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.864 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' A' ' 50' ' ' ILE . 36.4 Cg_endo -66.19 -27.64 48.73 Favored 'Trans proline' 0 CA--C 1.525 0.066 0 C-N-CA 122.539 2.159 . . . . 0.0 112.687 -177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -96.63 14.24 25.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.475 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -86.68 -22.58 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.254 0.55 . . . . 0.0 110.322 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -135.09 105.11 6.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.614 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.19 33.11 4.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.468 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 ' HB ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -108.6 163.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.291 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.55 109.61 4.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.307 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.7 27.44 15.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.32 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.66 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 11.2 m-85 -95.87 123.21 39.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.031 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 16.8 mttt -91.4 134.38 29.68 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.45 137.81 34.26 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.636 2.224 . . . . 0.0 111.175 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 21.5 m-85 -131.62 138.6 48.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -95.5 112.94 24.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 m -113.5 120.16 40.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 105.88 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.12 140.95 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.448 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.92 161.21 13.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.521 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.78 57.46 0.61 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.177 0.513 . . . . 0.0 110.585 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.82 -163.52 32.53 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.94 119.77 5.21 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.951 2.434 . . . . 0.0 111.856 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.08 -14.19 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.032 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.89 24.55 21.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.664 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.28 115.21 49.2 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 122.714 0.406 . . . . 0.0 111.434 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -92.66 94.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.316 2.677 . . . . 0.0 111.964 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.25 -35.23 0.54 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.932 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.63 103.81 15.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.267 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -83.41 -3.23 57.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.356 0.598 . . . . 0.0 110.202 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -98.98 2.14 46.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.979 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -100.47 161.74 13.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.44 ' H ' HD12 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -104.48 159.31 29.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.002 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.97 124.62 15.29 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.366 2.044 . . . . 0.0 111.473 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -173.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.97 172.19 14.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.507 . . . . 0.0 110.851 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -45.56 9.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.521 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 p -172.34 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 70.98 -49.91 0.68 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.928 0.891 . . . . 0.0 112.311 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.94 167.83 15.34 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 122.358 -0.214 . . . . 0.0 110.58 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.564 ' HB3' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -150.52 141.97 23.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.929 171.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.12 88.56 0.53 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.643 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.813 ' HB2' HD12 ' A' ' 75' ' ' ILE . 36.3 m -141.52 165.78 26.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.08 152.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.12 133.57 30.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.345 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.4 89.78 0.36 Allowed Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.903 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -61.36 117.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.537 0.208 . . . . 0.0 110.486 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.478 HG22 ' HD3' ' A' ' 6' ' ' PRO . 3.3 mp -56.79 116.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.75 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.19 -9.5 17.88 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.833 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.01 165.85 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 0.0 110.345 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -121.11 125.49 47.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.141 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 82.6 m -108.44 122.5 47.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.974 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.15 56.64 4.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.269 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.13 -165.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.6 136.21 35.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.747 0.308 . . . . 0.0 110.32 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.4 t -108.29 123.93 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.208 0.527 . . . . 0.0 110.796 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -130.22 171.15 13.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.12 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 95.6 m -114.78 120.53 40.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.97 0.414 . . . . 0.0 109.972 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.2 m -125.19 123.22 39.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.341 0.591 . . . . 0.0 111.586 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.85 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 23.1 tptt -88.2 90.69 8.49 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.44 130.42 44.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.518 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 52.65 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.129 0.49 . . . . 0.0 111.038 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.18 128.29 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.949 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -84.96 146.49 27.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -91.45 97.73 11.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.558 0.694 . . . . 0.0 111.102 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -24.9 12.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.534 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 57.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.665 -1.607 . . . . 0.0 109.67 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.19 97.31 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.212 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.54 -35.58 45.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.672 0.749 . . . . 0.0 109.282 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.32 146.85 50.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.61 92.42 5.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.996 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.98 126.69 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.902 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -92.9 136.51 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 -174.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -79.62 -9.74 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.59 36.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.523 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.08 -66.43 0.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.31 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.85 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.5 m-80 -122.5 85.05 2.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.881 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.3 m -114.99 130.26 56.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.042 0.449 . . . . 0.0 111.209 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.85 160.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.949 -179.532 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -86.46 126.76 34.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -90.33 135.69 33.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.041 175.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 30.0 mt -91.21 130.86 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.745 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.65 -170.07 40.85 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.16 -13.27 39.11 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.365 2.043 . . . . 0.0 111.701 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -78.92 -35.99 42.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.286 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.701 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 t -140.08 123.3 16.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.828 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.31 93.96 3.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -133.69 152.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -18.48 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.204 1.402 . . . . 0.0 114.09 -174.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -119.87 47.88 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.575 0.702 . . . . 0.0 109.658 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.4 m-85 -108.84 119.47 39.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.84 -176.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -92.91 134.29 27.67 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.658 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.6 Cg_exo -68.76 125.61 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.612 2.208 . . . . 0.0 111.363 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 16.0 m-85 -114.35 144.97 42.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.097 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.77 113.62 27.22 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.35 120.27 37.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.865 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 56' ' ' ALA . 17.8 mt-30 -82.03 103.96 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.96 28.9 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.906 -174.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -113.02 -65.38 1.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.215 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -108.23 135.37 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.39 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.93 -138.78 5.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.083 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.16 -4.2 14.12 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.689 2.259 . . . . 0.0 112.975 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.24 152.89 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.592 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.97 -122.84 1.16 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.607 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 2.0 m -71.0 -53.47 8.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 83.6 Cg_endo -86.66 154.74 8.92 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.796 1.664 . . . . 0.0 112.232 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.73 108.72 3.59 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.24 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.39 -174.54 3.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.863 0.363 . . . . 0.0 110.935 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.35 175.57 9.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.873 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -84.16 175.18 9.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.99 -16.55 63.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.425 0.631 . . . . 0.0 110.419 178.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.43 131.87 23.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.022 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.78 124.7 16.88 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.771 2.314 . . . . 0.0 112.077 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.82 129.33 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.381 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.5 118.02 35.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.577 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.27 24.55 8.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -100.09 -39.33 8.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 -57.85 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 2.1 m -123.27 -162.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.518 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.469 HD12 ' SG ' ' A' ' 45' ' ' CYS . 1.6 mm? -112.03 113.62 26.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.938 0.399 . . . . 0.0 110.951 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.79 66.64 3.87 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.08 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 43' ' ' LEU . 1.8 m -121.14 162.08 20.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.84 153.34 21.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -65.27 137.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.796 -178.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.87 119.72 5.78 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.667 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.86 108.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.92 0.39 . . . . 0.0 110.602 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 2.4 mp -54.43 118.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.181 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.26 -0.16 29.7 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.415 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.77 151.51 43.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 7.6 mt-30 -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 157.41 44.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.102 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.24 43.97 1.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 20' ' ' GLN . . . -142.25 -172.03 3.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.854 -0.173 . . . . 0.0 110.56 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 104.8 12.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 30.6 m -88.97 144.03 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 6.5 ptpt -157.33 171.55 20.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.483 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -110.5 122.06 46.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.973 0.416 . . . . 0.0 110.271 -177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.72 136.62 51.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.423 0.63 . . . . 0.0 111.755 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.53 136.03 53.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -157.18 177.1 11.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.07 27.77 6.35 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.446 0.641 . . . . 0.0 109.952 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.63 128.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.903 -178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 68' ' ' THR . 12.8 t -118.02 -175.12 2.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.112 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.1 -14.31 59.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 111.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 66' ' ' THR . 0.3 OUTLIER -80.85 70.11 7.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.77 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.908 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.28 170.71 15.32 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -24.64 61.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.258 0.551 . . . . 0.0 110.154 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -107.2 142.97 36.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.476 HD12 HG23 ' A' ' 47' ' ' VAL . 66.6 mt -78.92 92.91 4.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.034 0.445 . . . . 0.0 110.578 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -74.29 125.91 34.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.901 177.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 137.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.559 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 64.7 t30 -80.72 -4.95 56.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.547 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 64.56 26.92 13.36 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.625 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.72 87.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -130.27 75.25 1.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.665 177.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 9.5 m -113.85 130.2 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.651 0.263 . . . . 0.0 110.359 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.11 159.72 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.894 0.378 . . . . 0.0 110.958 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.371 178.168 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 99.86 10.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.45 126.92 31.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG21 ' HA3' ' A' ' 48' ' ' GLY . 25.7 mt -96.35 115.81 36.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.055 0.455 . . . . 0.0 111.646 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.93 17.49 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.496 ' HD3' HG12 ' A' ' 50' ' ' ILE . 47.1 Cg_endo -68.26 -23.24 39.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -84.23 -13.09 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.396 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -82.05 -53.69 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.872 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -152.65 105.01 2.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 111.175 -177.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.4 m -152.81 74.05 1.03 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.346 0.593 . . . . 0.0 109.586 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.61 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -94.59 -151.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.909 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.3 94.42 0.26 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.872 0.367 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 t0 54.5 37.3 27.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.039 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.61 ' HD2' ' HB ' ' A' ' 11' ' ' ILE . 6.2 m-85 -111.04 123.72 50.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.742 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -104.97 149.6 37.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.944 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.2 Cg_exo -77.33 138.73 18.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.88 2.387 . . . . 0.0 112.252 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' OH ' ' HB3' ' A' ' 64' ' ' ASP . 16.6 m-85 -126.31 145.06 50.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.225 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -96.74 112.94 24.48 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.21 141.99 18.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.068 0.461 . . . . 0.0 110.758 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -112.79 114.07 26.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 176.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 82.09 7.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.376 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -134.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.287 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 148.82 32.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.486 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . 175.37 -120.34 0.76 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.213 -0.518 . . . . 0.0 111.927 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 7.2 Cg_exo -73.17 89.16 0.92 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.289 2.659 . . . . 0.0 112.159 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 84.94 1.57 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.02 42.44 99.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.644 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -66.87 130.93 93.92 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.919 -177.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 13.1 Cg_exo -70.62 58.93 2.01 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.279 2.653 . . . . 0.0 112.416 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.79 36.75 0.2 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -85.47 -19.23 31.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 -177.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 pp -92.35 -17.63 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.457 176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.44 -25.17 42.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.763 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.22 177.94 5.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.373 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.03 101.56 53.54 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.8 123.79 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.38 2.053 . . . . 0.0 111.925 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.3 -56.26 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 109.422 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -161.03 162.62 31.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.113 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.38 -40.49 30.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.67 57.58 4.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.944 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.51 52.32 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 110.834 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.42 ' O ' HD21 ' A' ' 43' ' ' LEU . 5.5 m -150.24 92.97 1.93 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 111.416 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -132.44 103.34 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 0.0 110.281 175.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.21 98.99 0.65 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -153.55 -174.73 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.52 154.01 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 111.851 -170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.97 144.49 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -87.61 95.28 2.06 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.517 HG22 ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -63.87 127.12 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.718 0.294 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.496 HG12 ' HD3' ' A' ' 6' ' ' PRO . 1.7 mp -56.82 121.97 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.568 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.18 27.12 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' OG ' HG22 ' A' ' 49' ' ' VAL . 1.6 m -98.88 156.28 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.523 0.202 . . . . 0.0 110.577 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.57 154.56 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 m -134.19 145.51 49.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.054 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.08 -10.45 80.57 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 20' ' ' GLN . . . -89.52 -174.68 4.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.725 -0.737 . . . . 0.0 110.123 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -92.83 160.34 14.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.757 0.313 . . . . 0.0 110.415 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.55 128.62 53.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.03 153.85 26.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 106.36 14.82 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -121.49 148.17 44.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.452 0.644 . . . . 0.0 111.486 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.766 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.9 tttp -137.82 141.01 40.82 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.759 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 80.81 78.77 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.799 1.312 . . . . 0.0 109.271 -170.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.617 ' HA ' HG22 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -98.31 -109.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.194 -174.318 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' H ' ' HB2' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -107.82 134.66 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 111.121 -176.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -59.78 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.866 0.841 . . . . 0.0 110.255 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -115.59 139.45 50.08 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.639 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 51.8 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.15 0.5 . . . . 0.0 111.279 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.08 42.16 3.04 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.704 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.14 165.08 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -58.49 3.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.59 170.81 7.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.216 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -70.83 131.47 43.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.946 0.403 . . . . 0.0 111.177 -178.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.516 HD11 HG22 ' A' ' 74' ' ' ILE . 19.3 mt -118.3 133.43 65.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.012 178.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.617 HG22 ' HA ' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -102.93 142.16 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.284 -179.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -87.98 8.43 26.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.87 -124.6 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.976 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.38 -67.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.057 0.543 . . . . 0.0 111.377 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.766 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.2 m-80 -116.28 102.3 9.45 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 130.86 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.602 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.01 159.75 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.036 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.066 178.083 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.972 0.415 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 110.36 21.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -79.2 120.17 23.32 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 58' ' ' VAL . 6.0 mt -83.66 128.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 176.15 33.69 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.639 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.719 ' HA ' HG22 ' A' ' 50' ' ' ILE . 46.2 Cg_exo -57.15 -32.7 94.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.901 2.401 . . . . 0.0 112.093 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.07 87.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.779 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -36.68 82.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -103.39 156.16 17.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.95 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.41 51.59 1.47 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.529 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.507 HG23 HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -123.26 151.79 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.441 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.6 115.6 14.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.07 72.17 0.54 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.269 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.65 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 4.3 m-85 -125.9 141.58 51.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.242 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 11.4 mtmt -90.84 124.28 62.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.617 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.8 Cg_exo -76.03 139.27 21.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.089 2.526 . . . . 0.0 111.771 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.11 143.62 51.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -92.06 112.26 24.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' SG ' ' HG3' ' A' ' 59' ' ' LYS . 98.4 m -119.34 125.07 48.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.476 ' HG2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -107.48 -12.86 15.21 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.555 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 83.05 6.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.756 0.789 . . . . 0.0 110.529 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -11.05 32.72 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.286 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.62 149.51 5.02 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.372 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.84 121.17 9.51 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.716 2.277 . . . . 0.0 112.172 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.43 37.09 3.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.043 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.99 26.09 25.8 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.486 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -66.05 125.39 90.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 122.679 0.392 . . . . 0.0 111.029 -178.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 2.8 Cg_exo -76.56 40.6 0.79 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.322 2.681 . . . . 0.0 112.507 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.8 21.11 37.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.51 80.62 6.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.903 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.06 -11.68 35.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.619 0.723 . . . . 0.0 109.086 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -110.2 128.01 55.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.815 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.08 84.62 3.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.113 0.482 . . . . 0.0 111.826 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.88 94.14 48.87 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.18 124.32 14.98 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.722 2.281 . . . . 0.0 112.08 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.88 117.59 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.296 0.57 . . . . 0.0 110.967 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.28 148.44 46.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.072 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.84 21.4 4.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.168 0.508 . . . . 0.0 109.959 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -18.59 44.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.389 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.23 6.16 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -133.49 92.83 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.598 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -117.68 103.91 10.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.364 0.602 . . . . 0.0 111.049 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.71 94.56 0.57 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.171 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.58 ' HB2' HD13 ' A' ' 75' ' ' ILE . 80.1 m -136.53 177.79 7.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.13 148.77 23.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.906 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.496 ' H ' HG21 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -65.32 141.64 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.967 0.413 . . . . 0.0 110.589 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.72 136.42 14.04 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.195 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 22.0 t -80.32 113.95 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.719 HG22 ' HA ' ' A' ' 6' ' ' PRO . 29.7 pt -62.9 115.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 0.0 110.635 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.01 -12.11 34.39 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.963 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 71.0 m -102.78 170.19 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.671 0.272 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -106.15 140.97 38.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 -177.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.18 124.04 38.09 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.385 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.12 52.96 3.76 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.07 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' HG2' ' A' ' 20' ' ' GLN . . . -153.19 178.27 9.93 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -87.68 124.63 33.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.011 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.54 HG22 HG12 ' A' ' 4' ' ' ILE . 5.9 t -83.01 130.57 35.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.218 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HG3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -120.3 163.64 17.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.489 176.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.5 117.1 27.53 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -126.47 133.04 51.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.51 0.671 . . . . 0.0 111.646 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.65 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 7.6 ttpt -106.99 118.39 36.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.431 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.66 175.13 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.66 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -124.0 105.06 9.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.064 0.459 . . . . 0.0 110.733 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.82 115.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.485 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.99 94.29 6.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.332 0.587 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -79.76 86.88 5.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.6 0.714 . . . . 0.0 110.659 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -125.17 52.58 1.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.618 0.723 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.28 31.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -140.2 148.74 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.36 -17.11 20.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.37 155.95 26.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -82.98 94.06 7.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.086 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 45' ' ' CYS . 2.4 mt -92.48 135.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -18.45 65.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.16 37.81 29.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.877 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.57 -52.57 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 10.2 m-80 -123.87 81.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.312 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.7 m -116.4 129.92 56.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.271 0.558 . . . . 0.0 110.891 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.2 159.89 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.324 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.32 179.743 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 m -79.41 117.77 20.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.413 . . . . 0.0 110.621 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 115.14 25.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.642 HG12 HG13 ' A' ' 58' ' ' VAL . 4.7 mt -68.79 110.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 152.94 44.36 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.921 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.45 -37.86 96.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 112.256 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.04 75.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.69 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -42.64 59.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.4 m -126.87 145.16 50.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -97.88 69.62 2.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.191 0.52 . . . . 0.0 110.459 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 -145.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.012 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.09 -164.68 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.177 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.48 97.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.677 . . . . 0.0 109.785 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 9.1 m-85 -125.98 145.3 50.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.995 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.674 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -100.83 131.2 23.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 38.3 Cg_endo -71.15 130.49 17.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.331 2.021 . . . . 0.0 110.696 171.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.674 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 7.4 m-85 -114.7 139.78 49.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.8 0.334 . . . . 0.0 110.954 -175.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.3 t -94.04 113.03 24.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 t -146.88 158.86 44.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.622 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 7.8 pt20 -141.26 106.1 4.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.315 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.29 72.4 9.35 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.836 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -117.47 150.58 38.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.16 175.04 10.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.646 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.87 -110.79 3.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.189 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.25 64.46 4.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 112.867 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.79 87.0 7.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 0.0 110.382 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.89 -94.31 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.738 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.75 142.15 98.05 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.68 0.276 . . . . 0.0 110.74 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.0 123.05 10.75 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.783 2.322 . . . . 0.0 112.891 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.24 -0.01 89.43 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.822 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 mt 61.63 50.69 4.33 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.057 0.543 . . . . 0.0 111.393 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.84 -178.89 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.922 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -141.47 -171.93 3.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.926 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.7 -80.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 66.6 mt -129.06 111.22 18.37 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 16.2 Cg_exo -67.81 124.19 11.61 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.702 2.268 . . . . 0.0 111.929 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 39' ' ' LEU . 4.8 t -103.23 114.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.49 32.29 0.57 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.925 0.393 . . . . 0.0 111.008 -175.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 ' HB2' HG13 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -79.69 -5.98 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.648 -174.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -78.8 11.9 2.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.198 0.523 . . . . 0.0 110.958 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.01 -22.23 45.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.365 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -108.24 -166.69 1.15 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.405 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 2.7 mm? -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.44 66.98 0.56 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.993 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 77.3 m -134.25 171.75 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.466 0.174 . . . . 0.0 111.053 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.684 ' HA ' HD12 ' A' ' 73' ' ' LEU . 1.7 p -118.71 165.76 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -171.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 15' ' ' LYS . 32.0 t -69.15 136.31 26.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.725 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.47 132.84 11.26 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.478 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -73.34 136.79 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.091 0.472 . . . . 0.0 111.092 -177.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.76 147.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.36 12.55 79.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.02 152.4 47.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.707 0.289 . . . . 0.0 110.309 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -88.6 145.86 25.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.255 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.27 124.58 20.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.902 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.88 54.0 4.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.728 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.4 -163.73 1.24 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.76 147.73 22.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.642 HG13 HG12 ' A' ' 4' ' ' ILE . 7.7 t -111.37 120.67 62.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -108.66 169.23 8.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.827 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 81' ' ' VAL . 2.8 m -119.47 105.86 11.67 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.5 m -129.08 139.28 52.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.482 0.658 . . . . 0.0 112.009 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.6 tptt -121.19 121.14 37.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.157 169.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.53 171.42 14.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.77 63.88 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.595 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.13 107.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.218 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.78 171.15 8.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.025 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -87.89 49.38 1.79 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.143 0.497 . . . . 0.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -12.57 60.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.308 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 93.8 1.14 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.883 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -152.82 153.11 32.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.72 0.295 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -46.45 21.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.479 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -135.96 164.15 28.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.191 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -80.95 122.16 26.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.911 0.386 . . . . 0.0 110.964 -177.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.48 145.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.057 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.46 HD12 ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -109.49 124.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.282 0.563 . . . . 0.0 110.81 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -84.37 -3.72 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.109 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.91 32.9 15.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.664 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -54.72 29.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 3.0 m-80 -127.23 78.08 1.79 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 m -117.05 130.34 56.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 111.143 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 60' ' ' CYS . 0.0 OUTLIER -134.07 160.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.321 178.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.257 0.973 . . . . 0.0 111.052 178.804 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -89.03 108.64 19.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.311 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 113.36 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.031 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 HD12 ' SG ' ' A' ' 18' ' ' CYS . 29.8 mt -70.7 109.56 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.602 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.93 -173.17 30.36 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.981 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HA ' HG12 ' A' ' 50' ' ' ILE . 93.6 Cg_endo -83.72 8.03 4.85 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.979 2.453 . . . . 0.0 113.452 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.33 36.12 3.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -48.17 58.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.368 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.9 m -92.91 124.35 36.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.15 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.94 17.82 2.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -122.92 159.95 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.937 177.163 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 4.8 t0 -69.52 -89.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 5.5 t70 -84.46 79.21 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.351 0.596 . . . . 0.0 111.213 -173.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.68 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 20.9 m-85 -144.71 138.98 27.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.567 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -106.83 138.9 19.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.908 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.5 Cg_exo -70.85 133.62 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.743 2.295 . . . . 0.0 111.53 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.567 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 33.0 m-85 -126.17 135.49 51.71 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.049 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.414 ' SG ' HD12 ' A' ' 4' ' ' ILE . 1.3 m -91.37 112.01 23.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 95.7 m -115.13 127.73 55.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.894 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.14 113.34 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.436 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -45.53 85.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.7 0.762 . . . . 0.0 109.666 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.0 ttt -136.78 130.03 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.259 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -12.79 59.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.231 0.538 . . . . 0.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.74 -163.54 13.15 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.508 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.5 0.9 9.33 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.323 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 178.14 5.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.38 -177.14 20.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.204 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.0 m 57.68 78.74 0.35 Allowed Pre-proline 0 N--CA 1.464 0.231 0 C-N-CA 122.844 0.458 . . . . 0.0 111.613 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -82.64 146.37 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.296 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.55 73.04 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.64 -51.22 3.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.087 0.47 . . . . 0.0 110.908 -174.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -133.78 170.34 15.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.521 -177.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -79.47 78.65 5.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.37 0.605 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.46 HD11 HD11 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -124.32 134.0 53.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.244 -178.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.508 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -109.82 149.9 40.6 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.283 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.85 124.37 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.524 2.149 . . . . 0.0 111.975 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 t -109.76 -33.51 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.559 0.695 . . . . 0.0 109.686 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.63 154.55 36.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.956 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -149.63 0.44 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.876 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.52 45.43 0.58 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.66 -34.4 9.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -107.87 176.33 5.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.854 ' HB3' HD13 ' A' ' 75' ' ' ILE . 3.6 mm? -104.74 130.88 52.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.049 0.452 . . . . 0.0 111.015 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.75 65.3 0.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB2' HD12 ' A' ' 75' ' ' ILE . 20.8 m -119.37 172.19 7.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -118.73 158.16 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.027 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.57 127.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.368 0.604 . . . . 0.0 111.4 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.08 77.77 0.77 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.25 151.29 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 6' ' ' PRO . 3.9 mp -56.65 126.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.68 10.69 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.033 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 143.74 34.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.626 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -99.37 143.07 30.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.66 136.09 50.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.46 17.13 43.82 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.9 -171.73 2.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.401 -0.399 . . . . 0.0 110.285 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 110.94 15.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.78 125.46 42.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -131.06 168.93 16.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.015 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 43.7 m -106.56 118.98 38.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 m -121.62 154.54 36.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.042 0.449 . . . . 0.0 110.866 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 2.2 tptm -151.0 135.25 16.85 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.04 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 78' ' ' ALA . 3.2 t70 178.74 -176.72 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.293 175.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -90.56 96.63 10.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.72 100.33 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -160.79 0.8 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.079 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.25 58.6 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 111.37 -173.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 25.85 3.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.549 0.69 . . . . 0.0 109.926 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.17 84.4 1.43 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.285 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -79.15 119.54 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.3 m 72.28 -50.66 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.811 0.694 . . . . 0.0 111.184 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.01 166.43 29.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.296 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.492 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -89.12 107.95 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 -177.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.1 139.81 19.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.854 HD13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -111.84 134.7 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.316 0.579 . . . . 0.0 111.281 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.03 139.48 36.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.643 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 51.78 2.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 0.0 111.4 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.449 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . . . -99.53 -71.83 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.406 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 10.2 m-80 -102.73 70.01 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.565 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 54.6 m -118.16 128.69 54.96 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.037 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.414 HG22 HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -142.83 159.78 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.567 -176.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.567 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.689 0.281 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.13 100.82 7.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.204 0.526 . . . . 0.0 110.816 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -81.12 112.41 18.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.359 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 54' ' ' CYS . 12.9 mt -77.71 120.94 29.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.7 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.66 167.84 12.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.797 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.85 -16.62 41.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.919 2.413 . . . . 0.0 112.501 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 43.6 1.92 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.275 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -65.41 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.166 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 70.4 1.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.978 175.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.53 67.24 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.739 -172.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -87.83 -87.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 29.6 t0 -93.46 -167.19 1.66 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -73.79 76.47 1.59 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -95.82 137.16 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.648 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 22.8 mtmt -91.65 120.16 68.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 14.9 Cg_exo -69.01 141.71 49.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.712 2.275 . . . . 0.0 111.539 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -137.42 135.2 36.7 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.81 124.5 52.73 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.275 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 p -156.06 162.51 40.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.29 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.06 107.77 13.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.006 0.432 . . . . 0.0 110.281 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.828 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.342 0 CA-C-O 120.697 0.284 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -113.07 119.32 37.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.918 0.39 . . . . 0.0 110.155 176.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.1 87.45 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.221 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.9 m -137.73 171.3 14.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.569 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.44 154.07 22.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.931 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 134.1 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.221 0.534 . . . . 0.0 110.87 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' CA ' HD13 ' A' ' 4' ' ' ILE . . . -80.25 105.42 2.36 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.05 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HB ' ' OG ' ' A' ' 52' ' ' SER . 4.7 t -68.29 130.77 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 50' ' ' ILE . 5.4 pt -68.42 125.33 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.444 0.64 . . . . 0.0 110.456 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.74 -11.08 66.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.599 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.443 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 63.9 m -88.09 155.3 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.529 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.559 ' HG2' HG23 ' A' ' 3' ' ' THR . 26.1 mt-30 -108.46 121.51 45.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.645 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.491 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -114.44 116.68 29.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.88 56.22 3.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.19 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.88 -179.03 7.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.7 128.19 33.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.87 127.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.84 169.71 11.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.783 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.7 m -118.37 124.68 48.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.9 m -129.34 135.32 48.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 0.0 111.568 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 12.7 tttt -112.71 117.79 33.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.092 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -172.55 163.77 5.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.416 -176.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -109.36 111.62 23.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.159 0.505 . . . . 0.0 110.504 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.41 146.99 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.637 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.4 138.27 31.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.405 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -78.39 -30.1 47.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.382 0.611 . . . . 0.0 110.62 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 3.79 48.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.973 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.0 -76.16 0.63 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.083 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -119.04 -179.98 3.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.77 7.34 15.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.373 0.606 . . . . 0.0 110.746 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -156.56 169.85 23.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.622 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.15 92.88 5.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.102 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tt -75.62 136.29 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 43' ' ' LEU . 2.8 mt -92.18 128.78 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.961 0.41 . . . . 0.0 110.747 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 10.3 m-80 -64.18 -20.58 66.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.493 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 61.72 26.2 15.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.078 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -56.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 4.7 m-80 -124.33 84.19 2.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.924 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 33.2 m -115.55 135.78 53.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.949 0.404 . . . . 0.0 110.986 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.24 130.6 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.851 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.279 -178.678 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.678 0.275 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 103.41 12.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.813 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.24 137.37 37.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.801 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.621 HG21 ' HA3' ' A' ' 48' ' ' GLY . 7.8 mt -109.55 137.0 43.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.83 -169.76 17.73 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.163 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.11 -17.01 15.43 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.406 2.071 . . . . 0.0 112.649 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.37 13.54 33.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.806 0.336 . . . . 0.0 111.477 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -75.45 -29.73 59.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.33 89.97 1.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.967 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.41 27.98 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.036 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -84.03 -109.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.482 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 1.9 t70 -92.91 -164.31 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -74.55 66.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.617 0.722 . . . . 0.0 109.495 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 5.3 m-85 -93.85 128.02 39.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.42 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 18.0 mtmt -87.74 119.67 70.67 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.6 Cg_exo -72.29 144.43 41.4 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.013 2.476 . . . . 0.0 110.815 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.71 143.75 45.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.998 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.4 t -97.36 113.13 24.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 58.2 m -118.94 130.27 55.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 111.586 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -88.45 105.51 17.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.151 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.671 -178.731 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.825 0.345 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -140.75 104.31 4.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.46 89.74 0.44 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 43' ' ' LEU . 4.0 m -133.18 175.26 9.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 111.891 -171.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.17 156.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -61.98 139.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.387 . . . . 0.0 110.478 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.621 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -60.93 115.38 7.76 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.184 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.67 95.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -60.41 103.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.469 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.98 22.44 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.19 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -112.0 158.73 19.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.873 0.368 . . . . 0.0 110.526 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -98.65 153.16 18.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.229 0.537 . . . . 0.0 110.527 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 153.92 45.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.139 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.32 47.99 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.678 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.62 -171.82 3.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.44 137.26 37.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.87 121.71 58.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.978 0.418 . . . . 0.0 110.544 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 mtpp -122.96 170.01 10.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.67 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 70.9 m -129.5 123.48 31.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.9 45.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 0.0 112.242 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -105.35 113.11 26.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.42 163.55 19.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.949 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.04 93.14 5.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -85.59 132.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.366 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.09 143.3 31.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.921 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.05 5.53 38.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.29 0.566 . . . . 0.0 110.076 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.36 101.77 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.684 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.14 37.24 81.63 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -133.45 120.13 20.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.644 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -36.71 71.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.476 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -136.49 -168.26 2.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mp -90.67 95.8 10.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 112.069 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.76 118.38 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.874 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.7 mp -93.02 132.14 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -15.37 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.519 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.874 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 61.92 25.23 15.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.897 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.35 -56.31 11.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.015 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.635 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 12.0 m-80 -121.03 82.79 1.97 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.182 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -115.24 130.29 56.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.103 0.478 . . . . 0.0 111.06 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.45 159.47 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 O-C-N 123.686 0.616 . . . . 0.0 109.989 -175.933 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.763 0.316 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.29 99.52 9.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 2.0 m -81.15 113.84 19.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' HA3' ' A' ' 48' ' ' GLY . 23.4 mt -71.56 131.01 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.552 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -155.09 -164.57 13.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.793 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.04 -25.31 73.58 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.784 2.323 . . . . 0.0 111.934 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -90.07 77.06 6.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.944 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -100.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.377 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 91.97 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.67 67.33 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.577 0.703 . . . . 0.0 111.204 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -135.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.621 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.79 -165.32 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.01 107.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 15.5 m-85 -136.63 145.84 45.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.771 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.3 mtmt -102.33 124.85 38.15 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.804 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.9 Cg_exo -75.58 120.23 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.935 2.423 . . . . 0.0 111.981 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 81.6 m-85 -118.08 131.87 56.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.236 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.8 t -107.43 113.65 27.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.365 . . . . 0.0 110.959 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -148.09 151.09 35.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -80.09 104.97 11.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.706 0.765 . . . . 0.0 109.653 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.755 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 75' ' ' ILE . 0.9 OUTLIER -94.74 108.52 20.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.076 0.465 . . . . 0.0 111.204 -175.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.33 77.35 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 2.6 m -128.66 163.18 25.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.791 0.329 . . . . 0.0 111.134 -174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -118.28 155.12 20.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.027 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.81 128.19 31.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.423 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -85.86 102.96 2.71 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -71.7 139.14 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.552 HG23 ' HA2' ' A' ' 5' ' ' GLY . 1.8 mp -67.94 122.57 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.869 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.72 -12.51 20.64 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.19 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -102.03 141.5 34.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.941 0.4 . . . . 0.0 110.727 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.6 mp0 -86.17 144.91 27.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.449 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 143.8 51.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.782 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.5 43.74 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.738 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.45 -168.78 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.65 147.73 25.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.01 122.58 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 8.6 ptmt -128.55 156.56 43.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 1.3 m -106.14 129.61 54.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.831 0.348 . . . . 0.0 110.643 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m -127.62 140.77 51.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.5 . . . . 0.0 110.996 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.8 ttmm -123.13 127.53 48.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.692 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 175.39 169.08 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.612 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.06 99.69 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.553 HG11 ' CB ' ' A' ' 73' ' ' LEU . 95.5 t -82.49 118.68 30.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 125.92 54.86 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.353 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -77.67 106.91 9.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 111.052 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -87.32 59.31 5.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.578 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.58 52.53 45.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.973 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.15 157.4 46.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -39.67 72.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 46' ' ' VAL . 7.5 p90 -111.55 175.38 5.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.572 HD13 ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -93.38 120.86 34.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -176.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 65' ' ' VAL . 6.1 tt -87.8 123.97 40.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.187 0.517 . . . . 0.0 110.408 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.2 mp -93.8 135.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.805 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -69.46 -18.55 63.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.711 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.804 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 63.65 31.51 14.46 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.507 -177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.28 -56.73 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 6.5 m-80 -119.89 85.57 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.906 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 58.5 m -116.38 133.89 55.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.784 0.326 . . . . 0.0 110.431 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.77 141.48 44.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.425 0.631 . . . . 0.0 111.171 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.78 141.5 28.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -101.21 121.19 41.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.005 0.431 . . . . 0.0 110.787 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -84.55 124.72 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.182 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 168.4 12.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.936 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 50' ' ' ILE . 21.9 Cg_exo -64.85 -25.64 60.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.747 2.298 . . . . 0.0 111.635 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HA ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -138.44 55.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.828 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -44.94 77.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.301 0.572 . . . . 0.0 110.368 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.82 27.42 0.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.371 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.873 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -82.86 82.95 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.533 -174.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.9 mm -70.91 -55.02 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.503 0.668 . . . . 0.0 109.485 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -149.94 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.838 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.4 55.17 2.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.226 1.013 . . . . 0.0 109.229 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.873 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 7.0 m-30 -78.96 107.99 12.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.048 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -83.3 135.58 44.08 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.839 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.4 Cg_exo -70.12 133.94 26.06 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.461 2.107 . . . . 0.0 111.404 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -114.71 142.72 46.12 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 t -119.25 112.56 19.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.936 0.398 . . . . 0.0 110.578 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -152.57 146.8 25.5 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -93.32 136.07 33.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 0.0 111.02 -176.503 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.71 142.56 35.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.603 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -101.78 -53.34 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 169.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 m 65.38 -176.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.891 -0.654 . . . . 0.0 112.31 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.17 154.19 38.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 132.0 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.068 0.461 . . . . 0.0 110.45 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.1 134.75 13.14 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.185 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 52' ' ' SER . 1.4 p -69.23 129.58 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.793 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -71.2 135.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.075 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.17 76.58 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.522 ' HB2' HG13 ' A' ' 49' ' ' VAL . 14.8 m -108.33 170.66 7.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.015 0.436 . . . . 0.0 111.514 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -96.29 146.14 24.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.66 154.0 49.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.137 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.4 48.42 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.649 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.55 -171.46 3.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.502 0.192 . . . . 0.0 110.573 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -79.49 127.79 32.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.801 0.334 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.02 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.795 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -122.56 152.63 40.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 178.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 15.2 m -114.18 107.84 16.16 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -127.87 156.21 42.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.97 0.891 . . . . 0.0 113.345 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -145.86 150.8 36.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.631 -1.622 . . . . 0.0 107.047 168.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 1.5 m-20 -158.52 -165.53 1.69 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -88.57 4.47 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 75' ' ' ILE . 1.5 t -76.58 105.9 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.548 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -101.0 -120.7 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.268 176.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.48 ' H ' ' HB ' ' A' ' 66' ' ' THR . 13.7 t-20 -99.29 81.4 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.219 0.533 . . . . 0.0 110.074 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.18 151.11 23.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.72 69.73 3.27 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.637 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -137.97 165.6 26.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -30.67 71.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.184 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.703 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 8.7 p90 -145.94 -173.01 4.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.907 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -102.12 100.32 10.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -80.98 115.85 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.664 ' HA ' HG21 ' A' ' 65' ' ' VAL . 5.1 pt -92.44 154.73 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.05 -14.94 57.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.199 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.14 34.49 5.0 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.201 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . . . -88.47 -62.79 1.41 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.979 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 9.9 m-80 -95.35 50.91 1.27 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.168 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 51.1 t -123.81 129.94 51.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -129.73 123.78 57.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.687 -177.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.582 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.318 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.565 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -78.99 103.52 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.24 0.543 . . . . 0.0 111.258 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 135.61 33.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.415 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.04 124.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.661 0.267 . . . . 0.0 110.662 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -110.73 -168.43 19.23 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -0.82 9.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.783 2.322 . . . . 0.0 112.44 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 151.84 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.934 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.54 -70.66 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.553 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.69 42.68 0.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.151 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 14.5 m -79.86 76.05 6.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.822 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -92.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.058 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.79 88.78 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.561 0.22 . . . . 0.0 111.042 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.752 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.8 t70 50.47 38.47 18.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.431 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 13.4 m-85 -88.35 112.29 22.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.849 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.44 146.31 31.09 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.28 120.55 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.58 2.187 . . . . 0.0 111.458 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 3.3 m-85 -113.96 130.88 56.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.82 118.55 36.97 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.46 173.02 12.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.957 0.408 . . . . 0.0 110.922 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 158.76 26.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -138.71 104.68 5.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 0.0 110.883 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.75 75.23 0.21 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 43' ' ' LEU . 96.0 m -104.16 156.74 17.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -132.07 160.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.563 175.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.42 120.29 15.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.877 0.37 . . . . 0.0 110.804 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.88 112.12 3.98 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.0 151.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.309 0.576 . . . . 0.0 111.577 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 50' ' ' ILE . 4.9 mp -58.67 124.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.814 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.83 -23.8 11.46 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.21 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -83.08 149.64 26.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.841 0.353 . . . . 0.0 110.786 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -114.35 120.23 39.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.963 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -110.01 110.8 21.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.536 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.69 4.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.868 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.17 -113.24 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -131.08 119.64 22.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.023 0.439 . . . . 0.0 111.147 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.08 114.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.402 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -124.76 169.97 11.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.793 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 87.6 m -110.34 121.05 44.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -129.02 147.5 50.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.106 0.479 . . . . 0.0 110.799 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HE3' ' HB3' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -134.09 131.03 38.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.618 175.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.69 178.25 6.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.474 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.81 102.06 8.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.176 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.78 154.16 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.76 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.62 120.34 42.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.049 0.452 . . . . 0.0 111.106 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -92.86 55.62 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.465 0.65 . . . . 0.0 109.897 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -21.85 45.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.881 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.17 52.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -115.5 164.63 14.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.311 . . . . 0.0 110.672 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -42.84 13.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 109.909 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -145.26 165.37 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.799 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.543 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -87.1 93.46 9.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 110.97 -178.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.05 111.85 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -92.99 153.25 3.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -174.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.83 -11.09 59.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.721 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.85 33.06 12.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.506 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -58.67 3.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.287 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.2 m-80 -107.06 84.65 2.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.231 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.97 129.46 50.97 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.843 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.08 121.51 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.238 0.542 . . . . 0.0 111.038 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.724 176.478 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.595 ' HB1' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.43 109.01 13.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.029 0.442 . . . . 0.0 110.56 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.31 134.71 42.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.59 HG23 HG21 ' A' ' 8' ' ' THR . 4.7 mt -98.18 102.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.33 -167.86 16.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.946 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.85 -27.22 59.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 0.0 111.922 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -108.72 54.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.079 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.59 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.91 -74.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.159 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -104.55 126.25 51.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.908 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.49 70.52 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 111.307 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.5 -161.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.823 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -67.54 178.97 1.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.91 99.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.574 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.407 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 15.1 m-85 -115.33 157.29 24.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.936 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -90.78 117.55 68.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.0 Cg_exo -79.41 131.47 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.263 2.642 . . . . 0.0 111.777 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -125.88 141.61 51.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.1 m -95.49 112.49 24.19 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.465 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -131.91 141.39 49.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.675 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.71 105.45 17.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.843 0.354 . . . . 0.0 110.055 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.571 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 3.0 mm? -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.453 0.644 . . . . 0.0 111.16 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' A' ' 72' ' ' PHE . . . -165.57 93.04 0.11 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.494 ' HB2' HD11 ' A' ' 75' ' ' ILE . 56.3 m -139.47 -178.04 5.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.181 0.515 . . . . 0.0 111.733 -169.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.26 153.25 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.39 137.51 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.962 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.2 129.67 23.52 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.997 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.67 105.02 5.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 11.3 mt -64.66 108.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.747 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.39 -8.72 20.25 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.58 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -110.95 160.92 16.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG2' ' HB1' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -93.47 153.18 18.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.633 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 116.64 12.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.125 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.19 60.17 4.26 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 19' ' ' CYS . . . -158.32 -152.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 -174.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -114.81 136.63 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 110.174 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.73 117.53 37.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.424 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 4.7 mmpt? -109.96 138.96 45.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.077 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -111.98 100.97 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -120.83 135.21 55.23 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.347 0.594 . . . . 0.0 111.156 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -94.46 103.86 15.83 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.915 175.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -160.45 127.1 4.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.527 -1.669 . . . . 0.0 106.878 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.63 66.59 5.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 0.0 112.309 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -78.63 100.7 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 169.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -128.07 -32.76 2.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.795 0.807 . . . . 0.0 110.389 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -96.08 125.16 40.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.44 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 102.0 8.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.417 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 -32.98 49.91 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -124.57 -161.03 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.8 6.16 8.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HE2' ' C ' ' A' ' 44' ' ' GLY . 2.9 p90 -157.28 -158.88 0.79 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.112 -0.367 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp -104.13 99.24 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.144 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tp -81.55 116.51 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 109.908 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -101.48 137.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.22 -175.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -76.51 154.53 34.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.25 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.03 99.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 21.25 -102.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 125.198 1.561 . . . . 0.0 114.08 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 11.7 m-80 -121.08 70.87 0.92 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 38.6 t -114.3 129.9 56.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.376 -0.828 . . . . 0.0 111.199 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 135.81 42.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.152 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 112.4 20.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.719 0.295 . . . . 0.0 110.525 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.36 124.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.916 0.388 . . . . 0.0 111.081 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 54' ' ' CYS . 19.8 mt -88.48 94.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.284 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 175.58 30.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.369 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.96 -13.82 34.65 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.503 2.135 . . . . 0.0 111.983 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.31 41.59 1.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.484 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.6 -53.96 4.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.304 0.573 . . . . 0.0 110.749 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.18 64.85 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.459 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.75 65.32 4.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 110.659 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 -133.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.055 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.87 66.9 4.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.174 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 21.5 t0 46.79 80.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.927 0.767 . . . . 0.0 111.58 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -110.67 157.99 19.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.929 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 15.6 mtmt -106.31 124.52 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.799 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -80.33 128.68 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.142 2.561 . . . . 0.0 111.321 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.85 132.67 53.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.752 0.31 . . . . 0.0 110.723 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.52 113.2 26.53 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 126.42 33.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.269 0.556 . . . . 0.0 111.553 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.769 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 2.4 mp0 -80.3 129.64 34.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.202 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.897 0.38 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -145.95 102.94 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.11 94.14 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 75' ' ' ILE . 35.3 m -131.17 -176.09 3.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 111.284 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.26 159.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.295 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.14 133.75 30.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.38 104.66 0.95 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.867 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 110.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.851 0.358 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.4 pt -59.02 120.1 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.2 -26.61 9.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.565 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m -94.33 164.53 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.759 0.314 . . . . 0.0 110.491 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 68.1 mt-30 -106.09 149.37 26.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.168 0.509 . . . . 0.0 111.695 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.647 ' HB2' HD11 ' A' ' 4' ' ' ILE . 10.5 t -108.73 134.87 50.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.289 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.73 -19.47 51.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.104 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.769 ' HB3' ' HA ' ' A' ' 20' ' ' GLN . . . -125.39 -123.8 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.909 0.355 . . . . 0.0 111.941 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.19 96.84 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.258 0.551 . . . . 0.0 112.279 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.14 125.65 45.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -141.77 170.39 15.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.641 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -112.07 124.16 51.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 69.5 m -134.21 132.5 39.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.937 0.399 . . . . 0.0 110.473 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 14.9 tptm -104.38 121.89 44.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.597 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.692 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -164.96 165.51 20.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.768 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -115.01 102.61 10.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.961 0.41 . . . . 0.0 110.736 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -92.79 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.5 129.15 34.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -9.12 59.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.6 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.4 117.96 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.425 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.39 -50.49 0.78 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.787 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -123.15 149.99 43.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.45 -46.16 14.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.992 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.64 157.41 18.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -92.14 97.14 10.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -170.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mp -69.41 133.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 7.8 mt -91.44 129.81 41.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.323 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 21.5 m-80 -65.63 -16.03 63.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.103 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.53 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 57.84 36.02 25.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.341 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.7 -57.17 3.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.428 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.1 m-80 -117.5 97.96 6.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.595 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.5 m -124.04 130.55 52.76 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.922 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.69 152.95 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.254 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.582 -179.591 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.26 101.37 11.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.909 0.385 . . . . 0.0 110.265 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.31 125.13 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.939 -178.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.418 HD13 ' HA3' ' A' ' 48' ' ' GLY . 13.4 mt -86.04 86.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.172 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 169.49 51.27 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.762 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.79 -42.59 30.74 Favored 'Trans proline' 0 CA--C 1.527 0.168 0 C-N-CA 122.615 2.21 . . . . 0.0 113.045 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.88 33.09 3.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -59.29 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 110.233 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.82 71.44 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.123 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.8 8.85 11.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.47 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.6 mt -65.18 161.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.379 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -18.68 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.806 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.4 t70 -149.6 86.63 1.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 27.8 m-85 -140.95 166.21 25.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.978 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -117.25 142.36 30.03 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.507 175.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 9.3 Cg_exo -71.36 124.87 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.565 2.177 . . . . 0.0 111.281 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.2 m-85 -121.81 130.82 53.68 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.7 m -93.93 112.84 24.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.27 163.92 29.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.93 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -100.65 105.73 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.963 0.411 . . . . 0.0 110.301 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.324 -0.51 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.756 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.314 0.102 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -159.14 107.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.107 0.48 . . . . 0.0 110.458 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.06 87.13 0.38 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -128.53 168.59 15.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -176.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.6 158.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.588 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.73 142.03 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -76.31 147.13 34.02 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.396 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.3 t -86.0 120.78 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 0.0 110.561 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.38 123.12 21.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.67 3.32 68.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.068 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 19.6 m -108.09 160.34 15.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.017 0.436 . . . . 0.0 110.877 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.668 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -96.95 127.85 43.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.3 t -108.46 138.33 44.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.08 12.9 58.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.978 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.18 177.4 4.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 116.85 20.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.255 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.46 113.02 23.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.289 0.566 . . . . 0.0 111.244 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 12.6 ptpt -115.3 171.45 7.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.18 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 33.4 m -117.75 119.64 35.52 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.972 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.71 146.02 50.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.483 0.659 . . . . 0.0 111.427 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -137.77 133.36 33.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.014 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.5 t70 -160.84 -174.32 4.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.98 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -79.33 -72.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.51 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 73' ' ' LEU . 2.1 t 47.79 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.337 1.023 . . . . 0.0 112.89 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 t -84.15 139.11 32.64 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.383 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 59.84 0.87 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.237 0.541 . . . . 0.0 110.312 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -42.07 24.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.588 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.1 57.28 0.22 Allowed Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.51 139.82 52.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -42.68 95.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.691 -175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 162.41 33.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.285 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.609 ' HB2' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -90.87 130.53 36.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.96 0.409 . . . . 0.0 111.833 -172.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.43 128.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -97.47 150.36 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.843 0.354 . . . . 0.0 110.364 -178.008 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -95.98 -2.55 46.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.16 31.13 19.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.539 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.74 -46.94 67.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -127.4 97.93 5.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.13 139.07 33.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.24 0.543 . . . . 0.0 111.606 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.82 127.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.97 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 O-C-N 124.252 0.97 . . . . 0.0 111.346 -179.699 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.78 111.36 19.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.9 131.66 35.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 178.016 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.9 mt -83.1 103.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.647 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.73 -173.5 26.8 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.847 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -13.56 24.64 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.718 2.279 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.12 45.3 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.25 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.591 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -84.66 -61.96 1.66 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.077 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.3 p -160.63 164.41 31.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.662 0.267 . . . . 0.0 110.663 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.75 -113.25 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 175.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER 53.17 -110.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 122.953 0.501 . . . . 0.0 111.541 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.518 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.16 177.59 5.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' N ' ' CG ' ' A' ' 12' ' ' ASP . 12.2 t70 -67.29 77.18 0.15 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.768 0.794 . . . . 0.0 109.797 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.516 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 9.9 m-85 -97.5 140.89 31.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.805 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -105.39 135.09 19.39 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 8' ' ' THR . 41.0 Cg_endo -70.47 132.34 21.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.175 1.917 . . . . 0.0 111.137 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.89 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 6.7 m-85 -119.13 130.72 55.71 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.159 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.05 112.93 25.05 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 157.95 36.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.434 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -80.53 111.27 16.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.272 0.558 . . . . 0.0 110.533 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.106 177.487 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.634 HD12 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.43 176.99 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.348 . . . . 0.0 110.758 -175.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.9 -60.22 0.12 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 4.1 m 63.29 179.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.742 0.782 . . . . 0.0 112.701 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.19 146.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.889 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.87 122.1 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.067 0.461 . . . . 0.0 109.856 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 99.98 1.37 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.208 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.14 126.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.89 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.741 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.62 -17.18 12.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.061 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -89.44 162.9 15.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 3' ' ' THR . 6.7 mp0 -110.68 156.58 20.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.008 0.432 . . . . 0.0 111.113 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.37 137.85 47.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.01 -5.57 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.947 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -102.88 -105.77 0.27 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.89 147.08 49.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.551 0.215 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.57 106.19 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' H ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -120.33 157.52 29.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 60.0 m -104.0 120.13 40.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.084 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -124.53 151.7 44.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.356 0.598 . . . . 0.0 110.868 -176.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -137.93 135.35 35.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.087 174.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -153.46 -170.64 3.66 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -106.37 38.36 2.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 110.259 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 ' H ' ' A' ' 74' ' ' ILE . 3.1 p -103.32 129.24 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.404 0.621 . . . . 0.0 110.859 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -128.91 -174.06 3.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.23 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -117.58 130.66 56.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.209 0.528 . . . . 0.0 111.737 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -112.51 -6.32 13.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.059 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.61 43.89 0.25 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.1 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.16 170.48 9.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.734 0.302 . . . . 0.0 110.876 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -39.39 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 0.0 110.43 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.29 -174.18 1.65 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.519 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -85.91 155.56 20.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.879 ' H ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.74 114.43 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.971 176.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.634 HD11 HD12 ' A' ' 43' ' ' LEU . 4.3 pt -105.24 153.3 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.318 0.58 . . . . 0.0 111.189 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -94.52 -4.0 48.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.486 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.66 30.92 14.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.887 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.31 82.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.762 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.4 m-80 -129.05 80.44 1.97 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.61 54.69 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.481 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 148.24 30.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.043 0.449 . . . . 0.0 111.149 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.169 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.65 0.262 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.45 99.99 11.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.876 0.369 . . . . 0.0 110.293 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 110.07 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 18' ' ' CYS . 3.6 mt -70.6 122.44 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.13 -161.38 9.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.769 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.36 -22.19 52.98 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.128 2.552 . . . . 0.0 113.075 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -102.14 5.87 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -92.34 -47.79 7.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 10.2 t -135.39 87.54 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.966 0.412 . . . . 0.0 110.9 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -89.41 0.46 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.954 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.3 mt 54.5 -103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 122.934 0.494 . . . . 0.0 110.657 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 8.2 t70 -100.72 -113.59 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 24.3 t70 -121.06 66.43 0.86 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 167.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 2.5 m-85 -90.14 151.87 21.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.895 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 3.8 mtmt -102.14 127.46 30.76 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HG3' ' HB3' ' A' ' 9' ' ' CYS . 6.6 Cg_exo -72.8 136.19 24.91 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.543 2.162 . . . . 0.0 110.922 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -129.38 130.41 45.99 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.868 0.366 . . . . 0.0 110.255 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 m -99.48 112.59 24.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.854 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.8 m -115.13 115.73 27.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.787 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 9.9 pt20 -80.46 117.22 21.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -109.13 103.81 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.29 82.11 1.49 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.766 ' HB2' HD11 ' A' ' 75' ' ' ILE . 1.8 m -134.9 168.27 19.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.516 0.198 . . . . 0.0 110.506 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.55 157.25 21.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.971 0.415 . . . . 0.0 110.819 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.64 143.46 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.079 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.14 106.92 3.02 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.899 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -71.55 133.86 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.733 0.301 . . . . 0.0 110.726 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -71.22 140.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.8 -14.01 66.14 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.597 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -97.81 158.08 15.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -116.16 137.7 51.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 0.0 111.378 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.0 m -115.13 152.05 33.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.188 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -119.99 49.5 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 20' ' ' GLN . . . -153.25 -135.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.584 0.23 . . . . 0.0 110.809 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -107.41 122.49 46.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.077 0.465 . . . . 0.0 110.783 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.53 118.62 56.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.764 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -123.47 163.71 20.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.248 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 91.7 m -111.47 123.62 50.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 97.7 m -133.26 148.05 51.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.088 0.471 . . . . 0.0 111.192 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 2.4 tptm -130.35 140.49 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.698 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 p30 178.37 -177.29 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.877 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.06 116.13 28.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.179 0.514 . . . . 0.0 110.91 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.676 HG11 ' HA ' ' A' ' 73' ' ' LEU . 2.4 t -124.37 94.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.631 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.27 141.27 30.57 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.152 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.34 89.89 4.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.476 0.655 . . . . 0.0 110.64 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.53 75.16 1.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.87 -74.61 0.29 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.235 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.68 119.0 22.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.61 -3.54 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 110.663 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -99.07 148.32 24.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.676 ' HA ' HG11 ' A' ' 65' ' ' VAL . 2.0 mp -76.86 91.58 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.672 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -76.61 133.15 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.713 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.19 138.27 20.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.245 0.545 . . . . 0.0 111.069 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.13 -18.57 33.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 66.44 24.23 10.43 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.655 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.83 -55.27 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.321 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 5.7 m-80 -114.71 90.56 3.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.691 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 52.7 m -122.2 129.59 52.41 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.653 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 60' ' ' CYS . 0.9 OUTLIER -120.41 131.32 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.377 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.191 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.423 ' HB3' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.94 108.71 13.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.857 0.36 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 3.2 m -79.6 119.04 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 8' ' ' THR . 53.4 mt -68.82 119.22 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.879 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.68 -179.19 30.81 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.116 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HA ' HG12 ' A' ' 50' ' ' ILE . 57.2 Cg_endo -69.51 -38.93 7.63 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.43 54.46 2.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.664 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -74.72 -55.29 6.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.483 -176.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -83.0 123.88 29.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -22.87 43.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.612 0.72 . . . . 0.0 109.338 172.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.61 134.77 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.737 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.16 140.77 33.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.22 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 69.79 48.68 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.026 0.829 . . . . 0.0 111.19 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 4.7 m-85 -135.47 150.96 49.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 26.5 mtmt -99.09 135.32 20.86 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 4.5 Cg_exo -77.44 140.23 19.06 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.784 2.323 . . . . 0.0 111.511 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.44 140.07 42.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.8 114.12 27.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.78 132.75 54.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.768 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -80.67 121.59 26.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.995 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 0.0 110.071 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 43' ' ' LEU . 1.4 mm? -84.17 134.13 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 110.686 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.1 91.07 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.4 m -138.43 179.4 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.69 ' HA ' HD12 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -119.07 153.95 21.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.562 HG23 HD13 ' A' ' 73' ' ' LEU . 96.4 t -61.64 127.84 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.628 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.5 76.51 2.08 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.773 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.477 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -71.45 146.63 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.76 0.314 . . . . 0.0 110.2 178.01 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 6' ' ' PRO . 2.2 mt -61.75 124.11 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.669 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.03 -11.56 20.26 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -89.38 137.51 32.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -96.74 115.46 27.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -107.25 108.04 19.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.88 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.87 36.01 3.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.974 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.03 -110.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.329 0.109 . . . . 0.0 110.839 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.92 125.88 43.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.538 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 t -107.33 127.35 63.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.03 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 170.28 16.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.306 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 57.7 m -116.2 136.9 52.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 110.632 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.9 m -141.83 151.3 42.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.081 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -116.04 118.62 33.39 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.103 175.457 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -162.58 166.85 24.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.875 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.59 70.02 0.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.7 OUTLIER -76.58 1.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.424 0.63 . . . . 0.0 111.051 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.55 70.77 6.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.559 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.54 -171.32 2.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.137 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.23 108.18 12.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.001 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.66 150.96 18.61 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.751 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.97 119.17 22.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.412 0.148 . . . . 0.0 111.123 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 m 71.51 -59.24 0.55 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.084 0.865 . . . . 0.0 111.929 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -139.49 -163.06 1.42 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.62 0.248 . . . . 0.0 110.564 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.721 ' HB3' HG21 ' A' ' 65' ' ' VAL . 7.1 mt -82.48 108.4 15.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.628 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 65' ' ' VAL . 7.0 mm -84.84 116.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.4 mt -91.89 130.69 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 0.0 111.541 -170.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 6.7 t-20 -72.23 106.87 4.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.06 56.74 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 111.673 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.64 -60.73 1.8 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.093 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 6.8 m-80 -111.39 103.8 12.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.008 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.94 132.49 36.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.28 159.33 42.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.691 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 116.06 31.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.678 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 1.9 m -80.01 121.19 25.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.35 126.18 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 111.53 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.92 169.69 14.68 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.66 -40.36 46.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.305 2.67 . . . . 0.0 112.395 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 67.21 0.79 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.487 178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.589 HG21 HG11 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -62.1 -45.06 95.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.43 132.07 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.782 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 71.42 6.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.215 0.531 . . . . 0.0 111.421 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -172.2 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.8 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.35 -135.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.16 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.35 101.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.587 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 23.1 m-85 -146.53 150.62 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.568 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -116.26 135.48 22.84 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 177.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 7.3 Cg_exo -73.44 128.89 13.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.677 2.251 . . . . 0.0 111.646 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 75' ' ' ILE . 47.2 m-85 -123.74 146.49 48.26 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.66 112.74 24.37 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -124.61 151.49 44.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.994 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 10.5 mp0 -80.84 141.51 34.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.739 -176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -128.44 124.37 36.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.423 0.63 . . . . 0.0 111.092 -178.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.17 83.88 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 43' ' ' LEU . 24.4 m -127.35 173.09 10.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.251 0.548 . . . . 0.0 111.87 -172.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.97 158.82 19.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.641 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG13 ' HE3' ' A' ' 15' ' ' LYS . 23.5 t -63.98 129.05 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 132.91 17.09 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.088 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.5 t -87.92 114.45 26.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.43 118.13 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.18 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.44 -14.89 35.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.73 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.487 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 49.6 m -102.87 164.44 11.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.772 0.32 . . . . 0.0 110.143 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.2 pt20 -108.92 149.07 29.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.089 0.471 . . . . 0.0 110.759 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.4 m -122.15 120.81 35.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.448 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.59 48.41 3.67 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -158.18 -133.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.95 145.18 41.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.975 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.589 HG11 HG21 ' A' ' 8' ' ' THR . 21.9 t -102.93 109.52 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.77 156.48 17.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.118 -174.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 105.26 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -124.36 137.85 54.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.195 0.521 . . . . 0.0 110.998 -176.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -119.2 123.65 44.84 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.632 175.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' A' ' 75' ' ' ILE . 22.7 t70 -178.68 155.75 0.84 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.764 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 94.36 6.34 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.08 126.48 7.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.456 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.49 45.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.008 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -27.06 17.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.482 0.658 . . . . 0.0 110.126 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 86.48 5.01 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.681 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.48 -45.33 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -134.89 169.54 17.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.656 0.265 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -19.22 63.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.412 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.25 169.07 12.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.62 105.5 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 178.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.55 140.55 15.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.0 110.517 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -107.29 130.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.357 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -71.7 -13.2 61.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.727 0.298 . . . . 0.0 110.323 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . . . 59.49 28.8 18.27 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.653 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.82 82.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.823 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 2.9 m-80 -123.73 83.28 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.119 176.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 131.42 52.44 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.556 -176.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.01 148.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.504 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.669 0.271 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 136.65 35.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.667 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.16 137.03 40.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.803 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.475 HD11 ' SG ' ' A' ' 54' ' ' CYS . 44.1 mt -82.53 123.75 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.774 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 8' ' ' THR . . . -146.83 -178.93 22.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.68 -30.43 90.4 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.776 2.317 . . . . 0.0 112.093 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -114.3 62.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.511 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -72.27 -65.94 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 -178.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.75 157.51 15.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.932 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -82.84 85.36 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.163 0.506 . . . . 0.0 111.314 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -144.03 -170.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.295 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.32 108.95 3.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 11' ' ' ILE . 21.5 m-85 -132.58 156.41 46.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.359 -172.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.65 125.42 82.58 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.3 Cg_exo -76.59 125.46 8.28 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.789 2.326 . . . . 0.0 111.848 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 61' ' ' CYS . 93.7 m-85 -123.31 149.18 45.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.35 116.01 8.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.02 175.09 10.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.374 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 137.66 37.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.267 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 120.938 0.399 . . . . 0.0 109.933 178.329 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -138.34 110.45 7.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.059 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.0 112.87 2.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 t -153.97 178.33 10.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 m -122.05 158.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.72 125.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.56 135.61 41.78 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.118 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.43 98.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.405 HG22 ' HA2' ' A' ' 5' ' ' GLY . 2.7 pt -60.49 120.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.415 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 -8.02 26.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.957 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -116.93 154.22 31.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.802 0.334 . . . . 0.0 110.854 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 15.2 mt-30 -84.35 151.28 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.299 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -136.27 106.63 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.093 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.41 58.97 3.04 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.93 -166.59 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.08 95.75 6.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.619 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.67 135.52 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.175 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.17 155.15 45.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.9 m -128.32 108.44 10.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 70.7 m -124.01 142.02 51.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.362 0.601 . . . . 0.0 112.037 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.82 120.26 41.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.473 172.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 65' ' ' VAL . 2.8 p30 -144.35 -170.5 3.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.167 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.24 50.02 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.444 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG23 ' OD1' ' A' ' 63' ' ' ASP . 51.5 t -61.84 124.84 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.068 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.72 119.57 35.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -79.9 100.25 7.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.252 0.549 . . . . 0.0 111.854 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -19.93 48.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.912 0.863 . . . . 0.0 109.81 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.52 53.22 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -111.49 139.65 46.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.87 -51.29 68.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.428 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.12 148.06 41.88 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 98.75 8.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.488 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.46 ' H ' HG13 ' A' ' 74' ' ' ILE . 1.6 mt -69.18 126.16 28.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 77' ' ' ALA . 3.9 mt -92.33 146.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.227 0.537 . . . . 0.0 110.249 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -76.48 -0.48 23.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.281 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 64.42 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.04 -95.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.862 0.726 . . . . 0.0 111.496 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.611 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 19.4 m-80 -91.71 78.66 5.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.251 -176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.7 m -114.43 130.2 56.7 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.782 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -138.16 159.48 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.79 178.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.243 178.278 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 107.19 19.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.339 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -79.05 125.46 29.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.0 0.429 . . . . 0.0 110.826 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 54' ' ' CYS . 13.7 mt -80.53 95.06 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.368 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.41 171.08 17.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.78 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.77 -15.49 33.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 111.709 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -107.49 46.81 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.918 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -64.8 0.88 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 128.88 52.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.843 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.43 79.25 9.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.915 0.388 . . . . 0.0 110.853 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -145.2 -162.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 13.9 t0 -60.65 163.74 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.978 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.14 103.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 111.158 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 62' ' ' LYS . 6.3 m-85 -121.8 165.99 15.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.075 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -112.84 137.61 21.86 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -75.06 130.24 13.02 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.801 2.334 . . . . 0.0 111.31 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 40.1 m-85 -124.2 135.58 53.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.767 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -105.22 115.27 29.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.449 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.68 152.63 28.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.804 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -80.38 105.49 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.144 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.985 179.545 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -114.23 117.1 30.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.313 0.578 . . . . 0.0 111.341 -174.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.96 49.14 4.08 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 53.6 m -95.29 154.36 17.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.332 . . . . 0.0 110.797 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.84 152.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.77 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.42 117.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.97 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.53 125.33 6.9 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.057 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' OG ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -77.07 125.16 36.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 127.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.01 -16.77 11.96 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.211 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -97.69 165.06 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.783 0.325 . . . . 0.0 111.169 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -110.58 132.08 54.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -111.15 145.71 38.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.471 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.38 -11.1 46.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.495 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.23 -177.11 4.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.125 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 125.17 29.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.905 0.383 . . . . 0.0 110.519 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 3.9 t -97.11 120.15 46.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.902 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 mtpt -112.68 169.76 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.81 102.95 10.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 2.9 m -132.22 161.09 34.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.504 0.669 . . . . 0.0 112.099 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 2.2 pttt -156.45 157.73 36.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.456 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.6 -173.2 2.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.422 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.06 69.26 10.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.6 107.56 19.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.215 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -75.58 0.27 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.414 0.626 . . . . 0.0 110.946 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -149.19 147.43 28.42 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.075 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 120.14 7.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.78 46.9 3.19 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.121 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.85 175.12 6.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.27 -24.75 65.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.94 0.4 . . . . 0.0 111.531 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.22 152.72 20.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.004 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.494 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -112.23 125.13 53.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.043 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.46 136.47 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.373 0.606 . . . . 0.0 111.545 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.1 119.06 45.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 3.5 t-20 -63.81 -24.96 67.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 76' ' ' ASN . . . 81.3 31.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.734 0.814 . . . . 0.0 111.166 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -56.9 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.442 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -120.94 75.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.036 -179.048 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.614 ' SG ' ' HE2' ' A' ' 59' ' ' LYS . 18.3 t -134.79 130.32 35.94 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.02 152.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.379 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.902 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.312 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -84.18 121.69 27.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.923 0.392 . . . . 0.0 111.337 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -88.96 106.97 18.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.629 HD13 ' HA3' ' A' ' 48' ' ' GLY . 12.2 mt -82.75 130.25 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 111.384 -173.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -133.06 -171.86 12.84 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.864 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.19 -27.64 48.73 Favored 'Trans proline' 0 CA--C 1.525 0.066 0 C-N-CA 122.539 2.159 . . . . 0.0 112.687 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -96.63 14.24 25.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.475 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -86.68 -22.58 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.254 0.55 . . . . 0.0 110.322 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -135.09 105.11 6.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.614 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.19 33.11 4.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.468 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -108.6 163.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.291 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.55 109.61 4.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.307 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.7 27.44 15.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.32 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 11.2 m-85 -95.87 123.21 39.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.031 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 16.8 mttt -91.4 134.38 29.68 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.2 Cg_exo -70.45 137.81 34.26 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.636 2.224 . . . . 0.0 111.175 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 21.5 m-85 -131.62 138.6 48.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -95.5 112.94 24.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 m -113.5 120.16 40.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 105.88 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.448 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.538 0.209 . . . . 0.0 110.58 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -150.52 141.97 23.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.929 171.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.12 88.56 0.53 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.643 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' HD11 ' A' ' 75' ' ' ILE . 36.3 m -141.52 165.78 26.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.08 152.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.12 133.57 30.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.345 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -70.4 89.78 0.36 Allowed Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.903 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.36 117.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.537 0.208 . . . . 0.0 110.486 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 5' ' ' GLY . 3.3 mp -56.79 116.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.75 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.19 -9.5 17.88 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.833 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.01 165.85 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 0.0 110.345 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' THR . 86.3 mt-30 -121.11 125.49 47.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.141 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 82.6 m -108.44 122.5 47.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.974 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.15 56.64 4.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.269 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.13 -165.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.6 136.21 35.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.747 0.308 . . . . 0.0 110.32 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.4 t -108.29 123.93 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.208 0.527 . . . . 0.0 110.796 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -130.22 171.15 13.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.12 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 95.6 m -114.78 120.53 40.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.97 0.414 . . . . 0.0 109.972 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.2 m -125.19 123.22 39.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.341 0.591 . . . . 0.0 111.586 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.848 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 23.1 tptt -88.2 90.69 8.49 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.44 130.42 44.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.518 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 52.65 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.129 0.49 . . . . 0.0 111.038 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.18 128.29 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.949 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -84.96 146.49 27.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -91.45 97.73 11.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.558 0.694 . . . . 0.0 111.102 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -24.9 12.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.534 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 57.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.665 -1.607 . . . . 0.0 109.67 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.19 97.31 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.212 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.54 -35.58 45.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.672 0.749 . . . . 0.0 109.282 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.32 146.85 50.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.61 92.42 5.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.996 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.98 126.69 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.902 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.89 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -92.9 136.51 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 -174.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -79.62 -9.74 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.59 36.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.523 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.08 -66.43 0.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.31 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.5 m-80 -122.5 85.05 2.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.881 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.3 m -114.99 130.26 56.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.042 0.449 . . . . 0.0 111.209 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.85 160.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.949 -179.532 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -86.46 126.76 34.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -90.33 135.69 33.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.041 175.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.694 HG21 ' HA3' ' A' ' 48' ' ' GLY . 30.0 mt -91.21 130.86 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.745 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.65 -170.07 40.85 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.16 -13.27 39.11 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.365 2.043 . . . . 0.0 111.701 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -78.92 -35.99 42.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.286 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.701 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 t -140.08 123.3 16.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.828 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.31 93.96 3.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -133.69 152.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -18.48 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.204 1.402 . . . . 0.0 114.09 -174.465 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 21.4 t0 -119.87 47.88 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.575 0.702 . . . . 0.0 109.658 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.4 m-85 -108.84 119.47 39.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.84 -176.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -92.91 134.29 27.67 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.658 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.6 Cg_exo -68.76 125.61 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.612 2.208 . . . . 0.0 111.363 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 16.0 m-85 -114.35 144.97 42.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.097 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -106.77 113.62 27.22 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 176.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.35 120.27 37.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.865 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 17.8 mt-30 -82.03 103.96 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.906 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 2.1 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 77' ' ' ALA . 1.6 mm? -112.03 113.62 26.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.938 0.399 . . . . 0.0 110.951 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.542 ' HA2' HD12 ' A' ' 74' ' ' ILE . . . -83.79 66.64 3.87 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.08 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 43' ' ' LEU . 1.8 m -121.14 162.08 20.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.84 153.34 21.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -65.27 137.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.796 -178.386 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.694 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -75.87 119.72 5.78 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.667 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.86 108.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.92 0.39 . . . . 0.0 110.602 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 2.4 mp -54.43 118.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.181 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.26 -0.16 29.7 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.415 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.77 151.51 43.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 7.6 mt-30 -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 157.41 44.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.102 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.24 43.97 1.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . . . -142.25 -172.03 3.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.854 -0.173 . . . . 0.0 110.56 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 104.8 12.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 30.6 m -88.97 144.03 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 6.5 ptpt -157.33 171.55 20.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.483 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -110.5 122.06 46.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.973 0.416 . . . . 0.0 110.271 -177.054 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.72 136.62 51.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.423 0.63 . . . . 0.0 111.755 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.53 136.03 53.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.441 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.2 t70 -157.18 177.1 11.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.07 27.77 6.35 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.446 0.641 . . . . 0.0 109.952 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.836 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.4 t -72.63 128.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.903 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.668 HG23 ' H ' ' A' ' 68' ' ' THR . 12.8 t -118.02 -175.12 2.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.112 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.1 -14.31 59.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 111.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.668 ' H ' HG23 ' A' ' 66' ' ' THR . 0.3 OUTLIER -80.85 70.11 7.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.77 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.908 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.28 170.71 15.32 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -24.64 61.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.258 0.551 . . . . 0.0 110.154 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -107.2 142.97 36.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 47' ' ' VAL . 66.6 mt -78.92 92.91 4.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.034 0.445 . . . . 0.0 110.578 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.542 HD12 ' HA2' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -74.29 125.91 34.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.901 177.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 137.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.553 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 64.7 t30 -80.72 -4.95 56.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 43' ' ' LEU . . . 64.56 26.92 13.36 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.625 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.72 87.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -130.27 75.25 1.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.665 177.534 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 9.5 m -113.85 130.2 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.651 0.263 . . . . 0.0 110.359 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.11 159.72 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.894 0.378 . . . . 0.0 110.958 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.371 178.168 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 99.86 10.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.45 126.92 31.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.625 HG21 ' HA3' ' A' ' 48' ' ' GLY . 25.7 mt -96.35 115.81 36.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.055 0.455 . . . . 0.0 111.646 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.93 17.49 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HD3' HG12 ' A' ' 50' ' ' ILE . 47.1 Cg_endo -68.26 -23.24 39.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -84.23 -13.09 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.396 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -82.05 -53.69 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.872 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -152.65 105.01 2.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 111.175 -177.252 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.4 m -152.81 74.05 1.03 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.346 0.593 . . . . 0.0 109.586 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.618 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -94.59 -151.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.909 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.3 94.42 0.26 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.872 0.367 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 t0 54.5 37.3 27.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.039 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.618 ' HD2' ' HB ' ' A' ' 11' ' ' ILE . 6.2 m-85 -111.04 123.72 50.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.742 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -104.97 149.6 37.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.944 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.2 Cg_exo -77.33 138.73 18.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.88 2.387 . . . . 0.0 112.252 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' OH ' ' HB3' ' A' ' 64' ' ' ASP . 16.6 m-85 -126.31 145.06 50.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.225 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -96.74 112.94 24.48 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.21 141.99 18.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.068 0.461 . . . . 0.0 110.758 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -112.79 114.07 26.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 176.637 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.376 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.656 0.265 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -132.44 103.34 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 0.0 110.281 175.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.21 98.99 0.65 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -153.55 -174.73 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.52 154.01 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 111.851 -170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.97 144.49 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.625 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -87.61 95.28 2.06 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.47 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -63.87 127.12 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.718 0.294 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.494 HG12 ' HD3' ' A' ' 6' ' ' PRO . 1.7 mp -56.82 121.97 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.568 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.18 27.12 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.47 ' OG ' HG23 ' A' ' 49' ' ' VAL . 1.6 m -98.88 156.28 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.523 0.202 . . . . 0.0 110.577 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.57 154.56 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 m -134.19 145.51 49.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.054 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.08 -10.45 80.57 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.52 -174.68 4.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.725 -0.737 . . . . 0.0 110.123 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -92.83 160.34 14.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.757 0.313 . . . . 0.0 110.415 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.55 128.62 53.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.03 153.85 26.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 106.36 14.82 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -121.49 148.17 44.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.452 0.644 . . . . 0.0 111.486 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.9 tttp -137.82 141.01 40.82 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.759 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER 80.81 78.77 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.799 1.312 . . . . 0.0 109.271 -170.723 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.31 -109.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.194 -174.318 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' H ' ' HB2' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -107.82 134.66 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 111.121 -176.731 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -59.78 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.866 0.841 . . . . 0.0 110.255 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -115.59 139.45 50.08 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.639 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 51.8 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.15 0.5 . . . . 0.0 111.279 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.08 42.16 3.04 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.704 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.14 165.08 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -58.49 3.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.59 170.81 7.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.216 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -70.83 131.47 43.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.946 0.403 . . . . 0.0 111.177 -178.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.3 mt -118.3 133.43 65.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.012 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -102.93 142.16 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.284 -179.022 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -87.98 8.43 26.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.87 -124.6 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.976 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.38 -67.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.057 0.543 . . . . 0.0 111.377 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.6 m120 -116.28 102.3 9.45 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 130.86 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.602 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.01 159.75 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.036 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.066 178.083 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.972 0.415 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 110.36 21.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -79.2 120.17 23.32 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.551 HD12 ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -83.66 128.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 176.15 33.69 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.639 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.15 -32.7 94.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.901 2.401 . . . . 0.0 112.093 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.07 87.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.779 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -36.68 82.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -103.39 156.16 17.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.95 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.41 51.59 1.47 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.529 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -123.26 151.79 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.441 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.6 115.6 14.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.07 72.17 0.54 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.269 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 4.3 m-85 -125.9 141.58 51.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.242 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 11.4 mtmt -90.84 124.28 62.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.617 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.8 Cg_exo -76.03 139.27 21.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.089 2.526 . . . . 0.0 111.771 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.11 143.62 51.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -92.06 112.26 24.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 59' ' ' LYS . 98.4 m -119.34 125.07 48.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.555 -174.509 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.788 0.328 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -117.68 103.91 10.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.364 0.602 . . . . 0.0 111.049 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.71 94.56 0.57 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.171 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 75' ' ' ILE . 80.1 m -136.53 177.79 7.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.13 148.77 23.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.906 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 141.64 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.967 0.413 . . . . 0.0 110.589 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 4' ' ' ILE . . . -86.72 136.42 14.04 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.195 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 22.0 t -80.32 113.95 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 50' ' ' ILE . 29.7 pt -62.9 115.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 0.0 110.635 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.01 -12.11 34.39 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.963 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 71.0 m -102.78 170.19 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.671 0.272 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -106.15 140.97 38.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 -177.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.18 124.04 38.09 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.385 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.12 52.96 3.76 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.07 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.19 178.27 9.93 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -87.68 124.63 33.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.011 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.01 130.57 35.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.218 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -120.3 163.64 17.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.489 176.173 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.5 117.1 27.53 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -126.47 133.04 51.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.51 0.671 . . . . 0.0 111.646 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.655 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 7.6 ttpt -106.99 118.39 36.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.431 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.66 175.13 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.66 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -124.0 105.06 9.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.064 0.459 . . . . 0.0 110.733 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.82 115.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.485 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.99 94.29 6.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.332 0.587 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -79.76 86.88 5.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.6 0.714 . . . . 0.0 110.659 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -125.17 52.58 1.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.618 0.723 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.28 31.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -140.2 148.74 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.36 -17.11 20.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.37 155.95 26.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -82.98 94.06 7.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.086 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 45' ' ' CYS . 2.4 mt -92.48 135.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -18.45 65.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 56.16 37.81 29.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.877 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.57 -52.57 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 10.2 m-80 -123.87 81.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.312 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.7 m -116.4 129.92 56.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.271 0.558 . . . . 0.0 110.891 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.2 159.89 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.324 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.32 179.743 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 m -79.41 117.77 20.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.413 . . . . 0.0 110.621 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 115.14 25.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.79 110.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 152.94 44.36 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.921 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HA ' HG21 ' A' ' 50' ' ' ILE . 12.4 Cg_endo -56.45 -37.86 96.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 112.256 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.04 75.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.69 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -42.64 59.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.4 m -126.87 145.16 50.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -97.88 69.62 2.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.191 0.52 . . . . 0.0 110.459 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 -145.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.012 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.09 -164.68 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.177 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.48 97.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.677 . . . . 0.0 109.785 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 9.1 m-85 -125.98 145.3 50.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.995 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.667 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -100.83 131.2 23.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 38.3 Cg_endo -71.15 130.49 17.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.331 2.021 . . . . 0.0 110.696 171.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.667 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 7.4 m-85 -114.7 139.78 49.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.8 0.334 . . . . 0.0 110.954 -175.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.3 t -94.04 113.03 24.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 t -146.88 158.86 44.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.622 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -141.26 106.1 4.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.315 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.836 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.64 0.257 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 75' ' ' ILE . 2.7 mm? -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.44 66.98 0.56 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.993 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB2' HD11 ' A' ' 75' ' ' ILE . 77.3 m -134.25 171.75 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.466 0.174 . . . . 0.0 111.053 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 73' ' ' LEU . 1.7 p -118.71 165.76 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -171.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.0 t -69.15 136.31 26.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.725 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.47 132.84 11.26 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.34 136.79 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.091 0.472 . . . . 0.0 111.092 -177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 6' ' ' PRO . 1.1 pt -73.76 147.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.36 12.55 79.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.02 152.4 47.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.707 0.289 . . . . 0.0 110.309 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -88.6 145.86 25.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.255 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.27 124.58 20.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.902 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.88 54.0 4.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.728 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.4 -163.73 1.24 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.76 147.73 22.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 7.7 t -111.37 120.67 62.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -108.66 169.23 8.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.827 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -119.47 105.86 11.67 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.5 m -129.08 139.28 52.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.482 0.658 . . . . 0.0 112.009 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.6 tptt -121.19 121.14 37.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.157 169.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.53 171.42 14.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.77 63.88 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.595 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.13 107.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.218 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.78 171.15 8.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.025 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -87.89 49.38 1.79 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.143 0.497 . . . . 0.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -12.57 60.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.308 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 93.8 1.14 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.883 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -152.82 153.11 32.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.72 0.295 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -46.45 21.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.479 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -135.96 164.15 28.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.191 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -80.95 122.16 26.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.911 0.386 . . . . 0.0 110.964 -177.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.48 145.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.057 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.49 124.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.282 0.563 . . . . 0.0 110.81 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -84.37 -3.72 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.109 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.91 32.9 15.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.664 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -54.72 29.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 3.0 m-80 -127.23 78.08 1.79 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 m -117.05 130.34 56.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 111.143 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -134.07 160.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.321 178.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.257 0.973 . . . . 0.0 111.052 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -89.03 108.64 19.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.311 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 113.36 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.031 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 8' ' ' THR . 29.8 mt -70.7 109.56 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.602 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.93 -173.17 30.36 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.981 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 50' ' ' ILE . 93.6 Cg_endo -83.72 8.03 4.85 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.979 2.453 . . . . 0.0 113.452 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.33 36.12 3.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -70.09 -48.17 58.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.368 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD12 ' A' ' 11' ' ' ILE . 70.9 m -92.91 124.35 36.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.15 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.94 17.82 2.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.531 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -122.92 159.95 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.937 177.163 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 4.8 t0 -69.52 -89.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 5.5 t70 -84.46 79.21 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.351 0.596 . . . . 0.0 111.213 -173.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.684 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 20.9 m-85 -144.71 138.98 27.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -106.83 138.9 19.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.908 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.5 Cg_exo -70.85 133.62 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.743 2.295 . . . . 0.0 111.53 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 33.0 m-85 -126.17 135.49 51.71 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.049 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.3 m -91.37 112.01 23.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 95.7 m -115.13 127.73 55.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.894 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.14 113.34 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.436 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.7 0.762 . . . . 0.0 109.666 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.826 ' HB3' HD12 ' A' ' 75' ' ' ILE . 3.6 mm? -104.74 130.88 52.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.049 0.452 . . . . 0.0 111.015 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.75 65.3 0.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' A' ' 75' ' ' ILE . 20.8 m -119.37 172.19 7.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.73 158.16 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.027 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.57 127.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.368 0.604 . . . . 0.0 111.4 -176.182 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 4' ' ' ILE . . . -96.08 77.77 0.77 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.25 151.29 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 6' ' ' PRO . 3.9 mp -56.65 126.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.68 10.69 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.033 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 143.74 34.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.626 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -99.37 143.07 30.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.66 136.09 50.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.46 17.13 43.82 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.9 -171.73 2.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.401 -0.399 . . . . 0.0 110.285 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 110.94 15.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.78 125.46 42.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -131.06 168.93 16.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.015 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 43.7 m -106.56 118.98 38.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 m -121.62 154.54 36.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.042 0.449 . . . . 0.0 110.866 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 2.2 tptm -151.0 135.25 16.85 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.04 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 178.74 -176.72 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.293 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -90.56 96.63 10.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -96.72 100.33 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.103 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -160.79 0.8 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.079 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.25 58.6 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 111.37 -173.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 25.85 3.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.549 0.69 . . . . 0.0 109.926 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.17 84.4 1.43 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.285 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -79.15 119.54 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.3 m 72.28 -50.66 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.811 0.694 . . . . 0.0 111.184 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.01 166.43 29.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.296 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.526 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -89.12 107.95 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 -177.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.1 139.81 19.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -111.84 134.7 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.316 0.579 . . . . 0.0 111.281 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.03 139.48 36.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.643 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 51.78 2.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 0.0 111.4 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -99.53 -71.83 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 10.2 m-80 -102.73 70.01 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.565 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 54.6 m -118.16 128.69 54.96 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.037 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.83 159.78 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.567 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.567 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.689 0.281 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.13 100.82 7.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.204 0.526 . . . . 0.0 110.816 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -81.12 112.41 18.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.359 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 54' ' ' CYS . 12.9 mt -77.71 120.94 29.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.7 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.66 167.84 12.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.797 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.85 -16.62 41.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.919 2.413 . . . . 0.0 112.501 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 43.6 1.92 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.275 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -65.41 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.166 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 70.4 1.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.978 175.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.53 67.24 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.739 -172.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -87.83 -87.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 29.6 t0 -93.46 -167.19 1.66 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -73.79 76.47 1.59 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -95.82 137.16 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.648 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 22.8 mtmt -91.65 120.16 68.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 14.9 Cg_exo -69.01 141.71 49.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.712 2.275 . . . . 0.0 111.539 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -137.42 135.2 36.7 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.81 124.5 52.73 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.275 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 p -156.06 162.51 40.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.29 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.555 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 1.7 mt-30 -80.06 107.77 13.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.006 0.432 . . . . 0.0 110.281 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.29 27.78 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.828 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -89.39 -33.01 17.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.365 0.602 . . . . 0.0 109.546 173.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -160.46 -78.92 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.107 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . 159.27 131.71 1.28 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.603 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 6.5 Cg_exo -73.87 90.89 0.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.663 2.242 . . . . 0.0 111.47 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.7 -61.83 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.2 -143.77 16.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -75.18 116.68 56.65 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.506 0.193 . . . . 0.0 110.495 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.61 136.25 73.19 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.277 2.651 . . . . 0.0 112.716 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.84 -138.49 2.46 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.615 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.5 69.25 10.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.0 0.429 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.38 153.39 23.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.509 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -82.78 141.99 31.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.78 -18.16 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.119 0.485 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -114.18 132.24 22.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.574 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.96 124.22 15.47 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.502 2.135 . . . . 0.0 111.776 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.32 115.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.071 0.462 . . . . 0.0 111.453 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.08 166.69 27.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.2 -18.53 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.75 -80.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.288 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.12 132.93 4.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.924 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.55 103.24 9.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.515 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -113.07 119.32 37.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.918 0.39 . . . . 0.0 110.155 176.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.1 87.45 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.221 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.9 m -137.73 171.3 14.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.569 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.44 154.07 22.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.931 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 134.1 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.221 0.534 . . . . 0.0 110.87 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' CA ' HD13 ' A' ' 4' ' ' ILE . . . -80.25 105.42 2.36 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.05 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HB ' ' OG ' ' A' ' 52' ' ' SER . 4.7 t -68.29 130.77 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 50' ' ' ILE . 5.4 pt -68.42 125.33 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.444 0.64 . . . . 0.0 110.456 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.74 -11.08 66.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.599 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.443 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 63.9 m -88.09 155.3 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.529 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.559 ' HG2' HG23 ' A' ' 3' ' ' THR . 26.1 mt-30 -108.46 121.51 45.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.645 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.491 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -114.44 116.68 29.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.88 56.22 3.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.19 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.88 -179.03 7.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.7 128.19 33.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.87 127.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.84 169.71 11.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.783 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.7 m -118.37 124.68 48.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.9 m -129.34 135.32 48.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 0.0 111.568 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 12.7 tttt -112.71 117.79 33.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.092 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -172.55 163.77 5.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.416 -176.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -109.36 111.62 23.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.159 0.505 . . . . 0.0 110.504 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.41 146.99 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.637 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.4 138.27 31.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.405 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -78.39 -30.1 47.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.382 0.611 . . . . 0.0 110.62 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 3.79 48.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.973 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.0 -76.16 0.63 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.083 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -119.04 -179.98 3.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.77 7.34 15.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.373 0.606 . . . . 0.0 110.746 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -156.56 169.85 23.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.622 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.15 92.88 5.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.102 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tt -75.62 136.29 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 43' ' ' LEU . 2.8 mt -92.18 128.78 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.961 0.41 . . . . 0.0 110.747 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 10.3 m-80 -64.18 -20.58 66.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.493 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 61.72 26.2 15.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.078 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -56.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 4.7 m-80 -124.33 84.19 2.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.924 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 33.2 m -115.55 135.78 53.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.949 0.404 . . . . 0.0 110.986 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.24 130.6 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.851 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.279 -178.678 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.678 0.275 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 103.41 12.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.813 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.24 137.37 37.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.801 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.621 HG21 ' HA3' ' A' ' 48' ' ' GLY . 7.8 mt -109.55 137.0 43.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.83 -169.76 17.73 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.163 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.11 -17.01 15.43 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.406 2.071 . . . . 0.0 112.649 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.37 13.54 33.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.806 0.336 . . . . 0.0 111.477 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -75.45 -29.73 59.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.33 89.97 1.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.967 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.41 27.98 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.036 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -84.03 -109.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.482 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 1.9 t70 -92.91 -164.31 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -74.55 66.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.617 0.722 . . . . 0.0 109.495 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 5.3 m-85 -93.85 128.02 39.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.42 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 18.0 mtmt -87.74 119.67 70.67 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.6 Cg_exo -72.29 144.43 41.4 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.013 2.476 . . . . 0.0 110.815 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.71 143.75 45.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.998 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.4 t -97.36 113.13 24.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 58.2 m -118.94 130.27 55.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 111.586 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -88.45 105.51 17.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.151 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -102.16 138.17 39.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.671 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -89.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.43 -43.95 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.517 0.675 . . . . 0.0 110.598 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.32 -166.55 24.97 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.505 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.42 137.78 40.61 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.767 2.311 . . . . 0.0 112.179 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.34 22.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.16 -61.38 0.74 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.891 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.55 122.24 85.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.789 0.328 . . . . 0.0 111.492 -175.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 35' ' ' ILE . 7.4 Cg_exo -73.65 99.11 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.077 2.518 . . . . 0.0 111.757 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.8 35.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.345 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.2 18.93 12.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.062 0.458 . . . . 0.0 110.579 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.68 -35.15 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.272 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -100.15 127.31 46.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.48 131.84 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 111.192 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.674 HG12 ' HA ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -106.55 123.33 39.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.773 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 16.5 Cg_exo -67.42 124.2 11.77 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.449 2.099 . . . . 0.0 111.921 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.43 53.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.53 0.681 . . . . 0.0 110.115 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.15 159.88 32.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.645 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -1.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.058 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.35 -34.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -79.08 -4.13 48.76 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 91.98 5.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.825 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -140.75 104.31 4.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.46 89.74 0.44 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 43' ' ' LEU . 4.0 m -133.18 175.26 9.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 111.891 -171.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.17 156.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -61.98 139.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.387 . . . . 0.0 110.478 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.621 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -60.93 115.38 7.76 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.184 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.67 95.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -60.41 103.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.469 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.98 22.44 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.19 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -112.0 158.73 19.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.873 0.368 . . . . 0.0 110.526 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -98.65 153.16 18.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.229 0.537 . . . . 0.0 110.527 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 153.92 45.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.139 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.32 47.99 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.678 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.62 -171.82 3.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.44 137.26 37.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.87 121.71 58.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.978 0.418 . . . . 0.0 110.544 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 mtpp -122.96 170.01 10.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.67 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 70.9 m -129.5 123.48 31.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.9 45.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 0.0 112.242 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -105.35 113.11 26.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.42 163.55 19.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.949 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.04 93.14 5.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -85.59 132.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.366 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.09 143.3 31.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.921 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.05 5.53 38.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.29 0.566 . . . . 0.0 110.076 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.36 101.77 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.684 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.14 37.24 81.63 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -133.45 120.13 20.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.644 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -36.71 71.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.476 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -136.49 -168.26 2.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mp -90.67 95.8 10.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 112.069 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.76 118.38 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.874 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.7 mp -93.02 132.14 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -15.37 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.519 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.874 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 61.92 25.23 15.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.897 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.35 -56.31 11.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.015 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.635 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 12.0 m-80 -121.03 82.79 1.97 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.182 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -115.24 130.29 56.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.103 0.478 . . . . 0.0 111.06 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.45 159.47 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 O-C-N 123.686 0.616 . . . . 0.0 109.989 -175.933 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.763 0.316 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.29 99.52 9.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 2.0 m -81.15 113.84 19.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' HA3' ' A' ' 48' ' ' GLY . 23.4 mt -71.56 131.01 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.552 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -155.09 -164.57 13.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.793 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.04 -25.31 73.58 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.784 2.323 . . . . 0.0 111.934 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -90.07 77.06 6.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.944 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -100.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.377 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 91.97 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.67 67.33 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.577 0.703 . . . . 0.0 111.204 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -135.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.621 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.79 -165.32 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.01 107.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 15.5 m-85 -136.63 145.84 45.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.771 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.3 mtmt -102.33 124.85 38.15 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.804 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.9 Cg_exo -75.58 120.23 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.935 2.423 . . . . 0.0 111.981 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 81.6 m-85 -118.08 131.87 56.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.236 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.8 t -107.43 113.65 27.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.365 . . . . 0.0 110.959 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -148.09 151.09 35.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -80.09 104.97 11.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.706 0.765 . . . . 0.0 109.653 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 -18.07 5.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.755 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -87.22 74.5 9.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.322 0.582 . . . . 0.0 110.511 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 30.19 0.28 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.978 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.08 96.52 0.22 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.47 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.48 122.16 10.43 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.662 2.242 . . . . 0.0 111.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.08 40.57 6.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.397 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 123.51 30.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.655 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -109.89 148.41 38.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.625 0.25 . . . . 0.0 111.267 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 24.2 Cg_exo -64.22 138.76 62.85 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.036 2.49 . . . . 0.0 112.07 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.62 -67.22 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.23 -38.05 21.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.12 110.08 21.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.098 172.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -99.14 20.62 13.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.713 0.768 . . . . 0.0 109.915 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.82 152.48 51.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.347 177.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -98.05 113.72 64.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.106 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.17 121.81 8.4 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.058 1.839 . . . . 0.0 111.988 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.17 127.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.319 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -92.25 117.59 30.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.15 0.5 . . . . 0.0 109.66 173.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.51 10.25 31.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.085 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.12 1.37 17.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.057 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.24 50.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 0.0 111.508 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m -92.42 -162.14 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 75' ' ' ILE . 0.9 OUTLIER -94.74 108.52 20.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.076 0.465 . . . . 0.0 111.204 -175.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.33 77.35 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 2.6 m -128.66 163.18 25.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.791 0.329 . . . . 0.0 111.134 -174.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -118.28 155.12 20.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.027 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.81 128.19 31.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.423 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -85.86 102.96 2.71 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -71.7 139.14 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.552 HG23 ' HA2' ' A' ' 5' ' ' GLY . 1.8 mp -67.94 122.57 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.869 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.72 -12.51 20.64 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.19 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -102.03 141.5 34.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.941 0.4 . . . . 0.0 110.727 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.6 mp0 -86.17 144.91 27.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.449 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 143.8 51.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.782 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.5 43.74 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.738 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.45 -168.78 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.65 147.73 25.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.01 122.58 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 8.6 ptmt -128.55 156.56 43.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 1.3 m -106.14 129.61 54.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.831 0.348 . . . . 0.0 110.643 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m -127.62 140.77 51.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.5 . . . . 0.0 110.996 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.8 ttmm -123.13 127.53 48.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.692 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 175.39 169.08 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.612 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.06 99.69 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.553 HG11 ' CB ' ' A' ' 73' ' ' LEU . 95.5 t -82.49 118.68 30.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 125.92 54.86 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.353 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -77.67 106.91 9.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 111.052 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -87.32 59.31 5.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.578 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.58 52.53 45.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.973 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.15 157.4 46.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -39.67 72.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 46' ' ' VAL . 7.5 p90 -111.55 175.38 5.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.572 HD13 ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -93.38 120.86 34.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -176.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 65' ' ' VAL . 6.1 tt -87.8 123.97 40.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.187 0.517 . . . . 0.0 110.408 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.2 mp -93.8 135.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.805 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -69.46 -18.55 63.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.711 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.804 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 63.65 31.51 14.46 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.507 -177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.28 -56.73 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 6.5 m-80 -119.89 85.57 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.906 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 58.5 m -116.38 133.89 55.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.784 0.326 . . . . 0.0 110.431 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.77 141.48 44.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.425 0.631 . . . . 0.0 111.171 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.78 141.5 28.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -101.21 121.19 41.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.005 0.431 . . . . 0.0 110.787 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -84.55 124.72 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.182 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 168.4 12.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.936 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 50' ' ' ILE . 21.9 Cg_exo -64.85 -25.64 60.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.747 2.298 . . . . 0.0 111.635 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HA ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -138.44 55.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.828 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -44.94 77.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.301 0.572 . . . . 0.0 110.368 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.82 27.42 0.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.371 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.873 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -82.86 82.95 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.533 -174.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.9 mm -70.91 -55.02 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.503 0.668 . . . . 0.0 109.485 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -149.94 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.838 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.4 55.17 2.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.226 1.013 . . . . 0.0 109.229 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.873 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 7.0 m-30 -78.96 107.99 12.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.048 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -83.3 135.58 44.08 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.839 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.4 Cg_exo -70.12 133.94 26.06 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.461 2.107 . . . . 0.0 111.404 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -114.71 142.72 46.12 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 t -119.25 112.56 19.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.936 0.398 . . . . 0.0 110.578 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -152.57 146.8 25.5 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -93.32 136.07 33.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -89.84 50.87 1.95 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 0.0 111.02 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 116.85 5.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.591 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.88 -15.62 24.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.824 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.24 114.85 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.907 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.27 -167.51 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.94 2.426 . . . . 0.0 112.472 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.35 115.26 19.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.65 -94.92 1.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.247 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.34 112.58 51.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.732 0.301 . . . . 0.0 111.314 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.88 115.99 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.587 2.191 . . . . 0.0 111.133 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.16 -27.33 3.15 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.498 ' HB3' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -106.3 -137.65 0.36 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 177.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.498 ' H ' ' HB3' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -163.91 149.85 11.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.727 0.299 . . . . 0.0 110.667 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -87.23 101.31 13.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 125.96 29.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.236 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.35 130.78 14.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.414 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 131.76 32.45 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.629 2.219 . . . . 0.0 110.916 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.97 64.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.319 0.581 . . . . 0.0 110.995 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -93.86 112.51 24.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mp -86.54 151.26 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.247 -173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m 61.36 52.21 3.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.204 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.06 96.47 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.173 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.98 168.72 19.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.815 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.71 142.56 35.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.603 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -101.78 -53.34 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 169.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 m 65.38 -176.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.891 -0.654 . . . . 0.0 112.31 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.17 154.19 38.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 132.0 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.068 0.461 . . . . 0.0 110.45 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.1 134.75 13.14 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.185 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 52' ' ' SER . 1.4 p -69.23 129.58 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.793 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -71.2 135.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.075 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.17 76.58 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.522 ' HB2' HG13 ' A' ' 49' ' ' VAL . 14.8 m -108.33 170.66 7.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.015 0.436 . . . . 0.0 111.514 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -96.29 146.14 24.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.66 154.0 49.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.137 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.4 48.42 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.649 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.55 -171.46 3.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.502 0.192 . . . . 0.0 110.573 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -79.49 127.79 32.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.801 0.334 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.02 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.795 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -122.56 152.63 40.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 178.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 15.2 m -114.18 107.84 16.16 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -127.87 156.21 42.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.97 0.891 . . . . 0.0 113.345 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -145.86 150.8 36.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.631 -1.622 . . . . 0.0 107.047 168.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 1.5 m-20 -158.52 -165.53 1.69 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -88.57 4.47 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 75' ' ' ILE . 1.5 t -76.58 105.9 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.548 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -101.0 -120.7 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.268 176.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.48 ' H ' ' HB ' ' A' ' 66' ' ' THR . 13.7 t-20 -99.29 81.4 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.219 0.533 . . . . 0.0 110.074 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.18 151.11 23.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.72 69.73 3.27 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.637 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -137.97 165.6 26.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -30.67 71.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.184 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.703 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 8.7 p90 -145.94 -173.01 4.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.907 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -102.12 100.32 10.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -80.98 115.85 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.664 ' HA ' HG21 ' A' ' 65' ' ' VAL . 5.1 pt -92.44 154.73 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.05 -14.94 57.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.199 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.14 34.49 5.0 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.201 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . . . -88.47 -62.79 1.41 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.979 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 9.9 m-80 -95.35 50.91 1.27 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.168 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 51.1 t -123.81 129.94 51.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -129.73 123.78 57.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.687 -177.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.318 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.565 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -78.99 103.52 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.24 0.543 . . . . 0.0 111.258 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 135.61 33.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.415 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.04 124.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.661 0.267 . . . . 0.0 110.662 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -110.73 -168.43 19.23 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -0.82 9.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.783 2.322 . . . . 0.0 112.44 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 151.84 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.934 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.54 -70.66 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.553 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.69 42.68 0.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.151 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 14.5 m -79.86 76.05 6.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.822 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -92.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.058 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.79 88.78 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.561 0.22 . . . . 0.0 111.042 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.752 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.8 t70 50.47 38.47 18.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.431 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 13.4 m-85 -88.35 112.29 22.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.849 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.44 146.31 31.09 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.28 120.55 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.58 2.187 . . . . 0.0 111.458 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 3.3 m-85 -113.96 130.88 56.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.82 118.55 36.97 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.46 173.02 12.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.957 0.408 . . . . 0.0 110.922 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 158.76 26.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.64 103.5 9.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.634 ' HG2' HD21 ' A' ' 34' ' ' LEU . 4.8 ttp -80.35 109.02 14.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 0.0 109.743 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m -108.78 129.8 55.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.08 154.37 19.87 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.667 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.581 ' HG2' ' HG ' ' A' ' 32' ' ' LEU . 35.4 Cg_exo -60.41 120.27 7.93 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.035 2.49 . . . . 0.0 112.142 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.73 176.87 6.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.58 -96.49 2.09 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.511 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.1 85.96 57.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.827 0.346 . . . . 0.0 110.408 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 2.9 Cg_exo -75.69 57.87 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.124 2.549 . . . . 0.0 112.008 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.93 -23.96 70.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.355 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.625 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -90.33 -53.4 4.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -148.7 135.29 19.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.403 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 25.3 t-20 -95.36 -29.11 14.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.959 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.634 HD21 ' HG2' ' A' ' 22' ' ' MET . 0.3 OUTLIER 63.57 66.52 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.946 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -90.27 135.83 29.3 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.8 122.17 11.28 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.048 1.832 . . . . 0.0 111.957 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.99 88.62 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.32 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.94 169.87 16.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.18 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -21.26 18.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -145.53 -68.65 0.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.7 108.1 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.009 0.433 . . . . 0.0 112.049 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.54 91.98 7.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.333 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -138.71 104.68 5.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 0.0 110.883 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.75 75.23 0.21 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 43' ' ' LEU . 96.0 m -104.16 156.74 17.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -132.07 160.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.563 175.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.42 120.29 15.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.877 0.37 . . . . 0.0 110.804 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.88 112.12 3.98 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.0 151.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.309 0.576 . . . . 0.0 111.577 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 50' ' ' ILE . 4.9 mp -58.67 124.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.814 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.83 -23.8 11.46 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.21 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -83.08 149.64 26.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.841 0.353 . . . . 0.0 110.786 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -114.35 120.23 39.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.963 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -110.01 110.8 21.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.536 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.69 4.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.868 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.17 -113.24 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -131.08 119.64 22.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.023 0.439 . . . . 0.0 111.147 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.08 114.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.402 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -124.76 169.97 11.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.793 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 87.6 m -110.34 121.05 44.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -129.02 147.5 50.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.106 0.479 . . . . 0.0 110.799 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HE3' ' HB3' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -134.09 131.03 38.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.618 175.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.69 178.25 6.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.474 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.81 102.06 8.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.176 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.78 154.16 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.76 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.62 120.34 42.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.049 0.452 . . . . 0.0 111.106 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -92.86 55.62 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.465 0.65 . . . . 0.0 109.897 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -21.85 45.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.881 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.17 52.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -115.5 164.63 14.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.311 . . . . 0.0 110.672 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -42.84 13.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 109.909 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -145.26 165.37 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.799 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -87.1 93.46 9.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 110.97 -178.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.05 111.85 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -92.99 153.25 3.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -174.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.83 -11.09 59.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.721 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.85 33.06 12.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.506 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -58.67 3.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.287 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.2 m-80 -107.06 84.65 2.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.231 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.97 129.46 50.97 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.843 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.08 121.51 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.238 0.542 . . . . 0.0 111.038 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.724 176.478 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.595 ' HB1' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.43 109.01 13.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.029 0.442 . . . . 0.0 110.56 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.31 134.71 42.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.59 HG23 HG21 ' A' ' 8' ' ' THR . 4.7 mt -98.18 102.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.33 -167.86 16.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.946 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.85 -27.22 59.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 0.0 111.922 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -108.72 54.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.079 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.59 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.91 -74.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.159 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -104.55 126.25 51.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.908 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.49 70.52 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 111.307 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.5 -161.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.823 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -67.54 178.97 1.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.91 99.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.574 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 15.1 m-85 -115.33 157.29 24.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.936 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -90.78 117.55 68.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.0 Cg_exo -79.41 131.47 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.263 2.642 . . . . 0.0 111.777 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -125.88 141.61 51.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.1 m -95.49 112.49 24.19 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -131.91 141.39 49.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.675 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.71 105.45 17.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.843 0.354 . . . . 0.0 110.055 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.53 139.79 31.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.571 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.5 ttm -81.49 113.26 19.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.193 0.521 . . . . 0.0 110.161 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.23 49.38 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.676 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.56 177.63 47.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.527 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.07 120.08 7.75 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.85 85.95 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.025 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.24 173.14 17.74 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.521 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.24 123.14 44.27 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.03 115.93 2.78 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.323 . . . . 0.0 112.306 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.65 150.56 9.39 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.828 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB2' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -138.64 -121.46 0.13 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' H ' ' HB3' ' A' ' 31' ' ' LEU . 12.7 tp -86.52 -14.78 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.867 0.841 . . . . 0.0 109.024 175.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 157.88 43.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.992 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.4 101.7 2.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.08 0.466 . . . . 0.0 111.464 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -110.05 99.2 38.3 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.86 124.58 12.48 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.773 2.316 . . . . 0.0 113.118 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -119.7 120.62 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -103.24 144.42 31.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.412 0.625 . . . . 0.0 111.339 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -144.28 -4.25 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.424 174.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -34.82 10.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.208 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.23 19.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.105 0.479 . . . . 0.0 110.758 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 92.42 5.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.268 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 3.0 mm? -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.453 0.644 . . . . 0.0 111.16 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' A' ' 72' ' ' PHE . . . -165.57 93.04 0.11 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' HB2' HD11 ' A' ' 75' ' ' ILE . 56.3 m -139.47 -178.04 5.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.181 0.515 . . . . 0.0 111.733 -169.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.26 153.25 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.39 137.51 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.962 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.2 129.67 23.52 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.997 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.67 105.02 5.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 11.3 mt -64.66 108.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.747 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.39 -8.72 20.25 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.58 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -110.95 160.92 16.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG2' ' HB1' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -93.47 153.18 18.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.633 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 116.64 12.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.125 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.19 60.17 4.26 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 19' ' ' CYS . . . -158.32 -152.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 -174.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -114.81 136.63 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 110.174 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.73 117.53 37.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.424 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 4.7 mmpt? -109.96 138.96 45.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.077 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -111.98 100.97 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -120.83 135.21 55.23 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.347 0.594 . . . . 0.0 111.156 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -94.46 103.86 15.83 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.915 175.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -160.45 127.1 4.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.527 -1.669 . . . . 0.0 106.878 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.63 66.59 5.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 0.0 112.309 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -78.63 100.7 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 169.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -128.07 -32.76 2.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.795 0.807 . . . . 0.0 110.389 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -96.08 125.16 40.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.44 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 102.0 8.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.417 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 -32.98 49.91 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -124.57 -161.03 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.8 6.16 8.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HE2' ' C ' ' A' ' 44' ' ' GLY . 2.9 p90 -157.28 -158.88 0.79 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.112 -0.367 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp -104.13 99.24 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.144 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tp -81.55 116.51 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 109.908 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -101.48 137.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.22 -175.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -76.51 154.53 34.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.25 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.03 99.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 21.25 -102.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 125.198 1.561 . . . . 0.0 114.08 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 11.7 m-80 -121.08 70.87 0.92 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 38.6 t -114.3 129.9 56.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.376 -0.828 . . . . 0.0 111.199 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 135.81 42.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.152 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 112.4 20.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.719 0.295 . . . . 0.0 110.525 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.36 124.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.916 0.388 . . . . 0.0 111.081 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 54' ' ' CYS . 19.8 mt -88.48 94.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.284 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 175.58 30.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.369 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.96 -13.82 34.65 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.503 2.135 . . . . 0.0 111.983 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.31 41.59 1.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.484 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.6 -53.96 4.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.304 0.573 . . . . 0.0 110.749 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.18 64.85 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.459 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.75 65.32 4.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 110.659 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 -133.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.055 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.87 66.9 4.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.174 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 21.5 t0 46.79 80.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.927 0.767 . . . . 0.0 111.58 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -110.67 157.99 19.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.929 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 15.6 mtmt -106.31 124.52 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.799 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -80.33 128.68 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.142 2.561 . . . . 0.0 111.321 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.85 132.67 53.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.752 0.31 . . . . 0.0 110.723 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.52 113.2 26.53 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 126.42 33.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.269 0.556 . . . . 0.0 111.553 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.769 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 2.4 mp0 -80.3 129.64 34.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.92 110.98 5.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.202 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 ttm -96.26 104.18 16.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.058 0.456 . . . . 0.0 109.989 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.78 -12.66 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.221 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.1 152.08 16.29 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.781 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.75 20.49 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.848 2.365 . . . . 0.0 112.648 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.54 -65.13 0.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.319 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.93 171.91 12.35 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.728 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 46.4 m -139.7 120.37 9.41 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.553 0.216 . . . . 0.0 110.446 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 7.0 Cg_exo -73.11 169.06 23.15 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 112.143 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.21 74.63 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.399 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -46.16 7.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.116 0.484 . . . . 0.0 109.804 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -135.17 134.22 39.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.277 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.1 137.3 37.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.412 0.625 . . . . 0.0 110.701 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.41 136.66 26.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -99.74 115.79 65.31 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 14.9 Cg_exo -67.69 121.93 9.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.985 1.79 . . . . 0.0 111.333 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.52 137.94 55.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -123.64 78.72 1.63 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.11 0.3 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.896 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.98 -7.47 57.03 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.167 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 59.14 45.34 14.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.096 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.8 91.26 4.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.631 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -145.95 102.94 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.11 94.14 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 75' ' ' ILE . 35.3 m -131.17 -176.09 3.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 111.284 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.26 159.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.295 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.14 133.75 30.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.38 104.66 0.95 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.867 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 110.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.851 0.358 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.4 pt -59.02 120.1 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.2 -26.61 9.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.565 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m -94.33 164.53 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.759 0.314 . . . . 0.0 110.491 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 68.1 mt-30 -106.09 149.37 26.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.168 0.509 . . . . 0.0 111.695 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.647 ' HB2' HD11 ' A' ' 4' ' ' ILE . 10.5 t -108.73 134.87 50.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.289 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.73 -19.47 51.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.104 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.769 ' HB3' ' HA ' ' A' ' 20' ' ' GLN . . . -125.39 -123.8 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.909 0.355 . . . . 0.0 111.941 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.19 96.84 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.258 0.551 . . . . 0.0 112.279 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.14 125.65 45.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -141.77 170.39 15.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.641 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -112.07 124.16 51.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 69.5 m -134.21 132.5 39.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.937 0.399 . . . . 0.0 110.473 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 14.9 tptm -104.38 121.89 44.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.597 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.692 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -164.96 165.51 20.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.768 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -115.01 102.61 10.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.961 0.41 . . . . 0.0 110.736 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -92.79 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.5 129.15 34.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -9.12 59.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.6 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.4 117.96 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.425 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.39 -50.49 0.78 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.787 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -123.15 149.99 43.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.45 -46.16 14.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.992 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.64 157.41 18.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -92.14 97.14 10.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -170.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mp -69.41 133.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 7.8 mt -91.44 129.81 41.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.323 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 21.5 m-80 -65.63 -16.03 63.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.103 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.53 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 57.84 36.02 25.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.341 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.7 -57.17 3.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.428 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.1 m-80 -117.5 97.96 6.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.595 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.5 m -124.04 130.55 52.76 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.922 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.69 152.95 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.254 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.582 -179.591 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.26 101.37 11.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.909 0.385 . . . . 0.0 110.265 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.31 125.13 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.939 -178.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 HD13 ' HA3' ' A' ' 48' ' ' GLY . 13.4 mt -86.04 86.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.172 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 169.49 51.27 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.762 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.79 -42.59 30.74 Favored 'Trans proline' 0 CA--C 1.527 0.168 0 C-N-CA 122.615 2.21 . . . . 0.0 113.045 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.88 33.09 3.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -59.29 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 110.233 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.82 71.44 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.123 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.8 8.85 11.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.47 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.6 mt -65.18 161.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.379 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -18.68 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.806 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.4 t70 -149.6 86.63 1.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 27.8 m-85 -140.95 166.21 25.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.978 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -117.25 142.36 30.03 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.507 175.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 9.3 Cg_exo -71.36 124.87 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.565 2.177 . . . . 0.0 111.281 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.2 m-85 -121.81 130.82 53.68 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.7 m -93.93 112.84 24.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.27 163.92 29.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.93 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -100.65 105.73 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.963 0.411 . . . . 0.0 110.301 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -83.29 96.09 8.38 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.5 ttt -109.47 134.25 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.944 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.82 97.74 9.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.68 117.17 5.28 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.948 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.91 142.5 13.94 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.216 2.611 . . . . 0.0 111.901 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.15 50.21 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.426 0.632 . . . . 0.0 110.391 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.72 142.51 24.67 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.386 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.8 m -144.69 119.19 5.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.9 114.65 2.87 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.684 2.256 . . . . 0.0 111.6 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -143.1 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.91 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.7 126.82 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.833 0.349 . . . . 0.0 110.761 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.79 88.35 2.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.025 0.441 . . . . 0.0 109.863 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -79.7 133.64 36.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.32 84.92 7.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 110.189 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -89.95 142.78 29.18 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 122.73 11.8 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -152.11 158.35 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.374 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -124.05 130.49 52.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tp -123.33 25.82 8.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.523 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.24 -41.11 7.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.071 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.18 74.29 10.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.064 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 m -157.93 96.56 1.48 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.931 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -159.14 107.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.107 0.48 . . . . 0.0 110.458 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.06 87.13 0.38 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -128.53 168.59 15.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -176.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.6 158.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.588 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.73 142.03 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -76.31 147.13 34.02 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.396 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.3 t -86.0 120.78 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 0.0 110.561 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.38 123.12 21.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.67 3.32 68.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.068 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 19.6 m -108.09 160.34 15.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.017 0.436 . . . . 0.0 110.877 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.668 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -96.95 127.85 43.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.3 t -108.46 138.33 44.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.08 12.9 58.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.978 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.18 177.4 4.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 116.85 20.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.255 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.46 113.02 23.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.289 0.566 . . . . 0.0 111.244 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 12.6 ptpt -115.3 171.45 7.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.18 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 33.4 m -117.75 119.64 35.52 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.972 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.71 146.02 50.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.483 0.659 . . . . 0.0 111.427 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -137.77 133.36 33.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.014 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.5 t70 -160.84 -174.32 4.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.98 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -79.33 -72.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.51 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 73' ' ' LEU . 2.1 t 47.79 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.337 1.023 . . . . 0.0 112.89 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 t -84.15 139.11 32.64 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.383 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 59.84 0.87 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.237 0.541 . . . . 0.0 110.312 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -42.07 24.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.588 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.1 57.28 0.22 Allowed Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.51 139.82 52.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -42.68 95.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.691 -175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 162.41 33.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.285 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.609 ' HB2' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -90.87 130.53 36.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.96 0.409 . . . . 0.0 111.833 -172.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.43 128.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -97.47 150.36 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.843 0.354 . . . . 0.0 110.364 -178.008 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -95.98 -2.55 46.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.16 31.13 19.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.539 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.74 -46.94 67.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -127.4 97.93 5.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.13 139.07 33.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.24 0.543 . . . . 0.0 111.606 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.82 127.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.97 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 O-C-N 124.252 0.97 . . . . 0.0 111.346 -179.699 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.78 111.36 19.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.9 131.66 35.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 178.016 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.9 mt -83.1 103.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.647 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.73 -173.5 26.8 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.847 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -13.56 24.64 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.718 2.279 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.12 45.3 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.25 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.591 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -84.66 -61.96 1.66 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.077 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.3 p -160.63 164.41 31.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.662 0.267 . . . . 0.0 110.663 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.75 -113.25 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 175.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER 53.17 -110.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 122.953 0.501 . . . . 0.0 111.541 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.518 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.16 177.59 5.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' N ' ' CG ' ' A' ' 12' ' ' ASP . 12.2 t70 -67.29 77.18 0.15 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.768 0.794 . . . . 0.0 109.797 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.516 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 9.9 m-85 -97.5 140.89 31.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.805 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -105.39 135.09 19.39 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 8' ' ' THR . 41.0 Cg_endo -70.47 132.34 21.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.175 1.917 . . . . 0.0 111.137 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.89 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 6.7 m-85 -119.13 130.72 55.71 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.159 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.05 112.93 25.05 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 157.95 36.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.434 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -80.53 111.27 16.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.272 0.558 . . . . 0.0 110.533 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -117.98 130.3 56.11 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.106 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.8 ptm -91.05 -176.2 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -172.93 3.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.487 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 112.51 0.31 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.04 118.35 4.71 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.121 2.547 . . . . 0.0 112.961 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.49 -14.09 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 57.41 3.15 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.635 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m -122.91 116.1 29.03 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 3.6 Cg_exo -75.24 78.15 3.03 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.215 2.61 . . . . 0.0 112.324 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.16 113.85 2.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.253 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.21 73.97 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 109.779 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.64 91.37 4.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.504 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -93.57 143.07 26.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.303 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -79.11 -77.09 0.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.949 0.404 . . . . 0.0 110.606 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 34' ' ' LEU . 4.6 mt -120.07 112.44 34.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.759 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.014 1.809 . . . . 0.0 111.925 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.93 7.5 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.869 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.85 111.89 19.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.456 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mt -138.24 16.2 2.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.704 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.69 -2.17 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.63 18.07 2.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.39 . . . . 0.0 111.185 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 164.03 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.195 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.634 HD12 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.43 176.99 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.348 . . . . 0.0 110.758 -175.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.9 -60.22 0.12 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 4.1 m 63.29 179.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.742 0.782 . . . . 0.0 112.701 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.19 146.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.889 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.87 122.1 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.067 0.461 . . . . 0.0 109.856 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 99.98 1.37 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.208 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.14 126.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.89 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.741 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.62 -17.18 12.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.061 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -89.44 162.9 15.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 3' ' ' THR . 6.7 mp0 -110.68 156.58 20.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.008 0.432 . . . . 0.0 111.113 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.37 137.85 47.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.01 -5.57 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.947 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -102.88 -105.77 0.27 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.89 147.08 49.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.551 0.215 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.57 106.19 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' H ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -120.33 157.52 29.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 60.0 m -104.0 120.13 40.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.084 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -124.53 151.7 44.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.356 0.598 . . . . 0.0 110.868 -176.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -137.93 135.35 35.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.087 174.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -153.46 -170.64 3.66 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -106.37 38.36 2.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 110.259 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 ' H ' ' A' ' 74' ' ' ILE . 3.1 p -103.32 129.24 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.404 0.621 . . . . 0.0 110.859 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -128.91 -174.06 3.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.23 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -117.58 130.66 56.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.209 0.528 . . . . 0.0 111.737 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -112.51 -6.32 13.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.059 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.61 43.89 0.25 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.1 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.16 170.48 9.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.734 0.302 . . . . 0.0 110.876 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -39.39 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 0.0 110.43 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.29 -174.18 1.65 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.519 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -85.91 155.56 20.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.879 ' H ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.74 114.43 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.971 176.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.634 HD11 HD12 ' A' ' 43' ' ' LEU . 4.3 pt -105.24 153.3 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.318 0.58 . . . . 0.0 111.189 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -94.52 -4.0 48.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.486 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.66 30.92 14.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.887 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.31 82.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.762 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.4 m-80 -129.05 80.44 1.97 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.61 54.69 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.481 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 148.24 30.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.043 0.449 . . . . 0.0 111.149 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.169 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.65 0.262 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.45 99.99 11.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.876 0.369 . . . . 0.0 110.293 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 110.07 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 18' ' ' CYS . 3.6 mt -70.6 122.44 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.13 -161.38 9.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.769 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.36 -22.19 52.98 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.128 2.552 . . . . 0.0 113.075 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -102.14 5.87 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -92.34 -47.79 7.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 10.2 t -135.39 87.54 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.966 0.412 . . . . 0.0 110.9 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -89.41 0.46 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.954 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.3 mt 54.5 -103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 122.934 0.494 . . . . 0.0 110.657 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 8.2 t70 -100.72 -113.59 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 24.3 t70 -121.06 66.43 0.86 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 167.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 2.5 m-85 -90.14 151.87 21.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.895 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 3.8 mtmt -102.14 127.46 30.76 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HG3' ' HB3' ' A' ' 9' ' ' CYS . 6.6 Cg_exo -72.8 136.19 24.91 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.543 2.162 . . . . 0.0 110.922 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -129.38 130.41 45.99 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.868 0.366 . . . . 0.0 110.255 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 m -99.48 112.59 24.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.854 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.8 m -115.13 115.73 27.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.787 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 9.9 pt20 -80.46 117.22 21.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.91 143.45 50.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.43 84.91 2.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 110.203 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -79.24 122.29 26.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.824 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.39 160.06 35.88 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.408 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.88 -19.91 26.52 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 123.012 2.475 . . . . 0.0 112.698 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.76 112.04 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.251 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 91.58 0.86 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.041 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -54.07 131.71 59.35 Favored Pre-proline 0 C--N 1.324 -0.534 0 C-N-CA 122.586 0.354 . . . . 0.0 111.51 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 7.5 Cg_exo -72.97 59.89 3.65 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.509 2.806 . . . . 0.0 112.52 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.52 82.81 0.43 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 121.18 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.077 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.92 143.22 31.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.992 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.86 31.07 3.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.256 0.551 . . . . 0.0 110.077 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.66 141.56 47.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.387 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.51 143.44 32.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.078 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 123.31 10.34 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 111.969 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.39 -1.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.643 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -79.07 111.56 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.297 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -3.85 58.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.006 0.431 . . . . 0.0 110.773 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 37.49 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.475 0.655 . . . . 0.0 109.51 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.16 79.75 5.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.53 -162.01 0.89 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.095 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -109.13 103.81 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.29 82.11 1.49 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.766 ' HB2' HD11 ' A' ' 75' ' ' ILE . 1.8 m -134.9 168.27 19.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.516 0.198 . . . . 0.0 110.506 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.55 157.25 21.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.971 0.415 . . . . 0.0 110.819 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.64 143.46 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.079 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.14 106.92 3.02 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.899 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -71.55 133.86 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.733 0.301 . . . . 0.0 110.726 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -71.22 140.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.8 -14.01 66.14 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.597 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -97.81 158.08 15.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -116.16 137.7 51.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 0.0 111.378 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.0 m -115.13 152.05 33.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.188 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -119.99 49.5 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 20' ' ' GLN . . . -153.25 -135.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.584 0.23 . . . . 0.0 110.809 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -107.41 122.49 46.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.077 0.465 . . . . 0.0 110.783 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.53 118.62 56.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.764 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -123.47 163.71 20.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.248 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 91.7 m -111.47 123.62 50.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 97.7 m -133.26 148.05 51.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.088 0.471 . . . . 0.0 111.192 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 2.4 tptm -130.35 140.49 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.698 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 p30 178.37 -177.29 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.877 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.06 116.13 28.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.179 0.514 . . . . 0.0 110.91 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.676 HG11 ' HA ' ' A' ' 73' ' ' LEU . 2.4 t -124.37 94.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.631 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.27 141.27 30.57 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.152 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.34 89.89 4.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.476 0.655 . . . . 0.0 110.64 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.53 75.16 1.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.87 -74.61 0.29 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.235 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.68 119.0 22.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.61 -3.54 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 110.663 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -99.07 148.32 24.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.676 ' HA ' HG11 ' A' ' 65' ' ' VAL . 2.0 mp -76.86 91.58 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.672 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -76.61 133.15 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.713 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.19 138.27 20.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.245 0.545 . . . . 0.0 111.069 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.13 -18.57 33.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 66.44 24.23 10.43 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.655 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.83 -55.27 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.321 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 5.7 m-80 -114.71 90.56 3.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.691 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 52.7 m -122.2 129.59 52.41 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.653 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 60' ' ' CYS . 0.9 OUTLIER -120.41 131.32 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.377 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.191 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.423 ' HB3' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.94 108.71 13.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.857 0.36 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 3.2 m -79.6 119.04 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 8' ' ' THR . 53.4 mt -68.82 119.22 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.879 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.68 -179.19 30.81 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.116 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HA ' HG12 ' A' ' 50' ' ' ILE . 57.2 Cg_endo -69.51 -38.93 7.63 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.43 54.46 2.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.664 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -74.72 -55.29 6.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.483 -176.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -83.0 123.88 29.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -22.87 43.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.612 0.72 . . . . 0.0 109.338 172.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.61 134.77 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.737 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.16 140.77 33.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.22 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 69.79 48.68 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.026 0.829 . . . . 0.0 111.19 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 4.7 m-85 -135.47 150.96 49.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 26.5 mtmt -99.09 135.32 20.86 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 4.5 Cg_exo -77.44 140.23 19.06 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.784 2.323 . . . . 0.0 111.511 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.44 140.07 42.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.8 114.12 27.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.78 132.75 54.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.768 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -80.67 121.59 26.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.995 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.92 83.78 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 0.0 110.071 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.25 151.02 31.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 68.2 9.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.593 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.5 -158.44 10.07 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.187 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.72 113.33 2.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.072 2.515 . . . . 0.0 111.897 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.94 -24.05 19.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.667 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.62 119.66 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.01 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.88 89.85 35.02 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.73 141.85 42.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.333 2.022 . . . . 0.0 111.622 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.98 28.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tp -101.86 103.32 14.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 110.944 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mt -142.95 -157.9 0.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -106.64 98.04 7.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.04 114.07 15.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.157 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.487 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -108.03 147.78 36.17 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.934 177.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HB3' HD21 ' A' ' 39' ' ' LEU . 34.7 Cg_exo -62.16 124.36 14.22 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.517 2.145 . . . . 0.0 112.236 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.37 -44.68 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.324 0.583 . . . . 0.0 110.055 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.4 125.46 34.59 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 36' ' ' PRO . 41.7 mt -116.5 162.13 18.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.581 0.229 . . . . 0.0 111.517 -173.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.83 55.88 4.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.443 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.98 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.03 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -110.42 -170.12 1.59 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.029 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 43' ' ' LEU . 1.4 mm? -84.17 134.13 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 110.686 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.1 91.07 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.4 m -138.43 179.4 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.69 ' HA ' HD12 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -119.07 153.95 21.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.562 HG23 HD13 ' A' ' 73' ' ' LEU . 96.4 t -61.64 127.84 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.628 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.5 76.51 2.08 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.773 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.477 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -71.45 146.63 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.76 0.314 . . . . 0.0 110.2 178.01 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 6' ' ' PRO . 2.2 mt -61.75 124.11 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.669 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.03 -11.56 20.26 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -89.38 137.51 32.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -96.74 115.46 27.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -107.25 108.04 19.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.88 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.87 36.01 3.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.974 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.03 -110.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.329 0.109 . . . . 0.0 110.839 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.92 125.88 43.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.538 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 t -107.33 127.35 63.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.03 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 170.28 16.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.306 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 57.7 m -116.2 136.9 52.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 110.632 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.9 m -141.83 151.3 42.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.081 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -116.04 118.62 33.39 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.103 175.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -162.58 166.85 24.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.875 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.59 70.02 0.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.7 OUTLIER -76.58 1.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.424 0.63 . . . . 0.0 111.051 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.55 70.77 6.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.559 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.54 -171.32 2.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.137 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.23 108.18 12.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.001 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.66 150.96 18.61 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.751 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.97 119.17 22.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.412 0.148 . . . . 0.0 111.123 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 m 71.51 -59.24 0.55 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.084 0.865 . . . . 0.0 111.929 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -139.49 -163.06 1.42 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.62 0.248 . . . . 0.0 110.564 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.721 ' HB3' HG21 ' A' ' 65' ' ' VAL . 7.1 mt -82.48 108.4 15.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.628 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 65' ' ' VAL . 7.0 mm -84.84 116.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.4 mt -91.89 130.69 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 0.0 111.541 -170.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 6.7 t-20 -72.23 106.87 4.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.06 56.74 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 111.673 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.64 -60.73 1.8 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.093 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 6.8 m-80 -111.39 103.8 12.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.008 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.94 132.49 36.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.28 159.33 42.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.691 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 116.06 31.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.678 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 1.9 m -80.01 121.19 25.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.35 126.18 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 111.53 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.92 169.69 14.68 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.66 -40.36 46.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.305 2.67 . . . . 0.0 112.395 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 67.21 0.79 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.487 178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.589 HG21 HG11 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -62.1 -45.06 95.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.43 132.07 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.782 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 71.42 6.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.215 0.531 . . . . 0.0 111.421 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -172.2 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.8 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.35 -135.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.16 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.35 101.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.587 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 23.1 m-85 -146.53 150.62 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.568 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -116.26 135.48 22.84 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 177.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 7.3 Cg_exo -73.44 128.89 13.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.677 2.251 . . . . 0.0 111.646 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 75' ' ' ILE . 47.2 m-85 -123.74 146.49 48.26 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.66 112.74 24.37 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -124.61 151.49 44.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.994 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 10.5 mp0 -80.84 141.51 34.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.739 -176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.09 154.22 18.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.0 46.91 0.9 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.566 0.698 . . . . 0.0 109.751 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.91 73.19 6.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.285 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . -90.56 -118.25 1.99 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.864 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 6.5 Cg_exo -74.31 82.93 1.76 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.106 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.41 149.67 40.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.9 20.12 44.55 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.926 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.62 113.89 30.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.05 9.08 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.83 2.353 . . . . 0.0 112.993 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.15 54.85 0.55 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.093 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.86 -43.86 6.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.98 0.419 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mp 59.01 -161.61 0.26 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.207 -176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.55 62.26 0.38 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.105 0.479 . . . . 0.0 109.887 175.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -60.78 2.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.036 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.18 125.91 24.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -58.34 123.92 14.7 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.448 2.099 . . . . 0.0 112.259 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.52 99.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.846 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -102.37 142.84 32.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.75 34.67 2.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.318 0.58 . . . . 0.0 109.506 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.67 -9.39 20.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.59 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.83 11.06 39.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.875 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -142.12 107.41 5.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.991 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -128.44 124.37 36.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.423 0.63 . . . . 0.0 111.092 -178.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.17 83.88 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 43' ' ' LEU . 24.4 m -127.35 173.09 10.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.251 0.548 . . . . 0.0 111.87 -172.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.97 158.82 19.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.641 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG13 ' HE3' ' A' ' 15' ' ' LYS . 23.5 t -63.98 129.05 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 132.91 17.09 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.088 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.5 t -87.92 114.45 26.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.43 118.13 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.18 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.44 -14.89 35.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.73 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.487 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 49.6 m -102.87 164.44 11.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.772 0.32 . . . . 0.0 110.143 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.2 pt20 -108.92 149.07 29.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.089 0.471 . . . . 0.0 110.759 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.4 m -122.15 120.81 35.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.448 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.59 48.41 3.67 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -158.18 -133.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.95 145.18 41.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.975 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.589 HG11 HG21 ' A' ' 8' ' ' THR . 21.9 t -102.93 109.52 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.77 156.48 17.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.118 -174.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 105.26 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -124.36 137.85 54.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.195 0.521 . . . . 0.0 110.998 -176.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -119.2 123.65 44.84 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.632 175.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' A' ' 75' ' ' ILE . 22.7 t70 -178.68 155.75 0.84 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.764 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 94.36 6.34 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.08 126.48 7.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.456 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.49 45.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.008 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -27.06 17.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.482 0.658 . . . . 0.0 110.126 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 86.48 5.01 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.681 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.48 -45.33 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -134.89 169.54 17.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.656 0.265 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -19.22 63.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.412 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.25 169.07 12.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.62 105.5 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 178.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.55 140.55 15.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.0 110.517 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -107.29 130.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.357 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -71.7 -13.2 61.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.727 0.298 . . . . 0.0 110.323 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . . . 59.49 28.8 18.27 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.653 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.82 82.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.823 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 2.9 m-80 -123.73 83.28 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.119 176.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 131.42 52.44 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.556 -176.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.01 148.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.504 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.669 0.271 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 136.65 35.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.667 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.16 137.03 40.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.803 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.475 HD11 ' SG ' ' A' ' 54' ' ' CYS . 44.1 mt -82.53 123.75 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.774 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 8' ' ' THR . . . -146.83 -178.93 22.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.68 -30.43 90.4 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.776 2.317 . . . . 0.0 112.093 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -114.3 62.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.511 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -72.27 -65.94 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 -178.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.75 157.51 15.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.932 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -82.84 85.36 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.163 0.506 . . . . 0.0 111.314 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -144.03 -170.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.295 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.32 108.95 3.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 11' ' ' ILE . 21.5 m-85 -132.58 156.41 46.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.359 -172.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.65 125.42 82.58 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.3 Cg_exo -76.59 125.46 8.28 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.789 2.326 . . . . 0.0 111.848 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 61' ' ' CYS . 93.7 m-85 -123.31 149.18 45.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.35 116.01 8.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.02 175.09 10.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.374 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 137.66 37.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.267 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -89.18 116.05 27.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.938 0.399 . . . . 0.0 109.933 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.16 106.17 9.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.432 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.39 143.42 26.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.203 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . 173.16 -131.83 2.19 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.421 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 2.9 Cg_exo -75.23 70.05 5.56 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.183 2.589 . . . . 0.0 112.291 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.93 -48.54 9.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.667 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.17 168.05 38.55 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.056 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -118.48 133.86 23.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.431 0.158 . . . . 0.0 110.598 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 28.2 Cg_exo -61.98 107.65 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.187 2.591 . . . . 0.0 111.993 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.41 -140.37 9.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.284 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.65 2.8 55.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.635 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -148.05 174.19 12.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.803 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -79.77 144.16 33.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.965 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 133.89 43.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -118.74 106.72 43.57 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.429 -179.437 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.96 124.31 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.505 2.137 . . . . 0.0 111.903 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -79.24 -27.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.086 0.469 . . . . 0.0 110.033 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -113.26 108.13 16.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.118 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 -49.16 11.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.942 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -165.91 55.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.39 -5.61 26.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.255 0.55 . . . . 0.0 110.422 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -114.41 109.47 18.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.159 176.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -138.34 110.45 7.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.059 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.0 112.87 2.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 t -153.97 178.33 10.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 m -122.05 158.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.72 125.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.56 135.61 41.78 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.118 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.43 98.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.405 HG22 ' HA2' ' A' ' 5' ' ' GLY . 2.7 pt -60.49 120.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.415 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 -8.02 26.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.957 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -116.93 154.22 31.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.802 0.334 . . . . 0.0 110.854 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 15.2 mt-30 -84.35 151.28 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.299 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -136.27 106.63 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.093 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.41 58.97 3.04 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.93 -166.59 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.08 95.75 6.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.619 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.67 135.52 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.175 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.17 155.15 45.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.9 m -128.32 108.44 10.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 70.7 m -124.01 142.02 51.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.362 0.601 . . . . 0.0 112.037 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.82 120.26 41.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.473 172.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 65' ' ' VAL . 2.8 p30 -144.35 -170.5 3.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.167 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.24 50.02 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.444 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG23 ' OD1' ' A' ' 63' ' ' ASP . 51.5 t -61.84 124.84 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.068 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.72 119.57 35.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -79.9 100.25 7.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.252 0.549 . . . . 0.0 111.854 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -19.93 48.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.912 0.863 . . . . 0.0 109.81 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.52 53.22 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -111.49 139.65 46.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.87 -51.29 68.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.428 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.12 148.06 41.88 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 98.75 8.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.488 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.46 ' H ' HG13 ' A' ' 74' ' ' ILE . 1.6 mt -69.18 126.16 28.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 77' ' ' ALA . 3.9 mt -92.33 146.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.227 0.537 . . . . 0.0 110.249 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -76.48 -0.48 23.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.281 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 64.42 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.04 -95.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.862 0.726 . . . . 0.0 111.496 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.611 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 19.4 m-80 -91.71 78.66 5.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.251 -176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.7 m -114.43 130.2 56.7 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.782 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -138.16 159.48 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.79 178.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.243 178.278 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 107.19 19.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.339 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -79.05 125.46 29.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.0 0.429 . . . . 0.0 110.826 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 54' ' ' CYS . 13.7 mt -80.53 95.06 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.368 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.41 171.08 17.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.78 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.77 -15.49 33.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 111.709 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -107.49 46.81 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.918 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -64.8 0.88 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 128.88 52.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.843 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.43 79.25 9.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.915 0.388 . . . . 0.0 110.853 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -145.2 -162.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 13.9 t0 -60.65 163.74 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.978 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.14 103.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 111.158 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 62' ' ' LYS . 6.3 m-85 -121.8 165.99 15.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.075 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -112.84 137.61 21.86 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -75.06 130.24 13.02 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.801 2.334 . . . . 0.0 111.31 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 40.1 m-85 -124.2 135.58 53.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.767 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -105.22 115.27 29.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.449 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.68 152.63 28.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.804 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -80.38 105.49 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.144 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -125.18 -25.49 3.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.985 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.428 ' HB3' ' H ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -96.61 -100.38 0.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.779 -178.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -123.03 157.81 31.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.429 . . . . 0.0 111.116 -177.309 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.83 -151.56 22.75 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.996 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.92 112.55 2.05 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.757 2.305 . . . . 0.0 112.375 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 140.21 37.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.29 -57.44 1.37 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.671 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.1 m -140.4 130.74 13.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.583 0.23 . . . . 0.0 111.194 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.61 141.91 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.791 2.327 . . . . 0.0 111.997 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 62.91 3.34 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.379 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.06 -20.81 37.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.068 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -91.1 -164.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -79.25 125.04 28.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.902 0.382 . . . . 0.0 110.28 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.91 132.11 43.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.493 175.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -93.08 139.29 23.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 36.0 Cg_exo -61.51 122.0 10.41 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.891 1.727 . . . . 0.0 110.848 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -179.34 147.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.541 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -119.55 131.08 55.46 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -1.09 9.77 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.09 72.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 111.174 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.07 -8.81 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.195 0.522 . . . . 0.0 110.305 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.46 176.48 9.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.036 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -114.23 117.1 30.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.313 0.578 . . . . 0.0 111.341 -174.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.96 49.14 4.08 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 53.6 m -95.29 154.36 17.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.332 . . . . 0.0 110.797 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.84 152.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.77 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.42 117.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.97 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.53 125.33 6.9 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.057 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' OG ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -77.07 125.16 36.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 127.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.01 -16.77 11.96 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.211 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -97.69 165.06 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.783 0.325 . . . . 0.0 111.169 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -110.58 132.08 54.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -111.15 145.71 38.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.471 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.38 -11.1 46.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.495 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.23 -177.11 4.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.125 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 125.17 29.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.905 0.383 . . . . 0.0 110.519 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 3.9 t -97.11 120.15 46.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.902 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 mtpt -112.68 169.76 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.81 102.95 10.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 2.9 m -132.22 161.09 34.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.504 0.669 . . . . 0.0 112.099 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 2.2 pttt -156.45 157.73 36.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.456 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.6 -173.2 2.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.422 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.06 69.26 10.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.6 107.56 19.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.215 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -75.58 0.27 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.414 0.626 . . . . 0.0 110.946 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -149.19 147.43 28.42 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.075 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 120.14 7.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.78 46.9 3.19 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.121 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.85 175.12 6.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.27 -24.75 65.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.94 0.4 . . . . 0.0 111.531 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.22 152.72 20.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.004 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.494 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -112.23 125.13 53.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.043 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.46 136.47 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.373 0.606 . . . . 0.0 111.545 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.1 119.06 45.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 3.5 t-20 -63.81 -24.96 67.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 76' ' ' ASN . . . 81.3 31.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.734 0.814 . . . . 0.0 111.166 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.44 -56.9 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.442 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -120.94 75.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.036 -179.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.614 ' SG ' ' HE2' ' A' ' 59' ' ' LYS . 18.3 t -134.79 130.32 35.94 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.02 152.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.379 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.902 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.312 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -84.18 121.69 27.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.923 0.392 . . . . 0.0 111.337 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -88.96 106.97 18.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.629 HD13 ' HA3' ' A' ' 48' ' ' GLY . 12.2 mt -82.75 130.25 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 111.384 -173.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -133.06 -171.86 12.84 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.864 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.19 -27.64 48.73 Favored 'Trans proline' 0 CA--C 1.525 0.066 0 C-N-CA 122.539 2.159 . . . . 0.0 112.687 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -96.63 14.24 25.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.475 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -86.68 -22.58 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.254 0.55 . . . . 0.0 110.322 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -135.09 105.11 6.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.614 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.19 33.11 4.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.468 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -108.6 163.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.291 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.55 109.61 4.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.307 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.7 27.44 15.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.32 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 11.2 m-85 -95.87 123.21 39.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.031 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 16.8 mttt -91.4 134.38 29.68 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.2 Cg_exo -70.45 137.81 34.26 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.636 2.224 . . . . 0.0 111.175 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 21.5 m-85 -131.62 138.6 48.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -95.5 112.94 24.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 m -113.5 120.16 40.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 105.88 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.12 140.95 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.448 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.92 161.21 13.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.521 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.78 57.46 0.61 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.177 0.513 . . . . 0.0 110.585 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.82 -163.52 32.53 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.94 119.77 5.21 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.951 2.434 . . . . 0.0 111.856 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.08 -14.19 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.032 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.89 24.55 21.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.664 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.28 115.21 49.2 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 122.714 0.406 . . . . 0.0 111.434 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -92.66 94.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.316 2.677 . . . . 0.0 111.964 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.25 -35.23 0.54 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.932 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.63 103.81 15.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.267 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -83.41 -3.23 57.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.356 0.598 . . . . 0.0 110.202 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -98.98 2.14 46.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.979 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -100.47 161.74 13.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -104.48 159.31 29.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.002 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.97 124.62 15.29 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.366 2.044 . . . . 0.0 111.473 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -74.65 -173.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.274 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' H ' HG12 ' A' ' 37' ' ' VAL . 3.6 t0 -80.97 172.19 14.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.507 . . . . 0.0 110.851 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -45.56 9.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.521 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 p -172.34 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 70.98 -49.91 0.68 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.928 0.891 . . . . 0.0 112.311 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -126.94 167.83 15.34 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 122.358 -0.214 . . . . 0.0 110.58 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -150.52 141.97 23.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.929 171.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.12 88.56 0.53 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.643 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' HD11 ' A' ' 75' ' ' ILE . 36.3 m -141.52 165.78 26.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.08 152.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.12 133.57 30.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.345 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -70.4 89.78 0.36 Allowed Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.903 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.36 117.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.537 0.208 . . . . 0.0 110.486 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 5' ' ' GLY . 3.3 mp -56.79 116.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.75 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.19 -9.5 17.88 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.833 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.01 165.85 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 0.0 110.345 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' THR . 86.3 mt-30 -121.11 125.49 47.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.141 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 82.6 m -108.44 122.5 47.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.974 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.15 56.64 4.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.269 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.13 -165.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.6 136.21 35.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.747 0.308 . . . . 0.0 110.32 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.4 t -108.29 123.93 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.208 0.527 . . . . 0.0 110.796 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -130.22 171.15 13.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.12 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 95.6 m -114.78 120.53 40.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.97 0.414 . . . . 0.0 109.972 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.2 m -125.19 123.22 39.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.341 0.591 . . . . 0.0 111.586 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.848 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 23.1 tptt -88.2 90.69 8.49 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.44 130.42 44.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.518 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 52.65 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.129 0.49 . . . . 0.0 111.038 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.18 128.29 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.949 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -84.96 146.49 27.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -91.45 97.73 11.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.558 0.694 . . . . 0.0 111.102 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -24.9 12.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.534 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 57.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.665 -1.607 . . . . 0.0 109.67 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.19 97.31 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.212 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.54 -35.58 45.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.672 0.749 . . . . 0.0 109.282 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.32 146.85 50.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.61 92.42 5.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.996 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.98 126.69 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.902 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.89 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -92.9 136.51 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 -174.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -79.62 -9.74 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.59 36.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.523 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.08 -66.43 0.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.31 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.5 m-80 -122.5 85.05 2.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.881 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.3 m -114.99 130.26 56.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.042 0.449 . . . . 0.0 111.209 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.85 160.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.949 -179.532 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -86.46 126.76 34.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -90.33 135.69 33.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.041 175.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.694 HG21 ' HA3' ' A' ' 48' ' ' GLY . 30.0 mt -91.21 130.86 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.745 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.65 -170.07 40.85 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.16 -13.27 39.11 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.365 2.043 . . . . 0.0 111.701 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -78.92 -35.99 42.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.286 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.701 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 t -140.08 123.3 16.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.828 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.31 93.96 3.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -133.69 152.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -18.48 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.204 1.402 . . . . 0.0 114.09 -174.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 21.4 t0 -119.87 47.88 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.575 0.702 . . . . 0.0 109.658 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.4 m-85 -108.84 119.47 39.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.84 -176.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -92.91 134.29 27.67 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.658 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.6 Cg_exo -68.76 125.61 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.612 2.208 . . . . 0.0 111.363 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 16.0 m-85 -114.35 144.97 42.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.097 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -106.77 113.62 27.22 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 176.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.35 120.27 37.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.865 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 17.8 mt-30 -82.03 103.96 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.96 28.9 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.906 -174.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -113.02 -65.38 1.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.215 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -108.23 135.37 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.39 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.93 -138.78 5.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.083 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.16 -4.2 14.12 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.689 2.259 . . . . 0.0 112.975 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.24 152.89 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.592 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.97 -122.84 1.16 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.607 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.597 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 2.0 m -71.0 -53.47 8.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.597 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 83.6 Cg_endo -86.66 154.74 8.92 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.796 1.664 . . . . 0.0 112.232 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.73 108.72 3.59 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.24 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.39 -174.54 3.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.863 0.363 . . . . 0.0 110.935 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.35 175.57 9.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.873 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -84.16 175.18 9.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.99 -16.55 63.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.425 0.631 . . . . 0.0 110.419 178.666 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.43 131.87 23.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.022 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.78 124.7 16.88 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.771 2.314 . . . . 0.0 112.077 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.82 129.33 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.381 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.5 118.02 35.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.577 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.27 24.55 8.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -100.09 -39.33 8.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 -57.85 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 2.1 m -123.27 -162.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.518 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 77' ' ' ALA . 1.6 mm? -112.03 113.62 26.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.938 0.399 . . . . 0.0 110.951 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.542 ' HA2' HD12 ' A' ' 74' ' ' ILE . . . -83.79 66.64 3.87 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.08 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 43' ' ' LEU . 1.8 m -121.14 162.08 20.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.84 153.34 21.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -65.27 137.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.796 -178.386 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.694 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -75.87 119.72 5.78 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.667 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.86 108.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.92 0.39 . . . . 0.0 110.602 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 2.4 mp -54.43 118.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.181 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.26 -0.16 29.7 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.415 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.77 151.51 43.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 7.6 mt-30 -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 157.41 44.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.102 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.24 43.97 1.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . . . -142.25 -172.03 3.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.854 -0.173 . . . . 0.0 110.56 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 104.8 12.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 30.6 m -88.97 144.03 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 6.5 ptpt -157.33 171.55 20.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.483 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -110.5 122.06 46.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.973 0.416 . . . . 0.0 110.271 -177.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.72 136.62 51.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.423 0.63 . . . . 0.0 111.755 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.53 136.03 53.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.2 t70 -157.18 177.1 11.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.07 27.77 6.35 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.446 0.641 . . . . 0.0 109.952 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.836 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.4 t -72.63 128.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.903 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.668 HG23 ' H ' ' A' ' 68' ' ' THR . 12.8 t -118.02 -175.12 2.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.112 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.1 -14.31 59.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 111.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.668 ' H ' HG23 ' A' ' 66' ' ' THR . 0.3 OUTLIER -80.85 70.11 7.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.77 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.908 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.28 170.71 15.32 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -24.64 61.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.258 0.551 . . . . 0.0 110.154 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -107.2 142.97 36.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 47' ' ' VAL . 66.6 mt -78.92 92.91 4.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.034 0.445 . . . . 0.0 110.578 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.542 HD12 ' HA2' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -74.29 125.91 34.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.901 177.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 137.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.553 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 64.7 t30 -80.72 -4.95 56.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 43' ' ' LEU . . . 64.56 26.92 13.36 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.625 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.72 87.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -130.27 75.25 1.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.665 177.534 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 9.5 m -113.85 130.2 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.651 0.263 . . . . 0.0 110.359 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.11 159.72 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.894 0.378 . . . . 0.0 110.958 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.371 178.168 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 99.86 10.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.45 126.92 31.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.625 HG21 ' HA3' ' A' ' 48' ' ' GLY . 25.7 mt -96.35 115.81 36.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.055 0.455 . . . . 0.0 111.646 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.93 17.49 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HD3' HG12 ' A' ' 50' ' ' ILE . 47.1 Cg_endo -68.26 -23.24 39.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -84.23 -13.09 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.396 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -82.05 -53.69 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.872 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -152.65 105.01 2.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 111.175 -177.252 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.4 m -152.81 74.05 1.03 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.346 0.593 . . . . 0.0 109.586 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.618 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -94.59 -151.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.909 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.3 94.42 0.26 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.872 0.367 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 t0 54.5 37.3 27.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.039 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.618 ' HD2' ' HB ' ' A' ' 11' ' ' ILE . 6.2 m-85 -111.04 123.72 50.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.742 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -104.97 149.6 37.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.944 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.2 Cg_exo -77.33 138.73 18.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.88 2.387 . . . . 0.0 112.252 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' OH ' ' HB3' ' A' ' 64' ' ' ASP . 16.6 m-85 -126.31 145.06 50.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.225 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -96.74 112.94 24.48 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.21 141.99 18.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.068 0.461 . . . . 0.0 110.758 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -112.79 114.07 26.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 176.637 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 82.09 7.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.376 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -134.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.287 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 148.82 32.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.486 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . 175.37 -120.34 0.76 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.213 -0.518 . . . . 0.0 111.927 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 7.2 Cg_exo -73.17 89.16 0.92 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.289 2.659 . . . . 0.0 112.159 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 84.94 1.57 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.02 42.44 99.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.644 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -66.87 130.93 93.92 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.919 -177.254 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 13.1 Cg_exo -70.62 58.93 2.01 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.279 2.653 . . . . 0.0 112.416 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.79 36.75 0.2 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -85.47 -19.23 31.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 -177.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 pp -92.35 -17.63 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.457 176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.44 -25.17 42.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.763 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.22 177.94 5.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.373 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.03 101.56 53.54 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.8 123.79 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.38 2.053 . . . . 0.0 111.925 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.3 -56.26 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 109.422 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -161.03 162.62 31.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.113 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.38 -40.49 30.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.67 57.58 4.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.944 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.51 52.32 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 110.834 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -150.24 92.97 1.93 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 111.416 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -132.44 103.34 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 0.0 110.281 175.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.21 98.99 0.65 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -153.55 -174.73 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.52 154.01 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 111.851 -170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.97 144.49 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.625 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -87.61 95.28 2.06 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.47 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -63.87 127.12 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.718 0.294 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.494 HG12 ' HD3' ' A' ' 6' ' ' PRO . 1.7 mp -56.82 121.97 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.568 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.18 27.12 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.47 ' OG ' HG23 ' A' ' 49' ' ' VAL . 1.6 m -98.88 156.28 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.523 0.202 . . . . 0.0 110.577 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.57 154.56 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 m -134.19 145.51 49.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.054 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.08 -10.45 80.57 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.52 -174.68 4.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.725 -0.737 . . . . 0.0 110.123 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -92.83 160.34 14.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.757 0.313 . . . . 0.0 110.415 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.55 128.62 53.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.03 153.85 26.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 106.36 14.82 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -121.49 148.17 44.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.452 0.644 . . . . 0.0 111.486 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.9 tttp -137.82 141.01 40.82 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.759 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.2 OUTLIER 80.81 78.77 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.799 1.312 . . . . 0.0 109.271 -170.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.31 -109.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.194 -174.318 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' H ' ' HB2' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -107.82 134.66 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 111.121 -176.731 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -59.78 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.866 0.841 . . . . 0.0 110.255 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -115.59 139.45 50.08 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.639 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 51.8 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.15 0.5 . . . . 0.0 111.279 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.08 42.16 3.04 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.704 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.14 165.08 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -58.49 3.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.59 170.81 7.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.216 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -70.83 131.47 43.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.946 0.403 . . . . 0.0 111.177 -178.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.3 mt -118.3 133.43 65.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.012 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -102.93 142.16 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.284 -179.022 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -87.98 8.43 26.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.87 -124.6 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.976 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.38 -67.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.057 0.543 . . . . 0.0 111.377 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.6 m120 -116.28 102.3 9.45 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 130.86 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.602 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.01 159.75 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.036 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.066 178.083 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.972 0.415 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 110.36 21.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -79.2 120.17 23.32 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.551 HD12 ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -83.66 128.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 176.15 33.69 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.639 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.15 -32.7 94.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.901 2.401 . . . . 0.0 112.093 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.07 87.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.779 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -36.68 82.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -103.39 156.16 17.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.95 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.41 51.59 1.47 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.529 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -123.26 151.79 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.441 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.6 115.6 14.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.07 72.17 0.54 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.269 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 4.3 m-85 -125.9 141.58 51.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.242 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 11.4 mtmt -90.84 124.28 62.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.617 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.8 Cg_exo -76.03 139.27 21.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.089 2.526 . . . . 0.0 111.771 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.11 143.62 51.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -92.06 112.26 24.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 59' ' ' LYS . 98.4 m -119.34 125.07 48.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -107.48 -12.86 15.21 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.555 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 83.05 6.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.756 0.789 . . . . 0.0 110.529 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -11.05 32.72 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.286 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.62 149.51 5.02 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.372 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.84 121.17 9.51 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.716 2.277 . . . . 0.0 112.172 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.43 37.09 3.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.043 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.99 26.09 25.8 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -66.05 125.39 90.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 122.679 0.392 . . . . 0.0 111.029 -178.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 2.8 Cg_exo -76.56 40.6 0.79 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.322 2.681 . . . . 0.0 112.507 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.8 21.11 37.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.51 80.62 6.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.903 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.06 -11.68 35.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.619 0.723 . . . . 0.0 109.086 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -110.2 128.01 55.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.815 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 34' ' ' LEU . 9.2 tp -77.08 84.62 3.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.113 0.482 . . . . 0.0 111.826 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.88 94.14 48.87 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.18 124.32 14.98 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.722 2.281 . . . . 0.0 112.08 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.88 117.59 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.296 0.57 . . . . 0.0 110.967 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.28 148.44 46.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.072 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.84 21.4 4.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.168 0.508 . . . . 0.0 109.959 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -18.59 44.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.389 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.23 6.16 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -133.49 92.83 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.598 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -117.68 103.91 10.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.364 0.602 . . . . 0.0 111.049 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.71 94.56 0.57 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.171 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 75' ' ' ILE . 80.1 m -136.53 177.79 7.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.13 148.77 23.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.906 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 141.64 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.967 0.413 . . . . 0.0 110.589 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 4' ' ' ILE . . . -86.72 136.42 14.04 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.195 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 22.0 t -80.32 113.95 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 50' ' ' ILE . 29.7 pt -62.9 115.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 0.0 110.635 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.01 -12.11 34.39 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.963 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 71.0 m -102.78 170.19 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.671 0.272 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -106.15 140.97 38.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 -177.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.18 124.04 38.09 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.385 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.12 52.96 3.76 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.07 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.19 178.27 9.93 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -87.68 124.63 33.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.011 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.01 130.57 35.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.218 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -120.3 163.64 17.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.489 176.173 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.5 117.1 27.53 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -126.47 133.04 51.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.51 0.671 . . . . 0.0 111.646 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.655 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 7.6 ttpt -106.99 118.39 36.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.431 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.66 175.13 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.66 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -124.0 105.06 9.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.064 0.459 . . . . 0.0 110.733 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.82 115.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.485 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.99 94.29 6.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.332 0.587 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -79.76 86.88 5.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.6 0.714 . . . . 0.0 110.659 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -125.17 52.58 1.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.618 0.723 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.28 31.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -140.2 148.74 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.36 -17.11 20.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.37 155.95 26.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -82.98 94.06 7.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.086 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 45' ' ' CYS . 2.4 mt -92.48 135.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -18.45 65.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 56.16 37.81 29.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.877 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.57 -52.57 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 10.2 m-80 -123.87 81.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.312 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.7 m -116.4 129.92 56.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.271 0.558 . . . . 0.0 110.891 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.2 159.89 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.324 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.32 179.743 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 m -79.41 117.77 20.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.413 . . . . 0.0 110.621 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 115.14 25.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.79 110.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 152.94 44.36 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.921 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HA ' HG21 ' A' ' 50' ' ' ILE . 12.4 Cg_endo -56.45 -37.86 96.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 112.256 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.04 75.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.69 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -42.64 59.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.4 m -126.87 145.16 50.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -97.88 69.62 2.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.191 0.52 . . . . 0.0 110.459 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 -145.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.012 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.09 -164.68 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.177 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.48 97.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.677 . . . . 0.0 109.785 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 9.1 m-85 -125.98 145.3 50.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.995 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.667 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -100.83 131.2 23.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 38.3 Cg_endo -71.15 130.49 17.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.331 2.021 . . . . 0.0 110.696 171.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.667 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 7.4 m-85 -114.7 139.78 49.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.8 0.334 . . . . 0.0 110.954 -175.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.3 t -94.04 113.03 24.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 t -146.88 158.86 44.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.622 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -141.26 106.1 4.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.315 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.29 72.4 9.35 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.836 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -117.47 150.58 38.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.16 175.04 10.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.646 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.87 -110.79 3.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.189 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.25 64.46 4.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 112.867 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.79 87.0 7.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 0.0 110.382 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.89 -94.31 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.738 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.75 142.15 98.05 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.68 0.276 . . . . 0.0 110.74 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.0 123.05 10.75 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.783 2.322 . . . . 0.0 112.891 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.24 -0.01 89.43 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.822 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 mt 61.63 50.69 4.33 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.057 0.543 . . . . 0.0 111.393 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.84 -178.89 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.922 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -141.47 -171.93 3.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.926 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -84.7 -80.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.06 111.22 18.37 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.81 124.19 11.61 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.702 2.268 . . . . 0.0 111.929 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 39' ' ' LEU . 4.8 t -103.23 114.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.49 32.29 0.57 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.925 0.393 . . . . 0.0 111.008 -175.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.549 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -79.69 -5.98 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.648 -174.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -78.8 11.9 2.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.198 0.523 . . . . 0.0 110.958 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.01 -22.23 45.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.365 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -108.24 -166.69 1.15 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.405 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 75' ' ' ILE . 2.7 mm? -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.44 66.98 0.56 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.993 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB2' HD11 ' A' ' 75' ' ' ILE . 77.3 m -134.25 171.75 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.466 0.174 . . . . 0.0 111.053 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 73' ' ' LEU . 1.7 p -118.71 165.76 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -171.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.0 t -69.15 136.31 26.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.725 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.47 132.84 11.26 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.34 136.79 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.091 0.472 . . . . 0.0 111.092 -177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 6' ' ' PRO . 1.1 pt -73.76 147.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.36 12.55 79.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.02 152.4 47.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.707 0.289 . . . . 0.0 110.309 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -88.6 145.86 25.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.255 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.27 124.58 20.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.902 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.88 54.0 4.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.728 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.4 -163.73 1.24 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.76 147.73 22.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 7.7 t -111.37 120.67 62.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -108.66 169.23 8.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.827 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -119.47 105.86 11.67 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.5 m -129.08 139.28 52.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.482 0.658 . . . . 0.0 112.009 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.6 tptt -121.19 121.14 37.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.157 169.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.53 171.42 14.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.77 63.88 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.595 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.13 107.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.218 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.78 171.15 8.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.025 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -87.89 49.38 1.79 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.143 0.497 . . . . 0.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -12.57 60.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.308 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 93.8 1.14 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.883 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -152.82 153.11 32.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.72 0.295 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -46.45 21.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.479 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -135.96 164.15 28.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.191 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -80.95 122.16 26.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.911 0.386 . . . . 0.0 110.964 -177.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.48 145.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.057 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.49 124.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.282 0.563 . . . . 0.0 110.81 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -84.37 -3.72 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.109 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.91 32.9 15.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.664 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -54.72 29.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 3.0 m-80 -127.23 78.08 1.79 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 m -117.05 130.34 56.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 111.143 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -134.07 160.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.321 178.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.257 0.973 . . . . 0.0 111.052 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -89.03 108.64 19.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.311 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 113.36 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.031 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 8' ' ' THR . 29.8 mt -70.7 109.56 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.602 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.93 -173.17 30.36 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.981 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 50' ' ' ILE . 93.6 Cg_endo -83.72 8.03 4.85 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.979 2.453 . . . . 0.0 113.452 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.33 36.12 3.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -70.09 -48.17 58.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.368 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD12 ' A' ' 11' ' ' ILE . 70.9 m -92.91 124.35 36.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.15 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.94 17.82 2.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.531 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -122.92 159.95 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.937 177.163 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 4.8 t0 -69.52 -89.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 5.5 t70 -84.46 79.21 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.351 0.596 . . . . 0.0 111.213 -173.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.684 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 20.9 m-85 -144.71 138.98 27.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -106.83 138.9 19.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.908 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.5 Cg_exo -70.85 133.62 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.743 2.295 . . . . 0.0 111.53 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 33.0 m-85 -126.17 135.49 51.71 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.049 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.3 m -91.37 112.01 23.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 95.7 m -115.13 127.73 55.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.894 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.14 113.34 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.436 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -45.53 85.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.7 0.762 . . . . 0.0 109.666 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.0 ttt -136.78 130.03 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.259 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -12.79 59.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.231 0.538 . . . . 0.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.74 -163.54 13.15 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.508 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.5 0.9 9.33 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.323 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 178.14 5.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.38 -177.14 20.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.204 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.0 m 57.68 78.74 0.35 Allowed Pre-proline 0 N--CA 1.464 0.231 0 C-N-CA 122.844 0.458 . . . . 0.0 111.613 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -82.64 146.37 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.296 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.55 73.04 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.64 -51.22 3.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.087 0.47 . . . . 0.0 110.908 -174.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.78 170.34 15.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.521 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -79.47 78.65 5.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.37 0.605 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.32 134.0 53.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.244 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -109.82 149.9 40.6 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.283 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.85 124.37 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.524 2.149 . . . . 0.0 111.975 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 t -109.76 -33.51 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.559 0.695 . . . . 0.0 109.686 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.63 154.55 36.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.956 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -149.63 0.44 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.876 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.52 45.43 0.58 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.66 -34.4 9.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -107.87 176.33 5.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.826 ' HB3' HD12 ' A' ' 75' ' ' ILE . 3.6 mm? -104.74 130.88 52.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.049 0.452 . . . . 0.0 111.015 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.75 65.3 0.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' A' ' 75' ' ' ILE . 20.8 m -119.37 172.19 7.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.73 158.16 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.027 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.57 127.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.368 0.604 . . . . 0.0 111.4 -176.182 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 4' ' ' ILE . . . -96.08 77.77 0.77 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.25 151.29 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 6' ' ' PRO . 3.9 mp -56.65 126.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.68 10.69 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.033 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 143.74 34.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.626 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -99.37 143.07 30.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.66 136.09 50.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.46 17.13 43.82 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.9 -171.73 2.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.401 -0.399 . . . . 0.0 110.285 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 110.94 15.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.78 125.46 42.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -131.06 168.93 16.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.015 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 43.7 m -106.56 118.98 38.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 m -121.62 154.54 36.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.042 0.449 . . . . 0.0 110.866 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 2.2 tptm -151.0 135.25 16.85 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.04 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 178.74 -176.72 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.293 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -90.56 96.63 10.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -96.72 100.33 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.103 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -160.79 0.8 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.079 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.25 58.6 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 111.37 -173.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 25.85 3.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.549 0.69 . . . . 0.0 109.926 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.17 84.4 1.43 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.285 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -79.15 119.54 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.3 m 72.28 -50.66 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.811 0.694 . . . . 0.0 111.184 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.01 166.43 29.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.296 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.526 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -89.12 107.95 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 -177.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.1 139.81 19.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -111.84 134.7 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.316 0.579 . . . . 0.0 111.281 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.03 139.48 36.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.643 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 51.78 2.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 0.0 111.4 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -99.53 -71.83 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 10.2 m-80 -102.73 70.01 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.565 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 54.6 m -118.16 128.69 54.96 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.037 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.83 159.78 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.567 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.567 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.689 0.281 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.13 100.82 7.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.204 0.526 . . . . 0.0 110.816 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -81.12 112.41 18.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.359 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 54' ' ' CYS . 12.9 mt -77.71 120.94 29.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.7 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.66 167.84 12.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.797 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.85 -16.62 41.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.919 2.413 . . . . 0.0 112.501 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 43.6 1.92 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.275 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -65.41 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.166 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 70.4 1.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.978 175.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.53 67.24 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.739 -172.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -87.83 -87.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 29.6 t0 -93.46 -167.19 1.66 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -73.79 76.47 1.59 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -95.82 137.16 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.648 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 22.8 mtmt -91.65 120.16 68.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 14.9 Cg_exo -69.01 141.71 49.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.712 2.275 . . . . 0.0 111.539 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -137.42 135.2 36.7 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.81 124.5 52.73 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.275 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 p -156.06 162.51 40.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.29 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -80.06 107.77 13.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.006 0.432 . . . . 0.0 110.281 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.828 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.236 0.342 0 CA-C-O 120.697 0.284 . . . . 0.0 111.515 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -113.07 119.32 37.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.918 0.39 . . . . 0.0 110.155 176.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.1 87.45 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.221 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.9 m -137.73 171.3 14.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.569 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.44 154.07 22.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.931 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 134.1 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.221 0.534 . . . . 0.0 110.87 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' CA ' HD13 ' A' ' 4' ' ' ILE . . . -80.25 105.42 2.36 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.05 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HB ' ' OG ' ' A' ' 52' ' ' SER . 4.7 t -68.29 130.77 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.4 pt -68.42 125.33 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.444 0.64 . . . . 0.0 110.456 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.74 -11.08 66.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.599 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.443 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 63.9 m -88.09 155.3 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.529 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.559 ' HG2' HG23 ' A' ' 3' ' ' THR . 26.1 mt-30 -108.46 121.51 45.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.645 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.491 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -114.44 116.68 29.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.88 56.22 3.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.19 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.88 -179.03 7.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.7 128.19 33.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.87 127.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.84 169.71 11.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.783 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.7 m -118.37 124.68 48.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.9 m -129.34 135.32 48.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 0.0 111.568 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 12.7 tttt -112.71 117.79 33.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.092 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -172.55 163.77 5.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.416 -176.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -109.36 111.62 23.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.159 0.505 . . . . 0.0 110.504 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.41 146.99 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.637 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.4 138.27 31.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.405 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -78.39 -30.1 47.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.382 0.611 . . . . 0.0 110.62 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 3.79 48.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.973 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.0 -76.16 0.63 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.083 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -119.04 -179.98 3.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.77 7.34 15.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.373 0.606 . . . . 0.0 110.746 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -156.56 169.85 23.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.622 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.15 92.88 5.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.102 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tt -75.62 136.29 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 43' ' ' LEU . 2.8 mt -92.18 128.78 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.961 0.41 . . . . 0.0 110.747 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 10.3 m-80 -64.18 -20.58 66.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.493 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 61.72 26.2 15.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.078 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -56.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 4.7 m-80 -124.33 84.19 2.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.924 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 33.2 m -115.55 135.78 53.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.949 0.404 . . . . 0.0 110.986 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.24 130.6 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.851 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.279 -178.678 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.678 0.275 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 103.41 12.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.813 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.24 137.37 37.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.801 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.621 HG21 ' HA3' ' A' ' 48' ' ' GLY . 7.8 mt -109.55 137.0 43.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.83 -169.76 17.73 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.163 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.11 -17.01 15.43 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.406 2.071 . . . . 0.0 112.649 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.37 13.54 33.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.806 0.336 . . . . 0.0 111.477 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -75.45 -29.73 59.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.33 89.97 1.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.967 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.41 27.98 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.036 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -84.03 -109.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.482 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 1.9 t70 -92.91 -164.31 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -74.55 66.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.617 0.722 . . . . 0.0 109.495 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 5.3 m-85 -93.85 128.02 39.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.42 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 18.0 mtmt -87.74 119.67 70.67 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.6 Cg_exo -72.29 144.43 41.4 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.013 2.476 . . . . 0.0 110.815 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.71 143.75 45.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.998 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.4 t -97.36 113.13 24.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 58.2 m -118.94 130.27 55.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 111.586 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.437 ' HB3' HE21 ' A' ' 20' ' ' GLN . 0.0 OUTLIER -88.45 105.51 17.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.151 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.671 -178.731 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 CA-C-O 120.825 0.345 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -140.75 104.31 4.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.46 89.74 0.44 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 43' ' ' LEU . 4.0 m -133.18 175.26 9.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 111.891 -171.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.17 156.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -61.98 139.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.387 . . . . 0.0 110.478 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.621 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -60.93 115.38 7.76 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.184 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.67 95.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -60.41 103.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.469 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.98 22.44 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.19 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -112.0 158.73 19.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.873 0.368 . . . . 0.0 110.526 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -98.65 153.16 18.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.229 0.537 . . . . 0.0 110.527 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 153.92 45.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.139 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.32 47.99 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.678 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.62 -171.82 3.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.44 137.26 37.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.87 121.71 58.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.978 0.418 . . . . 0.0 110.544 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 mtpp -122.96 170.01 10.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.67 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 70.9 m -129.5 123.48 31.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.9 45.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 0.0 112.242 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -105.35 113.11 26.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.42 163.55 19.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.949 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.04 93.14 5.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -85.59 132.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.366 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.09 143.3 31.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.921 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.05 5.53 38.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.29 0.566 . . . . 0.0 110.076 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.36 101.77 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.684 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.14 37.24 81.63 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -133.45 120.13 20.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.644 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -36.71 71.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.476 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -136.49 -168.26 2.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mp -90.67 95.8 10.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 112.069 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.76 118.38 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.874 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.7 mp -93.02 132.14 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -15.37 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.519 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.874 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 61.92 25.23 15.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.897 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.35 -56.31 11.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.015 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.635 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 12.0 m-80 -121.03 82.79 1.97 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.182 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -115.24 130.29 56.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.103 0.478 . . . . 0.0 111.06 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.45 159.47 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 O-C-N 123.686 0.616 . . . . 0.0 109.989 -175.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.763 0.316 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.29 99.52 9.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 2.0 m -81.15 113.84 19.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' HA3' ' A' ' 48' ' ' GLY . 23.4 mt -71.56 131.01 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.552 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -155.09 -164.57 13.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.793 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.04 -25.31 73.58 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.784 2.323 . . . . 0.0 111.934 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -90.07 77.06 6.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.944 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -100.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.377 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 91.97 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.67 67.33 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.577 0.703 . . . . 0.0 111.204 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -135.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.621 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.79 -165.32 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.01 107.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 15.5 m-85 -136.63 145.84 45.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.771 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.3 mtmt -102.33 124.85 38.15 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.804 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.9 Cg_exo -75.58 120.23 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.935 2.423 . . . . 0.0 111.981 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 81.6 m-85 -118.08 131.87 56.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.236 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.8 t -107.43 113.65 27.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.365 . . . . 0.0 110.959 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -148.09 151.09 35.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -80.09 104.97 11.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.706 0.765 . . . . 0.0 109.653 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.755 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 75' ' ' ILE . 0.9 OUTLIER -94.74 108.52 20.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.076 0.465 . . . . 0.0 111.204 -175.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.33 77.35 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 2.6 m -128.66 163.18 25.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.791 0.329 . . . . 0.0 111.134 -174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -118.28 155.12 20.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.027 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.81 128.19 31.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.423 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -85.86 102.96 2.71 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -71.7 139.14 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.552 HG23 ' HA2' ' A' ' 5' ' ' GLY . 1.8 mp -67.94 122.57 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.869 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.72 -12.51 20.64 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.19 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -102.03 141.5 34.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.941 0.4 . . . . 0.0 110.727 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.6 mp0 -86.17 144.91 27.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.449 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 143.8 51.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.782 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.5 43.74 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.738 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.45 -168.78 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.65 147.73 25.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.01 122.58 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 8.6 ptmt -128.55 156.56 43.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 1.3 m -106.14 129.61 54.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.831 0.348 . . . . 0.0 110.643 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m -127.62 140.77 51.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.5 . . . . 0.0 110.996 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.8 ttmm -123.13 127.53 48.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.692 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 175.39 169.08 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.612 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.06 99.69 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.553 HG11 ' CB ' ' A' ' 73' ' ' LEU . 95.5 t -82.49 118.68 30.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 125.92 54.86 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.353 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -77.67 106.91 9.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 111.052 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -87.32 59.31 5.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.578 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.58 52.53 45.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.973 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.15 157.4 46.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -39.67 72.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 46' ' ' VAL . 7.5 p90 -111.55 175.38 5.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.572 HD13 ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -93.38 120.86 34.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -176.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 65' ' ' VAL . 6.1 tt -87.8 123.97 40.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.187 0.517 . . . . 0.0 110.408 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.2 mp -93.8 135.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.805 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -69.46 -18.55 63.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.711 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.804 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 63.65 31.51 14.46 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.507 -177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.28 -56.73 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 6.5 m-80 -119.89 85.57 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.906 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 58.5 m -116.38 133.89 55.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.784 0.326 . . . . 0.0 110.431 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.77 141.48 44.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.425 0.631 . . . . 0.0 111.171 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.78 141.5 28.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -101.21 121.19 41.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.005 0.431 . . . . 0.0 110.787 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -84.55 124.72 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.182 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 168.4 12.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.936 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 50' ' ' ILE . 21.9 Cg_exo -64.85 -25.64 60.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.747 2.298 . . . . 0.0 111.635 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HA ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -138.44 55.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.828 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -44.94 77.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.301 0.572 . . . . 0.0 110.368 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.82 27.42 0.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.371 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.873 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -82.86 82.95 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.533 -174.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.9 mm -70.91 -55.02 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.503 0.668 . . . . 0.0 109.485 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -149.94 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.838 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.4 55.17 2.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.226 1.013 . . . . 0.0 109.229 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.873 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 7.0 m-30 -78.96 107.99 12.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.048 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -83.3 135.58 44.08 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.839 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.4 Cg_exo -70.12 133.94 26.06 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.461 2.107 . . . . 0.0 111.404 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -114.71 142.72 46.12 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 t -119.25 112.56 19.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.936 0.398 . . . . 0.0 110.578 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -152.57 146.8 25.5 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -93.32 136.07 33.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 0.0 111.02 -176.503 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.365 0 CA-C-O 120.96 0.409 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.71 142.56 35.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.603 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -101.78 -53.34 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 169.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 m 65.38 -176.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.891 -0.654 . . . . 0.0 112.31 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.17 154.19 38.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 132.0 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.068 0.461 . . . . 0.0 110.45 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.1 134.75 13.14 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.185 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 52' ' ' SER . 1.4 p -69.23 129.58 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.793 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -71.2 135.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.075 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.17 76.58 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.522 ' HB2' HG13 ' A' ' 49' ' ' VAL . 14.8 m -108.33 170.66 7.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.015 0.436 . . . . 0.0 111.514 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -96.29 146.14 24.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.66 154.0 49.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.137 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.4 48.42 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.649 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.55 -171.46 3.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.502 0.192 . . . . 0.0 110.573 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -79.49 127.79 32.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.801 0.334 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.02 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.795 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -122.56 152.63 40.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 178.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 15.2 m -114.18 107.84 16.16 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -127.87 156.21 42.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.97 0.891 . . . . 0.0 113.345 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -145.86 150.8 36.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.631 -1.622 . . . . 0.0 107.047 168.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 1.5 m-20 -158.52 -165.53 1.69 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -88.57 4.47 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 75' ' ' ILE . 1.5 t -76.58 105.9 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.548 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -101.0 -120.7 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.268 176.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.48 ' H ' ' HB ' ' A' ' 66' ' ' THR . 13.7 t-20 -99.29 81.4 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.219 0.533 . . . . 0.0 110.074 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.18 151.11 23.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.72 69.73 3.27 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.637 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -137.97 165.6 26.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -30.67 71.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.184 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.703 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 8.7 p90 -145.94 -173.01 4.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.907 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -102.12 100.32 10.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -80.98 115.85 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.664 ' HA ' HG21 ' A' ' 65' ' ' VAL . 5.1 pt -92.44 154.73 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.05 -14.94 57.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.199 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.14 34.49 5.0 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.201 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . . . -88.47 -62.79 1.41 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.979 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 9.9 m-80 -95.35 50.91 1.27 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.168 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 51.1 t -123.81 129.94 51.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -129.73 123.78 57.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.687 -177.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.582 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.318 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.565 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -78.99 103.52 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.24 0.543 . . . . 0.0 111.258 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 135.61 33.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.415 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.04 124.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.661 0.267 . . . . 0.0 110.662 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -110.73 -168.43 19.23 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -0.82 9.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.783 2.322 . . . . 0.0 112.44 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 151.84 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.934 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.54 -70.66 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.553 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.69 42.68 0.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.151 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 14.5 m -79.86 76.05 6.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.822 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -92.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.058 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.79 88.78 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.561 0.22 . . . . 0.0 111.042 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.752 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.8 t70 50.47 38.47 18.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.431 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 13.4 m-85 -88.35 112.29 22.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.849 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.44 146.31 31.09 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.28 120.55 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.58 2.187 . . . . 0.0 111.458 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 3.3 m-85 -113.96 130.88 56.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.82 118.55 36.97 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.46 173.02 12.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.957 0.408 . . . . 0.0 110.922 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 158.76 26.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -174.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -138.71 104.68 5.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 0.0 110.883 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.75 75.23 0.21 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 43' ' ' LEU . 96.0 m -104.16 156.74 17.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -132.07 160.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.563 175.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.42 120.29 15.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.877 0.37 . . . . 0.0 110.804 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.88 112.12 3.98 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.0 151.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.309 0.576 . . . . 0.0 111.577 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 50' ' ' ILE . 4.9 mp -58.67 124.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.814 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.83 -23.8 11.46 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.21 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -83.08 149.64 26.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.841 0.353 . . . . 0.0 110.786 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -114.35 120.23 39.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.963 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -110.01 110.8 21.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.536 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.69 4.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.868 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.17 -113.24 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -131.08 119.64 22.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.023 0.439 . . . . 0.0 111.147 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.08 114.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.402 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -124.76 169.97 11.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.793 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 87.6 m -110.34 121.05 44.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -129.02 147.5 50.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.106 0.479 . . . . 0.0 110.799 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HE3' ' HB3' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -134.09 131.03 38.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.618 175.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.69 178.25 6.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.474 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.81 102.06 8.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.176 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.78 154.16 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.76 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.62 120.34 42.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.049 0.452 . . . . 0.0 111.106 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -92.86 55.62 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.465 0.65 . . . . 0.0 109.897 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -21.85 45.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.881 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.17 52.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -115.5 164.63 14.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.311 . . . . 0.0 110.672 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -42.84 13.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 109.909 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -145.26 165.37 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.799 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.543 ' HG ' ' H ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -87.1 93.46 9.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 110.97 -178.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.05 111.85 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -92.99 153.25 3.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -174.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.83 -11.09 59.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.721 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.85 33.06 12.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.506 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -58.67 3.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.287 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.2 m-80 -107.06 84.65 2.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.231 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.97 129.46 50.97 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.843 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.08 121.51 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.238 0.542 . . . . 0.0 111.038 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.724 176.478 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.595 ' HB1' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.43 109.01 13.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.029 0.442 . . . . 0.0 110.56 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.31 134.71 42.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.59 HG23 HG21 ' A' ' 8' ' ' THR . 4.7 mt -98.18 102.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.33 -167.86 16.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.946 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.85 -27.22 59.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 0.0 111.922 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -108.72 54.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.079 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.59 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.91 -74.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.159 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -104.55 126.25 51.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.908 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.49 70.52 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 111.307 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.5 -161.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.823 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -67.54 178.97 1.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.91 99.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.574 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.407 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 15.1 m-85 -115.33 157.29 24.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.936 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -90.78 117.55 68.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.0 Cg_exo -79.41 131.47 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.263 2.642 . . . . 0.0 111.777 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -125.88 141.61 51.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.1 m -95.49 112.49 24.19 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.465 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -131.91 141.39 49.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.675 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.71 105.45 17.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.843 0.354 . . . . 0.0 110.055 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.571 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 3.0 mm? -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.453 0.644 . . . . 0.0 111.16 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' A' ' 72' ' ' PHE . . . -165.57 93.04 0.11 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.494 ' HB2' HD11 ' A' ' 75' ' ' ILE . 56.3 m -139.47 -178.04 5.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.181 0.515 . . . . 0.0 111.733 -169.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.26 153.25 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.39 137.51 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.962 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.2 129.67 23.52 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.997 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.67 105.02 5.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 11.3 mt -64.66 108.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.747 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.39 -8.72 20.25 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.58 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -110.95 160.92 16.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG2' ' HB1' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -93.47 153.18 18.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.633 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 116.64 12.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.125 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.19 60.17 4.26 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 19' ' ' CYS . . . -158.32 -152.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 -174.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -114.81 136.63 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 110.174 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.73 117.53 37.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.424 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 4.7 mmpt? -109.96 138.96 45.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.077 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -111.98 100.97 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -120.83 135.21 55.23 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.347 0.594 . . . . 0.0 111.156 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -94.46 103.86 15.83 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.915 175.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -160.45 127.1 4.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.527 -1.669 . . . . 0.0 106.878 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.63 66.59 5.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 0.0 112.309 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -78.63 100.7 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 169.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -128.07 -32.76 2.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.795 0.807 . . . . 0.0 110.389 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -96.08 125.16 40.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.44 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 102.0 8.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.417 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 -32.98 49.91 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -124.57 -161.03 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.8 6.16 8.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HE2' ' C ' ' A' ' 44' ' ' GLY . 2.9 p90 -157.28 -158.88 0.79 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.112 -0.367 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp -104.13 99.24 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.144 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tp -81.55 116.51 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 109.908 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -101.48 137.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.22 -175.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -76.51 154.53 34.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.25 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.03 99.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 21.25 -102.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 125.198 1.561 . . . . 0.0 114.08 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 11.7 m-80 -121.08 70.87 0.92 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 38.6 t -114.3 129.9 56.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.376 -0.828 . . . . 0.0 111.199 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 135.81 42.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.152 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 112.4 20.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.719 0.295 . . . . 0.0 110.525 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.36 124.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.916 0.388 . . . . 0.0 111.081 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 54' ' ' CYS . 19.8 mt -88.48 94.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.284 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 175.58 30.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.369 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.96 -13.82 34.65 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.503 2.135 . . . . 0.0 111.983 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.31 41.59 1.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.484 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.6 -53.96 4.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.304 0.573 . . . . 0.0 110.749 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.18 64.85 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.459 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.75 65.32 4.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 110.659 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 -133.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.055 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.87 66.9 4.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.174 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 21.5 t0 46.79 80.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.927 0.767 . . . . 0.0 111.58 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -110.67 157.99 19.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.929 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 15.6 mtmt -106.31 124.52 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.799 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -80.33 128.68 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.142 2.561 . . . . 0.0 111.321 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.85 132.67 53.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.752 0.31 . . . . 0.0 110.723 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.52 113.2 26.53 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 126.42 33.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.269 0.556 . . . . 0.0 111.553 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.769 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 2.4 mp0 -80.3 129.64 34.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.202 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.897 0.38 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -145.95 102.94 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.11 94.14 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 75' ' ' ILE . 35.3 m -131.17 -176.09 3.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 111.284 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.26 159.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.295 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.14 133.75 30.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.38 104.66 0.95 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.867 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 110.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.851 0.358 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.4 pt -59.02 120.1 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.2 -26.61 9.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.565 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m -94.33 164.53 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.759 0.314 . . . . 0.0 110.491 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 68.1 mt-30 -106.09 149.37 26.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.168 0.509 . . . . 0.0 111.695 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.647 ' HB2' HD11 ' A' ' 4' ' ' ILE . 10.5 t -108.73 134.87 50.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.289 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.73 -19.47 51.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.104 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.769 ' HB3' ' HA ' ' A' ' 20' ' ' GLN . . . -125.39 -123.8 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.909 0.355 . . . . 0.0 111.941 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.19 96.84 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.258 0.551 . . . . 0.0 112.279 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.14 125.65 45.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -141.77 170.39 15.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.641 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -112.07 124.16 51.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 69.5 m -134.21 132.5 39.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.937 0.399 . . . . 0.0 110.473 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 14.9 tptm -104.38 121.89 44.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.597 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.692 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -164.96 165.51 20.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.768 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -115.01 102.61 10.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.961 0.41 . . . . 0.0 110.736 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -92.79 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.5 129.15 34.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -9.12 59.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.6 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.4 117.96 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.425 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.39 -50.49 0.78 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.787 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -123.15 149.99 43.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.45 -46.16 14.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.992 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.64 157.41 18.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -92.14 97.14 10.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -170.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mp -69.41 133.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 7.8 mt -91.44 129.81 41.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.323 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 21.5 m-80 -65.63 -16.03 63.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.103 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.53 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 57.84 36.02 25.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.341 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.7 -57.17 3.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.428 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.1 m-80 -117.5 97.96 6.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.595 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.5 m -124.04 130.55 52.76 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.922 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.69 152.95 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.254 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.582 -179.591 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.26 101.37 11.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.909 0.385 . . . . 0.0 110.265 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.31 125.13 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.939 -178.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.418 HD13 ' HA3' ' A' ' 48' ' ' GLY . 13.4 mt -86.04 86.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.172 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 169.49 51.27 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.762 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.79 -42.59 30.74 Favored 'Trans proline' 0 CA--C 1.527 0.168 0 C-N-CA 122.615 2.21 . . . . 0.0 113.045 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.88 33.09 3.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -59.29 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 110.233 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.82 71.44 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.123 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.8 8.85 11.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.47 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.6 mt -65.18 161.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.379 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -18.68 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.806 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.4 t70 -149.6 86.63 1.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 27.8 m-85 -140.95 166.21 25.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.978 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -117.25 142.36 30.03 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.507 175.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 9.3 Cg_exo -71.36 124.87 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.565 2.177 . . . . 0.0 111.281 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.2 m-85 -121.81 130.82 53.68 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.7 m -93.93 112.84 24.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.27 163.92 29.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.93 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -100.65 105.73 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.963 0.411 . . . . 0.0 110.301 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.324 -0.51 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.756 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.314 0.102 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -159.14 107.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.107 0.48 . . . . 0.0 110.458 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.06 87.13 0.38 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -128.53 168.59 15.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -176.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.6 158.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.588 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.73 142.03 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -76.31 147.13 34.02 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.396 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.3 t -86.0 120.78 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 0.0 110.561 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.38 123.12 21.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.67 3.32 68.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.068 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 19.6 m -108.09 160.34 15.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.017 0.436 . . . . 0.0 110.877 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.668 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -96.95 127.85 43.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.3 t -108.46 138.33 44.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.08 12.9 58.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.978 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.18 177.4 4.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 116.85 20.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.255 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.46 113.02 23.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.289 0.566 . . . . 0.0 111.244 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 12.6 ptpt -115.3 171.45 7.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.18 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 33.4 m -117.75 119.64 35.52 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.972 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.71 146.02 50.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.483 0.659 . . . . 0.0 111.427 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -137.77 133.36 33.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.014 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.5 t70 -160.84 -174.32 4.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.98 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -79.33 -72.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.51 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 73' ' ' LEU . 2.1 t 47.79 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.337 1.023 . . . . 0.0 112.89 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 t -84.15 139.11 32.64 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.383 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 59.84 0.87 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.237 0.541 . . . . 0.0 110.312 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -42.07 24.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.588 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.1 57.28 0.22 Allowed Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.51 139.82 52.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -42.68 95.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.691 -175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 162.41 33.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.285 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.609 ' HB2' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -90.87 130.53 36.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.96 0.409 . . . . 0.0 111.833 -172.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.43 128.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -97.47 150.36 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.843 0.354 . . . . 0.0 110.364 -178.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -95.98 -2.55 46.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.16 31.13 19.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.539 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.74 -46.94 67.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -127.4 97.93 5.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.13 139.07 33.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.24 0.543 . . . . 0.0 111.606 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.82 127.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.97 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 O-C-N 124.252 0.97 . . . . 0.0 111.346 -179.699 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.78 111.36 19.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.9 131.66 35.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 178.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.9 mt -83.1 103.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.647 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.73 -173.5 26.8 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.847 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -13.56 24.64 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.718 2.279 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.12 45.3 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.25 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.591 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -84.66 -61.96 1.66 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.077 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.3 p -160.63 164.41 31.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.662 0.267 . . . . 0.0 110.663 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.75 -113.25 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 175.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER 53.17 -110.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 122.953 0.501 . . . . 0.0 111.541 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.518 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.16 177.59 5.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' N ' ' CG ' ' A' ' 12' ' ' ASP . 12.2 t70 -67.29 77.18 0.15 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.768 0.794 . . . . 0.0 109.797 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.516 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 9.9 m-85 -97.5 140.89 31.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.805 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -105.39 135.09 19.39 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 8' ' ' THR . 41.0 Cg_endo -70.47 132.34 21.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.175 1.917 . . . . 0.0 111.137 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.89 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 6.7 m-85 -119.13 130.72 55.71 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.159 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.05 112.93 25.05 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 157.95 36.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.434 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -80.53 111.27 16.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.272 0.558 . . . . 0.0 110.533 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.106 177.487 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.634 HD12 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.43 176.99 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.348 . . . . 0.0 110.758 -175.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.9 -60.22 0.12 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 4.1 m 63.29 179.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.742 0.782 . . . . 0.0 112.701 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.19 146.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.889 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.87 122.1 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.067 0.461 . . . . 0.0 109.856 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 99.98 1.37 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.208 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.14 126.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.89 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.741 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.62 -17.18 12.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.061 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -89.44 162.9 15.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 3' ' ' THR . 6.7 mp0 -110.68 156.58 20.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.008 0.432 . . . . 0.0 111.113 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.37 137.85 47.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.01 -5.57 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.947 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -102.88 -105.77 0.27 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.89 147.08 49.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.551 0.215 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.57 106.19 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.462 ' H ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -120.33 157.52 29.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 60.0 m -104.0 120.13 40.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.084 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -124.53 151.7 44.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.356 0.598 . . . . 0.0 110.868 -176.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -137.93 135.35 35.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.087 174.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -153.46 -170.64 3.66 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -106.37 38.36 2.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 110.259 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 ' H ' ' A' ' 74' ' ' ILE . 3.1 p -103.32 129.24 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.404 0.621 . . . . 0.0 110.859 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -128.91 -174.06 3.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.23 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -117.58 130.66 56.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.209 0.528 . . . . 0.0 111.737 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -112.51 -6.32 13.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.059 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.61 43.89 0.25 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.1 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.16 170.48 9.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.734 0.302 . . . . 0.0 110.876 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -39.39 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 0.0 110.43 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.29 -174.18 1.65 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.519 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -85.91 155.56 20.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.879 ' H ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.74 114.43 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.971 176.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.634 HD11 HD12 ' A' ' 43' ' ' LEU . 4.3 pt -105.24 153.3 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.318 0.58 . . . . 0.0 111.189 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -94.52 -4.0 48.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.486 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.66 30.92 14.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.887 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.31 82.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.762 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.4 m-80 -129.05 80.44 1.97 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.61 54.69 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.481 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 148.24 30.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.043 0.449 . . . . 0.0 111.149 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.169 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.65 0.262 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.45 99.99 11.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.876 0.369 . . . . 0.0 110.293 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 110.07 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 18' ' ' CYS . 3.6 mt -70.6 122.44 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.13 -161.38 9.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.769 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.36 -22.19 52.98 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.128 2.552 . . . . 0.0 113.075 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -102.14 5.87 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -92.34 -47.79 7.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 10.2 t -135.39 87.54 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.966 0.412 . . . . 0.0 110.9 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -89.41 0.46 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.954 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.3 mt 54.5 -103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 122.934 0.494 . . . . 0.0 110.657 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 8.2 t70 -100.72 -113.59 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.438 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 24.3 t70 -121.06 66.43 0.86 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 167.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 2.5 m-85 -90.14 151.87 21.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.895 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 3.8 mtmt -102.14 127.46 30.76 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HG3' ' HB3' ' A' ' 9' ' ' CYS . 6.6 Cg_exo -72.8 136.19 24.91 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.543 2.162 . . . . 0.0 110.922 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -129.38 130.41 45.99 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.868 0.366 . . . . 0.0 110.255 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 m -99.48 112.59 24.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.854 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.8 m -115.13 115.73 27.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.787 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 9.9 pt20 -80.46 117.22 21.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.831 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -109.13 103.81 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.29 82.11 1.49 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.766 ' HB2' HD11 ' A' ' 75' ' ' ILE . 1.8 m -134.9 168.27 19.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.516 0.198 . . . . 0.0 110.506 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.55 157.25 21.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.971 0.415 . . . . 0.0 110.819 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.64 143.46 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.079 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.14 106.92 3.02 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.899 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -71.55 133.86 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.733 0.301 . . . . 0.0 110.726 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -71.22 140.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.8 -14.01 66.14 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.597 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -97.81 158.08 15.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -116.16 137.7 51.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 0.0 111.378 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.0 m -115.13 152.05 33.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.188 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -119.99 49.5 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 20' ' ' GLN . . . -153.25 -135.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.584 0.23 . . . . 0.0 110.809 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -107.41 122.49 46.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.077 0.465 . . . . 0.0 110.783 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.53 118.62 56.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.764 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -123.47 163.71 20.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.248 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 91.7 m -111.47 123.62 50.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 97.7 m -133.26 148.05 51.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.088 0.471 . . . . 0.0 111.192 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 2.4 tptm -130.35 140.49 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.698 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 p30 178.37 -177.29 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.877 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.06 116.13 28.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.179 0.514 . . . . 0.0 110.91 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.676 HG11 ' HA ' ' A' ' 73' ' ' LEU . 2.4 t -124.37 94.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.631 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.27 141.27 30.57 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.152 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.34 89.89 4.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.476 0.655 . . . . 0.0 110.64 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.53 75.16 1.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.87 -74.61 0.29 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.235 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.68 119.0 22.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.61 -3.54 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 110.663 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -99.07 148.32 24.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.676 ' HA ' HG11 ' A' ' 65' ' ' VAL . 2.0 mp -76.86 91.58 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.672 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -76.61 133.15 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.713 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.19 138.27 20.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.245 0.545 . . . . 0.0 111.069 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.13 -18.57 33.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 66.44 24.23 10.43 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.655 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.83 -55.27 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.321 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 5.7 m-80 -114.71 90.56 3.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.691 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 52.7 m -122.2 129.59 52.41 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.653 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 60' ' ' CYS . 0.9 OUTLIER -120.41 131.32 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.377 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.191 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.423 ' HB3' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.94 108.71 13.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.857 0.36 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 3.2 m -79.6 119.04 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 8' ' ' THR . 53.4 mt -68.82 119.22 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.879 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.68 -179.19 30.81 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.116 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HA ' HG12 ' A' ' 50' ' ' ILE . 57.2 Cg_endo -69.51 -38.93 7.63 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.43 54.46 2.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.664 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -74.72 -55.29 6.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.483 -176.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -83.0 123.88 29.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -22.87 43.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.612 0.72 . . . . 0.0 109.338 172.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.61 134.77 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.737 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.16 140.77 33.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.22 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 69.79 48.68 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.026 0.829 . . . . 0.0 111.19 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 4.7 m-85 -135.47 150.96 49.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 26.5 mtmt -99.09 135.32 20.86 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 4.5 Cg_exo -77.44 140.23 19.06 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.784 2.323 . . . . 0.0 111.511 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.44 140.07 42.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.8 114.12 27.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.78 132.75 54.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.768 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -80.67 121.59 26.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.995 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 0.0 110.071 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.741 0.305 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 43' ' ' LEU . 1.4 mm? -84.17 134.13 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 110.686 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.1 91.07 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.4 m -138.43 179.4 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.69 ' HA ' HD12 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -119.07 153.95 21.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.562 HG23 HD13 ' A' ' 73' ' ' LEU . 96.4 t -61.64 127.84 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.628 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.5 76.51 2.08 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.773 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.477 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -71.45 146.63 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.76 0.314 . . . . 0.0 110.2 178.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 6' ' ' PRO . 2.2 mt -61.75 124.11 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.669 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.03 -11.56 20.26 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -89.38 137.51 32.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -96.74 115.46 27.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -107.25 108.04 19.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.88 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.87 36.01 3.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.974 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.03 -110.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.329 0.109 . . . . 0.0 110.839 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.92 125.88 43.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.538 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 t -107.33 127.35 63.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.03 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 170.28 16.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.306 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 57.7 m -116.2 136.9 52.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 110.632 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.9 m -141.83 151.3 42.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.081 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -116.04 118.62 33.39 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.103 175.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -162.58 166.85 24.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.875 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.59 70.02 0.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.7 OUTLIER -76.58 1.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.424 0.63 . . . . 0.0 111.051 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.55 70.77 6.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.559 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.54 -171.32 2.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.137 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.23 108.18 12.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.001 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.66 150.96 18.61 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.751 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.97 119.17 22.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.412 0.148 . . . . 0.0 111.123 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 m 71.51 -59.24 0.55 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.084 0.865 . . . . 0.0 111.929 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -139.49 -163.06 1.42 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.62 0.248 . . . . 0.0 110.564 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.721 ' HB3' HG21 ' A' ' 65' ' ' VAL . 7.1 mt -82.48 108.4 15.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.628 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 65' ' ' VAL . 7.0 mm -84.84 116.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.4 mt -91.89 130.69 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 0.0 111.541 -170.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 6.7 t-20 -72.23 106.87 4.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.06 56.74 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 111.673 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.64 -60.73 1.8 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.093 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 6.8 m-80 -111.39 103.8 12.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.008 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.94 132.49 36.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.28 159.33 42.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.691 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 116.06 31.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.678 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 1.9 m -80.01 121.19 25.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.35 126.18 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 111.53 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.92 169.69 14.68 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.66 -40.36 46.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.305 2.67 . . . . 0.0 112.395 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 67.21 0.79 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.487 178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.589 HG21 HG11 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -62.1 -45.06 95.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.43 132.07 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.782 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 71.42 6.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.215 0.531 . . . . 0.0 111.421 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -172.2 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.8 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.35 -135.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.16 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.35 101.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.587 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 23.1 m-85 -146.53 150.62 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.568 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -116.26 135.48 22.84 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 177.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 7.3 Cg_exo -73.44 128.89 13.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.677 2.251 . . . . 0.0 111.646 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 75' ' ' ILE . 47.2 m-85 -123.74 146.49 48.26 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.66 112.74 24.37 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -124.61 151.49 44.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.994 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 10.5 mp0 -80.84 141.51 34.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.739 -176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -128.44 124.37 36.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.423 0.63 . . . . 0.0 111.092 -178.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.17 83.88 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 43' ' ' LEU . 24.4 m -127.35 173.09 10.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.251 0.548 . . . . 0.0 111.87 -172.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.97 158.82 19.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.641 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG13 ' HE3' ' A' ' 15' ' ' LYS . 23.5 t -63.98 129.05 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 132.91 17.09 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.088 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.5 t -87.92 114.45 26.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.43 118.13 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.18 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.44 -14.89 35.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.73 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.487 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 49.6 m -102.87 164.44 11.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.772 0.32 . . . . 0.0 110.143 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.2 pt20 -108.92 149.07 29.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.089 0.471 . . . . 0.0 110.759 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.4 m -122.15 120.81 35.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.448 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.59 48.41 3.67 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -158.18 -133.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.95 145.18 41.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.975 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.589 HG11 HG21 ' A' ' 8' ' ' THR . 21.9 t -102.93 109.52 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.77 156.48 17.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.118 -174.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 105.26 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -124.36 137.85 54.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.195 0.521 . . . . 0.0 110.998 -176.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -119.2 123.65 44.84 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.632 175.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' A' ' 75' ' ' ILE . 22.7 t70 -178.68 155.75 0.84 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.764 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 94.36 6.34 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.08 126.48 7.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.456 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.49 45.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.008 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -27.06 17.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.482 0.658 . . . . 0.0 110.126 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 86.48 5.01 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.681 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.48 -45.33 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -134.89 169.54 17.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.656 0.265 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -19.22 63.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.412 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.25 169.07 12.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.62 105.5 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 178.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.55 140.55 15.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.0 110.517 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -107.29 130.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.357 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -71.7 -13.2 61.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.727 0.298 . . . . 0.0 110.323 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . . . 59.49 28.8 18.27 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.653 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.82 82.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.823 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 2.9 m-80 -123.73 83.28 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.119 176.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 131.42 52.44 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.556 -176.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.01 148.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.504 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.669 0.271 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 136.65 35.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.667 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.16 137.03 40.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.803 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.475 HD11 ' SG ' ' A' ' 54' ' ' CYS . 44.1 mt -82.53 123.75 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.774 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 8' ' ' THR . . . -146.83 -178.93 22.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.68 -30.43 90.4 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.776 2.317 . . . . 0.0 112.093 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -114.3 62.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.511 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -72.27 -65.94 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 -178.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.75 157.51 15.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.932 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -82.84 85.36 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.163 0.506 . . . . 0.0 111.314 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -144.03 -170.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.295 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.32 108.95 3.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 11' ' ' ILE . 21.5 m-85 -132.58 156.41 46.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.359 -172.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.65 125.42 82.58 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.3 Cg_exo -76.59 125.46 8.28 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.789 2.326 . . . . 0.0 111.848 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 61' ' ' CYS . 93.7 m-85 -123.31 149.18 45.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.35 116.01 8.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.02 175.09 10.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.374 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 137.66 37.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.267 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 120.938 0.399 . . . . 0.0 109.933 178.329 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -138.34 110.45 7.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.059 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.0 112.87 2.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 t -153.97 178.33 10.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 m -122.05 158.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.72 125.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.56 135.61 41.78 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.118 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.43 98.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.405 HG22 ' HA2' ' A' ' 5' ' ' GLY . 2.7 pt -60.49 120.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.415 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 -8.02 26.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.957 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -116.93 154.22 31.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.802 0.334 . . . . 0.0 110.854 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 15.2 mt-30 -84.35 151.28 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.299 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -136.27 106.63 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.093 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.41 58.97 3.04 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.93 -166.59 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.08 95.75 6.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.619 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.67 135.52 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.175 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.17 155.15 45.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.9 m -128.32 108.44 10.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 70.7 m -124.01 142.02 51.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.362 0.601 . . . . 0.0 112.037 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.82 120.26 41.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.473 172.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 65' ' ' VAL . 2.8 p30 -144.35 -170.5 3.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.167 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.24 50.02 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.444 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG23 ' OD1' ' A' ' 63' ' ' ASP . 51.5 t -61.84 124.84 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.068 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.72 119.57 35.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -79.9 100.25 7.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.252 0.549 . . . . 0.0 111.854 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -19.93 48.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.912 0.863 . . . . 0.0 109.81 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.52 53.22 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -111.49 139.65 46.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.87 -51.29 68.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.428 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.12 148.06 41.88 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 98.75 8.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.488 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.46 ' H ' HG13 ' A' ' 74' ' ' ILE . 1.6 mt -69.18 126.16 28.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 77' ' ' ALA . 3.9 mt -92.33 146.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.227 0.537 . . . . 0.0 110.249 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -76.48 -0.48 23.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.281 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 64.42 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.04 -95.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.862 0.726 . . . . 0.0 111.496 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.611 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 19.4 m-80 -91.71 78.66 5.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.251 -176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.7 m -114.43 130.2 56.7 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.782 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -138.16 159.48 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.79 178.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.243 178.278 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 107.19 19.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.339 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -79.05 125.46 29.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.0 0.429 . . . . 0.0 110.826 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 54' ' ' CYS . 13.7 mt -80.53 95.06 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.368 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.41 171.08 17.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.78 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.77 -15.49 33.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 111.709 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 7' ' ' ASN . 4.2 m120 -107.49 46.81 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.918 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -64.8 0.88 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 128.88 52.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.843 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.43 79.25 9.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.915 0.388 . . . . 0.0 110.853 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -145.2 -162.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 13.9 t0 -60.65 163.74 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.978 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.14 103.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 111.158 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 62' ' ' LYS . 6.3 m-85 -121.8 165.99 15.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.075 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -112.84 137.61 21.86 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -75.06 130.24 13.02 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.801 2.334 . . . . 0.0 111.31 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 40.1 m-85 -124.2 135.58 53.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.767 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -105.22 115.27 29.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.449 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.68 152.63 28.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.804 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -80.38 105.49 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.144 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.985 179.545 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -114.23 117.1 30.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.313 0.578 . . . . 0.0 111.341 -174.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.96 49.14 4.08 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 53.6 m -95.29 154.36 17.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.332 . . . . 0.0 110.797 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.84 152.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.77 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.42 117.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.97 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.53 125.33 6.9 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.057 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' OG ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -77.07 125.16 36.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 127.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.01 -16.77 11.96 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.211 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -97.69 165.06 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.783 0.325 . . . . 0.0 111.169 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -110.58 132.08 54.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -111.15 145.71 38.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.471 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.38 -11.1 46.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.495 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.23 -177.11 4.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.125 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 125.17 29.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.905 0.383 . . . . 0.0 110.519 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 3.9 t -97.11 120.15 46.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.902 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 mtpt -112.68 169.76 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.81 102.95 10.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 2.9 m -132.22 161.09 34.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.504 0.669 . . . . 0.0 112.099 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 2.2 pttt -156.45 157.73 36.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.456 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.6 -173.2 2.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.422 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.06 69.26 10.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.6 107.56 19.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.215 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -75.58 0.27 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.414 0.626 . . . . 0.0 110.946 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -149.19 147.43 28.42 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.075 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 120.14 7.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.78 46.9 3.19 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.121 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.85 175.12 6.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.27 -24.75 65.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.94 0.4 . . . . 0.0 111.531 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.22 152.72 20.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.004 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.494 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -112.23 125.13 53.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.043 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.46 136.47 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.373 0.606 . . . . 0.0 111.545 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.1 119.06 45.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 78' ' ' ALA . 3.6 t30 -63.81 -24.96 67.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 76' ' ' ASN . . . 81.3 31.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.734 0.814 . . . . 0.0 111.166 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . . . -74.44 -56.9 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.442 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -120.94 75.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.036 -179.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.614 ' SG ' ' HE2' ' A' ' 59' ' ' LYS . 18.3 t -134.79 130.32 35.94 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.02 152.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.379 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.902 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.312 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -84.18 121.69 27.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.923 0.392 . . . . 0.0 111.337 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -88.96 106.97 18.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.629 HD13 ' HA3' ' A' ' 48' ' ' GLY . 12.2 mt -82.75 130.25 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 111.384 -173.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -133.06 -171.86 12.84 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.864 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.19 -27.64 48.73 Favored 'Trans proline' 0 CA--C 1.525 0.066 0 C-N-CA 122.539 2.159 . . . . 0.0 112.687 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -96.63 14.24 25.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.475 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -86.68 -22.58 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.254 0.55 . . . . 0.0 110.322 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -135.09 105.11 6.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.614 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.19 33.11 4.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.468 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -108.6 163.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.291 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.55 109.61 4.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.307 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.7 27.44 15.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.32 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 11.2 m-85 -95.87 123.21 39.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.031 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 16.8 mttt -91.4 134.38 29.68 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.2 Cg_exo -70.45 137.81 34.26 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.636 2.224 . . . . 0.0 111.175 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 21.5 m-85 -131.62 138.6 48.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -95.5 112.94 24.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 m -113.5 120.16 40.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 105.88 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.448 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.538 0.209 . . . . 0.0 110.58 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -150.52 141.97 23.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.929 171.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.12 88.56 0.53 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.643 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' HD11 ' A' ' 75' ' ' ILE . 36.3 m -141.52 165.78 26.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.08 152.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.12 133.57 30.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.345 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -70.4 89.78 0.36 Allowed Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.903 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.36 117.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.537 0.208 . . . . 0.0 110.486 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 5' ' ' GLY . 3.3 mp -56.79 116.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.75 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.19 -9.5 17.88 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.833 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.01 165.85 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 0.0 110.345 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' THR . 86.3 mt-30 -121.11 125.49 47.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.141 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 82.6 m -108.44 122.5 47.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.974 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.15 56.64 4.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.269 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.13 -165.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.6 136.21 35.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.747 0.308 . . . . 0.0 110.32 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.4 t -108.29 123.93 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.208 0.527 . . . . 0.0 110.796 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -130.22 171.15 13.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.12 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 95.6 m -114.78 120.53 40.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.97 0.414 . . . . 0.0 109.972 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.2 m -125.19 123.22 39.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.341 0.591 . . . . 0.0 111.586 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.848 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 23.1 tptt -88.2 90.69 8.49 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.44 130.42 44.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.518 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 52.65 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.129 0.49 . . . . 0.0 111.038 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.18 128.29 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.949 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -84.96 146.49 27.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -91.45 97.73 11.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.558 0.694 . . . . 0.0 111.102 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -24.9 12.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.534 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 57.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.665 -1.607 . . . . 0.0 109.67 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.19 97.31 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.212 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.54 -35.58 45.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.672 0.749 . . . . 0.0 109.282 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.32 146.85 50.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.61 92.42 5.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.996 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.98 126.69 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.902 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.89 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -92.9 136.51 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 -174.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -79.62 -9.74 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.59 36.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.523 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.08 -66.43 0.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.31 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.5 m-80 -122.5 85.05 2.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.881 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.3 m -114.99 130.26 56.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.042 0.449 . . . . 0.0 111.209 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.85 160.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.949 -179.532 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -86.46 126.76 34.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -90.33 135.69 33.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.041 175.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.694 HG21 ' HA3' ' A' ' 48' ' ' GLY . 30.0 mt -91.21 130.86 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.745 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.65 -170.07 40.85 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.16 -13.27 39.11 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.365 2.043 . . . . 0.0 111.701 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -78.92 -35.99 42.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.286 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.701 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 t -140.08 123.3 16.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.828 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.31 93.96 3.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -133.69 152.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -18.48 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.204 1.402 . . . . 0.0 114.09 -174.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 21.4 t0 -119.87 47.88 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.575 0.702 . . . . 0.0 109.658 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.4 m-85 -108.84 119.47 39.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.84 -176.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -92.91 134.29 27.67 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.658 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.6 Cg_exo -68.76 125.61 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.612 2.208 . . . . 0.0 111.363 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 16.0 m-85 -114.35 144.97 42.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.097 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -106.77 113.62 27.22 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 176.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.35 120.27 37.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.865 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 17.8 mt-30 -82.03 103.96 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.906 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 2.1 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.585 0.231 . . . . 0.0 110.518 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 77' ' ' ALA . 1.6 mm? -112.03 113.62 26.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.938 0.399 . . . . 0.0 110.951 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.542 ' HA2' HD12 ' A' ' 74' ' ' ILE . . . -83.79 66.64 3.87 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.08 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 43' ' ' LEU . 1.8 m -121.14 162.08 20.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.84 153.34 21.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -65.27 137.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.796 -178.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.694 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -75.87 119.72 5.78 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.667 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.86 108.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.92 0.39 . . . . 0.0 110.602 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 2.4 mp -54.43 118.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.181 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.26 -0.16 29.7 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.415 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.77 151.51 43.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 7.6 mt-30 -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 157.41 44.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.102 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.24 43.97 1.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . . . -142.25 -172.03 3.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.854 -0.173 . . . . 0.0 110.56 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 104.8 12.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 30.6 m -88.97 144.03 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 6.5 ptpt -157.33 171.55 20.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.483 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -110.5 122.06 46.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.973 0.416 . . . . 0.0 110.271 -177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.72 136.62 51.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.423 0.63 . . . . 0.0 111.755 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.53 136.03 53.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.2 t70 -157.18 177.1 11.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.07 27.77 6.35 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.446 0.641 . . . . 0.0 109.952 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.836 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.4 t -72.63 128.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.903 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.668 HG23 ' H ' ' A' ' 68' ' ' THR . 12.8 t -118.02 -175.12 2.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.112 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.1 -14.31 59.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 111.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.668 ' H ' HG23 ' A' ' 66' ' ' THR . 0.3 OUTLIER -80.85 70.11 7.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.77 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.908 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.28 170.71 15.32 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -24.64 61.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.258 0.551 . . . . 0.0 110.154 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -107.2 142.97 36.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 47' ' ' VAL . 66.6 mt -78.92 92.91 4.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.034 0.445 . . . . 0.0 110.578 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.542 HD12 ' HA2' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -74.29 125.91 34.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.901 177.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 137.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.553 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 64.7 t30 -80.72 -4.95 56.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 43' ' ' LEU . . . 64.56 26.92 13.36 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.625 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.72 87.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -130.27 75.25 1.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.665 177.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 9.5 m -113.85 130.2 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.651 0.263 . . . . 0.0 110.359 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.11 159.72 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.894 0.378 . . . . 0.0 110.958 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.371 178.168 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 99.86 10.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.45 126.92 31.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.625 HG21 ' HA3' ' A' ' 48' ' ' GLY . 25.7 mt -96.35 115.81 36.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.055 0.455 . . . . 0.0 111.646 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.93 17.49 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HD3' HG12 ' A' ' 50' ' ' ILE . 47.1 Cg_endo -68.26 -23.24 39.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -84.23 -13.09 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.396 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -82.05 -53.69 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.872 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -152.65 105.01 2.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 111.175 -177.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.4 m -152.81 74.05 1.03 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.346 0.593 . . . . 0.0 109.586 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.618 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -94.59 -151.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.909 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.3 94.42 0.26 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.872 0.367 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 t0 54.5 37.3 27.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.039 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.618 ' HD2' ' HB ' ' A' ' 11' ' ' ILE . 6.2 m-85 -111.04 123.72 50.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.742 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -104.97 149.6 37.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.944 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.2 Cg_exo -77.33 138.73 18.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.88 2.387 . . . . 0.0 112.252 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' OH ' ' HB3' ' A' ' 64' ' ' ASP . 16.6 m-85 -126.31 145.06 50.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.225 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -96.74 112.94 24.48 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.21 141.99 18.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.068 0.461 . . . . 0.0 110.758 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -112.79 114.07 26.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 176.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.376 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.656 0.265 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -132.44 103.34 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 0.0 110.281 175.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.21 98.99 0.65 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -153.55 -174.73 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.52 154.01 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 111.851 -170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.97 144.49 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.625 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -87.61 95.28 2.06 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.47 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -63.87 127.12 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.718 0.294 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.494 HG12 ' HD3' ' A' ' 6' ' ' PRO . 1.7 mp -56.82 121.97 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.568 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.18 27.12 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.47 ' OG ' HG23 ' A' ' 49' ' ' VAL . 1.6 m -98.88 156.28 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.523 0.202 . . . . 0.0 110.577 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.57 154.56 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 m -134.19 145.51 49.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.054 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.08 -10.45 80.57 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.52 -174.68 4.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.725 -0.737 . . . . 0.0 110.123 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -92.83 160.34 14.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.757 0.313 . . . . 0.0 110.415 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.55 128.62 53.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.03 153.85 26.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 106.36 14.82 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -121.49 148.17 44.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.452 0.644 . . . . 0.0 111.486 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.9 tttp -137.82 141.01 40.82 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.759 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB2' HD22 ' A' ' 79' ' ' ASN . 0.2 OUTLIER 80.81 78.77 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.799 1.312 . . . . 0.0 109.271 -170.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.31 -109.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.194 -174.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.504 ' H ' ' HB2' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -107.82 134.66 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 111.121 -176.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -59.78 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.866 0.841 . . . . 0.0 110.255 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -115.59 139.45 50.08 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.639 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 51.8 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.15 0.5 . . . . 0.0 111.279 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.08 42.16 3.04 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.704 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.14 165.08 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -58.49 3.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.59 170.81 7.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.216 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -70.83 131.47 43.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.946 0.403 . . . . 0.0 111.177 -178.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.3 mt -118.3 133.43 65.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.012 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -102.93 142.16 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.284 -179.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -87.98 8.43 26.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.87 -124.6 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.976 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.38 -67.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.057 0.543 . . . . 0.0 111.377 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.2 m-80 -116.28 102.3 9.45 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 130.86 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.602 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.01 159.75 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.036 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.066 178.083 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.972 0.415 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 110.36 21.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -79.2 120.17 23.32 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.551 HD12 ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -83.66 128.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 176.15 33.69 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.639 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.15 -32.7 94.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.901 2.401 . . . . 0.0 112.093 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.07 87.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.779 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -36.68 82.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -103.39 156.16 17.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.95 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.41 51.59 1.47 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.529 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -123.26 151.79 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.441 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.6 115.6 14.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.07 72.17 0.54 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.269 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 4.3 m-85 -125.9 141.58 51.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.242 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 11.4 mtmt -90.84 124.28 62.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.617 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.8 Cg_exo -76.03 139.27 21.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.089 2.526 . . . . 0.0 111.771 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.11 143.62 51.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -92.06 112.26 24.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 59' ' ' LYS . 98.4 m -119.34 125.07 48.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.526 ' HB3' HE21 ' A' ' 20' ' ' GLN . 0.0 OUTLIER -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.555 -174.509 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.788 0.328 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -117.68 103.91 10.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.364 0.602 . . . . 0.0 111.049 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.71 94.56 0.57 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.171 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 75' ' ' ILE . 80.1 m -136.53 177.79 7.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.13 148.77 23.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.906 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 141.64 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.967 0.413 . . . . 0.0 110.589 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 4' ' ' ILE . . . -86.72 136.42 14.04 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.195 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 22.0 t -80.32 113.95 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.7 pt -62.9 115.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 0.0 110.635 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.01 -12.11 34.39 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.963 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 71.0 m -102.78 170.19 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.671 0.272 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -106.15 140.97 38.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 -177.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.18 124.04 38.09 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.385 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.12 52.96 3.76 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.07 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.19 178.27 9.93 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -87.68 124.63 33.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.011 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.01 130.57 35.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.218 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -120.3 163.64 17.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.489 176.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.5 117.1 27.53 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -126.47 133.04 51.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.51 0.671 . . . . 0.0 111.646 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.655 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 7.6 ttpt -106.99 118.39 36.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.431 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.66 175.13 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.66 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -124.0 105.06 9.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.064 0.459 . . . . 0.0 110.733 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.82 115.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.485 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.99 94.29 6.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.332 0.587 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -79.76 86.88 5.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.6 0.714 . . . . 0.0 110.659 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -125.17 52.58 1.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.618 0.723 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.28 31.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -140.2 148.74 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.36 -17.11 20.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.37 155.95 26.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -82.98 94.06 7.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.086 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 45' ' ' CYS . 2.4 mt -92.48 135.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -18.45 65.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 56.16 37.81 29.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.877 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.57 -52.57 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 10.2 m-80 -123.87 81.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.312 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.7 m -116.4 129.92 56.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.271 0.558 . . . . 0.0 110.891 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.2 159.89 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.324 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.32 179.743 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 m -79.41 117.77 20.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.413 . . . . 0.0 110.621 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 115.14 25.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.79 110.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 152.94 44.36 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.921 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HA ' HG21 ' A' ' 50' ' ' ILE . 12.4 Cg_endo -56.45 -37.86 96.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 112.256 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.04 75.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.69 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -42.64 59.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.4 m -126.87 145.16 50.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -97.88 69.62 2.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.191 0.52 . . . . 0.0 110.459 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 -145.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.012 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.09 -164.68 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.177 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.48 97.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.677 . . . . 0.0 109.785 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 9.1 m-85 -125.98 145.3 50.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.995 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.667 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -100.83 131.2 23.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 38.3 Cg_endo -71.15 130.49 17.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.331 2.021 . . . . 0.0 110.696 171.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.667 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 7.4 m-85 -114.7 139.78 49.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.8 0.334 . . . . 0.0 110.954 -175.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.3 t -94.04 113.03 24.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 t -146.88 158.86 44.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.622 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -141.26 106.1 4.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.315 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.836 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 120.64 0.257 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 75' ' ' ILE . 2.7 mm? -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.44 66.98 0.56 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.993 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB2' HD11 ' A' ' 75' ' ' ILE . 77.3 m -134.25 171.75 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.466 0.174 . . . . 0.0 111.053 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 73' ' ' LEU . 1.7 p -118.71 165.76 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -171.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.0 t -69.15 136.31 26.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.725 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.47 132.84 11.26 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.34 136.79 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.091 0.472 . . . . 0.0 111.092 -177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 6' ' ' PRO . 1.1 pt -73.76 147.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.36 12.55 79.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.02 152.4 47.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.707 0.289 . . . . 0.0 110.309 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -88.6 145.86 25.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.255 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.27 124.58 20.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.902 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.88 54.0 4.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.728 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.4 -163.73 1.24 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.76 147.73 22.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 7.7 t -111.37 120.67 62.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -108.66 169.23 8.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.827 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -119.47 105.86 11.67 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.5 m -129.08 139.28 52.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.482 0.658 . . . . 0.0 112.009 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.6 tptt -121.19 121.14 37.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.157 169.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.53 171.42 14.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.77 63.88 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.595 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.13 107.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.218 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.78 171.15 8.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.025 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -87.89 49.38 1.79 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.143 0.497 . . . . 0.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -12.57 60.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.308 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 93.8 1.14 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.883 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -152.82 153.11 32.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.72 0.295 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -46.45 21.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.479 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -135.96 164.15 28.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.191 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -80.95 122.16 26.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.911 0.386 . . . . 0.0 110.964 -177.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.48 145.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.057 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.49 124.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.282 0.563 . . . . 0.0 110.81 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -84.37 -3.72 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.109 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.91 32.9 15.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.664 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -54.72 29.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 3.0 m-80 -127.23 78.08 1.79 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 m -117.05 130.34 56.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 111.143 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -134.07 160.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.321 178.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.257 0.973 . . . . 0.0 111.052 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -89.03 108.64 19.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.311 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 113.36 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.031 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 8' ' ' THR . 29.8 mt -70.7 109.56 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.602 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.93 -173.17 30.36 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.981 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 50' ' ' ILE . 93.6 Cg_endo -83.72 8.03 4.85 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.979 2.453 . . . . 0.0 113.452 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.33 36.12 3.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -70.09 -48.17 58.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.368 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD12 ' A' ' 11' ' ' ILE . 70.9 m -92.91 124.35 36.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.15 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.94 17.82 2.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.531 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -122.92 159.95 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.937 177.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 4.8 t0 -69.52 -89.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 5.5 t70 -84.46 79.21 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.351 0.596 . . . . 0.0 111.213 -173.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.684 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 20.9 m-85 -144.71 138.98 27.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -106.83 138.9 19.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.908 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.5 Cg_exo -70.85 133.62 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.743 2.295 . . . . 0.0 111.53 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 33.0 m-85 -126.17 135.49 51.71 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.049 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.3 m -91.37 112.01 23.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 95.7 m -115.13 127.73 55.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.894 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.14 113.34 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.436 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.7 0.762 . . . . 0.0 109.666 175.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.826 ' HB3' HD12 ' A' ' 75' ' ' ILE . 3.6 mm? -104.74 130.88 52.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.049 0.452 . . . . 0.0 111.015 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.75 65.3 0.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' A' ' 75' ' ' ILE . 20.8 m -119.37 172.19 7.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.73 158.16 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.027 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.57 127.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.368 0.604 . . . . 0.0 111.4 -176.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 4' ' ' ILE . . . -96.08 77.77 0.77 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.25 151.29 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 6' ' ' PRO . 3.9 mp -56.65 126.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.68 10.69 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.033 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 143.74 34.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.626 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -99.37 143.07 30.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.66 136.09 50.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.46 17.13 43.82 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.9 -171.73 2.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.401 -0.399 . . . . 0.0 110.285 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 110.94 15.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.78 125.46 42.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -131.06 168.93 16.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.015 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 43.7 m -106.56 118.98 38.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 m -121.62 154.54 36.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.042 0.449 . . . . 0.0 110.866 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 2.2 tptm -151.0 135.25 16.85 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.04 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 178.74 -176.72 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.293 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -90.56 96.63 10.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -96.72 100.33 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -160.79 0.8 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.079 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.25 58.6 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 111.37 -173.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 25.85 3.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.549 0.69 . . . . 0.0 109.926 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.17 84.4 1.43 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.285 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -79.15 119.54 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.3 m 72.28 -50.66 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.811 0.694 . . . . 0.0 111.184 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.01 166.43 29.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.296 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.526 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -89.12 107.95 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 -177.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.1 139.81 19.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -111.84 134.7 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.316 0.579 . . . . 0.0 111.281 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.03 139.48 36.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.643 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 51.78 2.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 0.0 111.4 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -99.53 -71.83 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 10.2 m-80 -102.73 70.01 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.565 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 54.6 m -118.16 128.69 54.96 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.037 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.83 159.78 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.567 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.567 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 120.689 0.281 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.13 100.82 7.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.204 0.526 . . . . 0.0 110.816 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -81.12 112.41 18.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.359 178.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 54' ' ' CYS . 12.9 mt -77.71 120.94 29.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.7 -177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -113.66 167.84 12.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.797 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.85 -16.62 41.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.919 2.413 . . . . 0.0 112.501 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 43.6 1.92 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.275 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -65.41 0.7 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.166 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 70.4 1.46 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.449 -0.796 . . . . 0.0 108.978 175.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.53 67.24 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.739 -172.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -87.83 -87.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 173.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 29.6 t0 -93.46 -167.19 1.66 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -73.79 76.47 1.59 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 171.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -95.82 137.16 35.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.648 -175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 22.8 mtmt -91.65 120.16 68.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 14.9 Cg_exo -69.01 141.71 49.1 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.712 2.275 . . . . 0.0 111.539 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -137.42 135.2 36.7 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 p -112.81 124.5 52.73 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.275 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 p -156.06 162.51 40.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.29 177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.555 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 1.7 mt-30 -80.06 107.77 13.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.006 0.432 . . . . 0.0 110.281 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.29 27.78 5.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.828 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -89.39 -33.01 17.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.365 0.602 . . . . 0.0 109.546 173.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -160.46 -78.92 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.107 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . 159.27 131.71 1.28 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.603 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 6.5 Cg_exo -73.87 90.89 0.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.663 2.242 . . . . 0.0 111.47 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.7 -61.83 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.2 -143.77 16.29 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -75.18 116.68 56.65 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.506 0.193 . . . . 0.0 110.495 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.61 136.25 73.19 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.277 2.651 . . . . 0.0 112.716 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.84 -138.49 2.46 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.615 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.5 69.25 10.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.0 0.429 . . . . 0.0 110.678 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.38 153.39 23.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.509 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -82.78 141.99 31.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.78 -18.16 60.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.119 0.485 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 mp -114.18 132.24 22.83 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.574 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.96 124.22 15.47 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.502 2.135 . . . . 0.0 111.776 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 t -106.32 115.59 48.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.071 0.462 . . . . 0.0 111.453 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -161.08 166.69 27.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.2 -18.53 55.35 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.75 -80.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.288 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.12 132.93 4.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.924 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.55 103.24 9.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.515 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -113.07 119.32 37.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.918 0.39 . . . . 0.0 110.155 176.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.1 87.45 0.46 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.221 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.9 m -137.73 171.3 14.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.852 0.358 . . . . 0.0 110.569 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.44 154.07 22.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.931 177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 134.1 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.221 0.534 . . . . 0.0 110.87 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' CA ' HD13 ' A' ' 4' ' ' ILE . . . -80.25 105.42 2.36 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.05 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HB ' ' OG ' ' A' ' 52' ' ' SER . 4.7 t -68.29 130.77 33.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 50' ' ' ILE . 5.4 pt -68.42 125.33 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.444 0.64 . . . . 0.0 110.456 -177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.74 -11.08 66.52 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.599 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.443 ' OG ' ' HB ' ' A' ' 49' ' ' VAL . 63.9 m -88.09 155.3 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.529 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.559 ' HG2' HG23 ' A' ' 3' ' ' THR . 26.1 mt-30 -108.46 121.51 45.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.645 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.491 ' HB2' HD11 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -114.44 116.68 29.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.88 56.22 3.89 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.19 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.88 -179.03 7.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.7 128.19 33.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.87 127.21 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.814 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.84 169.71 11.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.783 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.7 m -118.37 124.68 48.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.9 m -129.34 135.32 48.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 0.0 111.568 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.719 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 12.7 tttt -112.71 117.79 33.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.092 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -172.55 163.77 5.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.416 -176.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -109.36 111.62 23.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.159 0.505 . . . . 0.0 110.504 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.41 146.99 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.637 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.4 138.27 31.88 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.405 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -78.39 -30.1 47.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.382 0.611 . . . . 0.0 110.62 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 3.79 48.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.973 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.0 -76.16 0.63 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.083 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -119.04 -179.98 3.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.77 7.34 15.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.373 0.606 . . . . 0.0 110.746 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -156.56 169.85 23.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.622 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.15 92.88 5.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.102 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tt -75.62 136.29 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 43' ' ' LEU . 2.8 mt -92.18 128.78 43.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 120.961 0.41 . . . . 0.0 110.747 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.589 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 10.3 m-80 -64.18 -20.58 66.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.493 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 61.72 26.2 15.9 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.078 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.55 -56.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.345 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.719 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 4.7 m-80 -124.33 84.19 2.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.924 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 33.2 m -115.55 135.78 53.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.949 0.404 . . . . 0.0 110.986 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.24 130.6 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.851 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.279 -178.678 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.678 0.275 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.94 103.41 12.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.759 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.813 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.24 137.37 37.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.801 179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.621 HG21 ' HA3' ' A' ' 48' ' ' GLY . 7.8 mt -109.55 137.0 43.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.83 -169.76 17.73 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.163 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -77.11 -17.01 15.43 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.406 2.071 . . . . 0.0 112.649 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.37 13.54 33.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.806 0.336 . . . . 0.0 111.477 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 m -75.45 -29.73 59.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -146.33 89.97 1.91 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.967 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.41 27.98 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.079 0.466 . . . . 0.0 111.036 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -84.03 -109.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.482 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 1.9 t70 -92.91 -164.31 1.16 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -74.55 66.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.617 0.722 . . . . 0.0 109.495 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 5.3 m-85 -93.85 128.02 39.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.42 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 18.0 mtmt -87.74 119.67 70.67 Favored Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.6 Cg_exo -72.29 144.43 41.4 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.013 2.476 . . . . 0.0 110.815 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.71 143.75 45.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.998 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.4 t -97.36 113.13 24.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HD3' ' A' ' 59' ' ' LYS . 58.2 m -118.94 130.27 55.62 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 0.0 111.586 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.437 ' HB3' HE21 ' A' ' 20' ' ' GLN . 0.0 OUTLIER -88.45 105.51 17.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.151 177.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -102.16 138.17 39.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.671 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -89.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.43 -43.95 2.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.517 0.675 . . . . 0.0 110.598 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.32 -166.55 24.97 Favored Glycine 0 C--N 1.315 -0.63 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.505 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.42 137.78 40.61 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.767 2.311 . . . . 0.0 112.179 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.16 158.34 22.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.633 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.16 -61.38 0.74 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.891 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.55 122.24 85.99 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.789 0.328 . . . . 0.0 111.492 -175.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 35' ' ' ILE . 7.4 Cg_exo -73.65 99.11 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.077 2.518 . . . . 0.0 111.757 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.26 151.8 35.32 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.345 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.2 18.93 12.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.062 0.458 . . . . 0.0 110.579 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.68 -35.15 0.23 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.272 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -100.15 127.31 46.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.4 tp -68.48 131.84 45.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.135 0.493 . . . . 0.0 111.192 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.674 HG12 ' HA ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -106.55 123.33 39.07 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.773 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 16.5 Cg_exo -67.42 124.2 11.77 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.449 2.099 . . . . 0.0 111.921 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.43 53.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.53 0.681 . . . . 0.0 110.115 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.15 159.88 32.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.645 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -1.71 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.058 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.35 -34.92 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -172.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -79.08 -4.13 48.76 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.89 91.98 5.46 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.825 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.778 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -140.75 104.31 4.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.038 0.447 . . . . 0.0 110.895 178.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.46 89.74 0.44 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 43' ' ' LEU . 4.0 m -133.18 175.26 9.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.311 0.577 . . . . 0.0 111.891 -171.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -119.17 156.56 21.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -61.98 139.45 20.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.914 0.387 . . . . 0.0 110.478 -178.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.621 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -60.93 115.38 7.76 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.184 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.67 95.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -60.41 103.92 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.469 -175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.38 -8.98 22.44 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.19 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -112.0 158.73 19.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.873 0.368 . . . . 0.0 110.526 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.813 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -98.65 153.16 18.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.229 0.537 . . . . 0.0 110.527 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.03 153.92 45.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.139 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.32 47.99 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.678 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.62 -171.82 3.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.44 137.26 37.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.778 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.87 121.71 58.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.978 0.418 . . . . 0.0 110.544 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HD3' ' SG ' ' A' ' 19' ' ' CYS . 2.5 mtpp -122.96 170.01 10.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.67 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 70.9 m -129.5 123.48 31.59 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.26 136.9 45.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 0.0 112.242 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -105.35 113.11 26.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 169.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.42 163.55 19.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.949 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -100.04 93.14 5.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 91.7 t -85.59 132.68 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.366 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.09 143.3 31.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.921 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -103.05 5.53 38.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.29 0.566 . . . . 0.0 110.076 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.36 101.77 7.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.684 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.14 37.24 81.63 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -133.45 120.13 20.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.657 -0.271 . . . . 0.0 110.644 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -36.71 71.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.099 0.476 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -136.49 -168.26 2.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mp -90.67 95.8 10.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.121 0.486 . . . . 0.0 112.069 -173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.76 118.38 20.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.874 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.7 mp -93.02 132.14 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.897 0.38 . . . . 0.0 110.741 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -15.37 63.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.519 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.874 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 61.92 25.23 15.13 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.897 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.35 -56.31 11.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.015 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.635 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 12.0 m-80 -121.03 82.79 1.97 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.182 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -115.24 130.29 56.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.103 0.478 . . . . 0.0 111.06 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.45 159.47 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 173.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 O-C-N 123.686 0.616 . . . . 0.0 109.989 -175.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.763 0.316 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.29 99.52 9.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.518 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 2.0 m -81.15 113.84 19.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.614 HD13 ' HA3' ' A' ' 48' ' ' GLY . 23.4 mt -71.56 131.01 35.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.552 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -155.09 -164.57 13.16 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.793 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.04 -25.31 73.58 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.784 2.323 . . . . 0.0 111.934 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -90.07 77.06 6.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.944 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.14 -100.89 0.39 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.377 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.1 91.97 3.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.67 67.33 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.577 0.703 . . . . 0.0 111.204 -177.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -135.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.621 178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.79 -165.32 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.01 107.02 1.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 15.5 m-85 -136.63 145.84 45.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.771 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.3 mtmt -102.33 124.85 38.15 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.804 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.9 Cg_exo -75.58 120.23 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.935 2.423 . . . . 0.0 111.981 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 81.6 m-85 -118.08 131.87 56.41 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.236 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.8 t -107.43 113.65 27.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.365 . . . . 0.0 110.959 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -148.09 151.09 35.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 20' ' ' GLN . 0.0 OUTLIER -80.09 104.97 11.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.706 0.765 . . . . 0.0 109.653 179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.23 -18.07 5.5 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.755 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -87.22 74.5 9.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.322 0.582 . . . . 0.0 110.511 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 30.19 0.28 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.978 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.08 96.52 0.22 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.47 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.48 122.16 10.43 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.662 2.242 . . . . 0.0 111.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.08 40.57 6.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.397 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.59 123.51 30.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.655 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -109.89 148.41 38.19 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-O 120.625 0.25 . . . . 0.0 111.267 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 24.2 Cg_exo -64.22 138.76 62.85 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.036 2.49 . . . . 0.0 112.07 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.62 -67.22 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.23 -38.05 21.02 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.12 110.08 21.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.098 172.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -99.14 20.62 13.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.713 0.768 . . . . 0.0 109.915 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.82 152.48 51.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.347 177.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.492 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -98.05 113.72 64.2 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.17 121.81 8.4 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.058 1.839 . . . . 0.0 111.988 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.17 127.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.319 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -92.25 117.59 30.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.15 0.5 . . . . 0.0 109.66 173.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.51 10.25 31.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.085 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.12 1.37 17.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.057 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 147.24 50.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.761 0.315 . . . . 0.0 111.508 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m -92.42 -162.14 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.661 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 75' ' ' ILE . 0.9 OUTLIER -94.74 108.52 20.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.076 0.465 . . . . 0.0 111.204 -175.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.33 77.35 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 2.6 m -128.66 163.18 25.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.791 0.329 . . . . 0.0 111.134 -174.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -118.28 155.12 20.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.027 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.81 128.19 31.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.423 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.614 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -85.86 102.96 2.71 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.6 OUTLIER -71.7 139.14 20.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.072 0.463 . . . . 0.0 110.989 -178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.552 HG23 ' HA2' ' A' ' 5' ' ' GLY . 1.8 mp -67.94 122.57 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.869 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.72 -12.51 20.64 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.19 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -102.03 141.5 34.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.941 0.4 . . . . 0.0 110.727 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.6 mp0 -86.17 144.91 27.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.449 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 143.8 51.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.782 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.5 43.74 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.738 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -124.45 -168.78 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.65 147.73 25.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.01 122.58 67.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 8.6 ptmt -128.55 156.56 43.13 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 1.3 m -106.14 129.61 54.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.831 0.348 . . . . 0.0 110.643 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m -127.62 140.77 51.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.151 0.5 . . . . 0.0 110.996 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 9.8 ttmm -123.13 127.53 48.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.692 178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 175.39 169.08 0.33 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.612 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -92.06 99.69 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.553 HG11 ' CB ' ' A' ' 73' ' ' LEU . 95.5 t -82.49 118.68 30.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 125.92 54.86 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.353 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -77.67 106.91 9.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.335 0.588 . . . . 0.0 111.052 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -87.32 59.31 5.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.578 -176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.58 52.53 45.44 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.973 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.15 157.4 46.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.84 0.352 . . . . 0.0 110.806 -175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -39.67 72.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' HB2' HG23 ' A' ' 46' ' ' VAL . 7.5 p90 -111.55 175.38 5.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.572 HD13 ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -93.38 120.86 34.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.254 -176.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 65' ' ' VAL . 6.1 tt -87.8 123.97 40.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.187 0.517 . . . . 0.0 110.408 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 77' ' ' ALA . 2.2 mp -93.8 135.52 28.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.805 -174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -69.46 -18.55 63.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.711 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.804 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 63.65 31.51 14.46 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.507 -177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.28 -56.73 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.893 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 6.5 m-80 -119.89 85.57 2.41 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.906 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 58.5 m -116.38 133.89 55.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.784 0.326 . . . . 0.0 110.431 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.77 141.48 44.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.425 0.631 . . . . 0.0 111.171 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.213 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.78 141.5 28.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -101.21 121.19 41.41 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.005 0.431 . . . . 0.0 110.787 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -84.55 124.72 40.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.182 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.77 168.4 12.55 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.936 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 50' ' ' ILE . 21.9 Cg_exo -64.85 -25.64 60.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.747 2.298 . . . . 0.0 111.635 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HA ' ' OG ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -138.44 55.04 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.828 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -44.94 77.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.301 0.572 . . . . 0.0 110.368 175.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.82 27.42 0.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.371 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.873 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -82.86 82.95 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.533 -174.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.9 mm -70.91 -55.02 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.503 0.668 . . . . 0.0 109.485 173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.88 -149.94 0.23 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.109 -0.951 . . . . 0.0 108.838 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -82.4 55.17 2.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.226 1.013 . . . . 0.0 109.229 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.873 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 7.0 m-30 -78.96 107.99 12.1 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.048 -173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -83.3 135.58 44.08 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.382 -0.827 . . . . 0.0 108.839 176.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.4 Cg_exo -70.12 133.94 26.06 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.461 2.107 . . . . 0.0 111.404 176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -114.71 142.72 46.12 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.6 t -119.25 112.56 19.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.936 0.398 . . . . 0.0 110.578 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 55.6 m -152.57 146.8 25.5 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -93.32 136.07 33.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -89.84 50.87 1.95 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 0.0 111.02 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.3 116.85 5.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.591 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.88 -15.62 24.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.824 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.24 114.85 0.47 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.907 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.27 -167.51 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.94 2.426 . . . . 0.0 112.472 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.35 115.26 19.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.205 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.65 -94.92 1.23 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.247 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.34 112.58 51.83 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.732 0.301 . . . . 0.0 111.314 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.88 115.99 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.587 2.191 . . . . 0.0 111.133 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.16 -27.33 3.15 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.498 ' HB3' ' H ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -106.3 -137.65 0.36 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 177.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.498 ' H ' ' HB3' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -163.91 149.85 11.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.727 0.299 . . . . 0.0 110.667 -179.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -87.23 101.31 13.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 125.96 29.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.236 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.35 130.78 14.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.414 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.76 131.76 32.45 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.629 2.219 . . . . 0.0 110.916 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.97 64.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.319 0.581 . . . . 0.0 110.995 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -93.86 112.51 24.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mp -86.54 151.26 23.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.247 -173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m 61.36 52.21 3.91 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.204 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.06 96.47 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.173 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.98 168.72 19.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.815 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -105.71 142.56 35.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.603 -178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HE2' ' A' ' 72' ' ' PHE . . . -101.78 -53.34 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 169.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 m 65.38 -176.8 0.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.891 -0.654 . . . . 0.0 112.31 172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.17 154.19 38.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.74 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.0 t -74.69 132.0 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.068 0.461 . . . . 0.0 110.45 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.1 134.75 13.14 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.185 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG13 ' HB2' ' A' ' 52' ' ' SER . 1.4 p -69.23 129.58 33.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.1 0.476 . . . . 0.0 110.793 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -71.2 135.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.075 -176.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.17 76.58 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.522 ' HB2' HG13 ' A' ' 49' ' ' VAL . 14.8 m -108.33 170.66 7.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.015 0.436 . . . . 0.0 111.514 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -96.29 146.14 24.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.66 154.0 49.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.137 177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.4 48.42 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.649 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.55 -171.46 3.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.502 0.192 . . . . 0.0 110.573 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -79.49 127.79 32.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.801 0.334 . . . . 0.0 110.45 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.02 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.795 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -122.56 152.63 40.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.259 178.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 15.2 m -114.18 107.84 16.16 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -127.87 156.21 42.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.97 0.891 . . . . 0.0 113.345 -170.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER -145.86 150.8 36.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.631 -1.622 . . . . 0.0 107.047 168.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 1.5 m-20 -158.52 -165.53 1.69 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -88.57 4.47 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.664 HG21 ' HA ' ' A' ' 75' ' ' ILE . 1.5 t -76.58 105.9 5.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.548 178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.48 ' HB ' ' H ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -101.0 -120.7 0.16 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.268 176.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.48 ' H ' ' HB ' ' A' ' 66' ' ' THR . 13.7 t-20 -99.29 81.4 2.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.219 0.533 . . . . 0.0 110.074 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.18 151.11 23.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.72 69.73 3.27 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.637 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -137.97 165.6 26.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -30.67 71.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.782 0.325 . . . . 0.0 111.184 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.703 ' HE2' ' HA3' ' A' ' 44' ' ' GLY . 8.7 p90 -145.94 -173.01 4.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.907 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -102.12 100.32 10.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.752 0.31 . . . . 0.0 110.847 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -80.98 115.85 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.664 ' HA ' HG21 ' A' ' 65' ' ' VAL . 5.1 pt -92.44 154.73 3.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.05 -14.94 57.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.199 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 67.14 34.49 5.0 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.201 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . . . -88.47 -62.79 1.41 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.979 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 9.9 m-80 -95.35 50.91 1.27 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.168 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 51.1 t -123.81 129.94 51.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -129.73 123.78 57.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.687 -177.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.318 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.565 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -78.99 103.52 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.24 0.543 . . . . 0.0 111.258 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.67 135.61 33.75 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.415 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.04 124.84 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.661 0.267 . . . . 0.0 110.662 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -110.73 -168.43 19.23 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -0.82 9.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.783 2.322 . . . . 0.0 112.44 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 151.84 41.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.934 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.54 -70.66 0.1 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.553 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -159.69 42.68 0.21 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.151 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HA ' ' HB2' ' A' ' 14' ' ' TYR . 14.5 m -79.86 76.05 6.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.822 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -92.73 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.058 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -91.79 88.78 6.8 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.561 0.22 . . . . 0.0 111.042 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.752 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 20.8 t70 50.47 38.47 18.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.431 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.688 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 13.4 m-85 -88.35 112.29 22.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.849 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.44 146.31 31.09 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.28 120.55 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.58 2.187 . . . . 0.0 111.458 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 3.3 m-85 -113.96 130.88 56.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.4 t -103.82 118.55 36.97 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.46 173.02 12.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.957 0.408 . . . . 0.0 110.922 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.03 158.76 26.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.64 103.5 9.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.634 ' HG2' HD21 ' A' ' 34' ' ' LEU . 4.8 ttp -80.35 109.02 14.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 0.0 109.743 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.3 m -108.78 129.8 55.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.118 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.08 154.37 19.87 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.667 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.581 ' HG2' ' HG ' ' A' ' 32' ' ' LEU . 35.4 Cg_exo -60.41 120.27 7.93 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.035 2.49 . . . . 0.0 112.142 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.73 176.87 6.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.248 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.58 -96.49 2.09 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.511 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.1 85.96 57.38 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 120.827 0.346 . . . . 0.0 110.408 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 33' ' ' ASN . 2.9 Cg_exo -75.69 57.87 5.13 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.124 2.549 . . . . 0.0 112.008 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.93 -23.96 70.64 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.355 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.625 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -90.33 -53.4 4.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -148.7 135.29 19.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.403 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 29' ' ' PRO . 25.3 t-20 -95.36 -29.11 14.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.959 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.634 HD21 ' HG2' ' A' ' 22' ' ' MET . 0.3 OUTLIER 63.57 66.52 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.946 -179.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.458 HG13 ' H ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -90.27 135.83 29.3 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 172.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.8 122.17 11.28 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.048 1.832 . . . . 0.0 111.957 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.99 88.62 2.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.32 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.94 169.87 16.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.18 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -21.26 18.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.406 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -145.53 -68.65 0.29 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.208 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -163.7 108.1 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.009 0.433 . . . . 0.0 112.049 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.54 91.98 7.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.333 175.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -138.71 104.68 5.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 0.0 110.883 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.75 75.23 0.21 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.561 ' SG ' HD12 ' A' ' 43' ' ' LEU . 96.0 m -104.16 156.74 17.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.074 0.464 . . . . 0.0 111.134 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -132.07 160.06 42.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.563 175.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -68.42 120.29 15.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.877 0.37 . . . . 0.0 110.804 -178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.88 112.12 3.98 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.0 151.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.309 0.576 . . . . 0.0 111.577 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 50' ' ' ILE . 4.9 mp -58.67 124.27 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.814 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.83 -23.8 11.46 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.21 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.1 m -83.08 149.64 26.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.841 0.353 . . . . 0.0 110.786 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -114.35 120.23 39.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.963 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 61.4 m -110.01 110.8 21.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.536 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.93 52.69 4.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.868 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.17 -113.24 0.06 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.3 m -131.08 119.64 22.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.023 0.439 . . . . 0.0 111.147 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.08 114.87 43.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.402 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -124.76 169.97 11.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.793 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 87.6 m -110.34 121.05 44.36 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -129.02 147.5 50.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.106 0.479 . . . . 0.0 110.799 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HE3' ' HB3' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -134.09 131.03 38.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.618 175.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.69 178.25 6.07 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.474 177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.81 102.06 8.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.112 0.482 . . . . 0.0 111.176 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.78 154.16 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.76 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.62 120.34 42.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.049 0.452 . . . . 0.0 111.106 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -92.86 55.62 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.465 0.65 . . . . 0.0 109.897 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -21.85 45.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.881 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 168.17 52.93 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -115.5 164.63 14.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.311 . . . . 0.0 110.672 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.69 -42.84 13.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 109.909 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -145.26 165.37 28.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.799 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' HG ' ' H ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -87.1 93.46 9.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.856 0.36 . . . . 0.0 110.97 -178.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.05 111.85 4.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -92.99 153.25 3.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 -174.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.83 -11.09 59.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.721 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.85 33.06 12.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.506 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.03 -58.67 3.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.287 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.2 m-80 -107.06 84.65 2.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.231 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.97 129.46 50.97 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.843 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.08 121.51 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.238 0.542 . . . . 0.0 111.038 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.724 176.478 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.595 ' HB1' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.43 109.01 13.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.029 0.442 . . . . 0.0 110.56 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.31 134.71 42.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.555 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.59 HG23 HG21 ' A' ' 8' ' ' THR . 4.7 mt -98.18 102.11 13.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -114.33 -167.86 16.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.946 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.85 -27.22 59.26 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.755 2.303 . . . . 0.0 111.922 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -108.72 54.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.079 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.59 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -72.91 -74.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.159 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.9 m -104.55 126.25 51.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.908 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.49 70.52 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 111.307 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.5 -161.24 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.823 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -67.54 178.97 1.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.91 99.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.574 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 15.1 m-85 -115.33 157.29 24.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.936 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -90.78 117.55 68.02 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.0 Cg_exo -79.41 131.47 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.263 2.642 . . . . 0.0 111.777 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -125.88 141.61 51.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.97 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.1 m -95.49 112.49 24.19 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -131.91 141.39 49.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.675 177.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -90.71 105.45 17.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.843 0.354 . . . . 0.0 110.055 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.53 139.79 31.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.571 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.5 ttm -81.49 113.26 19.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.193 0.521 . . . . 0.0 110.161 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.23 49.38 1.78 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.676 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.56 177.63 47.02 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.527 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.07 120.08 7.75 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.85 85.95 0.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.025 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.24 173.14 17.74 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.521 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.24 123.14 44.27 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.03 115.93 2.78 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.785 2.323 . . . . 0.0 112.306 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.65 150.56 9.39 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.828 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB2' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -138.64 -121.46 0.13 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -178.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' H ' ' HB3' ' A' ' 31' ' ' LEU . 12.7 tp -86.52 -14.78 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.867 0.841 . . . . 0.0 109.024 175.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.01 157.88 43.75 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.992 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.4 101.7 2.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.08 0.466 . . . . 0.0 111.464 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -110.05 99.2 38.3 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.86 124.58 12.48 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.773 2.316 . . . . 0.0 113.118 -174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -119.7 120.62 63.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -103.24 144.42 31.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.412 0.625 . . . . 0.0 111.339 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -144.28 -4.25 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.424 174.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -34.82 10.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.208 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.17 -13.23 19.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.105 0.479 . . . . 0.0 110.758 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.99 92.42 5.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.268 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 3.0 mm? -109.87 135.66 50.39 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.453 0.644 . . . . 0.0 111.16 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' A' ' 72' ' ' PHE . . . -165.57 93.04 0.11 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.494 ' HB2' HD11 ' A' ' 75' ' ' ILE . 56.3 m -139.47 -178.04 5.21 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.181 0.515 . . . . 0.0 111.733 -169.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -119.26 153.25 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.562 175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG22 HD22 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.39 137.51 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.961 0.41 . . . . 0.0 110.962 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.2 129.67 23.52 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.997 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.67 105.02 5.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 11.3 mt -64.66 108.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.747 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.39 -8.72 20.25 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.58 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -110.95 160.92 16.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.031 0.443 . . . . 0.0 111.144 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG2' ' HB1' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -93.47 153.18 18.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.633 179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 116.64 12.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.125 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -79.19 60.17 4.26 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 19' ' ' CYS . . . -158.32 -152.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.652 0.263 . . . . 0.0 110.296 -174.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -114.81 136.63 52.87 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 110.174 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -93.73 117.53 37.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.424 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' CB ' ' A' ' 82' ' ' ALA . 4.7 mmpt? -109.96 138.96 45.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.077 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -111.98 100.97 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 1.8 m -120.83 135.21 55.23 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.347 0.594 . . . . 0.0 111.156 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.5 OUTLIER -94.46 103.86 15.83 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.915 175.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -160.45 127.1 4.22 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.527 -1.669 . . . . 0.0 106.878 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.63 66.59 5.15 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.2 0.524 . . . . 0.0 112.309 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -78.63 100.7 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 169.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -128.07 -32.76 2.25 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.795 0.807 . . . . 0.0 110.389 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -96.08 125.16 40.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.44 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 102.0 8.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.417 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 -32.98 49.91 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -124.57 -161.03 0.98 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.8 6.16 8.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HE2' ' C ' ' A' ' 44' ' ' GLY . 2.9 p90 -157.28 -158.88 0.79 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.112 -0.367 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp -104.13 99.24 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.98 0.419 . . . . 0.0 111.144 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.1 tp -81.55 116.51 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.963 0.411 . . . . 0.0 109.908 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -101.48 137.11 30.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.22 -175.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -76.51 154.53 34.53 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.25 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.49 -43.03 99.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 21.25 -102.28 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 125.198 1.561 . . . . 0.0 114.08 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 11.7 m-80 -121.08 70.87 0.92 Allowed 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -173.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 38.6 t -114.3 129.9 56.65 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 121.376 -0.828 . . . . 0.0 111.199 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.96 135.81 42.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.152 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.07 112.4 20.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.719 0.295 . . . . 0.0 110.525 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.36 124.62 28.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.916 0.388 . . . . 0.0 111.081 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 54' ' ' CYS . 19.8 mt -88.48 94.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.284 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.87 175.58 30.1 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.369 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.96 -13.82 34.65 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.503 2.135 . . . . 0.0 111.983 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.31 41.59 1.18 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.484 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.6 -53.96 4.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.304 0.573 . . . . 0.0 110.749 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.18 64.85 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.459 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.75 65.32 4.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.238 0.542 . . . . 0.0 110.659 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 -133.07 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.055 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.87 66.9 4.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.174 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' O ' ' HD3' ' A' ' 62' ' ' LYS . 21.5 t0 46.79 80.24 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.927 0.767 . . . . 0.0 111.58 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -110.67 157.99 19.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.929 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 15.6 mtmt -106.31 124.52 35.52 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.799 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -80.33 128.68 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.142 2.561 . . . . 0.0 111.321 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -123.85 132.67 53.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.752 0.31 . . . . 0.0 110.723 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.52 113.2 26.53 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 126.42 33.31 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.269 0.556 . . . . 0.0 111.553 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.769 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 2.4 mp0 -80.3 129.64 34.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.92 110.98 5.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.202 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 10.0 ttm -96.26 104.18 16.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.058 0.456 . . . . 0.0 109.989 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.78 -12.66 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.221 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.1 152.08 16.29 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.781 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.75 20.49 1.06 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.848 2.365 . . . . 0.0 112.648 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.54 -65.13 0.22 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.319 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.93 171.91 12.35 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.728 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 46.4 m -139.7 120.37 9.41 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.553 0.216 . . . . 0.0 110.446 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 7.0 Cg_exo -73.11 169.06 23.15 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.831 2.354 . . . . 0.0 112.143 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.21 74.63 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.399 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.81 -46.16 7.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.116 0.484 . . . . 0.0 109.804 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -135.17 134.22 39.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.277 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -79.1 137.3 37.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.412 0.625 . . . . 0.0 110.701 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.41 136.66 26.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.387 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -99.74 115.79 65.31 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 14.9 Cg_exo -67.69 121.93 9.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.985 1.79 . . . . 0.0 111.333 -178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.52 137.94 55.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.047 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -123.64 78.72 1.63 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.11 0.3 32.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.896 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.98 -7.47 57.03 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.167 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 59.14 45.34 14.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.096 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.8 91.26 4.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.631 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -145.95 102.94 3.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 177.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.11 94.14 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.415 ' HB2' HD11 ' A' ' 75' ' ' ILE . 35.3 m -131.17 -176.09 3.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.25 0.548 . . . . 0.0 111.284 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.26 159.96 36.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.295 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.14 133.75 30.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.38 104.66 0.95 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.867 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 110.46 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.851 0.358 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.4 pt -59.02 120.1 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -176.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.2 -26.61 9.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.565 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m -94.33 164.53 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.759 0.314 . . . . 0.0 110.491 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 68.1 mt-30 -106.09 149.37 26.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.168 0.509 . . . . 0.0 111.695 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.647 ' HB2' HD11 ' A' ' 4' ' ' ILE . 10.5 t -108.73 134.87 50.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.289 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.73 -19.47 51.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.104 -174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.769 ' HB3' ' HA ' ' A' ' 20' ' ' GLN . . . -125.39 -123.8 0.25 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.909 0.355 . . . . 0.0 111.941 -177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.19 96.84 10.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.258 0.551 . . . . 0.0 112.279 -172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.14 125.65 45.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -141.77 170.39 15.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.641 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -112.07 124.16 51.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.473 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' LYS . 69.5 m -134.21 132.5 39.81 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.937 0.399 . . . . 0.0 110.473 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 14.9 tptm -104.38 121.89 44.34 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.597 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.692 ' HB2' ' HB2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -164.96 165.51 20.15 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.768 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -115.01 102.61 10.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.961 0.41 . . . . 0.0 110.736 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -92.79 148.19 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.5 129.15 34.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -9.12 59.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.6 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.4 117.96 22.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.425 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.39 -50.49 0.78 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.787 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -123.15 149.99 43.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.45 -46.16 14.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.992 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -107.64 157.41 18.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -92.14 97.14 10.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -170.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 mp -69.41 133.46 31.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 166.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 43' ' ' LEU . 7.8 mt -91.44 129.81 41.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 120.862 0.363 . . . . 0.0 110.323 -173.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.692 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 21.5 m-80 -65.63 -16.03 63.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.103 -178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.53 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 57.84 36.02 25.98 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.341 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.7 -57.17 3.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.428 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.1 m-80 -117.5 97.96 6.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.595 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.5 m -124.04 130.55 52.76 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.922 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.69 152.95 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.254 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.582 -179.591 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.657 0.265 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.26 101.37 11.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.909 0.385 . . . . 0.0 110.265 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.31 125.13 29.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.939 -178.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 HD13 ' HA3' ' A' ' 48' ' ' GLY . 13.4 mt -86.04 86.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.172 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 169.49 51.27 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.762 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.79 -42.59 30.74 Favored 'Trans proline' 0 CA--C 1.527 0.168 0 C-N-CA 122.615 2.21 . . . . 0.0 113.045 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.88 33.09 3.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -175.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -59.29 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 110.233 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.6 t -84.82 71.44 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.123 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.8 8.85 11.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.47 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.6 mt -65.18 161.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.379 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.8 OUTLIER -18.68 -85.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.17 1.388 . . . . 0.0 113.806 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 17.4 t70 -149.6 86.63 1.47 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 27.8 m-85 -140.95 166.21 25.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.978 -173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -117.25 142.36 30.03 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.507 175.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 9.3 Cg_exo -71.36 124.87 10.77 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.565 2.177 . . . . 0.0 111.281 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.2 m-85 -121.81 130.82 53.68 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.529 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 4' ' ' ILE . 3.7 m -93.93 112.84 24.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.27 163.92 29.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.93 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -100.65 105.73 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.963 0.411 . . . . 0.0 110.301 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.1 m -83.29 96.09 8.38 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.5 ttt -109.47 134.25 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.944 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.82 97.74 9.34 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.556 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.68 117.17 5.28 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.948 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.91 142.5 13.94 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.216 2.611 . . . . 0.0 111.901 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.15 50.21 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.426 0.632 . . . . 0.0 110.391 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.72 142.51 24.67 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.386 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.8 m -144.69 119.19 5.78 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.9 114.65 2.87 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.684 2.256 . . . . 0.0 111.6 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.88 -143.1 17.98 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.084 -0.579 . . . . 0.0 111.91 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.7 126.82 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.833 0.349 . . . . 0.0 110.761 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.79 88.35 2.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.025 0.441 . . . . 0.0 109.863 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -79.7 133.64 36.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.445 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.32 84.92 7.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 110.189 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -89.95 142.78 29.18 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.58 122.73 11.8 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.48 2.12 . . . . 0.0 112.458 -177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -152.11 158.35 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.374 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -124.05 130.49 52.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tp -123.33 25.82 8.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.523 175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.24 -41.11 7.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.071 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.18 74.29 10.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.064 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 m -157.93 96.56 1.48 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.931 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.5 OUTLIER -159.14 107.02 1.81 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.107 0.48 . . . . 0.0 110.458 177.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.06 87.13 0.38 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -128.53 168.59 15.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.854 0.359 . . . . 0.0 110.855 -176.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.6 158.55 21.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.588 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -65.73 142.03 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -76.31 147.13 34.02 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.396 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.3 t -86.0 120.78 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 0.0 110.561 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.3 mt -68.38 123.12 21.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.681 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.67 3.32 68.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.068 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 19.6 m -108.09 160.34 15.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.017 0.436 . . . . 0.0 110.877 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.668 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -96.95 127.85 43.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.619 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.3 t -108.46 138.33 44.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.08 12.9 58.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.978 176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.18 177.4 4.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.677 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.49 116.85 20.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.255 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.46 113.02 23.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.289 0.566 . . . . 0.0 111.244 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 12.6 ptpt -115.3 171.45 7.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.18 177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 33.4 m -117.75 119.64 35.52 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.676 -0.41 . . . . 0.0 109.972 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.71 146.02 50.71 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.483 0.659 . . . . 0.0 111.427 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -137.77 133.36 33.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.014 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.5 t70 -160.84 -174.32 4.36 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.98 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -79.33 -72.66 0.38 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.51 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 73' ' ' LEU . 2.1 t 47.79 94.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 124.337 1.023 . . . . 0.0 112.89 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 t -84.15 139.11 32.64 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.383 175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 59.84 0.87 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.237 0.541 . . . . 0.0 110.312 -176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.96 -42.07 24.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.588 -178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.1 57.28 0.22 Allowed Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -128.51 139.82 52.12 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -42.68 95.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.691 -175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.55 162.41 33.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.285 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.609 ' HB2' HG11 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -90.87 130.53 36.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.96 0.409 . . . . 0.0 111.833 -172.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.43 128.91 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.809 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -97.47 150.36 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.843 0.354 . . . . 0.0 110.364 -178.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -95.98 -2.55 46.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.16 31.13 19.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.539 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.74 -46.94 67.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -127.4 97.93 5.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.13 139.07 33.89 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.24 0.543 . . . . 0.0 111.606 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.82 127.93 68.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.97 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 O-C-N 124.252 0.97 . . . . 0.0 111.346 -179.699 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.78 111.36 19.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 0.0 110.822 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.443 HG23 ' HG3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -79.9 131.66 35.9 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.557 178.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.9 mt -83.1 103.71 10.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.647 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.73 -173.5 26.8 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.847 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.66 -13.56 24.64 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.718 2.279 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -90.12 45.3 1.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.25 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.591 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -84.66 -61.96 1.66 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.077 -177.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.3 p -160.63 164.41 31.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.662 0.267 . . . . 0.0 110.663 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' H ' ' A' ' 11' ' ' ILE . 0.7 OUTLIER -120.75 -113.25 0.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 175.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.9 OUTLIER 53.17 -110.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 122.953 0.501 . . . . 0.0 111.541 -178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.518 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -97.16 177.59 5.53 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' N ' ' CG ' ' A' ' 12' ' ' ASP . 12.2 t70 -67.29 77.18 0.15 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.768 0.794 . . . . 0.0 109.797 175.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.516 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 9.9 m-85 -97.5 140.89 31.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.805 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -105.39 135.09 19.39 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 8' ' ' THR . 41.0 Cg_endo -70.47 132.34 21.99 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.175 1.917 . . . . 0.0 111.137 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.89 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 6.7 m-85 -119.13 130.72 55.71 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.159 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.4 t -91.05 112.93 25.05 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.71 157.95 36.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.434 -174.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -80.53 111.27 16.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.272 0.558 . . . . 0.0 110.533 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -117.98 130.3 56.11 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.106 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.8 ptm -91.05 -176.2 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.9 -172.93 3.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.487 -178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 112.51 0.31 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.04 118.35 4.71 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.121 2.547 . . . . 0.0 112.961 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.49 -14.09 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.64 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.04 57.41 3.15 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.635 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 1.1 m -122.91 116.1 29.03 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 3.6 Cg_exo -75.24 78.15 3.03 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.215 2.61 . . . . 0.0 112.324 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.16 113.85 2.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.253 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.21 73.97 10.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.19 0.519 . . . . 0.0 109.779 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.64 91.37 4.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.504 -173.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -93.57 143.07 26.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.303 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -79.11 -77.09 0.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.949 0.404 . . . . 0.0 110.606 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.461 ' H ' HD12 ' A' ' 34' ' ' LEU . 4.6 mt -120.07 112.44 34.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.759 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 122.8 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.014 1.809 . . . . 0.0 111.925 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.93 7.5 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.869 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.85 111.89 19.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.456 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 mt -138.24 16.2 2.79 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.704 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.69 -2.17 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.63 18.07 2.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.39 . . . . 0.0 111.185 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 164.03 24.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.195 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.634 HD12 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.43 176.99 5.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.83 0.348 . . . . 0.0 110.758 -175.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.9 -60.22 0.12 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 175.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' ' HD2' ' A' ' 17' ' ' TYR . 4.1 m 63.29 179.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.742 0.782 . . . . 0.0 112.701 173.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.19 146.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.889 176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.87 122.1 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.067 0.461 . . . . 0.0 109.856 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 99.98 1.37 Allowed Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.208 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.14 126.14 23.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.89 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.126 0.489 . . . . 0.0 110.741 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.62 -17.18 12.28 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.061 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -89.44 162.9 15.5 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 3' ' ' THR . 6.7 mp0 -110.68 156.58 20.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.008 0.432 . . . . 0.0 111.113 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.37 137.85 47.52 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.01 -5.57 50.02 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.947 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -102.88 -105.77 0.27 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.519 -0.178 . . . . 0.0 110.519 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.89 147.08 49.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.551 0.215 . . . . 0.0 110.606 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.57 106.19 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.462 ' H ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -120.33 157.52 29.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.313 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 60.0 m -104.0 120.13 40.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.084 -177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.405 ' SG ' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -124.53 151.7 44.37 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.356 0.598 . . . . 0.0 110.868 -176.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -137.93 135.35 35.98 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.087 174.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB3' HG12 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -153.46 -170.64 3.66 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.082 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -106.37 38.36 2.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.232 0.539 . . . . 0.0 110.259 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 ' H ' ' A' ' 74' ' ' ILE . 3.1 p -103.32 129.24 55.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.404 0.621 . . . . 0.0 110.859 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 t -128.91 -174.06 3.15 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.23 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -117.58 130.66 56.54 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.209 0.528 . . . . 0.0 111.737 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -112.51 -6.32 13.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.059 171.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.61 43.89 0.25 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.1 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.16 170.48 9.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.734 0.302 . . . . 0.0 110.876 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -39.39 94.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 0.0 110.43 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.29 -174.18 1.65 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.519 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -85.91 155.56 20.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.879 ' H ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -132.74 114.43 22.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.971 176.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.634 HD11 HD12 ' A' ' 43' ' ' LEU . 4.3 pt -105.24 153.3 6.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.318 0.58 . . . . 0.0 111.189 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -94.52 -4.0 48.84 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.486 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.66 30.92 14.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.887 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.0 -38.31 82.49 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.762 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.4 m-80 -129.05 80.44 1.97 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.974 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.61 54.69 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.481 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 148.24 30.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.043 0.449 . . . . 0.0 111.149 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 117.852 -1.071 . . . . 0.0 109.169 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.65 0.262 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.45 99.99 11.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 120.876 0.369 . . . . 0.0 110.293 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 110.07 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 18' ' ' CYS . 3.6 mt -70.6 122.44 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.699 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.13 -161.38 9.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.769 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.36 -22.19 52.98 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.128 2.552 . . . . 0.0 113.075 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -102.14 5.87 40.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -92.34 -47.79 7.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 111.184 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 10.2 t -135.39 87.54 2.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.966 0.412 . . . . 0.0 110.9 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.0 -89.41 0.46 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.954 175.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 1.3 mt 54.5 -103.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 C-N-CA 122.934 0.494 . . . . 0.0 110.657 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 8.2 t70 -100.72 -113.59 0.18 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 174.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.438 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 24.3 t70 -121.06 66.43 0.86 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 167.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 2.5 m-85 -90.14 151.87 21.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.895 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 3.8 mtmt -102.14 127.46 30.76 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HG3' ' HB3' ' A' ' 9' ' ' CYS . 6.6 Cg_exo -72.8 136.19 24.91 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.543 2.162 . . . . 0.0 110.922 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -129.38 130.41 45.99 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.868 0.366 . . . . 0.0 110.255 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 4' ' ' ILE . 2.1 m -99.48 112.59 24.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.854 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.8 m -115.13 115.73 27.24 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.787 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.655 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 9.9 pt20 -80.46 117.22 21.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.568 0.699 . . . . 0.0 110.513 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.91 143.45 50.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.804 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.43 84.91 2.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 110.203 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -79.24 122.29 26.13 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.824 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.39 160.06 35.88 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.408 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.88 -19.91 26.52 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 123.012 2.475 . . . . 0.0 112.698 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.76 112.04 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.251 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 91.58 0.86 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.041 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.488 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -54.07 131.71 59.35 Favored Pre-proline 0 C--N 1.324 -0.534 0 C-N-CA 122.586 0.354 . . . . 0.0 111.51 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 7.5 Cg_exo -72.97 59.89 3.65 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.509 2.806 . . . . 0.0 112.52 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.52 82.81 0.43 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 121.18 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 111.077 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.92 143.22 31.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.992 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.86 31.07 3.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.256 0.551 . . . . 0.0 110.077 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.66 141.56 47.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.387 -178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.51 143.44 32.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.078 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.59 123.31 10.34 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 111.969 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.39 -1.74 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.643 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -79.07 111.56 15.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.297 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -3.85 58.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.006 0.431 . . . . 0.0 110.773 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.11 37.49 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.475 0.655 . . . . 0.0 109.51 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.16 79.75 5.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.266 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.53 -162.01 0.89 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.095 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' HG13 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -109.13 103.81 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.847 0.356 . . . . 0.0 111.13 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.29 82.11 1.49 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.766 ' HB2' HD11 ' A' ' 75' ' ' ILE . 1.8 m -134.9 168.27 19.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.516 0.198 . . . . 0.0 110.506 -177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.55 157.25 21.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.971 0.415 . . . . 0.0 110.819 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.64 143.46 14.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.079 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.14 106.92 3.02 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.899 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -71.55 133.86 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.733 0.301 . . . . 0.0 110.726 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 pt -71.22 140.69 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.8 -14.01 66.14 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.597 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -97.81 158.08 15.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -116.16 137.7 51.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 0.0 111.378 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 33.0 m -115.13 152.05 33.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.188 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -119.99 49.5 0.87 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.655 ' CB ' ' HA ' ' A' ' 20' ' ' GLN . . . -153.25 -135.43 0.06 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.584 0.23 . . . . 0.0 110.809 -176.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -107.41 122.49 46.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.077 0.465 . . . . 0.0 110.783 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.53 118.62 56.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.764 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -123.47 163.71 20.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.248 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 91.7 m -111.47 123.62 50.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 97.7 m -133.26 148.05 51.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.088 0.471 . . . . 0.0 111.192 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 2.4 tptm -130.35 140.49 50.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.698 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.6 p30 178.37 -177.29 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.877 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.06 116.13 28.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.179 0.514 . . . . 0.0 110.91 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.676 HG11 ' HA ' ' A' ' 73' ' ' LEU . 2.4 t -124.37 94.43 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.631 172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.27 141.27 30.57 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.152 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.34 89.89 4.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.476 0.655 . . . . 0.0 110.64 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.53 75.16 1.35 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.87 -74.61 0.29 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.235 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.68 119.0 22.01 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.61 -3.54 54.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.039 0.447 . . . . 0.0 110.663 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -99.07 148.32 24.16 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.676 ' HA ' HG11 ' A' ' 65' ' ' VAL . 2.0 mp -76.86 91.58 3.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.672 -176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -76.61 133.15 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.713 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -94.19 138.27 20.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.245 0.545 . . . . 0.0 111.069 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -85.13 -18.57 33.79 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HA ' ' SG ' ' A' ' 80' ' ' CYS . . . 66.44 24.23 10.43 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.655 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.83 -55.27 11.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.321 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 5.7 m-80 -114.71 90.56 3.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.691 177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.577 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 52.7 m -122.2 129.59 52.41 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.653 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 60' ' ' CYS . 0.9 OUTLIER -120.41 131.32 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.377 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.191 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.423 ' HB3' ' HG2' ' A' ' 53' ' ' GLN . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.94 108.71 13.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.857 0.36 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 3.2 m -79.6 119.04 22.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.664 HG23 HG21 ' A' ' 8' ' ' THR . 53.4 mt -68.82 119.22 14.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.879 -176.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.68 -179.19 30.81 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.116 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.455 ' HA ' HG12 ' A' ' 50' ' ' ILE . 57.2 Cg_endo -69.51 -38.93 7.63 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.063 2.509 . . . . 0.0 112.904 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.43 54.46 2.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.308 0.575 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.664 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -74.72 -55.29 6.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.483 -176.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -83.0 123.88 29.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.184 0.516 . . . . 0.0 111.159 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -22.87 43.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.612 0.72 . . . . 0.0 109.338 172.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.61 134.77 26.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.737 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.16 140.77 33.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.22 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.9 t70 69.79 48.68 0.56 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.026 0.829 . . . . 0.0 111.19 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.606 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 4.7 m-85 -135.47 150.96 49.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.933 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 26.5 mtmt -99.09 135.32 20.86 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 4.5 Cg_exo -77.44 140.23 19.06 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.784 2.323 . . . . 0.0 111.511 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.44 140.07 42.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.6 t -107.8 114.12 27.84 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.78 132.75 54.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.768 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -80.67 121.59 26.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.995 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.92 83.78 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 0.0 110.071 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.25 151.02 31.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.076 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.1 68.2 9.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.593 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.5 -158.44 10.07 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.187 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.72 113.33 2.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.072 2.515 . . . . 0.0 111.897 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.94 -24.05 19.39 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.667 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.62 119.66 3.39 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.01 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.88 89.85 35.02 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 120.713 0.292 . . . . 0.0 110.787 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.73 141.85 42.26 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.333 2.022 . . . . 0.0 111.622 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.98 28.78 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.4 tp -101.86 103.32 14.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 110.944 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mt -142.95 -157.9 0.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -106.64 98.04 7.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 173.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.04 114.07 15.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.058 0.456 . . . . 0.0 111.157 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.487 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -108.03 147.78 36.17 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.934 177.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HB3' HD21 ' A' ' 39' ' ' LEU . 34.7 Cg_exo -62.16 124.36 14.22 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.517 2.145 . . . . 0.0 112.236 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.37 -44.68 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.324 0.583 . . . . 0.0 110.055 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.4 125.46 34.59 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 36' ' ' PRO . 41.7 mt -116.5 162.13 18.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.581 0.229 . . . . 0.0 111.517 -173.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.83 55.88 4.38 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.443 176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.75 106.98 4.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.03 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -110.42 -170.12 1.59 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.029 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 43' ' ' LEU . 1.4 mm? -84.17 134.13 34.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.949 0.404 . . . . 0.0 110.686 -177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.1 91.07 0.32 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.4 m -138.43 179.4 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.69 ' HA ' HD12 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -119.07 153.95 21.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 175.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.562 HG23 HD13 ' A' ' 73' ' ' LEU . 96.4 t -61.64 127.84 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.074 0.464 . . . . 0.0 110.628 -177.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.5 76.51 2.08 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.773 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.477 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -71.45 146.63 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.76 0.314 . . . . 0.0 110.2 178.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 6' ' ' PRO . 2.2 mt -61.75 124.11 15.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.669 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.03 -11.56 20.26 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.477 ' OG ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -89.38 137.51 32.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.889 0.376 . . . . 0.0 110.74 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -96.74 115.46 27.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 21.7 t -107.25 108.04 19.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.88 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -93.87 36.01 3.93 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.974 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.03 -110.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.329 0.109 . . . . 0.0 110.839 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.92 125.88 43.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.538 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 t -107.33 127.35 63.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.03 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.87 170.28 16.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.306 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 57.7 m -116.2 136.9 52.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.789 0.328 . . . . 0.0 110.632 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.9 m -141.83 151.3 42.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.081 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -116.04 118.62 33.39 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.103 175.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -162.58 166.85 24.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.875 -173.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -105.59 70.02 0.86 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 73' ' ' LEU . 0.7 OUTLIER -76.58 1.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.424 0.63 . . . . 0.0 111.051 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.55 70.77 6.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.559 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -161.54 -171.32 2.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.137 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.23 108.18 12.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.001 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.66 150.96 18.61 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.751 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.97 119.17 22.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.412 0.148 . . . . 0.0 111.123 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 m 71.51 -59.24 0.55 Allowed 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.084 0.865 . . . . 0.0 111.929 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -139.49 -163.06 1.42 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.62 0.248 . . . . 0.0 110.564 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.721 ' HB3' HG21 ' A' ' 65' ' ' VAL . 7.1 mt -82.48 108.4 15.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.113 0.482 . . . . 0.0 111.628 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 65' ' ' VAL . 7.0 mm -84.84 116.7 28.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.4 mt -91.89 130.69 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 0.0 111.541 -170.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 63' ' ' ASP . 6.7 t-20 -72.23 106.87 4.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.06 56.74 1.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 111.673 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.64 -60.73 1.8 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.093 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 6.8 m-80 -111.39 103.8 12.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.008 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.5 m -135.94 132.49 36.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.005 0.431 . . . . 0.0 111.021 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.28 159.33 42.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.691 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.663 0.268 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.95 116.06 31.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.678 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 1.9 m -80.01 121.19 25.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -80.35 126.18 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.029 0.442 . . . . 0.0 111.53 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.92 169.69 14.68 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.727 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.66 -40.36 46.8 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.305 2.67 . . . . 0.0 112.395 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.23 67.21 0.79 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.487 178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.589 HG21 HG11 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -62.1 -45.06 95.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.43 132.07 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.782 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 71.42 6.33 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.215 0.531 . . . . 0.0 111.421 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -172.2 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.8 178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.35 -135.62 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.16 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.35 101.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.587 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 23.1 m-85 -146.53 150.62 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.568 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -116.26 135.48 22.84 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 177.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 7.3 Cg_exo -73.44 128.89 13.19 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.677 2.251 . . . . 0.0 111.646 177.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 75' ' ' ILE . 47.2 m-85 -123.74 146.49 48.26 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.9 t -96.66 112.74 24.37 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.9 m -124.61 151.49 44.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.994 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HA ' ' HB1' ' A' ' 56' ' ' ALA . 10.5 mp0 -80.84 141.51 34.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.861 0.362 . . . . 0.0 110.739 -176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.09 154.22 18.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.0 46.91 0.9 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.566 0.698 . . . . 0.0 109.751 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.91 73.19 6.69 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.285 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . -90.56 -118.25 1.99 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.864 176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 6.5 Cg_exo -74.31 82.93 1.76 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.192 2.595 . . . . 0.0 112.106 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.41 149.67 40.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.071 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.9 20.12 44.55 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.926 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.62 113.89 30.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.05 9.08 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.83 2.353 . . . . 0.0 112.993 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.15 54.85 0.55 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.093 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.86 -43.86 6.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.98 0.419 . . . . 0.0 110.254 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 mp 59.01 -161.61 0.26 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.207 -176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.55 62.26 0.38 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.105 0.479 . . . . 0.0 109.887 175.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -60.78 2.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.036 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -127.18 125.91 24.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -58.34 123.92 14.7 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.448 2.099 . . . . 0.0 112.259 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.52 99.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.846 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -102.37 142.84 32.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.941 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.75 34.67 2.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.318 0.58 . . . . 0.0 109.506 175.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.67 -9.39 20.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.59 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.83 11.06 39.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.875 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -142.12 107.41 5.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.991 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 45' ' ' CYS . 0.6 OUTLIER -128.44 124.37 36.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.423 0.63 . . . . 0.0 111.092 -178.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.17 83.88 0.35 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.636 ' SG ' HD12 ' A' ' 43' ' ' LEU . 24.4 m -127.35 173.09 10.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.251 0.548 . . . . 0.0 111.87 -172.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.97 158.82 19.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.641 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG13 ' HE3' ' A' ' 15' ' ' LYS . 23.5 t -63.98 129.05 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.41 132.91 17.09 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.088 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 2.5 t -87.92 114.45 26.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.891 0.377 . . . . 0.0 110.533 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -64.43 118.13 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.18 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.44 -14.89 35.77 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.73 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.487 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 49.6 m -102.87 164.44 11.62 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 120.772 0.32 . . . . 0.0 110.143 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.2 pt20 -108.92 149.07 29.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.089 0.471 . . . . 0.0 110.759 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.4 m -122.15 120.81 35.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.448 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.59 48.41 3.67 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' A' ' 20' ' ' GLN . . . -158.18 -133.98 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.95 145.18 41.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.975 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.589 HG11 HG21 ' A' ' 8' ' ' THR . 21.9 t -102.93 109.52 26.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 172.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.77 156.48 17.96 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.118 -174.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.27 105.26 12.35 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -124.36 137.85 54.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.195 0.521 . . . . 0.0 110.998 -176.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -119.2 123.65 44.84 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.632 175.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' A' ' 75' ' ' ILE . 22.7 t70 -178.68 155.75 0.84 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.764 177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.69 94.36 6.34 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.08 126.48 7.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.456 -177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 137.49 45.91 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.008 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -27.06 17.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.482 0.658 . . . . 0.0 110.126 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.25 86.48 5.01 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.681 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 165.48 -45.33 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -134.89 169.54 17.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.656 0.265 . . . . 0.0 110.792 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -19.22 63.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.412 -177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -124.25 169.07 12.12 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -65.62 105.5 1.24 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.552 178.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.55 140.55 15.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.988 0.423 . . . . 0.0 110.517 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -107.29 130.49 59.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.357 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -71.7 -13.2 61.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.727 0.298 . . . . 0.0 110.323 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . . . 59.49 28.8 18.27 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.653 176.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.82 82.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.395 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.823 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 2.9 m-80 -123.73 83.28 2.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.119 176.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 131.42 52.44 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.556 -176.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.01 148.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.504 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.747 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.669 0.271 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.06 136.65 35.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.667 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.16 137.03 40.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.803 -178.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.475 HD11 ' SG ' ' A' ' 54' ' ' CYS . 44.1 mt -82.53 123.75 38.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.961 0.41 . . . . 0.0 110.774 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.629 ' H ' HG23 ' A' ' 8' ' ' THR . . . -146.83 -178.93 22.55 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.68 -30.43 90.4 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.776 2.317 . . . . 0.0 112.093 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -114.3 62.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.511 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.629 HG23 ' H ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER -72.27 -65.94 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 -178.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.75 157.51 15.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.932 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -82.84 85.36 7.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.163 0.506 . . . . 0.0 111.314 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -144.03 -170.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.295 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.87 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.214 0.53 . . . . 0.0 110.732 178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.32 108.95 3.82 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.596 ' HB2' HD13 ' A' ' 11' ' ' ILE . 21.5 m-85 -132.58 156.41 46.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.359 -172.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -79.65 125.42 82.58 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.3 Cg_exo -76.59 125.46 8.28 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.789 2.326 . . . . 0.0 111.848 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 61' ' ' CYS . 93.7 m-85 -123.31 149.18 45.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -144.35 116.01 8.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.835 0.35 . . . . 0.0 110.468 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.02 175.09 10.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.374 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.66 137.66 37.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.68 0.276 . . . . 0.0 110.267 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -89.18 116.05 27.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.938 0.399 . . . . 0.0 109.933 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 7.3 mtm -78.16 106.17 9.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.432 -175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.39 143.42 26.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.203 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . 173.16 -131.83 2.19 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.421 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 2.9 Cg_exo -75.23 70.05 5.56 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.183 2.589 . . . . 0.0 112.291 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.93 -48.54 9.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.667 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.17 168.05 38.55 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.056 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -118.48 133.86 23.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.431 0.158 . . . . 0.0 110.598 -179.274 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 28.2 Cg_exo -61.98 107.65 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.187 2.591 . . . . 0.0 111.993 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.41 -140.37 9.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.284 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.6 mt -90.65 2.8 55.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.0 110.635 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -148.05 174.19 12.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.803 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -79.77 144.16 33.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.965 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.67 133.89 43.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.418 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -118.74 106.72 43.57 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.429 -179.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.96 124.31 10.48 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.505 2.137 . . . . 0.0 111.903 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -79.24 -27.96 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.086 0.469 . . . . 0.0 110.033 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -113.26 108.13 16.84 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.118 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 -49.16 11.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.942 -178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -165.91 55.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.39 -5.61 26.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.255 0.55 . . . . 0.0 110.422 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.423 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -114.41 109.47 18.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.159 176.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -138.34 110.45 7.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.059 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.0 112.87 2.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 173.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.1 t -153.97 178.33 10.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 m -122.05 158.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.72 125.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.56 135.61 41.78 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.118 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.43 98.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.953 0.406 . . . . 0.0 110.898 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.405 HG22 ' HA2' ' A' ' 5' ' ' GLY . 2.7 pt -60.49 120.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.415 177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.46 -8.02 26.42 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.957 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 m -116.93 154.22 31.23 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.802 0.334 . . . . 0.0 110.854 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 15.2 mt-30 -84.35 151.28 24.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.299 177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.475 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -136.27 106.63 6.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.093 -177.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.41 58.97 3.04 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.93 -166.59 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.08 95.75 6.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 0.0 110.619 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.67 135.52 25.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.175 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.17 155.15 45.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.956 0.408 . . . . 0.0 110.503 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 33.9 m -128.32 108.44 10.59 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 70.7 m -124.01 142.02 51.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.362 0.601 . . . . 0.0 112.037 -174.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -108.82 120.26 41.96 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.473 172.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' OD1' HG23 ' A' ' 65' ' ' VAL . 2.8 p30 -144.35 -170.5 3.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.167 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.24 50.02 1.62 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.444 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG23 ' OD1' ' A' ' 63' ' ' ASP . 51.5 t -61.84 124.84 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.068 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.72 119.57 35.87 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.358 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -79.9 100.25 7.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.252 0.549 . . . . 0.0 111.854 -174.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.1 m -79.43 -19.93 48.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.912 0.863 . . . . 0.0 109.81 174.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 143.52 53.22 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.413 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -111.49 139.65 46.74 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.87 -51.29 68.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.428 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.12 148.06 41.88 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.04 98.75 8.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.452 . . . . 0.0 111.488 -175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.46 ' H ' HG13 ' A' ' 74' ' ' ILE . 1.6 mt -69.18 126.16 28.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 77' ' ' ALA . 3.9 mt -92.33 146.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.227 0.537 . . . . 0.0 110.249 -174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -76.48 -0.48 23.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.281 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 64.42 -89.76 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.009 -175.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.04 -95.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.862 0.726 . . . . 0.0 111.496 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.611 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 19.4 m-80 -91.71 78.66 5.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.251 -176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.7 m -114.43 130.2 56.7 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.782 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -138.16 159.48 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.79 178.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.243 178.278 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.08 107.19 19.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.339 178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -79.05 125.46 29.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.0 0.429 . . . . 0.0 110.826 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' SG ' ' A' ' 54' ' ' CYS . 13.7 mt -80.53 95.06 2.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.368 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.41 171.08 17.05 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.78 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.77 -15.49 33.32 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 111.709 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 7' ' ' ASN . 4.2 m120 -107.49 46.81 0.92 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.918 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -64.8 0.88 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.534 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 128.88 52.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.843 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.43 79.25 9.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.915 0.388 . . . . 0.0 110.853 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -145.2 -162.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 11' ' ' ILE . 13.9 t0 -60.65 163.74 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.978 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -55.14 103.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.246 0.546 . . . . 0.0 111.158 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 62' ' ' LYS . 6.3 m-85 -121.8 165.99 15.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.075 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -112.84 137.61 21.86 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 175.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 3.4 Cg_exo -75.06 130.24 13.02 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.801 2.334 . . . . 0.0 111.31 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 40.1 m-85 -124.2 135.58 53.56 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.767 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.9 m -105.22 115.27 29.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.449 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.68 152.63 28.86 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.804 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -80.38 105.49 11.68 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.144 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -125.18 -25.49 3.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.985 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.428 ' HB3' ' H ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -96.61 -100.38 0.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.779 -178.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 22' ' ' MET . 0.7 OUTLIER -123.03 157.81 31.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.002 0.429 . . . . 0.0 111.116 -177.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.83 -151.56 22.75 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.996 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.92 112.55 2.05 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.757 2.305 . . . . 0.0 112.375 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.59 140.21 37.22 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.29 -57.44 1.37 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.671 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.1 m -140.4 130.74 13.7 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.583 0.23 . . . . 0.0 111.194 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.61 141.91 11.28 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.791 2.327 . . . . 0.0 111.997 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 62.91 3.34 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.379 -178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.06 -20.81 37.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.057 0.456 . . . . 0.0 111.068 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -91.1 -164.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.269 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -79.25 125.04 28.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.902 0.382 . . . . 0.0 110.28 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.91 132.11 43.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.493 175.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -93.08 139.29 23.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 36.0 Cg_exo -61.51 122.0 10.41 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.891 1.727 . . . . 0.0 110.848 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -179.34 147.86 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.541 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -119.55 131.08 55.46 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.25 -1.09 9.77 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.09 72.0 1.04 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 111.174 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.07 -8.81 59.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.195 0.522 . . . . 0.0 110.305 175.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.46 176.48 9.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.036 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 43' ' ' LEU . 0.9 OUTLIER -114.23 117.1 30.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.313 0.578 . . . . 0.0 111.341 -174.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.96 49.14 4.08 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 174.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 53.6 m -95.29 154.36 17.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.796 0.332 . . . . 0.0 110.797 -175.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.84 152.73 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.77 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.42 117.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.97 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.53 125.33 6.9 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.057 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' OG ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -77.07 125.16 36.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.01 127.11 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.01 -16.77 11.96 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.211 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.454 ' OG ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -97.69 165.06 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.783 0.325 . . . . 0.0 111.169 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -110.58 132.08 54.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.478 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -111.15 145.71 38.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.471 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.38 -11.1 46.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.495 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.23 -177.11 4.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.125 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 125.17 29.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.905 0.383 . . . . 0.0 110.519 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 3.9 t -97.11 120.15 46.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.49 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.902 ' HE3' ' HB2' ' A' ' 82' ' ' ALA . 14.6 mtpt -112.68 169.76 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.314 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.81 102.95 10.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 80' ' ' CYS . 2.9 m -132.22 161.09 34.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.504 0.669 . . . . 0.0 112.099 -172.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 14' ' ' TYR . 2.2 pttt -156.45 157.73 36.03 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.456 172.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.6 -173.2 2.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.422 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.06 69.26 10.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.366 0.603 . . . . 0.0 110.055 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.6 107.56 19.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.215 175.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.07 -75.58 0.27 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.414 0.626 . . . . 0.0 110.946 -177.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -149.19 147.43 28.42 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.075 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.58 120.14 7.99 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.289 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.78 46.9 3.19 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.121 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -121.85 175.12 6.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.27 -24.75 65.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.94 0.4 . . . . 0.0 111.531 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -160.22 152.72 20.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.004 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.494 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -112.23 125.13 53.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.043 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.46 136.47 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.373 0.606 . . . . 0.0 111.545 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 35.8 mm -98.1 119.06 45.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 78' ' ' ALA . 3.6 t30 -63.81 -24.96 67.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 76' ' ' ASN . . . 81.3 31.45 0.13 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.734 0.814 . . . . 0.0 111.166 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' HB2' ' ND2' ' A' ' 76' ' ' ASN . . . -74.44 -56.9 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.681 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.442 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -120.94 75.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.036 -179.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.614 ' SG ' ' HE2' ' A' ' 59' ' ' LYS . 18.3 t -134.79 130.32 35.94 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.02 152.56 36.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.379 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.902 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.312 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.66 0.267 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 m -84.18 121.69 27.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.923 0.392 . . . . 0.0 111.337 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -88.96 106.97 18.76 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.629 HD13 ' HA3' ' A' ' 48' ' ' GLY . 12.2 mt -82.75 130.25 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.316 0.579 . . . . 0.0 111.384 -173.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.677 ' HA2' HG23 ' A' ' 50' ' ' ILE . . . -133.06 -171.86 12.84 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.864 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.19 -27.64 48.73 Favored 'Trans proline' 0 CA--C 1.525 0.066 0 C-N-CA 122.539 2.159 . . . . 0.0 112.687 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -96.63 14.24 25.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.475 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 m -86.68 -22.58 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.254 0.55 . . . . 0.0 110.322 175.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 t -135.09 105.11 6.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.614 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.19 33.11 4.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.468 -174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -108.6 163.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.291 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.55 109.61 4.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.307 -173.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.7 27.44 15.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.32 175.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 11.2 m-85 -95.87 123.21 39.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.031 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 16.8 mttt -91.4 134.38 29.68 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.075 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.2 Cg_exo -70.45 137.81 34.26 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.636 2.224 . . . . 0.0 111.175 176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 21.5 m-85 -131.62 138.6 48.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.208 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -95.5 112.94 24.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 173.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 m -113.5 120.16 40.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.025 -175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 105.88 18.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.875 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.12 140.95 40.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.448 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.92 161.21 13.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.521 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.78 57.46 0.61 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.177 0.513 . . . . 0.0 110.585 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.82 -163.52 32.53 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.94 119.77 5.21 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.951 2.434 . . . . 0.0 111.856 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.08 -14.19 7.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.032 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.89 24.55 21.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.664 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.28 115.21 49.2 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 122.714 0.406 . . . . 0.0 111.434 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -92.66 94.34 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.316 2.677 . . . . 0.0 111.964 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.25 -35.23 0.54 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.932 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -99.63 103.81 15.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.066 0.46 . . . . 0.0 111.267 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -83.41 -3.23 57.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.356 0.598 . . . . 0.0 110.202 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -98.98 2.14 46.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.979 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -100.47 161.74 13.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 -179.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -104.48 159.31 29.74 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.002 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.97 124.62 15.29 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.366 2.044 . . . . 0.0 111.473 175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -74.65 -173.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 -179.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' H ' HG12 ' A' ' 37' ' ' VAL . 3.6 t0 -80.97 172.19 14.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.164 0.507 . . . . 0.0 110.851 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -45.56 9.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.521 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 p -172.34 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 70.98 -49.91 0.68 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.928 0.891 . . . . 0.0 112.311 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.464 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -126.94 167.83 15.34 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 122.358 -0.214 . . . . 0.0 110.58 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -150.52 141.97 23.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.929 171.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.12 88.56 0.53 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.643 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.89 ' HB2' HD11 ' A' ' 75' ' ' ILE . 36.3 m -141.52 165.78 26.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.08 152.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.12 133.57 30.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.345 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.629 ' HA3' HD13 ' A' ' 4' ' ' ILE . . . -70.4 89.78 0.36 Allowed Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.903 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.36 117.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.537 0.208 . . . . 0.0 110.486 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.677 HG23 ' HA2' ' A' ' 5' ' ' GLY . 3.3 mp -56.79 116.31 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.75 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.19 -9.5 17.88 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.833 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.01 165.85 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.78 0.324 . . . . 0.0 110.345 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' THR . 86.3 mt-30 -121.11 125.49 47.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.141 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 82.6 m -108.44 122.5 47.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.974 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.15 56.64 4.29 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.269 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.13 -165.81 1.8 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.6 136.21 35.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.747 0.308 . . . . 0.0 110.32 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 73.4 t -108.29 123.93 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.208 0.527 . . . . 0.0 110.796 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -130.22 171.15 13.19 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.12 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 95.6 m -114.78 120.53 40.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.97 0.414 . . . . 0.0 109.972 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.2 m -125.19 123.22 39.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.341 0.591 . . . . 0.0 111.586 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.848 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 23.1 tptt -88.2 90.69 8.49 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.44 130.42 44.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.518 177.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.4 52.65 0.86 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.129 0.49 . . . . 0.0 111.038 -172.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.18 128.29 33.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.949 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 p -84.96 146.49 27.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.86 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -91.45 97.73 11.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.558 0.694 . . . . 0.0 111.102 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.98 -24.9 12.76 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.534 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 57.75 0.2 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 113.665 -1.607 . . . . 0.0 109.67 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.19 97.31 7.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.383 -0.408 . . . . 0.0 111.212 -173.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.54 -35.58 45.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.672 0.749 . . . . 0.0 109.282 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.32 146.85 50.64 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.61 92.42 5.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.996 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.98 126.69 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.902 177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.89 HD11 ' HB2' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -92.9 136.51 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.79 -174.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -79.62 -9.74 59.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.774 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.59 36.5 13.67 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.523 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.08 -66.43 0.61 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.31 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.848 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 8.5 m-80 -122.5 85.05 2.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.881 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.3 m -114.99 130.26 56.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.042 0.449 . . . . 0.0 111.209 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.85 160.59 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.001 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.949 -179.532 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.692 0.282 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -86.46 126.76 34.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.809 0.338 . . . . 0.0 111.247 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -90.33 135.69 33.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.041 175.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.694 HG21 ' HA3' ' A' ' 48' ' ' GLY . 30.0 mt -91.21 130.86 39.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.186 0.517 . . . . 0.0 111.745 -176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.65 -170.07 40.85 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.16 -13.27 39.11 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.365 2.043 . . . . 0.0 111.701 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -78.92 -35.99 42.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.286 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -53.85 23.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.701 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.6 t -140.08 123.3 16.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.828 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.31 93.96 3.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.844 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -133.69 152.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -18.48 -89.25 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.204 1.402 . . . . 0.0 114.09 -174.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 21.4 t0 -119.87 47.88 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.575 0.702 . . . . 0.0 109.658 177.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.4 m-85 -108.84 119.47 39.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.84 -176.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -92.91 134.29 27.67 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.658 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 16.6 Cg_exo -68.76 125.61 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.612 2.208 . . . . 0.0 111.363 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 16.0 m-85 -114.35 144.97 42.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.097 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' SG ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -106.77 113.62 27.22 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 176.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.35 120.27 37.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.865 177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 56' ' ' ALA . 17.8 mt-30 -82.03 103.96 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.96 28.9 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.906 -174.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -113.02 -65.38 1.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.215 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -108.23 135.37 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.39 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.93 -138.78 5.37 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.083 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.16 -4.2 14.12 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.689 2.259 . . . . 0.0 112.975 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.24 152.89 30.59 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.592 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.97 -122.84 1.16 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.972 -0.632 . . . . 0.0 111.607 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.597 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 2.0 m -71.0 -53.47 8.44 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.597 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 83.6 Cg_endo -86.66 154.74 8.92 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.796 1.664 . . . . 0.0 112.232 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.73 108.72 3.59 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.24 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.39 -174.54 3.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.863 0.363 . . . . 0.0 110.935 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.35 175.57 9.29 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.873 -179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -84.16 175.18 9.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -69.99 -16.55 63.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.425 0.631 . . . . 0.0 110.419 178.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.43 131.87 23.64 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.022 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.78 124.7 16.88 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.771 2.314 . . . . 0.0 112.077 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.82 129.33 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.381 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.5 118.02 35.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.577 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.27 24.55 8.02 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -100.09 -39.33 8.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.94 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.19 -57.85 7.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.001 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 76' ' ' ASN . 2.1 m -123.27 -162.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.518 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.715 HD23 ' HB2' ' A' ' 77' ' ' ALA . 1.6 mm? -112.03 113.62 26.02 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.938 0.399 . . . . 0.0 110.951 -176.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.542 ' HA2' HD12 ' A' ' 74' ' ' ILE . . . -83.79 66.64 3.87 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.08 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 43' ' ' LEU . 1.8 m -121.14 162.08 20.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.84 153.34 21.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -65.27 137.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.796 -178.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.694 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -75.87 119.72 5.78 Favored Glycine 0 N--CA 1.438 -1.221 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.667 178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -68.86 108.88 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.92 0.39 . . . . 0.0 110.602 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 2.4 mp -54.43 118.29 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.181 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.26 -0.16 29.7 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.415 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.77 151.51 43.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 7.6 mt-30 -79.98 162.29 24.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 157.41 44.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.102 177.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.24 43.97 1.25 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 20' ' ' GLN . . . -142.25 -172.03 3.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.854 -0.173 . . . . 0.0 110.56 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 104.8 12.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.873 0.368 . . . . 0.0 110.452 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 30.6 m -88.97 144.03 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.155 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 6.5 ptpt -157.33 171.55 20.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.483 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -110.5 122.06 46.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.973 0.416 . . . . 0.0 110.271 -177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 47.6 m -127.72 136.62 51.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.423 0.63 . . . . 0.0 111.755 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -115.53 136.03 53.48 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 169.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.836 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.2 t70 -157.18 177.1 11.87 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -102.07 27.77 6.35 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.446 0.641 . . . . 0.0 109.952 -177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.836 HG23 ' HB3' ' A' ' 63' ' ' ASP . 6.4 t -72.63 128.6 35.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.903 -178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.668 HG23 ' H ' ' A' ' 68' ' ' THR . 12.8 t -118.02 -175.12 2.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.112 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.1 -14.31 59.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.974 0.416 . . . . 0.0 111.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.668 ' H ' HG23 ' A' ' 66' ' ' THR . 0.3 OUTLIER -80.85 70.11 7.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -163.77 -77.66 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.908 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.28 170.71 15.32 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.59 -24.64 61.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.258 0.551 . . . . 0.0 110.154 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CZ ' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -107.2 142.97 36.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 47' ' ' VAL . 66.6 mt -78.92 92.91 4.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.034 0.445 . . . . 0.0 110.578 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.542 HD12 ' HA2' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -74.29 125.91 34.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.901 177.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 137.3 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.988 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.553 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 64.7 t30 -80.72 -4.95 56.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 43' ' ' LEU . . . 64.56 26.92 13.36 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.625 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.72 87.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 0.6 OUTLIER -130.27 75.25 1.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.665 177.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 77' ' ' ALA . 9.5 m -113.85 130.2 56.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.651 0.263 . . . . 0.0 110.359 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.11 159.72 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.894 0.378 . . . . 0.0 110.958 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.371 178.168 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 99.86 10.78 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.45 126.92 31.81 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 176.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.625 HG21 ' HA3' ' A' ' 48' ' ' GLY . 25.7 mt -96.35 115.81 36.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.055 0.455 . . . . 0.0 111.646 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.4 -170.93 17.49 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.218 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HD3' HG12 ' A' ' 50' ' ' ILE . 47.1 Cg_endo -68.26 -23.24 39.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.714 2.276 . . . . 0.0 112.164 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -84.23 -13.09 53.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.396 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -82.05 -53.69 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.872 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -152.65 105.01 2.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 111.175 -177.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.4 m -152.81 74.05 1.03 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.346 0.593 . . . . 0.0 109.586 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.618 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -94.59 -151.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.909 179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -66.3 94.42 0.26 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.872 0.367 . . . . 0.0 111.05 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 t0 54.5 37.3 27.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.039 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.618 ' HD2' ' HB ' ' A' ' 11' ' ' ILE . 6.2 m-85 -111.04 123.72 50.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.742 -176.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -104.97 149.6 37.76 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.944 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 6.2 Cg_exo -77.33 138.73 18.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.88 2.387 . . . . 0.0 112.252 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' OH ' ' HB3' ' A' ' 64' ' ' ASP . 16.6 m-85 -126.31 145.06 50.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.225 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.1 t -96.74 112.94 24.48 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.21 141.99 18.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.068 0.461 . . . . 0.0 110.758 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -112.79 114.07 26.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 176.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 82.09 7.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.376 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -134.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.287 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 148.82 32.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.486 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 25' ' ' PRO . . . 175.37 -120.34 0.76 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.213 -0.518 . . . . 0.0 111.927 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 7.2 Cg_exo -73.17 89.16 0.92 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 123.289 2.659 . . . . 0.0 112.159 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -147.5 84.94 1.57 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.02 42.44 99.73 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.644 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -66.87 130.93 93.92 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.919 -177.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 13.1 Cg_exo -70.62 58.93 2.01 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.279 2.653 . . . . 0.0 112.416 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.79 36.75 0.2 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -85.47 -19.23 31.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.929 0.395 . . . . 0.0 110.436 -177.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 pp -92.35 -17.63 24.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.457 176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -79.44 -25.17 42.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.763 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.22 177.94 5.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.373 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.03 101.56 53.54 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.8 123.79 8.74 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.38 2.053 . . . . 0.0 111.925 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.3 -56.26 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.404 0.621 . . . . 0.0 109.422 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -161.03 162.62 31.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.113 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.38 -40.49 30.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 178.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.67 57.58 4.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.944 -178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.51 52.32 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.992 0.425 . . . . 0.0 110.834 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -150.24 92.97 1.93 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.656 0.265 . . . . 0.0 111.416 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -132.44 103.34 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 0.0 110.281 175.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.21 98.99 0.65 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -153.55 -174.73 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.52 154.01 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.135 0.493 . . . . 0.0 111.851 -170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.97 144.49 14.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.638 179.201 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.625 ' HA3' HG21 ' A' ' 4' ' ' ILE . . . -87.61 95.28 2.06 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.47 HG23 ' OG ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -63.87 127.12 23.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.718 0.294 . . . . 0.0 110.512 179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.494 HG12 ' HD3' ' A' ' 6' ' ' PRO . 1.7 mp -56.82 121.97 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.568 -173.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.11 -7.18 27.12 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.47 ' OG ' HG23 ' A' ' 49' ' ' VAL . 1.6 m -98.88 156.28 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.523 0.202 . . . . 0.0 110.577 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.57 154.56 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 m -134.19 145.51 49.28 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.054 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.08 -10.45 80.57 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.52 -174.68 4.43 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.725 -0.737 . . . . 0.0 110.123 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -92.83 160.34 14.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.757 0.313 . . . . 0.0 110.415 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.55 128.62 53.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.033 0.444 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.03 153.85 26.23 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.46 106.36 14.82 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -121.49 148.17 44.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.452 0.644 . . . . 0.0 111.486 -173.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.9 tttp -137.82 141.01 40.82 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.759 176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB2' HD22 ' A' ' 79' ' ' ASN . 0.2 OUTLIER 80.81 78.77 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.799 1.312 . . . . 0.0 109.271 -170.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.31 -109.34 0.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.194 -174.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.504 ' H ' ' HB2' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -107.82 134.66 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 111.121 -176.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -59.78 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.866 0.841 . . . . 0.0 110.255 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -115.59 139.45 50.08 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.639 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 51.8 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.15 0.5 . . . . 0.0 111.279 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.08 42.16 3.04 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.704 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -148.14 165.08 31.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -58.49 3.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.252 0.549 . . . . 0.0 110.504 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -103.59 170.81 7.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.216 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.437 HD13 HG22 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -70.83 131.47 43.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.946 0.403 . . . . 0.0 111.177 -178.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.3 mt -118.3 133.43 65.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.012 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -102.93 142.16 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.284 -179.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -87.98 8.43 26.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.734 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.87 -124.6 1.34 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.976 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 69.38 -67.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.057 0.543 . . . . 0.0 111.377 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 1.2 m-80 -116.28 102.3 9.45 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.45 130.86 16.65 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.602 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.01 159.75 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.036 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.066 178.083 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.972 0.415 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.15 110.36 21.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -79.2 120.17 23.32 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.551 HD12 ' HA3' ' A' ' 48' ' ' GLY . 6.0 mt -83.66 128.42 38.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.589 -176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 176.15 33.69 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.639 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.15 -32.7 94.18 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.901 2.401 . . . . 0.0 112.093 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.07 87.92 1.85 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.779 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -36.68 82.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.121 177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -103.39 156.16 17.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.95 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.41 51.59 1.47 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.529 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.49 ' HB ' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -123.26 151.79 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.441 178.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.6 115.6 14.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.07 72.17 0.54 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.269 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.655 ' CE2' ' HB2' ' A' ' 62' ' ' LYS . 4.3 m-85 -125.9 141.58 51.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.242 177.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 11.4 mtmt -90.84 124.28 62.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.617 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 2.8 Cg_exo -76.03 139.27 21.54 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.089 2.526 . . . . 0.0 111.771 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -127.11 143.62 51.23 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.393 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -92.06 112.26 24.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 172.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 59' ' ' LYS . 98.4 m -119.34 125.07 48.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.993 0.425 . . . . 0.0 111.16 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.526 ' HB3' HE21 ' A' ' 20' ' ' GLN . 0.0 OUTLIER -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -107.48 -12.86 15.21 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.555 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 83.05 6.22 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.756 0.789 . . . . 0.0 110.529 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -11.05 32.72 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.286 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.62 149.51 5.02 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.372 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.84 121.17 9.51 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.716 2.277 . . . . 0.0 112.172 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.43 37.09 3.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.043 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.99 26.09 25.8 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -66.05 125.39 90.0 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 122.679 0.392 . . . . 0.0 111.029 -178.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 2.8 Cg_exo -76.56 40.6 0.79 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.322 2.681 . . . . 0.0 112.507 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.8 21.11 37.18 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.51 80.62 6.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.903 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.06 -11.68 35.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.619 0.723 . . . . 0.0 109.086 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -110.2 128.01 55.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.815 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 34' ' ' LEU . 9.2 tp -77.08 84.62 3.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.113 0.482 . . . . 0.0 111.826 -174.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.88 94.14 48.87 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.18 124.32 14.98 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.722 2.281 . . . . 0.0 112.08 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.88 117.59 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.296 0.57 . . . . 0.0 110.967 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.28 148.44 46.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.072 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.84 21.4 4.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.168 0.508 . . . . 0.0 109.959 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -18.59 44.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.389 -174.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.23 6.16 35.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.896 0.379 . . . . 0.0 111.052 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -133.49 92.83 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.598 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 75' ' ' ILE . 1.0 OUTLIER -117.68 103.91 10.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.364 0.602 . . . . 0.0 111.049 -177.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.71 94.56 0.57 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.171 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.591 ' HB2' HD11 ' A' ' 75' ' ' ILE . 80.1 m -136.53 177.79 7.57 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.877 0.37 . . . . 0.0 110.801 -177.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.13 148.77 23.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.906 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 141.64 17.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.967 0.413 . . . . 0.0 110.589 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 4' ' ' ILE . . . -86.72 136.42 14.04 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.195 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 52' ' ' SER . 22.0 t -80.32 113.95 20.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.441 ' O ' HG13 ' A' ' 50' ' ' ILE . 29.7 pt -62.9 115.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 0.0 110.635 -176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.01 -12.11 34.39 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.963 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 71.0 m -102.78 170.19 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.671 0.272 . . . . 0.0 110.773 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -106.15 140.97 38.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.108 0.48 . . . . 0.0 110.858 -177.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -127.18 124.04 38.09 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.385 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.12 52.96 3.76 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.07 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.19 178.27 9.93 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 m -87.68 124.63 33.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.011 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.01 130.57 35.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.218 -176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HG3' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -120.3 163.64 17.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.489 176.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.5 117.1 27.53 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -126.47 133.04 51.3 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.51 0.671 . . . . 0.0 111.646 -176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.655 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 7.6 ttpt -106.99 118.39 36.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.431 170.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.66 175.13 4.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.66 -174.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -124.0 105.06 9.28 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.064 0.459 . . . . 0.0 110.733 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -69.82 115.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.485 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.99 94.29 6.47 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.332 0.587 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -79.76 86.88 5.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.6 0.714 . . . . 0.0 110.659 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.1 t -125.17 52.58 1.58 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.618 0.723 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.28 31.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -140.2 148.74 41.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.36 -17.11 20.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.37 155.95 26.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -82.98 94.06 7.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tp -74.49 132.01 34.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.086 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.591 HD11 ' HB2' ' A' ' 45' ' ' CYS . 2.4 mt -92.48 135.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -18.45 65.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.662 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' H ' HG22 ' A' ' 75' ' ' ILE . . . 56.16 37.81 29.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.877 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.57 -52.57 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 10.2 m-80 -123.87 81.02 1.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.312 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 65.7 m -116.4 129.92 56.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.271 0.558 . . . . 0.0 110.891 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.2 159.89 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.324 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.32 179.743 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.9 m -79.41 117.77 20.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.966 0.413 . . . . 0.0 110.621 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.56 115.14 25.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 mt -68.79 110.93 2.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.156 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 152.94 44.36 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.921 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HA ' HG21 ' A' ' 50' ' ' ILE . 12.4 Cg_endo -56.45 -37.86 96.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 112.256 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.04 75.24 0.94 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.69 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -42.64 59.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.956 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.4 m -126.87 145.16 50.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 m -97.88 69.62 2.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.191 0.52 . . . . 0.0 110.459 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 -145.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.012 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -80.09 -164.68 0.71 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.177 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.48 97.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.677 . . . . 0.0 109.785 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HE1' ' O ' ' A' ' 79' ' ' ASN . 9.1 m-85 -125.98 145.3 50.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.995 -178.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.667 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -100.83 131.2 23.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.133 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 38.3 Cg_endo -71.15 130.49 17.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.331 2.021 . . . . 0.0 110.696 171.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.667 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 7.4 m-85 -114.7 139.78 49.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.8 0.334 . . . . 0.0 110.954 -175.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.3 t -94.04 113.03 24.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.0 t -146.88 158.86 44.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.622 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -141.26 106.1 4.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.315 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.29 72.4 9.35 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.836 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -117.47 150.58 38.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.16 175.04 10.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.646 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.87 -110.79 3.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.189 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.25 64.46 4.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.975 2.45 . . . . 0.0 112.867 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.79 87.0 7.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 0.0 110.382 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 159.89 -94.31 0.13 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.738 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.75 142.15 98.05 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.68 0.276 . . . . 0.0 110.74 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.0 123.05 10.75 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.783 2.322 . . . . 0.0 112.891 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.24 -0.01 89.43 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.822 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 mt 61.63 50.69 4.33 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.057 0.543 . . . . 0.0 111.393 177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.84 -178.89 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.922 176.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -141.47 -171.93 3.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.926 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -84.7 -80.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.6 mt -129.06 111.22 18.37 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.81 124.19 11.61 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.702 2.268 . . . . 0.0 111.929 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 39' ' ' LEU . 4.8 t -103.23 114.28 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.49 32.29 0.57 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.925 0.393 . . . . 0.0 111.008 -175.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.549 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -79.69 -5.98 56.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.648 -174.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -78.8 11.9 2.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.198 0.523 . . . . 0.0 110.958 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.01 -22.23 45.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.365 175.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 m -108.24 -166.69 1.15 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.405 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 75' ' ' ILE . 2.7 mm? -109.83 125.81 53.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.904 0.383 . . . . 0.0 110.935 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.44 66.98 0.56 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.993 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB2' HD11 ' A' ' 75' ' ' ILE . 77.3 m -134.25 171.75 13.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.466 0.174 . . . . 0.0 111.053 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG23 ' HG ' ' A' ' 73' ' ' LEU . 1.7 p -118.71 165.76 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -171.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.0 t -69.15 136.31 26.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.725 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.47 132.84 11.26 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.34 136.79 24.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.091 0.472 . . . . 0.0 111.092 -177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 6' ' ' PRO . 1.1 pt -73.76 147.62 9.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.36 12.55 79.99 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.588 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.02 152.4 47.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.707 0.289 . . . . 0.0 110.309 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -88.6 145.86 25.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.255 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.27 124.58 20.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.902 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.88 54.0 4.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.728 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.4 -163.73 1.24 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.76 147.73 22.77 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 7.7 t -111.37 120.67 62.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -108.66 169.23 8.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.827 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -119.47 105.86 11.67 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.5 m -129.08 139.28 52.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.482 0.658 . . . . 0.0 112.009 -172.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 2.6 tptt -121.19 121.14 37.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.786 -1.097 . . . . 0.0 108.157 169.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.53 171.42 14.49 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.841 0.353 . . . . 0.0 111.233 -177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.77 63.88 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.595 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.13 107.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.218 177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.78 171.15 8.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.025 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -87.89 49.38 1.79 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.143 0.497 . . . . 0.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.83 -12.57 60.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.308 -177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 93.8 1.14 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.883 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -152.82 153.11 32.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.72 0.295 . . . . 0.0 110.728 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -46.45 21.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.479 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -135.96 164.15 28.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.191 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -80.95 122.16 26.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.911 0.386 . . . . 0.0 110.964 -177.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.48 145.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.057 177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.685 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.49 124.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.282 0.563 . . . . 0.0 110.81 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -84.37 -3.72 58.46 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.109 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 62.91 32.9 15.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.664 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.19 -54.72 29.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 3.0 m-80 -127.23 78.08 1.79 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 6.4 m -117.05 130.34 56.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.952 0.406 . . . . 0.0 111.143 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -134.07 160.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.321 178.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 81' ' ' VAL . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.257 0.973 . . . . 0.0 111.052 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 m -89.03 108.64 19.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.311 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.83 113.36 17.93 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.031 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 8' ' ' THR . 29.8 mt -70.7 109.56 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.602 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.93 -173.17 30.36 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.981 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 50' ' ' ILE . 93.6 Cg_endo -83.72 8.03 4.85 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.979 2.453 . . . . 0.0 113.452 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.33 36.12 3.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.201 0.524 . . . . 0.0 110.169 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -70.09 -48.17 58.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.368 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' HD12 ' A' ' 11' ' ' ILE . 70.9 m -92.91 124.35 36.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.15 -176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.94 17.82 2.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.582 0.706 . . . . 0.0 110.684 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.531 ' HB ' ' HD2' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -122.92 159.95 26.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.937 177.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HB3' ' H ' ' A' ' 13' ' ' ASP . 4.8 t0 -69.52 -89.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 12' ' ' ASP . 5.5 t70 -84.46 79.21 9.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.351 0.596 . . . . 0.0 111.213 -173.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.684 ' HB3' ' HB3' ' A' ' 60' ' ' CYS . 20.9 m-85 -144.71 138.98 27.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.573 ' HG3' ' HE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -106.83 138.9 19.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.908 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 15' ' ' LYS . 11.5 Cg_exo -70.85 133.62 23.94 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.743 2.295 . . . . 0.0 111.53 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 33.0 m-85 -126.17 135.49 51.71 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.049 178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 4' ' ' ILE . 1.3 m -91.37 112.01 23.74 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 95.7 m -115.13 127.73 55.76 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.894 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.14 113.34 22.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.436 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -45.53 85.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.7 0.762 . . . . 0.0 109.666 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.0 ttt -136.78 130.03 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.259 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -12.79 59.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.231 0.538 . . . . 0.0 110.516 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.74 -163.54 13.15 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.508 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.5 0.9 9.33 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.806 2.337 . . . . 0.0 112.323 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.79 178.14 5.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.979 -178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.38 -177.14 20.6 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.204 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.0 m 57.68 78.74 0.35 Allowed Pre-proline 0 N--CA 1.464 0.231 0 C-N-CA 122.844 0.458 . . . . 0.0 111.613 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -82.64 146.37 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.296 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.55 73.04 0.45 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.64 -51.22 3.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.087 0.47 . . . . 0.0 110.908 -174.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.78 170.34 15.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.521 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -79.47 78.65 5.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.37 0.605 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.32 134.0 53.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.244 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -109.82 149.9 40.6 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.283 -179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.85 124.37 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.524 2.149 . . . . 0.0 111.975 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 t -109.76 -33.51 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.559 0.695 . . . . 0.0 109.686 177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.63 154.55 36.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.956 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.84 -149.63 0.44 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.876 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.52 45.43 0.58 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.66 -34.4 9.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.645 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 m -107.87 176.33 5.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.826 ' HB3' HD12 ' A' ' 75' ' ' ILE . 3.6 mm? -104.74 130.88 52.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.049 0.452 . . . . 0.0 111.015 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.75 65.3 0.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HB2' HD11 ' A' ' 75' ' ' ILE . 20.8 m -119.37 172.19 7.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.73 158.16 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.027 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -68.57 127.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.368 0.604 . . . . 0.0 111.4 -176.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 4' ' ' ILE . . . -96.08 77.77 0.77 Allowed Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.25 151.29 7.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 6' ' ' PRO . 3.9 mp -56.65 126.85 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.985 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.68 10.69 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.033 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.7 143.74 34.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.738 0.304 . . . . 0.0 110.626 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -99.37 143.07 30.05 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.66 136.09 50.17 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.955 0.407 . . . . 0.0 111.14 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.46 17.13 43.82 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.9 -171.73 2.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.401 -0.399 . . . . 0.0 110.285 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 110.94 15.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.78 125.46 42.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -131.06 168.93 16.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.015 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 43.7 m -106.56 118.98 38.08 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 m -121.62 154.54 36.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.042 0.449 . . . . 0.0 110.866 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 2.2 tptm -151.0 135.25 16.85 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.04 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 178.74 -176.72 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.293 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -90.56 96.63 10.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -96.72 100.33 10.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 -160.79 0.8 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.079 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -83.25 58.6 4.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.373 0.606 . . . . 0.0 111.37 -173.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.05 25.85 3.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.549 0.69 . . . . 0.0 109.926 175.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.17 84.4 1.43 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.285 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -79.15 119.54 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.3 m 72.28 -50.66 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.811 0.694 . . . . 0.0 111.184 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -150.01 166.43 29.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.666 0.269 . . . . 0.0 110.296 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.526 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -89.12 107.95 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.153 -177.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.1 139.81 19.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -111.84 134.7 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.316 0.579 . . . . 0.0 111.281 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.03 139.48 36.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.643 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 51.78 2.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.073 0.463 . . . . 0.0 111.4 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -99.53 -71.83 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.4 ' O ' ' HE1' ' A' ' 14' ' ' TYR . 10.2 m-80 -102.73 70.01 1.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.565 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 54.6 m -118.16 128.69 54.96 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.037 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.83 159.78 18.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.567 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.567 179.991 . . . . . . . . 0 0 . 1 stop_ save_